<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Mobile phone text messaging for medication adherence in secondary prevention of cardiovascular disease - Redfern, J - 2024 | Cochrane Library</title> <meta content="Mobile phone text messaging for medication adherence in secondary prevention of cardiovascular disease - Redfern, J - 2024 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011851.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Mobile phone text messaging for medication adherence in secondary prevention of cardiovascular disease - Redfern, J - 2024 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011851.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD011851.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Mobile phone text messaging for medication adherence in secondary prevention of cardiovascular disease" name="citation_title"/> <meta content="Julie Redfern&lt;sup&gt;a&lt;/sup&gt;" name="citation_author"/> <meta content="julie.redfern@sydney.edu.au" name="citation_author_email"/> <meta content="Qiang Tu&lt;sup&gt;a&lt;/sup&gt;" name="citation_author"/> <meta content="The University of Sydney" name="citation_author_institution"/> <meta content="Karice Hyun" name="citation_author"/> <meta content="Matthew A Hollings" name="citation_author"/> <meta content="The University of Sydney" name="citation_author_institution"/> <meta content="Nashid Hafiz" name="citation_author"/> <meta content="The University of Sydney" name="citation_author_institution"/> <meta content="Clara Zwack" name="citation_author"/> <meta content="The University of Sydney" name="citation_author_institution"/> <meta content="Caroline Free" name="citation_author"/> <meta content="London School of Hygiene and Tropical Medicine" name="citation_author_institution"/> <meta content="Pablo Perel" name="citation_author"/> <meta content="London School of Hygiene and Tropical Medicine" name="citation_author_institution"/> <meta content="Clara K Chow" name="citation_author"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="3" name="citation_issue"/> <meta content="10.1002/14651858.CD011851.pub3" name="citation_doi"/> <meta content="2024" name="citation_date"/> <meta content="2024/03/27" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011851.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011851.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011851.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Bias; *Cardiovascular Diseases [prevention &amp; control]; *Cell Phone; *Medication Adherence; Myocardial Infarction [prevention &amp; control]; *Randomized Controlled Trials as Topic; Reminder Systems; *Secondary Prevention [methods]; Stroke [prevention &amp; control]; *Text Messaging" name="citation_keywords"/> <meta content="" name="citation_fulltext_world_readable"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011851.pub3&amp;doi=10.1002/14651858.CD011851.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011851.pub3&amp;doi=10.1002/14651858.CD011851.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011851.pub3&amp;doi=10.1002/14651858.CD011851.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011851.pub3&amp;doi=10.1002/14651858.CD011851.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011851.pub3&amp;doi=10.1002/14651858.CD011851.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011851.pub3&amp;doi=10.1002/14651858.CD011851.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011851.pub3&amp;doi=10.1002/14651858.CD011851.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011851.pub3&amp;doi=10.1002/14651858.CD011851.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011851.pub3&amp;doi=10.1002/14651858.CD011851.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011851.pub3&amp;doi=10.1002/14651858.CD011851.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011851.pub3&amp;doi=10.1002/14651858.CD011851.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011851.pub3&amp;doi=10.1002/14651858.CD011851.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011851.pub3&amp;doi=10.1002/14651858.CD011851.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011851.pub3&amp;doi=10.1002/14651858.CD011851.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011851.pub3&amp;doi=10.1002/14651858.CD011851.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011851.pub3&amp;doi=10.1002/14651858.CD011851.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011851.pub3&amp;doi=10.1002/14651858.CD011851.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011851.pub3&amp;doi=10.1002/14651858.CD011851.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011851.pub3&amp;doi=10.1002/14651858.CD011851.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011851.pub3&amp;doi=10.1002/14651858.CD011851.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011851.pub3&amp;doi=10.1002/14651858.CD011851.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011851.pub3&amp;doi=10.1002/14651858.CD011851.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011851.pub3&amp;doi=10.1002/14651858.CD011851.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="UiM8QuvV";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD011851\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD011851\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011851\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011851\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","zh_HANS","zh_HANT","ko","ms","id","fa","fr","pl"],languageCode:"en",accessStatus:"open-access",doi:"10.1002/14651858.CD011851.pub3",title:"Mobile phone text messaging for medication adherence in secondary prevention of cardiovascular disease",firstPublishedDate:"Mar 27, 2024 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Heart Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=UiM8QuvV&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011851.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011851.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD011851.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD011851.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011851.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD011851.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;id&quot;,&quot;title&quot;:&quot;Saripati tinjauan sistematik&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD011851.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD011851.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD011851.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD011851.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>2724 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD011851.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011851.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011851.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011851.pub3/full#CD011851-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011851.pub3/full#CD011851-sec-0083"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011851.pub3/full#CD011851-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011851.pub3/full#CD011851-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011851.pub3/full#CD011851-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011851.pub3/full#CD011851-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011851.pub3/full#CD011851-sec-0039"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011851.pub3/full#CD011851-sec-0077"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011851.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011851.pub3/appendices#CD011851-sec-0089"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011851.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011851.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/supinfo/CD011851-dataPackage.zip?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/supinfo/CD011851-dataPackage.zip?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011851.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011851.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011851.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011851.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011851.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD011851.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2024 The Authors. Cochrane Database of Systematic Reviews published by John Wiley &amp; Sons, Ltd. on behalf of The Cochrane Collaboration." data-creative-commons="true" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Mobile phone text messaging for medication adherence in secondary prevention of cardiovascular disease </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author custom-tooltip" title="These authors should be considered joint first author."><a href="/cdsr/doi/10.1002/14651858.CD011851.pub3/information#CD011851-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Julie Redfern</a><sup>a</sup></li> <li class="author custom-tooltip" title="These authors should be considered joint first author."><a href="/cdsr/doi/10.1002/14651858.CD011851.pub3/information#CD011851-cr-0005">Qiang Tu</a><sup>a</sup></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011851.pub3/information#CD011851-cr-0006">Karice Hyun</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011851.pub3/information#CD011851-cr-0007">Matthew A Hollings</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011851.pub3/information#CD011851-cr-0008">Nashid Hafiz</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011851.pub3/information#CD011851-cr-0009">Clara Zwack</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011851.pub3/information#CD011851-cr-0010">Caroline Free</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011851.pub3/information#CD011851-cr-0011">Pablo Perel</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011851.pub3/information#CD011851-cr-0012">Clara K Chow</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/information/en#CD011851-sec-0103">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 27 March 2024 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD011851.pub3">https://doi.org/10.1002/14651858.CD011851.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD011851-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011851-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011851-abs-0016">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011851-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD011851-abs-0013">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD011851-abs-0007">한국어</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011851-abs-0004">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD011851-abs-0001" lang="en"> <section id="CD011851-sec-0001"> <h3 class="title" id="CD011851-sec-0001">Background</h3> <p>Cardiovascular diseases (CVDs) are the leading cause of death globally, accounting for almost 18 million deaths annually. People with CVDs have a five times greater chance of suffering a recurrent cardiovascular event than people without known CVDs. Although drug interventions have been shown to be cost‐effective in reducing the risk of recurrent cardiovascular events, adherence to medication remains suboptimal. As a scalable and cost‐effective approach, mobile phone text messaging presents an opportunity to convey health information, deliver electronic reminders, and encourage behaviour change. However, it is uncertain whether text messaging can improve medication adherence and clinical outcomes. This is an update of a Cochrane review published in 2017. </p> </section> <section id="CD011851-sec-0002"> <h3 class="title" id="CD011851-sec-0002">Objectives</h3> <p>To evaluate the benefits and harms of mobile phone text messaging for improving medication adherence in people with CVDs compared to usual care. </p> </section> <section id="CD011851-sec-0003"> <h3 class="title" id="CD011851-sec-0003">Search methods</h3> <p>We searched CENTRAL, MEDLINE, Embase, four other databases, and two trial registers. We also checked the reference lists of all primary included studies and relevant systematic reviews and meta‐analyses. The date of the latest search was 30 August 2023. </p> </section> <section id="CD011851-sec-0004"> <h3 class="title" id="CD011851-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials (RCTs) with participants with established arterial occlusive events. We included trials investigating interventions using short message service (SMS) or multimedia messaging service (MMS) with the aim of improving adherence to medication for the secondary prevention of cardiovascular events. The comparator was usual care. We excluded cluster‐RCTs and quasi‐RCTs. </p> </section> <section id="CD011851-sec-0005"> <h3 class="title" id="CD011851-sec-0005">Data collection and analysis</h3> <p>We used standard Cochrane methods. Our primary outcomes were medication adherence, fatal cardiovascular events, non‐fatal cardiovascular events, and combined CVD event. Secondary outcomes were low‐density lipoprotein cholesterol for the effect of statins, blood pressure for antihypertensive drugs, heart rate for the effect of beta‐blockers, urinary 11‐dehydrothromboxane B2 for the antiplatelet effects of aspirin, adverse effects, and patient‐reported experience. We used GRADE to assess the certainty of the evidence for each outcome. </p> </section> <section id="CD011851-sec-0006"> <h3 class="title" id="CD011851-sec-0006">Main results</h3> <p>We included 18 RCTs involving a total of 8136 participants with CVDs. We identified 11 new studies in the review update and seven studies in the previous version of the review. Participants had various CVDs including acute coronary syndrome, coronary heart disease, stroke, myocardial infarction, and angina. All studies were conducted in middle‐ and high‐income countries, with no studies conducted in low‐income countries. The mean age of participants was 53 to 64 years. Participants were recruited from hospitals or cardiac rehabilitation facilities. Follow‐up ranged from one to 12 months. There was variation in the characteristics of text messages amongst studies (e.g. delivery method, frequency, theoretical grounding, content used, personalisation, and directionality). The content of text messages varied across studies, but generally included medication reminders and healthy lifestyle information such as diet, physical activity, and weight loss. Text messages offered advice, motivation, social support, and health education to promote behaviour changes and regular medication‐taking. </p> <p>We assessed risk of bias for all studies as high, as all studies had at least one domain at unclear or high risk of bias. </p> <p><b>Medication adherence</b> </p> <p>Due to different evaluation score systems and inconsistent definitions applied for the measurement of medication adherence, we did not conduct meta‐analysis for medication adherence. Ten out of 18 studies showed a beneficial effect of mobile phone text messaging for medication adherence compared to usual care, whereas the other eight studies showed either a reduction or no difference in medication adherence with text messaging compared to usual care. Overall, the evidence is very uncertain about the effects of mobile phone text messaging for medication adherence when compared to usual care. </p> <p><b>Fatal cardiovascular events</b> </p> <p>Text messaging may have little to no effect on fatal cardiovascular events compared to usual care (odds ratio 0.83, 95% confidence interval (CI) 0.47 to 1.45; 4 studies, 1654 participants; low‐certainty evidence). </p> <p><b>Non‐fatal cardiovascular events</b> </p> <p>We found very low‐certainty evidence that text messaging may have little to no effect on non‐fatal cardiovascular events. Two studies reported non‐fatal cardiovascular events, neither of which found evidence of a difference between groups. </p> <p><b>Combined CVD events</b> </p> <p>We found very low‐certainty evidence that text messaging may have little to no effect on combined CVD events. Only one study reported combined CVD events, and did not find evidence of a difference between groups. </p> <p><b>Low‐density lipoprotein cholesterol</b> </p> <p>Text messaging may have little to no effect on low‐density lipoprotein cholesterol compared to usual care (mean difference (MD) −1.79 mg/dL, 95% CI −4.71 to 1.12; 8 studies, 4983 participants; very low‐certainty evidence). </p> <p><b>Blood pressure</b> </p> <p>Text messaging may have little to no effect on systolic blood pressure (MD −0.93 mmHg, 95% CI −3.55 to 1.69; 8 studies, 5173 participants; very low‐certainty evidence) and diastolic blood pressure (MD −1.00 mmHg, 95% CI −2.49 to 0.50; 5 studies, 3137 participants; very low‐certainty evidence) when compared to usual care. </p> <p><b>Heart rate</b> </p> <p>Text messaging may have little to no effect on heart rate compared to usual care (MD −0.46 beats per minute, 95% CI −1.74 to 0.82; 4 studies, 2946 participants; very low‐certainty evidence). </p> </section> <section id="CD011851-sec-0007"> <h3 class="title" id="CD011851-sec-0007">Authors' conclusions</h3> <p>Due to limited evidence, we are uncertain if text messaging reduces medication adherence, fatal and non‐fatal cardiovascular events, and combined cardiovascular events in people with cardiovascular diseases when compared to usual care. Furthermore, text messaging may result in little or no effect on low‐density lipoprotein cholesterol, blood pressure, and heart rate compared to usual care. The included studies were of low methodological quality, and no studies assessed the effects of text messaging in low‐income countries or beyond the 12‐month follow‐up. Long‐term and high‐quality randomised trials are needed, particularly in low‐income countries. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD011851-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011851-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD011851-abs-0003">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD011851-abs-0017">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011851-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD011851-abs-0014">Français</a> </li> <li class="section-language"> <a class="" href="full/id#CD011851-abs-0010">Bahasa Indonesia</a> </li> <li class="section-language"> <a class="" href="full/ko#CD011851-abs-0008">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD011851-abs-0009">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD011851-abs-0015">Polski</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011851-abs-0005">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD011851-abs-0006">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD011851-abs-0002" lang="en"> <h3>Can text message reminders help people with heart disease take their medications regularly?</h3> <p><b>Key messages</b> </p> <p>Due to a lack of strong evidence, the benefits of text messaging for medication adherence, fatal cardiovascular events (death from heart disease), non‐fatal cardiovascular events (heart complications or stroke), combined cardiovascular events (death from heart disease, heart complications, or stroke), cholesterol, blood pressure, and heart rate are unclear. </p> <p>Larger and well‐designed studies are needed to measure the longer‐term effects of text messaging on improving medication adherence in people with heart disease, particularly in low‐income countries. </p> <p><b>Why is this review important?</b> </p> <p>At least 523 million people suffer from heart disease worldwide. Medicines are often prescribed to treat the condition. However, the majority of people do not take the medications they need to keep them from having more heart problems. One possible method to improve medication‐taking behaviours is by using text message‐based reminders. Mobile phone text messaging may help people with heart disease take their medications by sending health information and text reminders to these people. However, it is still unclear whether text messaging can help people with heart disease take their medications regularly. </p> <p><b>What did we want to find out?</b> </p> <p>We wanted to find out if text messaging was effective in improving medication adherence in people with heart disease compared to people who did not receive text messages. We were also interested in the effects of text messaging on fatal cardiovascular events (death from heart disease), non‐fatal cardiovascular events (heart complications or stroke), combined cardiovascular events (death from heart disease, heart complications, or stroke), blood pressure, cholesterol, and heart rate. </p> <p><b>What did we do?</b> </p> <p>We searched medical databases for studies looking at the effects of mobile phone text messaging on medication adherence in people with heart disease. </p> <p><b>What did we find?</b> </p> <p>We found 18 studies involving 8136 people with heart disease. The studies took place in 11 countries. All studies compared using text messages to not using text messages. </p> <p><b>Main results</b> </p> <p>All studies took place in middle‐ and high‐income countries, with no studies being performed in low‐income countries. People had various types of heart diseases and were on average 53 to 64 years old. Most people came from hospitals or cardiac rehabilitation facilities. Studies lasted for one to 12 months. The delivery method and frequency of text messages differed amongst studies. Some studies sent text messages customised to patient characteristics and allowed people to reply to the messages. The content of text messages also varied across studies. Generally, text messages included medication reminders and healthy lifestyle information such as diet, physical activity, and weight loss. </p> <p>The studies used different ways of measuring and definitions of medication adherence, which prevented us from combining the findings of the studies for this outcome. As a result, the combined effects of text messaging on medication adherence are unknown. Of the 18 included studies, 10 studies showed that text messaging was effective in improving medication adherence. The other eight studies showed either a reduction or no difference in medication adherence compared to those people who did not receive text messages. Given that results on medication adherence differed across studies, we are not sure if text messaging can improve medication adherence. </p> <p>We found that text messaging may make little to no difference to fatal cardiovascular events (death from heart disease). In addition, we are very uncertain whether using text messaging can reduce blood pressure, cholesterol, heart rate, non‐fatal cardiovascular events (heart complications or stroke), and combined cardiovascular events (death from heart disease, heart complications, or stroke) compared with people who did not receive text messages. Two studies reported non‐fatal cardiovascular events, with neither study finding evidence of difference between groups. Only one study reported combined cardiovascular events, and found no evidence of a difference between groups. </p> <p><b>What are the limitations of the evidence?</b> </p> <p>Our confidence in the evidence is low to very low. Three main factors reduced our confidence in the evidence. Firstly, the research methods that the studies used were not of the best quality. It is possible that people in the studies were aware of which treatment they were getting, which could have influenced the results. Also, not all studies provided data about everything that we were interested in. Secondly, the content and delivery method of text messages differed across studies. Thirdly, results were very inconsistent across the different studies, and there were not enough studies to be certain about the results of our outcomes. </p> <p><b>How up‐to‐date is this evidence?</b> </p> <p>This review updates our previous review. The evidence is current to August 2023.</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD011851-sec-0083" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD011851-sec-0083"></div> <h3 class="title" id="CD011851-sec-0084">Implications for practice</h3> <section id="CD011851-sec-0084"> <p>Overall, this review suggests that the current evidence for the use of text messaging in people with cardiovascular disease (CVD) is of low or very low certainty. Half of the included studies (10/18) showed that text messaging interventions improved medication adherence. The remaining eight studies showed that text messaging resulted in either a reduction or no difference in medication adherence when compared with usual care. Due to the heterogeneous nature of study outcomes, we could not conduct meta‐analysis for medication adherence. Consequently, there is insufficient evidence to determine the effects of text messaging on medication adherence for people with CVD. </p> <p>Due to limited evidence, we are uncertain if text messaging reduces fatal and non‐fatal cardiovascular events, and combined cardiovascular events in people with CVD when compared to usual care. Furthermore, there may be little to no impact of text messaging on low‐density lipoprotein cholesterol, blood pressure, and heart rate for people with CVD. The findings of this review therefore cannot provide important implications for practices, and further evaluation is warranted. </p> </section> <h3 class="title" id="CD011851-sec-0085">Implications for research</h3> <section id="CD011851-sec-0085"> <p>The results of the review update should be interpreted with caution, as pooling of the results may be influenced by methodological and clinical heterogeneity. More large‐scale, theory‐based randomised trials that are adequately powered and of high quality are therefore needed to provide more precise estimates of the effect of interventions. Future studies should synthesise data from high‐quality studies in order to provide stronger evidence. </p> <p>Given that the effectiveness of text messaging may be strongly influenced by the context in which it is applied, the need to perform process evaluation and qualitative studies to enhance contextual understanding of randomised controlled trial findings and identify the individual and organisational‐level factors affecting the implementation, adoption, and effectiveness of interventions is highlighted. There is a lack of evidence from low‐income countries, as all of the included studies were conducted in middle‐ and high‐income countries. More research should be conducted in low‐income countries to bridge the knowledge gap and to assess whether text messaging is beneficial in that setting. No studies included in our review update investigated the long‐term effects (&gt; 12 months) of text messaging. Given that in most cases lifelong adherence to medications is required, a long‐term sustainability (&gt; 12 months) of text messaging should be explored in future studies. The findings of high utility, feasibility, and satisfaction for the delivery of text messaging are encouraging for future studies of mobile text messaging to support secondary prevention goals. </p> <p>We were unable to perform subgroup analysis (e.g. directionality of text messaging, personalisation, intervention modality) in this updated review due to insufficient data. Whilst there has been growing research in this area, there are still a lot of unsolved questions. This review identified that large variability exists with regard to the content of text messages. It suggests that future reviews should carry out content analysis of text messages to ascertain the optimal content of text messages. In addition, seven out of 18 studies did not specify if text messages were designed based on a theoretical approach or framework (e.g. behavioural change techniques or psychological theories). Consequently, there is a need for improvement in intervention design through incorporation of theory‐based tailoring strategies to address medication non‐adherence. Furthermore, future reviews need to explore the optimal frequency and timing of intervention delivery and use process evaluations to assess the mechanisms by which messages have an effect. In future studies, the form of text messaging might be changed into graphics, video, or audio that is delivered via multimedia messaging services. Future studies should therefore provide sufficient detailed description of the intervention to allow identification of the effective intervention components and to enable rigorous evaluations to be performed. In the future development of text messaging interventions, a wide range of factors influencing adherence that may be amenable to change needs to be fully considered. In addition, cost‐effectiveness of text messaging was seldom evaluated amongst the included studies; in future studies, cost efficiency should be considered. </p> <p>We found that substantial variability exists with regard to the definition of medication adherence and methods of adherence assessment across studies, making it difficult to group studies for comprehensive comparison. The vast majority of the studies evaluating medication adherence were reliant on participants’ self‐report and subjective measurement, which are subject to recall bias and social desirability bias. It is therefore of particular importance that standardised and objective approaches to quantify medication adherence (e.g. development of free and validated scores, pill counts or prescription refill rates) are used to improve comparability of outcome measures across studies for a more reliable and rigorous assessment of the effectiveness of text messaging for CVD. Although there is a lack of high‐quality evidence of supporting the intervention effects in this review update, the high number of ongoing studies indicate that the evidence will continue to evolve over time. Consequently, we recommend that review updates be performed regularly to provide nuanced insight and exert new evidence to guide policy and research. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD011851-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD011851-sec-0008"></div> <div class="table" id="CD011851-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Mobile phone text messaging compared to usual care for medication adherence in secondary prevention of cardiovascular disease</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p>Mobile phone text messaging compared to usual care for medication adherence in secondary prevention of cardiovascular disease </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with established arterial occlusive events<br/><b>Setting:</b> hospital/cardiac rehabilitation facility<br/><b>Intervention:</b> mobile phone text messaging<br/><b>Comparison:</b> usual care </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>No. of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with usual care</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with text messaging interventions</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Medication adherence</b> (self‐reported adherence, questionnaire, tablet counts, medication event monitoring systems, pharmacy prescription data) </p> <p>Follow‐up: range 1 to 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>10 out of 18 studies showed a beneficial effect of text messaging on medication adherence compared to usual care. The other 8 studies showed that text messaging resulted in either a reduction or no difference in medication adherence when compared with usual care. </p> <p>Of the 10 studies showing beneficial effects, 4 studies found that text messaging improved the proportion of participants who took medications as prescribed (RR 1.10, RR 1.14, OR 0.43, and OR 0.37, respectively). 3 studies found an improved medication adherence score with text messaging (MD varied from 0.54 to 1.50). 2 studies found that text messaging reduced the risk of being low adherent (RR 4.09) or non‐adherent (OR 0.34). 1 study found that text messaging improved the percentage of correct doses taken by 12.0% (P = 0.02) and percentage of prescribed doses taken on schedule by 9.7% (P = 0.01). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8136<br/>(18 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low<sup>a,b,c</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Fatal cardiovascular events</b> (percentage of people having fatal cardiovascular events) </p> <p>Follow‐up: range 1 to 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.83 (0.47 to 1.45)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1654</p> <p>(4 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝</p> <p><b>Low<sup>a,c</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>36 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>30 per 1000</b> </p> <p>(17 to 52)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Non‐fatal cardiovascular events</b> (percentage of people having non‐fatal cardiovascular events) </p> <p>Follow‐up: range 1 to 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>2 studies reported non‐fatal cardiovascular events, neither of which reported a difference between groups. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low<sup>a,b,c</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Combined CVD events</b> (percentage of people having combined CVD events) </p> <p>Follow‐up: range 1 to 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>1 study reported combined CVD events and found no difference between groups.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low<sup>a,b,c</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Low‐density lipoprotein cholesterol (mg/dL)</b> </p> <p>(endpoint low‐density lipoprotein cholesterol reading)</p> <p>Follow‐up: range 1 to 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean low‐density lipoprotein cholesterol score ranged across the control groups from <b>73.47 to 99.3</b>. </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean low‐density lipoprotein cholesterol score in the intervention groups was, on average, <b>1.79 lower</b> (95% CI −4.71 to 1.12). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4983</p> <p>(8 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low<sup>a,b,c</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Blood pressure (mmHg)</b> (endpoint blood pressure reading) </p> <p>Follow‐up: range 1 to 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Systolic blood pressure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>5173</p> <p>(8 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low<sup>a,b,c</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean systolic blood pressure score ranged across the control groups from <b>121.0 to 136.0</b>. </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean systolic blood pressure score in the intervention groups was, on average, <b>0.93 lower</b> (95% CI −3.55 to 1.69). </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Diastolic blood pressure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>3137</p> <p>(5 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low<sup>a,b,c</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean diastolic blood pressure score ranged across the control groups from <b>72.2 to 84.0</b>. </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean diastolic blood pressure score in the intervention groups was, on average, <b>1.00 lower</b> (95% CI −2.49 to 0.50). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Heart rate (beats per minute)</b> (endpoint heart rate reading) </p> <p>Follow‐up: range 1 to 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean heart rate score ranged across the control groups from <b>67.0 to 69.0</b>. </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean heart rate score in the intervention groups was, on average, <b>0.46 lower</b> (95% CI −1.74 to 0.82). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2946</p> <p>(4 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low<sup>a,b,c</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Abbreviations: CI:</b> confidence interval; <b>CVD:</b> cardiovascular disease; <b>MD:</b> mean difference; <b>OR:</b> odds ratio; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for risk of bias: most trials were at unclear or high risk of bias for multiple domains.<br/><sup>b</sup>Downgraded one level for inconsistency: trial results included large variations in the degree to which the outcome was affected, or substantial heterogeneity (e.g. varying characteristics of the intervention and the comparators, diverse measurement methods, and various definitions of medication adherence).<br/><sup>c</sup>Downgraded one level for imprecision: very few events, or wide CIs encompassing intervention benefit and harm. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD011851-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD011851-sec-0009"></div> <section id="CD011851-sec-0010"> <h3 class="title" id="CD011851-sec-0010">Description of the condition</h3> <p>Worldwide, there are an estimated 17.9 million deaths due to cardiovascular disease (CVD) each year, with over three‐quarters of associated deaths occurring in low‐ and middle‐income countries (<a href="./references#CD011851-bbs2-0107" title="World Health Organization. Cardiovascular diseases (CVDs). www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds) (accessed 30 August 2023).">WHO 2023</a>). It is estimated that approximately three times as many people will suffer non‐fatal cardiovascular events, and that each year 35 million people have an acute coronary or cerebrovascular event. Worldwide, approximately 523 million people are thought to have prevalent CVD (<a href="./references#CD011851-bbs2-0082" title="NieuwlaatR , SchwalmJD , KhatibR , YusufS . Why are we failing to implement effective therapies in cardiovascular disease. European Heart Journal2013;34(17):1262-9. [DOI: 10.1093/eurheartj/ehs481]">Nieuwlaat 2013</a>; <a href="./references#CD011851-bbs2-0088" title="PerelP , AvezumA , HuffmanM , PaisP , RodgersA , VedanthanR , et al. Reducing premature cardiovascular morbidity and mortality in people with atherosclerotic vascular disease: the World Heart Federation roadmap for secondary prevention of cardiovascular disease. Global Heart2015;10(2):99-110. [DOI: 10.1016/j.gheart.2015.04.003]">Perel 2015</a>; <a href="./references#CD011851-bbs2-0094" title="RothGA , MensahGA , JohnsonCO , AddoloratoG , AmmiratiE , BaddourLM , et al. Global burden of cardiovascular diseases and risk factors, 1990–2019. Journal of the American College of Cardiology2020;76(25):2982-3021. [DOI: 10.1016/j.jacc.2020.11.010]">Roth 2020</a>). This population has a five times greater chance of suffering a new cardiovascular event than people without known CVD (<a href="./references#CD011851-bbs2-0077" title="KerrAJ , BroadJ , WellsS , RiddellT , JacksonR . Should the first priority in cardiovascular risk management be those with prior cardiovascular disease. Heart2009;95(2):125-9. [DOI: 10.1136/hrt.2007.140905]">Kerr 2009</a>). </p> </section> <section id="CD011851-sec-0011"> <h3 class="title" id="CD011851-sec-0011">Description of the intervention</h3> <p>Secondary CVD prevention is defined as health care aimed at preventing recurrent cardiovascular events in people diagnosed with CVD (<a href="./references#CD011851-bbs2-0088" title="PerelP , AvezumA , HuffmanM , PaisP , RodgersA , VedanthanR , et al. Reducing premature cardiovascular morbidity and mortality in people with atherosclerotic vascular disease: the World Heart Federation roadmap for secondary prevention of cardiovascular disease. Global Heart2015;10(2):99-110. [DOI: 10.1016/j.gheart.2015.04.003]">Perel 2015</a>). It is widely recommended by international guidelines that effective secondary prevention strategies for CVD include appropriate treatments with evidence‐based medications and comprehensive management of risk factors (<a href="./references#CD011851-bbs2-0101" title="TaylorRS , FredericksS , JonesI , NeubeckL , SandersJ , StoutzND , et al. Global perspectives on heart disease rehabilitation and secondary prevention: a scientific statement from the Association of Cardiovascular Nursing and Allied Professions, European Association of Preventive Cardiology, and International Council of Cardiovascular Prevention and Rehabilitation. European Heart Journal2023;44(28):2515-25. [DOI: 10.1093/eurheartj/ehad225]">Taylor 2023</a>). The use of evidence‐based medication, such as antiplatelet therapy, angiotensin‐converting enzyme (ACE) inhibitors/angiotensin receptor blockers (ARBs), beta‐blockers, and statins, has been shown to be a cost‐effective intervention for the prevention of fatal and non‐fatal cardiovascular events in people with established atherosclerotic cardiovascular diseases (<a href="./references#CD011851-bbs2-0088" title="PerelP , AvezumA , HuffmanM , PaisP , RodgersA , VedanthanR , et al. Reducing premature cardiovascular morbidity and mortality in people with atherosclerotic vascular disease: the World Heart Federation roadmap for secondary prevention of cardiovascular disease. Global Heart2015;10(2):99-110. [DOI: 10.1016/j.gheart.2015.04.003]">Perel 2015</a>). </p> <p>Unfortunately, there is a well‐documented knowledge‐practice gap in the implementation of these proven cost‐effective interventions. For example, the Prospective Urban Rural Epidemiology (PURE) study reported that in low‐ and middle‐income countries, up to 75% of people with known CVD are not using even one recommended medication (<a href="./references#CD011851-bbs2-0111" title="YusufS , IslamS , ChowCK , RangarajanS , DaenaisG , DiazR , et al. Use of secondary prevention drugs for cardiovascular disease in the community in high income, middle-income and low income countries (the PURE study): a prospective epidemiological survey. Lancet2011;378:1231-43. [DOI: 10.1016/S0140-6736(11)61215-4]">Yusuf 2011</a>). Even in high‐income countries, adherence to recommended treatments remains suboptimal. A systematic review showed that amongst people diagnosed with hypertension, 83.7% of people with uncontrolled blood pressure were not adherent to their prescribed antihypertensive medications (<a href="./references#CD011851-bbs2-0046" title="AbegazTM , ShehabA , GebreyohannesEA , BhagavathulaAS , ElnourAA . Nonadherence to antihypertensive drugs: a systematic review and meta-analysis. Medicine2017;96(4):e5641. [DOI: 10.1097/MD.0000000000005641]">Abegaz 2017</a>). Adherence to statin medication was low as well, with approximately 33% to 50% of people discontinuing statin medication within one year (<a href="./references#CD011851-bbs2-0054" title="BosworthHB , NgouyomboB , LiskaJ , ZulligLL , AtlaniC , BealAC . The importance of cholesterol medication adherence: the need for behavioral change intervention programs. Patient Preference and Adherence2018;12:341-8. [DOI: 10.2147/PPA.S153766]">Bosworth 2018</a>). </p> <p>It has been shown that a considerable proportion of cardiovascular events could be attributed to poor adherence to medication, with 9% of cardiovascular events in Europe attributed to poor adherence to medication (<a href="./references#CD011851-bbs2-0055" title="ChowdhuryR , KhanH , HeydonE , ShroufiA , FahimiS , MooreC , et al. Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences. European Heart Journal2013;34(38):2940-8. [DOI: 10.1093/eurheartj/eht295]">Chowdhury 2013</a>). It is estimated that good adherence to medication may be associated with a 20% lower risk of CVD and a 35% reduction in all‐cause mortality (<a href="./references#CD011851-bbs2-0055" title="ChowdhuryR , KhanH , HeydonE , ShroufiA , FahimiS , MooreC , et al. Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences. European Heart Journal2013;34(38):2940-8. [DOI: 10.1093/eurheartj/eht295]">Chowdhury 2013</a>). This evidence–practice gap might be influenced by different factors, including health system issues such as lack of accessibility and affordability; treatment complexity; or patients' non‐compliance with recommendations (<a href="./references#CD011851-bbs2-0082" title="NieuwlaatR , SchwalmJD , KhatibR , YusufS . Why are we failing to implement effective therapies in cardiovascular disease. European Heart Journal2013;34(17):1262-9. [DOI: 10.1093/eurheartj/ehs481]">Nieuwlaat 2013</a>).In order to influence non‐compliance, there is a need to develop behaviour change interventions. However, a Cochrane review showed that traditional behaviour change interventions to improve medication adherence are complex and not very effective, which indicates a need for convenient and feasible innovations to improve patient adherence to medication (<a href="./references#CD011851-bbs2-0083" title="NieuwlaatR , WilczynskiN , NavarroT , HobsonN , JefferyR , KeepanasserilA , et al. Interventions for enhancing medication adherence. Cochrane Database of Systematic Reviews2014, Issue 11. Art. No: CD000011. [DOI: 10.1002/14651858.CD000011.pub4]">Nieuwlaat 2014</a>). </p> <p>The widespread ownership of mobile phones and the possibility of automation leads to a potential to deliver behaviour change interventions to large numbers of people at low cost. The global number of mobile phone subscribers is estimated at 8600 million (<a href="./references#CD011851-bbs2-0098" title="Statista. Number of mobile (cellular) subscriptions worldwide from 1993 to 2021. www.statista.com/statistics/262950/global-mobile-subscriptions-since-1993 (accessed 30 August 2022).">Statista 2022</a>). Even in low‐ and middle‐income countries, the penetration rate of mobile phones is over 90% (<a href="./references#CD011851-bbs2-0065" title="FerozA , JabeenR , SaleemS . Using mobile phones to improve community health workers performance in low-and-middle-income countries. BMC Public Health2020;20(49):1-6. [DOI: 10.1186/s12889-020-8173-3]">Feroz 2020</a>). As a basic function of the mobile phone, short message services (SMS) are increasingly being used worldwide for communications. There has been an emergence of studies investigating if medication adherence could be improved by sending messages as reminders for medication‐taking. </p> </section> <section id="CD011851-sec-0012"> <h3 class="title" id="CD011851-sec-0012">How the intervention might work</h3> <p>Mobile phone text messaging has been shown to improve medication adherence for a variety of conditions, including HIV, asthma, and mental illness (<a href="./references#CD011851-bbs2-0062" title="DongJ , ReevesL , AliA , FreemanMK , AdunlinG . A systematic review of the effectiveness of text message reminders on asthma medication adherence. Innovations in Pharmacy2018;9(3):1-7. [DOI: 10.24926/iip.v9i3.1370]">Dong 2018</a>; <a href="./references#CD011851-bbs2-0075" title="IbenemeSC , NdukwuSC , MyezwaH , IremFO , EzenwankwoFE , AjidahunAT , et al. Effectiveness of mobile text reminder in improving adherence to medication, physical exercise, and quality of life in patients living with HIV: a systematic review. BMC Infectious Diseases2021;21(1):859. [DOI: 10.1186/s12879-021-06563-0]">Ibeneme 2021</a>; <a href="./references#CD011851-bbs2-0097" title="SimonE , EdwardsAM , SajatovicM , JainN , MontoyaJL , LevinJB . Systematic literature review of text messaging interventions to promote medication adherence among people with serious mental illness. Psychiatric Services2022;73(10):1153-64. [DOI: 10.1176/appi.ps.202100634]">Simon 2022</a>). The development of messages should follow some theoretical framework, and text messages should be developed specifically for the target population and intervention (<a href="./references#CD011851-bbs2-0080" title="MacPhersonMM , CranstonKD , LockeSR , BourneJE , JungME . Using the behavior change wheel to develop text messages to promote diet and physical activity adherence following a diabetes prevention program. Translational Behavioral Medicine2021;11(8):1585-95. [DOI: 10.1093/tbm/ibab058]">MacPherson 2021</a>). Text messages as an intervention are relatively cost‐effective and quick, and do not require that the intended audience search for information, as it is delivered to them (<a href="./references#CD011851-bbs2-0108" title="WillemsR , AnnemansL , SiopisG , MoschonisG , VedanthanR , JungJ , et al. Cost effectiveness review of text messaging, smartphone application, and website interventions targeting T2DM or hypertension. NPJ Digital Medicine2023;6(150):1-15. [DOI: 10.1038/s41746-023-00876-x]">Willems 2023</a>). Two previous systematic reviews addressed the question of using mobile phones for all types of medication adherence (<a href="./references#CD011851-bbs2-0051" title="Anglada-MartinezH , Riu-ViladomsG , Martin-CondeM , Rovira-IllamolaM , Sotoca-MomblonaJM , Codina-JaneC . Does mHealth increase adherence to medication? Results of a systematic review. International Journal of Clinical Practice2015;69(1):9-32. [DOI: 10.1111/ijcp.12582]">Anglada‐Martinez 2015</a>; <a href="./references#CD011851-bbs2-0086" title="ParkLG , Howie-EsquivelJ , DracupK . A quantitative systematic review of the efficacy of mobile phone interventions to improve medication adherence. Journal of Advanced Nursing2014;70(9):1932-53. [DOI: 10.1111/jan.12400]">Park 2014b</a>). The majority of studies included in the reviews found significant improvement in medication adherence through the use of text messages. </p> <p>Previous mixed‐methods research has identified three dominant theoretical frameworks as driving behaviour change (including medication adherence) resulting from text messaging programmes for people with CVD. These have been found to include the Information‐Motivation‐Behavior Skills Theoretical Model (<a href="./references#CD011851-bbs2-0066" title="FisherJD , FisherWA , AmicoKR , HarmanJJ . An information-motivation-behavioral skills model of adherence to antiretroviral therapy. Health Psychology2006;25(4):462-73. [DOI: 10.1037/0278-6133.25.4.462]">Fisher 2006</a>), because participants felt motivated and engaged with the text message programme, it provided advice and skills with solutions and content was considered credible and meaningful (<a href="./references#CD011851-bbs2-0090" title="RedfernJ , SantoK , CooreyG , ThakkarJ , HackettM , ThiagalingamA , et al. Factors influencing engagement, perceived usefulness and behavioral mechanisms associated with a text message support program. PLOS ONE2016;11(10):e0163929. [DOI: 10.1371/journal.pone.0163929]">Redfern 2016</a>). Social‐Cognitive Theory, <a href="./references#CD011851-bbs2-0052" title="BanduraA . Social Foundations of Thought and Action: A Social Cognitive Theory. Englewood Cliffs, NJ: Prentice-Hall, 1986. [LC: 85009310]">Bandura 1989</a>, was also found to influence adherence if social recognition, improved self‐efficacy, the provision of achievable task‐setting suggestions, practical advice and positive reinforcement were built into the text message programme (<a href="./references#CD011851-bbs2-0090" title="RedfernJ , SantoK , CooreyG , ThakkarJ , HackettM , ThiagalingamA , et al. Factors influencing engagement, perceived usefulness and behavioral mechanisms associated with a text message support program. PLOS ONE2016;11(10):e0163929. [DOI: 10.1371/journal.pone.0163929]">Redfern 2016</a>). Furthermore, previous qualitative data suggested that, over time, participants became ‘conditioned’ towards healthy behaviours irrespective of the specific content of the individual messages received at a certain time, which aligns with operant condition (<a href="./references#CD011851-bbs2-0090" title="RedfernJ , SantoK , CooreyG , ThakkarJ , HackettM , ThiagalingamA , et al. Factors influencing engagement, perceived usefulness and behavioral mechanisms associated with a text message support program. PLOS ONE2016;11(10):e0163929. [DOI: 10.1371/journal.pone.0163929]">Redfern 2016</a>); that is, through repeated presentation of a stimulus (in this case cardiovascular health‐related text messages), the participants eventually learnt to associate the stimulus with overall cardiovascular health behaviour and consequently messages about diet, also resulting in improved medication adherence and vice versa. In addition, the mechanism of text messaging improving medication adherence could be attributed to the Behaviour Change Techniques proposed by the Capability, Opportunity, Motivation‐Behaviour (COM‐B) framework, which emphasises that capability, opportunity, and motivation are three essential components of behaviour change (<a href="./references#CD011851-bbs2-0080" title="MacPhersonMM , CranstonKD , LockeSR , BourneJE , JungME . Using the behavior change wheel to develop text messages to promote diet and physical activity adherence following a diabetes prevention program. Translational Behavioral Medicine2021;11(8):1585-95. [DOI: 10.1093/tbm/ibab058]">MacPherson 2021</a>; <a href="./references#CD011851-bbs2-0093" title="RichardsonM , KhoujaCL , SutcliffeK , ThomasJ . Using the theoretical domains framework and the behavioural change wheel in an overarching synthesis of systematic reviews. BMJ Open2019;9:e024950. [DOI: 10.1136/bmjopen-2018-024950]">Richardson 2019</a>). Overall, the mechanisms associated with text message programmes are complex and multidimensional and varied between and within individuals; however, repeated reminders and positive reinforcement of healthy behaviours serve to influence attention, memory, and decision processes, which also supports medication adherence as part of the overall programme (<a href="./references#CD011851-bbs2-0090" title="RedfernJ , SantoK , CooreyG , ThakkarJ , HackettM , ThiagalingamA , et al. Factors influencing engagement, perceived usefulness and behavioral mechanisms associated with a text message support program. PLOS ONE2016;11(10):e0163929. [DOI: 10.1371/journal.pone.0163929]">Redfern 2016</a>). </p> </section> <section id="CD011851-sec-0013"> <h3 class="title" id="CD011851-sec-0013">Why it is important to do this review</h3> <p>Whilst there is a great deal of enthusiasm for mobile health (mHealth) interventions amongst researchers and policymakers, there is still limited evidence for its effectiveness (<a href="./references#CD011851-bbs2-0105" title="UnalE , GiakoumidakisK , KhanE , PatelarouE . Mobile phone text messaging for improving secondary prevention in cardiovascular diseases: a systematic review. Heart &amp; Lung2018;47(4):351-9. [DOI: 10.1016/j.hrtlng.2018.05.009]">Unal 2018</a>). Systematic reviews have been conducted on adherence to medications and reported promising results (<a href="./references#CD011851-bbs2-0051" title="Anglada-MartinezH , Riu-ViladomsG , Martin-CondeM , Rovira-IllamolaM , Sotoca-MomblonaJM , Codina-JaneC . Does mHealth increase adherence to medication? Results of a systematic review. International Journal of Clinical Practice2015;69(1):9-32. [DOI: 10.1111/ijcp.12582]">Anglada‐Martinez 2015</a>; <a href="./references#CD011851-bbs2-0064" title="Ershad SarabiR , SadoughiF , Jamshidi OrakR , BahaadinbeigyK . The effectiveness of mobile phone text messaging in improving medication adherence for patients with chronic diseases: a systematic review. Iranian Red Crescent Medical Journal2016;18(5):e25183. [DOI: 10.5812/ircmj.25183]">Ershad 2016</a>; <a href="./references#CD011851-bbs2-0086" title="ParkLG , Howie-EsquivelJ , DracupK . A quantitative systematic review of the efficacy of mobile phone interventions to improve medication adherence. Journal of Advanced Nursing2014;70(9):1932-53. [DOI: 10.1111/jan.12400]">Park 2014b</a>; <a href="./references#CD011851-bbs2-0102" title="ThakkarJ , KurupR , LabaTL , SantoK , ThiagalingamA , RodgersA , et al. Mobile phone text messaging for medication adherence in chronic disease: a meta-analysis. JAMA Internal Medicine2016;176(3):340-9. [DOI: 10.1001/jamainternmed.2015.7667]">Thakkar 2016</a>; <a href="./references#CD011851-bbs2-0112" title="ZhaoYY , DangFP , ZhaiTT , LiHJ , WangRJ , RenJJ . The effect of text message reminders on medication adherence among patients with coronary heart disease: a systematic review and meta-analysis. Medicine2019;98(52):e18353. [DOI: 10.1097/MD.0000000000018353]">Zhao 2019</a>). The previous version of this review was conducted to evaluate specifically the effect of mobile phone text messaging on medication adherence for secondary CVD prevention and to try to examine how text messages are created and if SMS are tailored based on individual patient characteristics (<a href="./references#CD011851-bbs2-0114" title="AdlerAJ , MartinN , MarianiJ , TajerCD , OwolabiOO , FreeC , et al. Mobile phone text messaging to improve medication adherence in secondary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews2017, Issue 4. Art. No: CD011851. [DOI: 10.1002/14651858.CD011851.pub2]">Adler 2017</a>). However, the effects of text messaging were inconclusive due to the limited number of included studies and lack of meta‐analysis. It remains unclear if text messaging can improve medication adherence and other clinical outcomes (e.g. cardiovascular events, blood pressure, low‐density lipoprotein (LDL) cholesterol, and heart rate). Given that research evolves rapidly in this area, and the findings of the previous review could be changed by the new studies recently published, a review update with introduction of the most recent evidence is warranted. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD011851-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD011851-sec-0014"></div> <p>To evaluate the benefits and harms of mobile phone text messaging for improving medication adherence in people with cardiovascular diseases compared to usual care. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD011851-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD011851-sec-0015"></div> <section id="CD011851-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD011851-sec-0017"> <h4 class="title">Types of studies</h4> <p>We only included randomised controlled trials (RCTs). We excluded cluster‐RCTs because our goal was to focus on interventions aimed at individuals. We also excluded quasi‐RCTs because quasi‐RCTs do not use a full randomisation and limit the study’s ability to conclude a causal association between an intervention and an outcome. A quasi‐randomised trial is defined as a trial allocating participants to different groups using a method of allocation that is not truly random; for example, allocation by date of birth, medical record number, or the order in which participants were recruited (<a href="./references#CD011851-bbs2-0091" title="ReevesBC , DeeksJJ , HigginsJP , SheaB , TugwellP , WellsGA . Chapter 24: Including non-randomized studies on intervention effects. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.4 (updated August 2023). Cochrane, 2023. Available from www.training.cochrane.org/handbook.">Reeves 2023</a>).Cross‐over trials were eligible for inclusion. </p> </section> <section id="CD011851-sec-0018"> <h4 class="title">Types of participants</h4> <p>We included participants with established arterial occlusive events, including coronary artery disease, cerebrovascular artery disease, peripheral artery disease, and atherosclerotic aortic disease, for whom antiplatelet, blood pressure‐lowering medications, and lipid‐lowering medications are recommended. We included all studies irrespective of where participants were enrolled (community or clinic). We excluded mixed‐disease populations (e.g. study participants with either CVDs or other diseases). Established arterial occlusive events were defined by authors. </p> </section> <section id="CD011851-sec-0019"> <h4 class="title">Types of interventions</h4> <p>We included trials comparing interventions using short messaging service (SMS) or multimedia messaging service (MMS) to improve adherence to medication for the secondary prevention of cardiovascular events. We compared mobile phone messaging with usual care. We did not exclude studies based on how the text messages were developed, or if they were sent one way versus two ways. We only included trials that included adherence, but we also included trials of interventions that targeted medication adherence alongside other lifestyle modifications. </p> </section> <section id="CD011851-sec-0020"> <h4 class="title">Types of outcome measures</h4> <p>For studies with multiple outcome measurements, we selected the longest follow‐up from each study. </p> <p>Reporting one or more of the outcomes listed below was not an inclusion criterion for this review. Where a published report did not appear to report one of these outcomes, we accessed the trial protocol and contacted the trial authors to ascertain whether the outcomes were measured but not reported. Relevant trials that measured these outcomes but did not report the data, or did not report the data in a usable format, were included in the review as part of the narrative. </p> <section id="CD011851-sec-0021"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD011851-list-0001"> <li> <p>Medication adherence (self‐reported adherence, questionnaire, tablet counts, medication event monitoring systems, pharmacy prescription data). </p> </li> <li> <p>Fatal cardiovascular events (death caused by cardiovascular events), defined as the proportion of participants with fatal cardiovascular events. </p> </li> <li> <p>Non‐fatal cardiovascular events (coronary heart disease, revascularisation, stroke), defined as the proportion of participants with non‐fatal cardiovascular events. </p> </li> <li> <p>Combined CVD event (fatal or non‐fatal CVD events), defined as the proportion of participants with a combined CVD event. </p> </li> </ol> </p> </section> <section id="CD011851-sec-0022"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD011851-list-0002"> <li> <p>Low‐density lipoprotein (LDL) cholesterol for the effect of statins.</p> </li> <li> <p>Blood pressure for antihypertensive drugs (systolic blood pressure and diastolic blood pressure). </p> </li> <li> <p>Heart rate for the effect of beta‐blockers.</p> </li> <li> <p>Urinary 11‐dehydrothromboxane B2 for the antiplatelet effects of aspirin.</p> </li> <li> <p>Adverse effects:</p> <ol id="CD011851-list-0003"> <li> <p>self‐reported road traffic crashes;</p> </li> <li> <p>repetitive thumb strain.</p> </li> </ol> </li> <li> <p>Patient‐reported experience (utility, acceptability, and satisfaction).</p> </li> </ol> </p> </section> </section> </section> <section id="CD011851-sec-0023"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD011851-sec-0024"> <h4 class="title">Electronic searches</h4> <p>We identified relevant studies through systematic searches of the following bibliographic databases and trial registers on 30 August 2023. </p> <p> <ol id="CD011851-list-0004"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL; 2023, Issue 8) in the Cochrane Library (searched 30 August 2023). </p> </li> <li> <p>MEDLINE In‐Process &amp; Other Non‐Indexed Citations and MEDLINE Ovid (1946 to 30 August 2023). </p> </li> <li> <p>Embase Classic and Embase Ovid (1947 to 30 August 2023).</p> </li> <li> <p>Conference Proceedings Citation Index ‐ Science Web of Science (CPCI‐S; Thomson Reuters; 1990 to 30 August 2023). </p> </li> <li> <p>CINAHL Complete EBSCO (Cumulated Index to Nursing and Allied Health Literature; 1937 to 30 August 2023). </p> </li> <li> <p>Scopus Elsevier (1966 to 30 August 2023).</p> </li> <li> <p>ProQuest Central (1938 to 30 August 2023).</p> </li> <li> <p>ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov;</a>searched 30 August 2023). </p> </li> <li> <p>World Health Organization International Clinical Trials Registry Platform (WHO ICTRP; <a href="http://apps.who.int/trialsearch/" target="_blank">apps.who.int/trialsearch</a>; searched 30 August 2023). </p> </li> </ol> </p> <p>The Cochrane sensitivity‐maximising RCT filter was applied to MEDLINE Ovid and adaptations of it to the other databases, except CENTRAL (<a href="./references#CD011851-bbs2-0079" title="LefebvreC , GlanvilleJ , BriscoeS , FeatherstoneR , LittlewoodA , MarshallC , et al. Chapter 4: Searching for and selecting studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022. Available from training.cochrane.org/handbook/archive/v6.3.">Lefebvre 2022</a>). Search strategies are provided in <a href="./appendices#CD011851-sec-0090">Appendix 1</a>. We searched all databases from their inception to the present, and imposed no restrictions on language of publication, publication date, or publication status. </p> </section> <section id="CD011851-sec-0025"> <h4 class="title">Searching other resources</h4> <p>We checked the reference lists of all included primary studies and reviewed relevant systematic reviews and meta‐analyses for additional references (<a href="./references#CD011851-bbs2-0048" title="AkinosunAS , PolsonR , Diaz-SkeeteY , De KockJH , CarragherL , LeslieS , et al. Digital technology interventions for risk factor modification in patients with cardiovascular disease: systematic review and meta-analysis. JMIR mHealth and uHealth2021;9(3):e21061. [DOI: 10.2196/21061]">Akinosun 2021</a>; <a href="./references#CD011851-bbs2-0049" title="Al-ArkeeS , MasonJ , LaneDA , FabritzL , ChuaW , HaqueMS . Mobile apps to improve medication adherence in cardiovascular disease: systematic review and meta-analysis. Journal of Medical Internet Research2021;23(5):e24190. [DOI: 10.2196/24190]">Al‐Arkee 2021</a>; <a href="./references#CD011851-bbs2-0050" title="AllidaS , DuH , XuX , PrichardR , ChangS , HickmanLD , et al. mHealth education interventions in heart failure. Cochrane Database of Systematic Reviews2020, Issue 7. Art. No: CD011845. [DOI: 10.1002/14651858.CD011845.pub2]">Allida 2020</a>; <a href="./references#CD011851-bbs2-0053" title="BondZ , ScanlonT , JudahG . Systematic review of RCTs assessing the effectiveness of mHealth interventions to improve statin medication adherence: using the behaviour-change technique taxonomy to identify the techniques that improve adherence. Healthcare2021;9(10):1282. [DOI: 10.3390/healthcare9101282]">Bond 2021</a>; <a href="./references#CD011851-bbs2-0056" title="ChowdhuryFM , AyalaC , DalmatD , ShantharamS , ChangT , RussellZ , et al. Effectiveness of telehealth on hypertension management among disparate populations: a systematic review. Circulation Cardiovascular Quality and Outcomes2017;10(Suppl 3):A216. [DOI: 10.1161/circoutcomes.10.suppl_3.216]">Chowdhury 2017</a>; <a href="./references#CD011851-bbs2-0067" title="FullerRH , PerelP , Navarro-RuanT , NieuwlaatR , HaynesRB , HuffmanMD . Improving medication adherence in patients with cardiovascular disease: a systematic review. Heart2018;104(15):1238-43. [DOI: 10.1136/heartjnl-2017-312571]">Fuller 2018</a>; <a href="./references#CD011851-bbs2-0068" title="FultonRL , KrollT , McMurdoMET , MolloyGJ , WithamMD . Interventions to enhance medication adherence in older heart failure patients - a systematic review. Age and Ageing2017;46(Suppl 1):i25-6. [DOI: 10.1093/ageing/afx059.104]">Fulton 2017</a>; <a href="./references#CD011851-bbs2-0070" title="GandapurY , KianoushS , KelliHM , MisraS , UrreaB , BlahaMJ , et al. The role of mHealth for improving medication adherence in patients with cardiovascular disease: a systematic review. European Heart Journal - Quality of Care &amp; Clinical Outcomes2016;2(4):237-44. [DOI: 10.1093/ehjqcco/qcw018]">Gandapur 2016</a>; <a href="./references#CD011851-bbs2-0076" title="KassavouA , SuttonS . Automated telecommunication interventions to promote adherence to cardio-metabolic medications: meta-analysis of effectiveness and meta-regression of behaviour change techniques. Health Psychology Review2018;12(1):25-42. [DOI: 10.1080/17437199.2017.1365617]">Kassavou 2018</a>; <a href="./references#CD011851-bbs2-0100" title="TamHL , WongEM , CheungK , ChungSF . Effectiveness of text messaging interventions on blood pressure control among patients with hypertension: systematic review of randomized controlled trials. JMIR mHealth uHealth2021;9(9):e24527. [DOI: 10.2196/24527]">Tam 2021</a>; <a href="./references#CD011851-bbs2-0104" title="TreskesRW , Van der VeldeET , SchoonesJW , SchalijMJ . Implementation of smart technology to improve medication adherence in patients with cardiovascular disease: is it effective. Expert Review of Medical Devices2018;15(2):119-26. [DOI: 10.1080/17434440.2018.1421456]">Treskes 2018</a>; <a href="./references#CD011851-bbs2-0105" title="UnalE , GiakoumidakisK , KhanE , PatelarouE . Mobile phone text messaging for improving secondary prevention in cardiovascular diseases: a systematic review. Heart &amp; Lung2018;47(4):351-9. [DOI: 10.1016/j.hrtlng.2018.05.009]">Unal 2018</a>; <a href="./references#CD011851-bbs2-0110" title="XiongS , BerkhouseH , SchoolerM , PuW , SunA , GongE , et al. Effectiveness of mHealth interventions in improving medication adherence among people with hypertension: a systematic review. Current Hypertension Reports2018;20(10):86. [DOI: 10.1007/s11906-018-0886-7]">Xiong 2018</a>; <a href="./references#CD011851-bbs2-0112" title="ZhaoYY , DangFP , ZhaiTT , LiHJ , WangRJ , RenJJ . The effect of text message reminders on medication adherence among patients with coronary heart disease: a systematic review and meta-analysis. Medicine2019;98(52):e18353. [DOI: 10.1097/MD.0000000000018353]">Zhao 2019</a>). </p> </section> </section> <section id="CD011851-sec-0026"> <h3 class="title" id="CD011851-sec-0026">Data collection and analysis</h3> <section id="CD011851-sec-0027"> <h4 class="title">Selection of studies</h4> <p>We used a dual screening process involving two teams of two review authors (team 1: MH &amp; CZ; team 2: QT &amp; NH) for study inclusion and data extraction. Each team was assigned half the number of total records yielded by the searches to assess for eligibility. Each review author independently screened the titles and abstracts for inclusion (therefore, each record was double screened) and decided to retrieve the full‐text copies or to discard them. If there were any disagreements, the other team arbitrated. We retrieved the full‐text study reports/publications, and all four review authors independently screened the full texts and identified studies for inclusion. Any disagreements were resolved by discussion or through arbitration with the other team if necessary. We identified and excluded duplicates and collated multiple reports of the same study so that each study, rather than each report, was the unit of interest in the review. We completed a PRISMA flow diagram, <a href="./references#CD011851-bbs2-0099" title="StovoldE , BeecherD , FoxleeR , Noel-StorrA . Study flow diagrams in Cochrane systematic review updates: an adapted PRISMA flow diagram. Systematic Reviews2014;3(54):1-5. [DOI: 10.1186/2046-4053-3-54]">Stovold 2014</a>, and 'Characteristics of excluded studies' table. </p> </section> <section id="CD011851-sec-0028"> <h4 class="title">Data extraction and management</h4> <p>We used a data collection form to extract study characteristics and outcome data previously piloted on at least one study in the review. Two review authors (MH, CZ, QT, or NH) independently extracted study characteristics for each included study. We extracted the following study characteristics. </p> <p> <ol id="CD011851-list-0005"> <li> <p>Methods: study design, total duration of study, study setting, withdrawals, and date and country of study. </p> </li> <li> <p>Participants: number, mean age, age range, gender, condition, diagnostic criteria, smoking history, inclusion criteria, and exclusion criteria. </p> </li> <li> <p>Interventions: intervention, comparison, concomitant medications, excluded medications, how text messages were developed, behaviour change technique, any theoretical framework/s used to develop the intervention, time from arterial occlusive event, if SMS was personalised, mode of delivery (frequency and timing of messaging, duration of programme). </p> </li> <li> <p>Outcomes: primary and secondary outcomes specified and collected, method of measurement, and time points reported. </p> </li> <li> <p>Notes: funding for trial, and notable conflicts of interest of trial authors.</p> </li> </ol> </p> <p>We resolved any disagreements by consensus or by involving a third person (MH). One review author (QT) transferred data into Review Manager Web (<a href="./references#CD011851-bbs2-0092" title="Review Manager Web (RevMan Web). Version 4.12.0. The Cochrane Collaboration, 2022. Available at revman.cochrane.org.">RevMan Web 2022</a>). We double‐checked the data entry for accuracy against the data extraction sheets. </p> </section> <section id="CD011851-sec-0029"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two of four review authors (MH, CZ, QT, NH) independently assessed the risk of bias for each included study using the RoB 1 tool, as outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011851-bbs2-0072" title="HigginsJP , AltmanDG , SterneJA , editor(s). Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>). Any disagreements were resolved by discussion with the other two review authors who were not initially involved in the assessment (MH, CZ, QT, NH). We assessed risk of bias according to the following domains. </p> <p> <ol id="CD011851-list-0006"> <li> <p>Random sequence generation.</p> </li> <li> <p>Allocation concealment.</p> </li> <li> <p>Blinding of participants and personnel.</p> </li> <li> <p>Blinding of outcome assessment.</p> </li> <li> <p>Incomplete outcome data.</p> </li> <li> <p>Selective outcome reporting.</p> </li> <li> <p>Other biases.</p> </li> </ol> </p> <p>We graded each potential source of bias as low, high, or unclear and provided evidence from the study report together with a justification for our judgement in the risk of bias table. We summarised the risk of bias judgements across different studies for each of the domains listed. Where information on risk of bias related to unpublished data or correspondence with a trialist, we noted this in the risk of bias table. </p> <p>Given the nature of the interventions included in this review, it was likely that blinding of participants and personnel would be impossible, as would blinding of self‐reported outcome assessment, so we expected trials to be categorised at high risk of bias for both of these domains. </p> <p>For the overall study assessment, we categorised a trial as being at low risk of bias if it was rated as low risk in all the domains listed above (with the exception of blinding of participants and personnel/self‐reported outcome assessment). We categorised trials that were at high or unclear risk of bias for any risk of bias domain (except blinding of participants and personnel/self‐reported outcome assessment) as being at high risk of bias. We assessed trials as at unclear risk of bias when too few details were available to permit a judgement of low or high risk of bias. </p> <p>When considering treatment effects, we took into account the risk of bias for the studies that contributed to that outcome. </p> </section> <section id="CD011851-sec-0030"> <h4 class="title">Measures of treatment effect</h4> <p>For continuous outcomes, to enable pooling and comparison of the outcomes, mean difference (MD) with 95% confidence interval (CI) was calculated as effect size. For dichotomous outcomes, odds ratio (OR) with 95% CI was calculated as effective size (<a href="./references#CD011851-bbs2-0073" title="HigginsJP , LiT , DeeksJJ , editor(s). Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022. Available from training.cochrane.org/handbook/archive/v6.3.">Higgins 2022</a>). For dichotomous outcomes (e.g. medication adherence) that were reported as risk ratio (RR) in the original study and did not allow for meta‐analysis, we reported RR as per the original reporting. </p> <p>We entered data presented as a scale with a consistent direction of effect. We narratively described skewed data reported as medians and interquartile ranges. </p> </section> <section id="CD011851-sec-0031"> <h4 class="title">Unit of analysis issues</h4> <p>We did not encounter any unit of analysis issues, so the unit of analysis was the individual. </p> </section> <section id="CD011851-sec-0032"> <h4 class="title">Dealing with missing data</h4> <p>We contacted investigators to verify key study characteristics and to obtain missing numerical outcome data where possible (e.g. when a study was identified as abstract only). If no additional data were provided by the authors, we used available‐case analysis, which included analysis of the available data only (thus ignoring the missing data), assuming the data were missing at random. </p> </section> <section id="CD011851-sec-0033"> <h4 class="title">Assessment of heterogeneity</h4> <p>We evaluated clinical heterogeneity by assessment of variability in the participants, interventions, and outcomes in studies. We assessed methodological heterogeneity by assessment of variability in study design, outcome measurement tools, and risk of bias. We tested for statistical heterogeneity by inspecting the overlap of CIs and quantifying this using the Chi<sup>2</sup> test and the I<sup>2</sup> statistic (which describes the percentage of the variability in effect estimates due to heterogeneity rather than sampling error). We assessed heterogeneity according to the guidance in the <i>Cochrane Handbook</i> (<a href="./references#CD011851-bbs2-0060" title="DeeksJJ , HigginsJP , AltmanDG , editor(s). Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.4 (updated August 2023). Cochrane, 2023. Available from www.training.cochrane.org/handbook.">Deeks 2023</a>), using the following thresholds: </p> <p> <ol id="CD011851-list-0007"> <li> <p>0% to 40%: might not be important;</p> </li> <li> <p>30% to 60%: may represent moderate heterogeneity;</p> </li> <li> <p>50% to 90%: may represent substantial heterogeneity; or</p> </li> <li> <p>75% to 100%: considerable heterogeneity.</p> </li> </ol> </p> <p>We used 40% as a cut‐off value for important heterogeneity, which means that we considered an I<sup>2</sup> under 40% as low heterogeneity. When possible, we assessed the potential causes of heterogeneity by sensitivity analyses (<a href="#CD011851-sec-0037">Sensitivity analysis</a>). </p> </section> <section id="CD011851-sec-0034"> <h4 class="title">Assessment of reporting biases</h4> <p>We planned but could not assess the potential publication bias using funnel plots and Egger’s test (<a href="./references#CD011851-bbs2-0084" title="PageMJ , HigginsJPT , SterneJAC . Chapter 13: Assessing risk of bias due to missing results in a synthesis. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane, 2023. Available from www.training.cochrane.org/handbook.">Page 2023</a>), as there were fewer than 10 studies within the analysed outcome. </p> </section> <section id="CD011851-sec-0035"> <h4 class="title">Data synthesis</h4> <p>We planned but did not conduct a meta‐analysis for medication adherence due to a large variation in the way medication adherence was defined and measured. In addition, we aimed to but could not conduct a meta‐analysis for non‐fatal cardiovascular events, combined cardiovascular events, and urinary 11‐dehydrothromboxane B2 due to a lack of reported outcomes in the studies. However, we conducted a meta‐analysis for fatal cardiovascular events, LDL cholesterol, blood pressure, and heart rate. We used a random‐effects model and inverse variance method for meta‐analysis because of foreseen heterogeneity. </p> <p>We performed a narrative synthesis if quantitative synthesis was deemed inappropriate due to significant statistical, clinical, or methodological heterogeneity. </p> </section> <section id="CD011851-sec-0036"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We were not able to conduct our preplanned subgroup analyses due to inadequate data available for analysis (<a href="./references#CD011851-bbs2-0113" title="AdlerAJ , MartinN , MarianiJ , TajerCD , SerranoNC , CasasJP , et al. Mobile phone text messaging to improve adherence to cardiovascular disease secondary prevention interventions. Cochrane Database of Systematic Reviews2015, Issue 8. Art. No: CD011851. [DOI: 10.1002/14651858.CD011851]">Adler 2015</a>). </p> </section> <section id="CD011851-sec-0037"> <h4 class="title">Sensitivity analysis</h4> <p>We assessed the robustness of the effect estimate by performing the following sensitivity analyses. </p> <p> <ol id="CD011851-list-0008"> <li> <p>Using a fixed‐effect model.</p> </li> <li> <p>Excluding outliers.</p> </li> <li> <p>Including only those studies with a 'low' risk of bias (defined as those studies where there is a low risk of bias classification across all key domains except performance bias, given that it is not feasible to blind participants to a text messaging intervention). </p> </li> </ol> </p> </section> <section id="CD011851-sec-0038"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>We used GRADEpro GDT software to construct a summary of findings table for the following comparison: text messaging versus usual care (<a href="./references#CD011851-bbs2-0071" title="GRADEpro GDT. Version accessed 20 October 2023. Hamilton (ON): McMaster University (developed by Evidence Prime). Available at gradepro.org.">GRADEpro GDT</a>). The summary of findings table includes all primary outcomes (medication adherence, fatal cardiovascular events, non‐fatal cardiovascular events, and combined CVD events) and three secondary outcomes (LDL cholesterol, blood pressure, and heart rate) at follow‐up of one to 12 months. We selected these outcomes because they were the most clinically relevant. We used the methods and recommendations described in Chapter 14 of the <i>Cochrane Handbook</i> (<a href="./references#CD011851-bbs2-0096" title="SchünemannHJ , HigginsJP , VistGE , GlasziouP , AklEA , SkoetzN , et al. Chapter 14: Completing ‘Summary of findings’ tables and grading the certainty of the evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.4 (updated August 2023). Cochrane, 2023. Available from www.training.cochrane.org/handbook.">Schünemann 2023</a>). </p> <p>We used the five GRADE considerations (risk of bias, consistency of effect, imprecision, indirectness, and publication bias) to assess the certainty of the evidence. We downgraded the certainty of the evidence for each outcome up to a maximum of three levels. We rated the certainty of the evidence for each outcome as high, moderate, low, or very low. Two review authors (NH and QT) independently assessed the certainty of the evidence for each outcome, with any differences of opinion resolved by consulting a third review author (MH). We justified all decisions to downgrade the certainty of studies using footnotes, and made comments to aid the reader's understanding of the review where necessary. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD011851-sec-0039" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD011851-sec-0039"></div> <section id="CD011851-sec-0040"> <h3 class="title">Description of studies</h3> <section id="CD011851-sec-0041"> <h4 class="title">Results of the search</h4> <p>A study flow diagram is shown in <a href="#CD011851-fig-0001">Figure 1</a>. The new search of the databases retrieved 15,085 records. Our search of the clinical trial registers and our manual search retrieved an additional 346 and 12 records, respectively. After removal of duplicates, we screened 12,263 records based on title and abstract, excluding 12,197 records as irrelevant. We obtained and assessed the full texts of the remaining 66 reports, and excluded 20 reports (18 studies), resulting in 11 new completed studies (35 reports) and nine ongoing studies (11 reports). After combining the seven completed studies from the original review, the updated search resulted in a total of 18 completed studies and nine ongoing studies. </p> <div class="figure" id="CD011851-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD011851-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_n/nCD011851-FIG-01.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> <p>A search for the clinical trial registry numbers of the nine ongoing studies revealed that one study is completed but study results are not published yet (<a href="./references#CD011851-bbs2-0043" title="ISRCTN10549665. Improving medication taking in patients with coronary heart disease using a mobile health technology, a feasibility study. www.isrctn.com/ISRCTN10549665 (first received 26 November 2019). [DOI: 10.1186/ISRCTN10549665]">ISRCTN10549665</a>). </p> </section> <section id="CD011851-sec-0042"> <h4 class="title">Included studies</h4> <p>Details of the methods, participants, intervention, comparison group and outcome measures for each of the studies included in the review are shown in the <a href="./references#CD011851-sec-0111" title="">Characteristics of included studies</a> tables. </p> <p>We included 18 studies (<a href="./references#CD011851-bbs2-0001" title="BaeJW , WooSI , LeeJ , ParkSD , KwonSW , ChoiSH , et al. mHealth interventions for lifestyle and risk factor modification in coronary heart disease: randomized controlled trial. JMIR mHealth and uHealth2021;9(9):e29928. [DOI: 10.2196/29928]KCT0005087. Effect of text messaging program on lifestyle and clinical outcomes in patients with cardiovascular disease. cris.nih.go.kr/cris/search/detailSearch.do/19282 (first received 11 September 2019). ">Bae 2021</a>; <a href="./references#CD011851-bbs2-0002" title="BermonA , UribeAF , Pérez-RiveroPF , Prieto-MerinoD , SaaibiJF , SilvaFA , et al. Efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: TXT2HEART Colombia randomized controlled trial. JMIR mHealth and uHealth2021;9(7):e25548. [DOI: 10.2196/25548]BermonA , Uribe-RodríguezAF , Pérez-RiveroPF , Prieto-MerinoD , RiveraDIC , GuioE , et al. Evaluation of the efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: the txt2heart Colombia randomised controlled trial protocol. BMJ Open2019;9:e028017. [DOI: 10.1136/ bmjopen-2018-028017]NCT03098186. TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention [TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention]. clinicaltrials.gov/ct2/show/NCT03098186 (first received 3 March 2017). ">Bermon 2021</a>; <a href="./references#CD011851-bbs2-0003" title="ChenC , LiX , KangY , LiuH , LiangYD , ZhangQ . Post-discharge short service message improves short-term clinical outcome and self-care behavior in Chinese patients with chronic heart failure. European Heart Journal2018;39(Suppl 1):797-8. [DOI: 10.1093/eurheartj/ehy563.P3770]ChenC , LiX , SunL , CaoS , KangY , HongL , et al. Post-discharge short message service improves short-term clinical outcome and self-care behaviour in chronic heart failure. ESC Heart Failure2019;6(1):164-73. [DOI: 10.1002/ehf2.12380]ChiCTR-INR-17012316. Effect of post-discharge text messages on clinical outcomes in patients with heart failure [Effect of post-discharge text messages on clinical outcomes in patients with heart failure]. trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR-INR-17012316 (first received 9 August 2018). LiX , ChenC , YouGY , ZhangQ . Post-discharge text messaging intervention improved clinical outcomes in patients with heart failure. European Heart Journal2016;37(Suppl 1):727-8. [DOI: 10.1093/eurheartj/ehw433]">Chen 2019</a>; <a href="./references#CD011851-bbs2-0004" title="ACTRN12611000161921. Tobacco, EXercise and dieT MEssages (TEXT ME): the effect of semi-personalised lifestyle reminder text message intervention on cardiovascular disease risk [Tobacco, EXercise and dieT MEssages (TEXT ME): The effect of a semi-personalised lifestyle reminder text message intervention on cardiovascular risk factors in patients with cardiovascular disease and those who are at high risk of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12611000161921 (first received 3 February 2011). ChowCK , RedfernJ , HillisGS , ThakkarJ , SantoK , HackettML , et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA2015;314(12):1255-63. [DOI: 10.1001/jama.2015.10945]ChowCK , RedfernJ , ThiagalingamA , JanS , WhittakerR , HackettM , et al. Design and rationale of the tobacco, exercise and diet messages (TEXT ME) trial of a text message-based intervention for ongoing prevention of cardiovascular disease in people with coronary disease: a randomised controlled trial protocol. BMJ Open2012;2(1):e000606. [DOI: 10.1136/bmjopen-2011-000606]RedfernJ , SantoK , CooreyG , ThakkarJ , HackettM , ThiagalingamA , et al. Factors influencing engagement, perceived usefulness and behavioral mechanisms associated with a text message support program. PLOS ONE2016;11(10):e0163929. [DOI: 10.1371/journal.pone.0163929]ThakkarJ , RedfernJ , De KeizerL , ThiagalingamA , ChowC . Patient perceptions of text message-based intervention for secondary prevention of cardiovascular events. Heart, Lung and Circulation2013;22(Suppl 1):S264. [DOI: 10.1016/j.hlc.2013.05.630]ThakkarJ , RedfernJ , ThiagalingamA , ChowCK . Patterns, predictors and effects of texting intervention on physical activity in CHD – insights from the TEXT ME randomized clinical trial. European Journal of Preventive Cardiology2016;23(17):1894-902. [DOI: 10.1177/2047487316664190]">Chow 2015</a>; <a href="./references#CD011851-bbs2-0005" title="ACTRN12613000793718. TEXT messages to improve MEDication adherence &amp; Secondary prevention – TEXTMEDS [TEXT messages to improve MEDication adherence &amp; Secondary prevention in patients with acute coronary syndrome - TEXTMEDS]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364448&amp;isReview=true (first received 18 June 2013). ChowCK , KlimisH , ThiagalingamA , RedfernJ , HillisGS , BriegerD , et al. Text messages to improve medication adherence and secondary prevention after acute coronary syndrome: the TEXTMEDS randomized clinical trial. Circulation2022;145(19):1443-55. [DOI: 10.1161/CIRCULATIONAHA.121.056161]ChowCK , ThiagalingamA , SantoK , KokC , ThakkarJ , StepienS , et al. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol. BMJ Open2018;8:e019463. [DOI: 10.1136/bmjopen-2017-019463]">Chow 2022</a>; <a href="./references#CD011851-bbs2-0006" title="ACTRN12613000901707. Text4Heart: a text message and internet-based comprehensive cardiac rehabilitation intervention [A randomised controlled trial to determine the efficacy of a text message and Internet-based comprehensive cardiac rehabilitation programme to improve adherence to lifestyle change compared with usual care in New Zealand adults with a diagnosis of cardiovascular disease]. anzctr.org.au/ACTRN12613000901707.aspx (first received 9 August 2013). DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Improving coronary heart disease self-management using mobile technologies (Text4Heart): a randomised controlled trial protocol. Trials2014;15(71):1-9. [DOI: 10.1186/1745-6215-15-71]DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Text message and internet support for coronary heart disease self-management: results from the Text4Heart randomized controlled trial. Journal of Medical Internet Research2015;17(10):e237. [DOI: 10.2196/jmir.4944]">Dale 2015a</a>; <a href="./references#CD011851-bbs2-0007" title="FangR , LiX . Electronic messaging support service programs improve adherence to lipid-lowering therapy among outpatients with coronary artery disease: an exploratory randomised control study. Journal of Clinical Nursing2016;25(5-6):664-71. [DOI: 10.1111/jocn.12988]">Fang 2016</a>; <a href="./references#CD011851-bbs2-0008" title="HuoX , KrumholzHM , BaiX , SpatzES , DingQ , HorakP , et al. Effects of mobile text messaging on glycemic control in patients with coronary heart disease and diabetes mellitus: a randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(9):e005805. [DOI: 10.1161/CIRCOUTCOMES.119.005805]NCT02883842. Cardiovascular Health and Text Messaging-Diabetes Mellitus (CHAT-DM) Study [Effectiveness of text messaging on risk factors control and medication adherence among patients with Coronary Heart Disease and Diabetes in China: cardiovascular health andtext messaging-Diabetes Mellitus (CHAT-DM) study]. clinicaltrials.gov/ct2/show/NCT02883842 (first received 30 August 2016). ">Huo 2019</a>; <a href="./references#CD011851-bbs2-0009" title="KamalAK , ShaikQN , PashaO , AzamI , IslamM , MemonAA , et al. Improving medication adherence in stroke patients through Short Text Messages (SMS4Stroke)-study protocol for a randomized, controlled trial. BMC Neurology2015;15:157. [DOI: 10.1186/s12883-015-0413-2]KamalAK , ShaikhQ , PashaO , AzamI , IslamM , MemonAA , et al. A randomized controlled behavioral intervention trial to improve medication adherence in adult stroke patients with prescription tailored short messaging service (SMS)-SMS4Stroke study. BMC Neurolology2015;15:212. [DOI: 10.1186/s12883-015-0471-5]">Kamal 2015</a>; <a href="./references#CD011851-bbs2-0010" title="KhonsariS , SubramanianP , ChinnaK , LatifLA , LingLW , GholamiO . Effect of a reminder system using an automated short message service on medication adherence following acute coronary syndrome. European Journal of Cardiovascular Nursing2015;14(2):170-9. [DOI: 10.1177/1474515114521910]">Khonsari 2015</a>; <a href="./references#CD011851-bbs2-0011" title="ACTRN12616000422426. Text4Heart Partnership: a text messaging program to enhance self-management of cardiovascular disease [Text messaging to enhance self-management of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12616000422426 (first received 23 March 2016). MaddisonR , JiangY , StewartR , ScottT , KerrA , WhittakerR , et al. An intervention to improve medication adherence in people with heart disease (Text4HeartII): randomized controlled trial. JMIR mHealth and uHealth2021;9(6):e24952. [DOI: 10.2196/24952]MaddisonR , StewartR , DoughtyR , ScottT , KerrA , BenatarJ , et al. Text4Heart II - improving medication adherence in people with heart disease: a study protocol for a randomized controlled trial. Trials2018;19(1):70. [DOI: 10.1186/s13063-018-2468-z]">Maddison 2021</a>; <a href="./references#CD011851-bbs2-0012" title="NCT02793830. A mobile phone based medication reminder program [A mobile phone based medication reminder program for patients in China with coronary heart disease: a pilot study]. clinicaltrials.gov/ct2/show/NCT02793830 (first received 8 June 2016). NiZ , WuB , YangQ , YanLL , LiuC , ShawRJ . An mHealth intervention to improve medication adherence and health outcomes among patients with coronary heart disease: randomized controlled trial. Journal of Medical Internet Research2022;24(3):e27202. [DOI: 10.2196/27202]">Ni 2022</a>; <a href="./references#CD011851-bbs2-0013" title="NCT02783287. The impact of text messaging on medication adherence and exercise regimen among post-myocardial infarction patients. clinicaltrials.gov/ct2/show/NCT02783287 (first received 26 May 2016). PandeyA , ChoudhryN . An m-health application of daily text messages to address forgetfulness as contributor to non-adherence to medications post-myocardial infarction. Circulation2015;132:A18641. [DOI: 10.1161/circ.132.suppl_3.18641]PandeyA , KrummeAA , PatelT , ChoudhryNK . The impact of text messaging on medication adherence and exercise among postmyocardial infarction patients: randomized controlled pilot trial. JMIR mHealth and uHealth2017;5(8):e110. [DOI: 10.2196/mhealth.7144]PandeyAK , ChoudhryN . Text message reminders to address medication non-adherence in post-MI patients: a one year intervention study. Canadian Journal of Cardiology2014;30(10):S179. [DOI: 10.1016/j.cjca.2014.07.280]">Pandey 2017</a>; <a href="./references#CD011851-bbs2-0014" title="ParkLG , Howie-EsquivelJ , ChungM , DracupK . A text messaging intervention improves medication adherence for patients with coronary heart disease: a randomized controlled trial. Circulation2013;128(Suppl 22):A15249. [DOI: 10.1161/circ.128.suppl_22.A15249]ParkLG , Howie-EsquivelJ , ChungML , DracupK . A text messaging intervention to promote medication adherence for patients with coronary heart disease: a randomized controlled trial. Patient Education and Counseling2014;94(2):261-8. [DOI: 10.1016/j.pec.2013.10.027]ParkLG , Howie-EsquivelJ , WhooleyMA , DracupK . Psychosocial factors and medication adherence among patients with coronary heart disease: a text messaging intervention. European Journal of Cardiovascular Nursing2015;14(3):264-73. [DOI: 10.1177/1474515114537024]">Park 2014a</a>; <a href="./references#CD011851-bbs2-0015" title="NCT03414190. Impact of text messages to promote secondary prevention after acute coronary syndrome [Impact of a mobile phone text messages intervention on the secondary prevention of cardiovascular events after acute coronary syndrome]. clinicaltrials.gov/show/NCT03414190 (first received 29 January 2018). PassagliaLG , BrantLC , NascimentoBR , RibeiroAL . Impact of text messages in a middle-income country to promote secondary prevention after acute coronary syndrome (IMPACS): a randomized trial. Medicine2019;98(22):e15681. [DOI: 10.1097/MD.0000000000015681]PassagliaLG , BrantLC , SilvaJL , NascimentoBR , RibeiroAL . Text messages to promote secondary prevention after acute coronary syndrome (IMPACS trial). International Journal of Cardiovascular Sciences2021;35(2):202-13. [DOI: 10.36660/ijcs.20200378]">Passaglia 2021</a>; <a href="./references#CD011851-bbs2-0016" title="QuiliciJ , FugonL , BeguinS , MorangePE , BonnetJL , AlessiMC , et al. Effect of motivational mobile phone short message service on aspirin adherence after coronary stenting for acute coronary syndrome. International Journal of Cardiology2013;168(1):568-9. [DOI: 10.1016/j.ijcard.2013.01.252]">Quilici 2013</a>; <a href="./references#CD011851-bbs2-0017" title="NCT02336919. The use of texting messaging to improve the hospital-to-community transition period in cardiovascular disease patients (Txt2Prevent) [The use of texting messaging to improve the hospital-to-community transition and prevent readmission in patients with cardiovascular disease (Txt2Prevent)]. clinicaltrials.gov/ct2/show/NCT02336919 (first received 13 January 2015). RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of SMS text messaging to improve the hospital-to-community transition in patients with acute coronary syndrome (Txt2Prevent): results from a pilot randomized controlled trial. JMIR mHealth and uHealth2021;9(5):e24530. [DOI: 10.2196/24530]RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of text messaging to improve the hospital-to-community transition in acute coronary syndrome patients (Txt2Prevent): intervention development and pilot randomized controlled trial protocol. JMIR Research Protocols2017;6(5):e91. [DOI: 10.2196/resprot.6968]">Ross 2021</a>; <a href="./references#CD011851-bbs2-0018" title="HuoX , SpatzES , DingQ , HorakP , ZhengX , MastersC , et al. Design and rationale of the Cardiovascular Health and Text Messaging (CHAT) study and the CHAT-Diabetes Mellitus (CHAT-DM) study: two randomised controlled trials of text messaging to improve secondary prevention for coronary heart disease and diabetes. BMJ Open2017;7(12):e018302. [DOI: 10.1136/bmjopen-2017-018302]ZhengX , SpatzES , BaiX , HuoX , DingQ , HorakP , et al. Effect of text messaging on risk factor management in patients with coronary heart disease: the CHAT randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(4):e005616. [DOI: 10.1161/CIRCOUTCOMES.119.005616]">Zheng 2019</a>). In the original review, <a href="./references#CD011851-bbs2-0085" title="PandeyAK , ChoudhryN . Text message reminders to address medication non-adherence in post-MI patients: a one year intervention study. Canadian Journal of Cardiology2014;1:S179. [DOI: 10.1016/j.cjca.2014.07.280]">Pandey 2014</a> was included but only an abstract was available. The full paper of the abstract was published in 2017 (<a href="./references#CD011851-bbs2-0013" title="NCT02783287. The impact of text messaging on medication adherence and exercise regimen among post-myocardial infarction patients. clinicaltrials.gov/ct2/show/NCT02783287 (first received 26 May 2016). PandeyA , ChoudhryN . An m-health application of daily text messages to address forgetfulness as contributor to non-adherence to medications post-myocardial infarction. Circulation2015;132:A18641. [DOI: 10.1161/circ.132.suppl_3.18641]PandeyA , KrummeAA , PatelT , ChoudhryNK . The impact of text messaging on medication adherence and exercise among postmyocardial infarction patients: randomized controlled pilot trial. JMIR mHealth and uHealth2017;5(8):e110. [DOI: 10.2196/mhealth.7144]PandeyAK , ChoudhryN . Text message reminders to address medication non-adherence in post-MI patients: a one year intervention study. Canadian Journal of Cardiology2014;30(10):S179. [DOI: 10.1016/j.cjca.2014.07.280]">Pandey 2017</a>), therefore <a href="./references#CD011851-bbs2-0013" title="NCT02783287. The impact of text messaging on medication adherence and exercise regimen among post-myocardial infarction patients. clinicaltrials.gov/ct2/show/NCT02783287 (first received 26 May 2016). PandeyA , ChoudhryN . An m-health application of daily text messages to address forgetfulness as contributor to non-adherence to medications post-myocardial infarction. Circulation2015;132:A18641. [DOI: 10.1161/circ.132.suppl_3.18641]PandeyA , KrummeAA , PatelT , ChoudhryNK . The impact of text messaging on medication adherence and exercise among postmyocardial infarction patients: randomized controlled pilot trial. JMIR mHealth and uHealth2017;5(8):e110. [DOI: 10.2196/mhealth.7144]PandeyAK , ChoudhryN . Text message reminders to address medication non-adherence in post-MI patients: a one year intervention study. Canadian Journal of Cardiology2014;30(10):S179. [DOI: 10.1016/j.cjca.2014.07.280]">Pandey 2017</a> replaced <a href="./references#CD011851-bbs2-0085" title="PandeyAK , ChoudhryN . Text message reminders to address medication non-adherence in post-MI patients: a one year intervention study. Canadian Journal of Cardiology2014;1:S179. [DOI: 10.1016/j.cjca.2014.07.280]">Pandey 2014</a> in this review update. We attempted to make contact with the authors of two studies to obtain information on non‐fatal cardiovascular events (<a href="./references#CD011851-bbs2-0008" title="HuoX , KrumholzHM , BaiX , SpatzES , DingQ , HorakP , et al. Effects of mobile text messaging on glycemic control in patients with coronary heart disease and diabetes mellitus: a randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(9):e005805. [DOI: 10.1161/CIRCOUTCOMES.119.005805]NCT02883842. Cardiovascular Health and Text Messaging-Diabetes Mellitus (CHAT-DM) Study [Effectiveness of text messaging on risk factors control and medication adherence among patients with Coronary Heart Disease and Diabetes in China: cardiovascular health andtext messaging-Diabetes Mellitus (CHAT-DM) study]. clinicaltrials.gov/ct2/show/NCT02883842 (first received 30 August 2016). ">Huo 2019</a>; <a href="./references#CD011851-bbs2-0018" title="HuoX , SpatzES , DingQ , HorakP , ZhengX , MastersC , et al. Design and rationale of the Cardiovascular Health and Text Messaging (CHAT) study and the CHAT-Diabetes Mellitus (CHAT-DM) study: two randomised controlled trials of text messaging to improve secondary prevention for coronary heart disease and diabetes. BMJ Open2017;7(12):e018302. [DOI: 10.1136/bmjopen-2017-018302]ZhengX , SpatzES , BaiX , HuoX , DingQ , HorakP , et al. Effect of text messaging on risk factor management in patients with coronary heart disease: the CHAT randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(4):e005616. [DOI: 10.1161/CIRCOUTCOMES.119.005616]">Zheng 2019</a>), but did not receive a response. </p> <section id="CD011851-sec-0043"> <h5 class="title">Participants</h5> <p>The sample size of included studies ranged from 34, in <a href="./references#CD011851-bbs2-0013" title="NCT02783287. The impact of text messaging on medication adherence and exercise regimen among post-myocardial infarction patients. clinicaltrials.gov/ct2/show/NCT02783287 (first received 26 May 2016). PandeyA , ChoudhryN . An m-health application of daily text messages to address forgetfulness as contributor to non-adherence to medications post-myocardial infarction. Circulation2015;132:A18641. [DOI: 10.1161/circ.132.suppl_3.18641]PandeyA , KrummeAA , PatelT , ChoudhryNK . The impact of text messaging on medication adherence and exercise among postmyocardial infarction patients: randomized controlled pilot trial. JMIR mHealth and uHealth2017;5(8):e110. [DOI: 10.2196/mhealth.7144]PandeyAK , ChoudhryN . Text message reminders to address medication non-adherence in post-MI patients: a one year intervention study. Canadian Journal of Cardiology2014;30(10):S179. [DOI: 10.1016/j.cjca.2014.07.280]">Pandey 2017</a>, to 1424, in <a href="./references#CD011851-bbs2-0005" title="ACTRN12613000793718. TEXT messages to improve MEDication adherence &amp; Secondary prevention – TEXTMEDS [TEXT messages to improve MEDication adherence &amp; Secondary prevention in patients with acute coronary syndrome - TEXTMEDS]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364448&amp;isReview=true (first received 18 June 2013). ChowCK , KlimisH , ThiagalingamA , RedfernJ , HillisGS , BriegerD , et al. Text messages to improve medication adherence and secondary prevention after acute coronary syndrome: the TEXTMEDS randomized clinical trial. Circulation2022;145(19):1443-55. [DOI: 10.1161/CIRCULATIONAHA.121.056161]ChowCK , ThiagalingamA , SantoK , KokC , ThakkarJ , StepienS , et al. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol. BMJ Open2018;8:e019463. [DOI: 10.1136/bmjopen-2017-019463]">Chow 2022</a>. The total number of included participants was 8136, of which 7272 completed follow‐up. </p> <p>All 18 studies targeted people with CVD. Different definitions of CVD were used in the included studies. Six studies included participants with acute coronary syndrome (<a href="./references#CD011851-bbs2-0005" title="ACTRN12613000793718. TEXT messages to improve MEDication adherence &amp; Secondary prevention – TEXTMEDS [TEXT messages to improve MEDication adherence &amp; Secondary prevention in patients with acute coronary syndrome - TEXTMEDS]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364448&amp;isReview=true (first received 18 June 2013). ChowCK , KlimisH , ThiagalingamA , RedfernJ , HillisGS , BriegerD , et al. Text messages to improve medication adherence and secondary prevention after acute coronary syndrome: the TEXTMEDS randomized clinical trial. Circulation2022;145(19):1443-55. [DOI: 10.1161/CIRCULATIONAHA.121.056161]ChowCK , ThiagalingamA , SantoK , KokC , ThakkarJ , StepienS , et al. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol. BMJ Open2018;8:e019463. [DOI: 10.1136/bmjopen-2017-019463]">Chow 2022</a>; <a href="./references#CD011851-bbs2-0010" title="KhonsariS , SubramanianP , ChinnaK , LatifLA , LingLW , GholamiO . Effect of a reminder system using an automated short message service on medication adherence following acute coronary syndrome. European Journal of Cardiovascular Nursing2015;14(2):170-9. [DOI: 10.1177/1474515114521910]">Khonsari 2015</a>; <a href="./references#CD011851-bbs2-0011" title="ACTRN12616000422426. Text4Heart Partnership: a text messaging program to enhance self-management of cardiovascular disease [Text messaging to enhance self-management of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12616000422426 (first received 23 March 2016). MaddisonR , JiangY , StewartR , ScottT , KerrA , WhittakerR , et al. An intervention to improve medication adherence in people with heart disease (Text4HeartII): randomized controlled trial. JMIR mHealth and uHealth2021;9(6):e24952. [DOI: 10.2196/24952]MaddisonR , StewartR , DoughtyR , ScottT , KerrA , BenatarJ , et al. Text4Heart II - improving medication adherence in people with heart disease: a study protocol for a randomized controlled trial. Trials2018;19(1):70. [DOI: 10.1186/s13063-018-2468-z]">Maddison 2021</a>; <a href="./references#CD011851-bbs2-0015" title="NCT03414190. Impact of text messages to promote secondary prevention after acute coronary syndrome [Impact of a mobile phone text messages intervention on the secondary prevention of cardiovascular events after acute coronary syndrome]. clinicaltrials.gov/show/NCT03414190 (first received 29 January 2018). PassagliaLG , BrantLC , NascimentoBR , RibeiroAL . Impact of text messages in a middle-income country to promote secondary prevention after acute coronary syndrome (IMPACS): a randomized trial. Medicine2019;98(22):e15681. [DOI: 10.1097/MD.0000000000015681]PassagliaLG , BrantLC , SilvaJL , NascimentoBR , RibeiroAL . Text messages to promote secondary prevention after acute coronary syndrome (IMPACS trial). International Journal of Cardiovascular Sciences2021;35(2):202-13. [DOI: 10.36660/ijcs.20200378]">Passaglia 2021</a>; <a href="./references#CD011851-bbs2-0016" title="QuiliciJ , FugonL , BeguinS , MorangePE , BonnetJL , AlessiMC , et al. Effect of motivational mobile phone short message service on aspirin adherence after coronary stenting for acute coronary syndrome. International Journal of Cardiology2013;168(1):568-9. [DOI: 10.1016/j.ijcard.2013.01.252]">Quilici 2013</a>; <a href="./references#CD011851-bbs2-0017" title="NCT02336919. The use of texting messaging to improve the hospital-to-community transition period in cardiovascular disease patients (Txt2Prevent) [The use of texting messaging to improve the hospital-to-community transition and prevent readmission in patients with cardiovascular disease (Txt2Prevent)]. clinicaltrials.gov/ct2/show/NCT02336919 (first received 13 January 2015). RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of SMS text messaging to improve the hospital-to-community transition in patients with acute coronary syndrome (Txt2Prevent): results from a pilot randomized controlled trial. JMIR mHealth and uHealth2021;9(5):e24530. [DOI: 10.2196/24530]RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of text messaging to improve the hospital-to-community transition in acute coronary syndrome patients (Txt2Prevent): intervention development and pilot randomized controlled trial protocol. JMIR Research Protocols2017;6(5):e91. [DOI: 10.2196/resprot.6968]">Ross 2021</a>), and seven studies included participants with coronary heart disease (<a href="./references#CD011851-bbs2-0001" title="BaeJW , WooSI , LeeJ , ParkSD , KwonSW , ChoiSH , et al. mHealth interventions for lifestyle and risk factor modification in coronary heart disease: randomized controlled trial. JMIR mHealth and uHealth2021;9(9):e29928. [DOI: 10.2196/29928]KCT0005087. Effect of text messaging program on lifestyle and clinical outcomes in patients with cardiovascular disease. cris.nih.go.kr/cris/search/detailSearch.do/19282 (first received 11 September 2019). ">Bae 2021</a>; <a href="./references#CD011851-bbs2-0004" title="ACTRN12611000161921. Tobacco, EXercise and dieT MEssages (TEXT ME): the effect of semi-personalised lifestyle reminder text message intervention on cardiovascular disease risk [Tobacco, EXercise and dieT MEssages (TEXT ME): The effect of a semi-personalised lifestyle reminder text message intervention on cardiovascular risk factors in patients with cardiovascular disease and those who are at high risk of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12611000161921 (first received 3 February 2011). ChowCK , RedfernJ , HillisGS , ThakkarJ , SantoK , HackettML , et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA2015;314(12):1255-63. [DOI: 10.1001/jama.2015.10945]ChowCK , RedfernJ , ThiagalingamA , JanS , WhittakerR , HackettM , et al. Design and rationale of the tobacco, exercise and diet messages (TEXT ME) trial of a text message-based intervention for ongoing prevention of cardiovascular disease in people with coronary disease: a randomised controlled trial protocol. BMJ Open2012;2(1):e000606. [DOI: 10.1136/bmjopen-2011-000606]RedfernJ , SantoK , CooreyG , ThakkarJ , HackettM , ThiagalingamA , et al. Factors influencing engagement, perceived usefulness and behavioral mechanisms associated with a text message support program. PLOS ONE2016;11(10):e0163929. [DOI: 10.1371/journal.pone.0163929]ThakkarJ , RedfernJ , De KeizerL , ThiagalingamA , ChowC . Patient perceptions of text message-based intervention for secondary prevention of cardiovascular events. Heart, Lung and Circulation2013;22(Suppl 1):S264. [DOI: 10.1016/j.hlc.2013.05.630]ThakkarJ , RedfernJ , ThiagalingamA , ChowCK . Patterns, predictors and effects of texting intervention on physical activity in CHD – insights from the TEXT ME randomized clinical trial. European Journal of Preventive Cardiology2016;23(17):1894-902. [DOI: 10.1177/2047487316664190]">Chow 2015</a>; <a href="./references#CD011851-bbs2-0006" title="ACTRN12613000901707. Text4Heart: a text message and internet-based comprehensive cardiac rehabilitation intervention [A randomised controlled trial to determine the efficacy of a text message and Internet-based comprehensive cardiac rehabilitation programme to improve adherence to lifestyle change compared with usual care in New Zealand adults with a diagnosis of cardiovascular disease]. anzctr.org.au/ACTRN12613000901707.aspx (first received 9 August 2013). DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Improving coronary heart disease self-management using mobile technologies (Text4Heart): a randomised controlled trial protocol. Trials2014;15(71):1-9. [DOI: 10.1186/1745-6215-15-71]DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Text message and internet support for coronary heart disease self-management: results from the Text4Heart randomized controlled trial. Journal of Medical Internet Research2015;17(10):e237. [DOI: 10.2196/jmir.4944]">Dale 2015a</a>; <a href="./references#CD011851-bbs2-0008" title="HuoX , KrumholzHM , BaiX , SpatzES , DingQ , HorakP , et al. Effects of mobile text messaging on glycemic control in patients with coronary heart disease and diabetes mellitus: a randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(9):e005805. [DOI: 10.1161/CIRCOUTCOMES.119.005805]NCT02883842. Cardiovascular Health and Text Messaging-Diabetes Mellitus (CHAT-DM) Study [Effectiveness of text messaging on risk factors control and medication adherence among patients with Coronary Heart Disease and Diabetes in China: cardiovascular health andtext messaging-Diabetes Mellitus (CHAT-DM) study]. clinicaltrials.gov/ct2/show/NCT02883842 (first received 30 August 2016). ">Huo 2019</a>; <a href="./references#CD011851-bbs2-0012" title="NCT02793830. A mobile phone based medication reminder program [A mobile phone based medication reminder program for patients in China with coronary heart disease: a pilot study]. clinicaltrials.gov/ct2/show/NCT02793830 (first received 8 June 2016). NiZ , WuB , YangQ , YanLL , LiuC , ShawRJ . An mHealth intervention to improve medication adherence and health outcomes among patients with coronary heart disease: randomized controlled trial. Journal of Medical Internet Research2022;24(3):e27202. [DOI: 10.2196/27202]">Ni 2022</a>; <a href="./references#CD011851-bbs2-0014" title="ParkLG , Howie-EsquivelJ , ChungM , DracupK . A text messaging intervention improves medication adherence for patients with coronary heart disease: a randomized controlled trial. Circulation2013;128(Suppl 22):A15249. [DOI: 10.1161/circ.128.suppl_22.A15249]ParkLG , Howie-EsquivelJ , ChungML , DracupK . A text messaging intervention to promote medication adherence for patients with coronary heart disease: a randomized controlled trial. Patient Education and Counseling2014;94(2):261-8. [DOI: 10.1016/j.pec.2013.10.027]ParkLG , Howie-EsquivelJ , WhooleyMA , DracupK . Psychosocial factors and medication adherence among patients with coronary heart disease: a text messaging intervention. European Journal of Cardiovascular Nursing2015;14(3):264-73. [DOI: 10.1177/1474515114537024]">Park 2014a</a>; <a href="./references#CD011851-bbs2-0018" title="HuoX , SpatzES , DingQ , HorakP , ZhengX , MastersC , et al. Design and rationale of the Cardiovascular Health and Text Messaging (CHAT) study and the CHAT-Diabetes Mellitus (CHAT-DM) study: two randomised controlled trials of text messaging to improve secondary prevention for coronary heart disease and diabetes. BMJ Open2017;7(12):e018302. [DOI: 10.1136/bmjopen-2017-018302]ZhengX , SpatzES , BaiX , HuoX , DingQ , HorakP , et al. Effect of text messaging on risk factor management in patients with coronary heart disease: the CHAT randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(4):e005616. [DOI: 10.1161/CIRCOUTCOMES.119.005616]">Zheng 2019</a>). <a href="./references#CD011851-bbs2-0009" title="KamalAK , ShaikQN , PashaO , AzamI , IslamM , MemonAA , et al. Improving medication adherence in stroke patients through Short Text Messages (SMS4Stroke)-study protocol for a randomized, controlled trial. BMC Neurology2015;15:157. [DOI: 10.1186/s12883-015-0413-2]KamalAK , ShaikhQ , PashaO , AzamI , IslamM , MemonAA , et al. A randomized controlled behavioral intervention trial to improve medication adherence in adult stroke patients with prescription tailored short messaging service (SMS)-SMS4Stroke study. BMC Neurolology2015;15:212. [DOI: 10.1186/s12883-015-0471-5]">Kamal 2015</a> reported on participants with stroke. <a href="./references#CD011851-bbs2-0003" title="ChenC , LiX , KangY , LiuH , LiangYD , ZhangQ . Post-discharge short service message improves short-term clinical outcome and self-care behavior in Chinese patients with chronic heart failure. European Heart Journal2018;39(Suppl 1):797-8. [DOI: 10.1093/eurheartj/ehy563.P3770]ChenC , LiX , SunL , CaoS , KangY , HongL , et al. Post-discharge short message service improves short-term clinical outcome and self-care behaviour in chronic heart failure. ESC Heart Failure2019;6(1):164-73. [DOI: 10.1002/ehf2.12380]ChiCTR-INR-17012316. Effect of post-discharge text messages on clinical outcomes in patients with heart failure [Effect of post-discharge text messages on clinical outcomes in patients with heart failure]. trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR-INR-17012316 (first received 9 August 2018). LiX , ChenC , YouGY , ZhangQ . Post-discharge text messaging intervention improved clinical outcomes in patients with heart failure. European Heart Journal2016;37(Suppl 1):727-8. [DOI: 10.1093/eurheartj/ehw433]">Chen 2019</a> included participants with chronic heart failure. <a href="./references#CD011851-bbs2-0013" title="NCT02783287. The impact of text messaging on medication adherence and exercise regimen among post-myocardial infarction patients. clinicaltrials.gov/ct2/show/NCT02783287 (first received 26 May 2016). PandeyA , ChoudhryN . An m-health application of daily text messages to address forgetfulness as contributor to non-adherence to medications post-myocardial infarction. Circulation2015;132:A18641. [DOI: 10.1161/circ.132.suppl_3.18641]PandeyA , KrummeAA , PatelT , ChoudhryNK . The impact of text messaging on medication adherence and exercise among postmyocardial infarction patients: randomized controlled pilot trial. JMIR mHealth and uHealth2017;5(8):e110. [DOI: 10.2196/mhealth.7144]PandeyAK , ChoudhryN . Text message reminders to address medication non-adherence in post-MI patients: a one year intervention study. Canadian Journal of Cardiology2014;30(10):S179. [DOI: 10.1016/j.cjca.2014.07.280]">Pandey 2017</a> included participants with myocardial infarction. <a href="./references#CD011851-bbs2-0007" title="FangR , LiX . Electronic messaging support service programs improve adherence to lipid-lowering therapy among outpatients with coronary artery disease: an exploratory randomised control study. Journal of Clinical Nursing2016;25(5-6):664-71. [DOI: 10.1111/jocn.12988]">Fang 2016</a> included participants with chronic stable angina. <a href="./references#CD011851-bbs2-0002" title="BermonA , UribeAF , Pérez-RiveroPF , Prieto-MerinoD , SaaibiJF , SilvaFA , et al. Efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: TXT2HEART Colombia randomized controlled trial. JMIR mHealth and uHealth2021;9(7):e25548. [DOI: 10.2196/25548]BermonA , Uribe-RodríguezAF , Pérez-RiveroPF , Prieto-MerinoD , RiveraDIC , GuioE , et al. Evaluation of the efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: the txt2heart Colombia randomised controlled trial protocol. BMJ Open2019;9:e028017. [DOI: 10.1136/ bmjopen-2018-028017]NCT03098186. TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention [TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention]. clinicaltrials.gov/ct2/show/NCT03098186 (first received 3 March 2017). ">Bermon 2021</a> included participants with arterial occlusive events, including acute coronary syndrome, stable angina, ischaemic cerebrovascular disease, peripheral arterial disease, and coronary revascularisation. </p> <p>The mean age ranged from 53.6 years, in <a href="./references#CD011851-bbs2-0007" title="FangR , LiX . Electronic messaging support service programs improve adherence to lipid-lowering therapy among outpatients with coronary artery disease: an exploratory randomised control study. Journal of Clinical Nursing2016;25(5-6):664-71. [DOI: 10.1111/jocn.12988]">Fang 2016</a>, to 64 years, in <a href="./references#CD011851-bbs2-0016" title="QuiliciJ , FugonL , BeguinS , MorangePE , BonnetJL , AlessiMC , et al. Effect of motivational mobile phone short message service on aspirin adherence after coronary stenting for acute coronary syndrome. International Journal of Cardiology2013;168(1):568-9. [DOI: 10.1016/j.ijcard.2013.01.252]">Quilici 2013</a>. The proportion of male participants was higher than 70% in all studies. Only three studies had a proportion of male participants of less than 70%: <a href="./references#CD011851-bbs2-0013" title="NCT02783287. The impact of text messaging on medication adherence and exercise regimen among post-myocardial infarction patients. clinicaltrials.gov/ct2/show/NCT02783287 (first received 26 May 2016). PandeyA , ChoudhryN . An m-health application of daily text messages to address forgetfulness as contributor to non-adherence to medications post-myocardial infarction. Circulation2015;132:A18641. [DOI: 10.1161/circ.132.suppl_3.18641]PandeyA , KrummeAA , PatelT , ChoudhryNK . The impact of text messaging on medication adherence and exercise among postmyocardial infarction patients: randomized controlled pilot trial. JMIR mHealth and uHealth2017;5(8):e110. [DOI: 10.2196/mhealth.7144]PandeyAK , ChoudhryN . Text message reminders to address medication non-adherence in post-MI patients: a one year intervention study. Canadian Journal of Cardiology2014;30(10):S179. [DOI: 10.1016/j.cjca.2014.07.280]">Pandey 2017</a> (59% males), <a href="./references#CD011851-bbs2-0009" title="KamalAK , ShaikQN , PashaO , AzamI , IslamM , MemonAA , et al. Improving medication adherence in stroke patients through Short Text Messages (SMS4Stroke)-study protocol for a randomized, controlled trial. BMC Neurology2015;15:157. [DOI: 10.1186/s12883-015-0413-2]KamalAK , ShaikhQ , PashaO , AzamI , IslamM , MemonAA , et al. A randomized controlled behavioral intervention trial to improve medication adherence in adult stroke patients with prescription tailored short messaging service (SMS)-SMS4Stroke study. BMC Neurolology2015;15:212. [DOI: 10.1186/s12883-015-0471-5]">Kamal 2015</a> (67.5% males), and <a href="./references#CD011851-bbs2-0003" title="ChenC , LiX , KangY , LiuH , LiangYD , ZhangQ . Post-discharge short service message improves short-term clinical outcome and self-care behavior in Chinese patients with chronic heart failure. European Heart Journal2018;39(Suppl 1):797-8. [DOI: 10.1093/eurheartj/ehy563.P3770]ChenC , LiX , SunL , CaoS , KangY , HongL , et al. Post-discharge short message service improves short-term clinical outcome and self-care behaviour in chronic heart failure. ESC Heart Failure2019;6(1):164-73. [DOI: 10.1002/ehf2.12380]ChiCTR-INR-17012316. Effect of post-discharge text messages on clinical outcomes in patients with heart failure [Effect of post-discharge text messages on clinical outcomes in patients with heart failure]. trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR-INR-17012316 (first received 9 August 2018). LiX , ChenC , YouGY , ZhangQ . Post-discharge text messaging intervention improved clinical outcomes in patients with heart failure. European Heart Journal2016;37(Suppl 1):727-8. [DOI: 10.1093/eurheartj/ehw433]">Chen 2019</a> (56.5% males). </p> </section> <section id="CD011851-sec-0044"> <h5 class="title">Settings</h5> <p>Sixteen studies recruited participants from hospitals including large metropolitan hospitals (<a href="./references#CD011851-bbs2-0006" title="ACTRN12613000901707. Text4Heart: a text message and internet-based comprehensive cardiac rehabilitation intervention [A randomised controlled trial to determine the efficacy of a text message and Internet-based comprehensive cardiac rehabilitation programme to improve adherence to lifestyle change compared with usual care in New Zealand adults with a diagnosis of cardiovascular disease]. anzctr.org.au/ACTRN12613000901707.aspx (first received 9 August 2013). DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Improving coronary heart disease self-management using mobile technologies (Text4Heart): a randomised controlled trial protocol. Trials2014;15(71):1-9. [DOI: 10.1186/1745-6215-15-71]DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Text message and internet support for coronary heart disease self-management: results from the Text4Heart randomized controlled trial. Journal of Medical Internet Research2015;17(10):e237. [DOI: 10.2196/jmir.4944]">Dale 2015a</a>; <a href="./references#CD011851-bbs2-0007" title="FangR , LiX . Electronic messaging support service programs improve adherence to lipid-lowering therapy among outpatients with coronary artery disease: an exploratory randomised control study. Journal of Clinical Nursing2016;25(5-6):664-71. [DOI: 10.1111/jocn.12988]">Fang 2016</a>; <a href="./references#CD011851-bbs2-0011" title="ACTRN12616000422426. Text4Heart Partnership: a text messaging program to enhance self-management of cardiovascular disease [Text messaging to enhance self-management of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12616000422426 (first received 23 March 2016). MaddisonR , JiangY , StewartR , ScottT , KerrA , WhittakerR , et al. An intervention to improve medication adherence in people with heart disease (Text4HeartII): randomized controlled trial. JMIR mHealth and uHealth2021;9(6):e24952. [DOI: 10.2196/24952]MaddisonR , StewartR , DoughtyR , ScottT , KerrA , BenatarJ , et al. Text4Heart II - improving medication adherence in people with heart disease: a study protocol for a randomized controlled trial. Trials2018;19(1):70. [DOI: 10.1186/s13063-018-2468-z]">Maddison 2021</a>), tertiary teaching hospital (<a href="./references#CD011851-bbs2-0001" title="BaeJW , WooSI , LeeJ , ParkSD , KwonSW , ChoiSH , et al. mHealth interventions for lifestyle and risk factor modification in coronary heart disease: randomized controlled trial. JMIR mHealth and uHealth2021;9(9):e29928. [DOI: 10.2196/29928]KCT0005087. Effect of text messaging program on lifestyle and clinical outcomes in patients with cardiovascular disease. cris.nih.go.kr/cris/search/detailSearch.do/19282 (first received 11 September 2019). ">Bae 2021</a>; <a href="./references#CD011851-bbs2-0004" title="ACTRN12611000161921. Tobacco, EXercise and dieT MEssages (TEXT ME): the effect of semi-personalised lifestyle reminder text message intervention on cardiovascular disease risk [Tobacco, EXercise and dieT MEssages (TEXT ME): The effect of a semi-personalised lifestyle reminder text message intervention on cardiovascular risk factors in patients with cardiovascular disease and those who are at high risk of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12611000161921 (first received 3 February 2011). ChowCK , RedfernJ , HillisGS , ThakkarJ , SantoK , HackettML , et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA2015;314(12):1255-63. [DOI: 10.1001/jama.2015.10945]ChowCK , RedfernJ , ThiagalingamA , JanS , WhittakerR , HackettM , et al. Design and rationale of the tobacco, exercise and diet messages (TEXT ME) trial of a text message-based intervention for ongoing prevention of cardiovascular disease in people with coronary disease: a randomised controlled trial protocol. BMJ Open2012;2(1):e000606. [DOI: 10.1136/bmjopen-2011-000606]RedfernJ , SantoK , CooreyG , ThakkarJ , HackettM , ThiagalingamA , et al. Factors influencing engagement, perceived usefulness and behavioral mechanisms associated with a text message support program. PLOS ONE2016;11(10):e0163929. [DOI: 10.1371/journal.pone.0163929]ThakkarJ , RedfernJ , De KeizerL , ThiagalingamA , ChowC . Patient perceptions of text message-based intervention for secondary prevention of cardiovascular events. Heart, Lung and Circulation2013;22(Suppl 1):S264. [DOI: 10.1016/j.hlc.2013.05.630]ThakkarJ , RedfernJ , ThiagalingamA , ChowCK . Patterns, predictors and effects of texting intervention on physical activity in CHD – insights from the TEXT ME randomized clinical trial. European Journal of Preventive Cardiology2016;23(17):1894-902. [DOI: 10.1177/2047487316664190]">Chow 2015</a>; <a href="./references#CD011851-bbs2-0005" title="ACTRN12613000793718. TEXT messages to improve MEDication adherence &amp; Secondary prevention – TEXTMEDS [TEXT messages to improve MEDication adherence &amp; Secondary prevention in patients with acute coronary syndrome - TEXTMEDS]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364448&amp;isReview=true (first received 18 June 2013). ChowCK , KlimisH , ThiagalingamA , RedfernJ , HillisGS , BriegerD , et al. Text messages to improve medication adherence and secondary prevention after acute coronary syndrome: the TEXTMEDS randomized clinical trial. Circulation2022;145(19):1443-55. [DOI: 10.1161/CIRCULATIONAHA.121.056161]ChowCK , ThiagalingamA , SantoK , KokC , ThakkarJ , StepienS , et al. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol. BMJ Open2018;8:e019463. [DOI: 10.1136/bmjopen-2017-019463]">Chow 2022</a>; <a href="./references#CD011851-bbs2-0008" title="HuoX , KrumholzHM , BaiX , SpatzES , DingQ , HorakP , et al. Effects of mobile text messaging on glycemic control in patients with coronary heart disease and diabetes mellitus: a randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(9):e005805. [DOI: 10.1161/CIRCOUTCOMES.119.005805]NCT02883842. Cardiovascular Health and Text Messaging-Diabetes Mellitus (CHAT-DM) Study [Effectiveness of text messaging on risk factors control and medication adherence among patients with Coronary Heart Disease and Diabetes in China: cardiovascular health andtext messaging-Diabetes Mellitus (CHAT-DM) study]. clinicaltrials.gov/ct2/show/NCT02883842 (first received 30 August 2016). ">Huo 2019</a>; <a href="./references#CD011851-bbs2-0009" title="KamalAK , ShaikQN , PashaO , AzamI , IslamM , MemonAA , et al. Improving medication adherence in stroke patients through Short Text Messages (SMS4Stroke)-study protocol for a randomized, controlled trial. BMC Neurology2015;15:157. [DOI: 10.1186/s12883-015-0413-2]KamalAK , ShaikhQ , PashaO , AzamI , IslamM , MemonAA , et al. A randomized controlled behavioral intervention trial to improve medication adherence in adult stroke patients with prescription tailored short messaging service (SMS)-SMS4Stroke study. BMC Neurolology2015;15:212. [DOI: 10.1186/s12883-015-0471-5]">Kamal 2015</a>; <a href="./references#CD011851-bbs2-0010" title="KhonsariS , SubramanianP , ChinnaK , LatifLA , LingLW , GholamiO . Effect of a reminder system using an automated short message service on medication adherence following acute coronary syndrome. European Journal of Cardiovascular Nursing2015;14(2):170-9. [DOI: 10.1177/1474515114521910]">Khonsari 2015</a>; <a href="./references#CD011851-bbs2-0012" title="NCT02793830. A mobile phone based medication reminder program [A mobile phone based medication reminder program for patients in China with coronary heart disease: a pilot study]. clinicaltrials.gov/ct2/show/NCT02793830 (first received 8 June 2016). NiZ , WuB , YangQ , YanLL , LiuC , ShawRJ . An mHealth intervention to improve medication adherence and health outcomes among patients with coronary heart disease: randomized controlled trial. Journal of Medical Internet Research2022;24(3):e27202. [DOI: 10.2196/27202]">Ni 2022</a>; <a href="./references#CD011851-bbs2-0015" title="NCT03414190. Impact of text messages to promote secondary prevention after acute coronary syndrome [Impact of a mobile phone text messages intervention on the secondary prevention of cardiovascular events after acute coronary syndrome]. clinicaltrials.gov/show/NCT03414190 (first received 29 January 2018). PassagliaLG , BrantLC , NascimentoBR , RibeiroAL . Impact of text messages in a middle-income country to promote secondary prevention after acute coronary syndrome (IMPACS): a randomized trial. Medicine2019;98(22):e15681. [DOI: 10.1097/MD.0000000000015681]PassagliaLG , BrantLC , SilvaJL , NascimentoBR , RibeiroAL . Text messages to promote secondary prevention after acute coronary syndrome (IMPACS trial). International Journal of Cardiovascular Sciences2021;35(2):202-13. [DOI: 10.36660/ijcs.20200378]">Passaglia 2021</a>; <a href="./references#CD011851-bbs2-0017" title="NCT02336919. The use of texting messaging to improve the hospital-to-community transition period in cardiovascular disease patients (Txt2Prevent) [The use of texting messaging to improve the hospital-to-community transition and prevent readmission in patients with cardiovascular disease (Txt2Prevent)]. clinicaltrials.gov/ct2/show/NCT02336919 (first received 13 January 2015). RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of SMS text messaging to improve the hospital-to-community transition in patients with acute coronary syndrome (Txt2Prevent): results from a pilot randomized controlled trial. JMIR mHealth and uHealth2021;9(5):e24530. [DOI: 10.2196/24530]RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of text messaging to improve the hospital-to-community transition in acute coronary syndrome patients (Txt2Prevent): intervention development and pilot randomized controlled trial protocol. JMIR Research Protocols2017;6(5):e91. [DOI: 10.2196/resprot.6968]">Ross 2021</a>; <a href="./references#CD011851-bbs2-0018" title="HuoX , SpatzES , DingQ , HorakP , ZhengX , MastersC , et al. Design and rationale of the Cardiovascular Health and Text Messaging (CHAT) study and the CHAT-Diabetes Mellitus (CHAT-DM) study: two randomised controlled trials of text messaging to improve secondary prevention for coronary heart disease and diabetes. BMJ Open2017;7(12):e018302. [DOI: 10.1136/bmjopen-2017-018302]ZhengX , SpatzES , BaiX , HuoX , DingQ , HorakP , et al. Effect of text messaging on risk factor management in patients with coronary heart disease: the CHAT randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(4):e005616. [DOI: 10.1161/CIRCOUTCOMES.119.005616]">Zheng 2019</a>), tertiary referral hospital (<a href="./references#CD011851-bbs2-0002" title="BermonA , UribeAF , Pérez-RiveroPF , Prieto-MerinoD , SaaibiJF , SilvaFA , et al. Efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: TXT2HEART Colombia randomized controlled trial. JMIR mHealth and uHealth2021;9(7):e25548. [DOI: 10.2196/25548]BermonA , Uribe-RodríguezAF , Pérez-RiveroPF , Prieto-MerinoD , RiveraDIC , GuioE , et al. Evaluation of the efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: the txt2heart Colombia randomised controlled trial protocol. BMJ Open2019;9:e028017. [DOI: 10.1136/ bmjopen-2018-028017]NCT03098186. TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention [TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention]. clinicaltrials.gov/ct2/show/NCT03098186 (first received 3 March 2017). ">Bermon 2021</a>; <a href="./references#CD011851-bbs2-0003" title="ChenC , LiX , KangY , LiuH , LiangYD , ZhangQ . Post-discharge short service message improves short-term clinical outcome and self-care behavior in Chinese patients with chronic heart failure. European Heart Journal2018;39(Suppl 1):797-8. [DOI: 10.1093/eurheartj/ehy563.P3770]ChenC , LiX , SunL , CaoS , KangY , HongL , et al. Post-discharge short message service improves short-term clinical outcome and self-care behaviour in chronic heart failure. ESC Heart Failure2019;6(1):164-73. [DOI: 10.1002/ehf2.12380]ChiCTR-INR-17012316. Effect of post-discharge text messages on clinical outcomes in patients with heart failure [Effect of post-discharge text messages on clinical outcomes in patients with heart failure]. trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR-INR-17012316 (first received 9 August 2018). LiX , ChenC , YouGY , ZhangQ . Post-discharge text messaging intervention improved clinical outcomes in patients with heart failure. European Heart Journal2016;37(Suppl 1):727-8. [DOI: 10.1093/eurheartj/ehw433]">Chen 2019</a>), and non‐profit community hospital (<a href="./references#CD011851-bbs2-0014" title="ParkLG , Howie-EsquivelJ , ChungM , DracupK . A text messaging intervention improves medication adherence for patients with coronary heart disease: a randomized controlled trial. Circulation2013;128(Suppl 22):A15249. [DOI: 10.1161/circ.128.suppl_22.A15249]ParkLG , Howie-EsquivelJ , ChungML , DracupK . A text messaging intervention to promote medication adherence for patients with coronary heart disease: a randomized controlled trial. Patient Education and Counseling2014;94(2):261-8. [DOI: 10.1016/j.pec.2013.10.027]ParkLG , Howie-EsquivelJ , WhooleyMA , DracupK . Psychosocial factors and medication adherence among patients with coronary heart disease: a text messaging intervention. European Journal of Cardiovascular Nursing2015;14(3):264-73. [DOI: 10.1177/1474515114537024]">Park 2014a</a>). One study took place in a cardiac rehabilitation facility (<a href="./references#CD011851-bbs2-0013" title="NCT02783287. The impact of text messaging on medication adherence and exercise regimen among post-myocardial infarction patients. clinicaltrials.gov/ct2/show/NCT02783287 (first received 26 May 2016). PandeyA , ChoudhryN . An m-health application of daily text messages to address forgetfulness as contributor to non-adherence to medications post-myocardial infarction. Circulation2015;132:A18641. [DOI: 10.1161/circ.132.suppl_3.18641]PandeyA , KrummeAA , PatelT , ChoudhryNK . The impact of text messaging on medication adherence and exercise among postmyocardial infarction patients: randomized controlled pilot trial. JMIR mHealth and uHealth2017;5(8):e110. [DOI: 10.2196/mhealth.7144]PandeyAK , ChoudhryN . Text message reminders to address medication non-adherence in post-MI patients: a one year intervention study. Canadian Journal of Cardiology2014;30(10):S179. [DOI: 10.1016/j.cjca.2014.07.280]">Pandey 2017</a>). In one study the setting was not reported (<a href="./references#CD011851-bbs2-0016" title="QuiliciJ , FugonL , BeguinS , MorangePE , BonnetJL , AlessiMC , et al. Effect of motivational mobile phone short message service on aspirin adherence after coronary stenting for acute coronary syndrome. International Journal of Cardiology2013;168(1):568-9. [DOI: 10.1016/j.ijcard.2013.01.252]">Quilici 2013</a>). </p> <p>Seventeen studies reported the country in which they took place: Australia (<a href="./references#CD011851-bbs2-0004" title="ACTRN12611000161921. Tobacco, EXercise and dieT MEssages (TEXT ME): the effect of semi-personalised lifestyle reminder text message intervention on cardiovascular disease risk [Tobacco, EXercise and dieT MEssages (TEXT ME): The effect of a semi-personalised lifestyle reminder text message intervention on cardiovascular risk factors in patients with cardiovascular disease and those who are at high risk of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12611000161921 (first received 3 February 2011). ChowCK , RedfernJ , HillisGS , ThakkarJ , SantoK , HackettML , et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA2015;314(12):1255-63. [DOI: 10.1001/jama.2015.10945]ChowCK , RedfernJ , ThiagalingamA , JanS , WhittakerR , HackettM , et al. Design and rationale of the tobacco, exercise and diet messages (TEXT ME) trial of a text message-based intervention for ongoing prevention of cardiovascular disease in people with coronary disease: a randomised controlled trial protocol. BMJ Open2012;2(1):e000606. [DOI: 10.1136/bmjopen-2011-000606]RedfernJ , SantoK , CooreyG , ThakkarJ , HackettM , ThiagalingamA , et al. Factors influencing engagement, perceived usefulness and behavioral mechanisms associated with a text message support program. PLOS ONE2016;11(10):e0163929. [DOI: 10.1371/journal.pone.0163929]ThakkarJ , RedfernJ , De KeizerL , ThiagalingamA , ChowC . Patient perceptions of text message-based intervention for secondary prevention of cardiovascular events. Heart, Lung and Circulation2013;22(Suppl 1):S264. [DOI: 10.1016/j.hlc.2013.05.630]ThakkarJ , RedfernJ , ThiagalingamA , ChowCK . Patterns, predictors and effects of texting intervention on physical activity in CHD – insights from the TEXT ME randomized clinical trial. European Journal of Preventive Cardiology2016;23(17):1894-902. [DOI: 10.1177/2047487316664190]">Chow 2015</a>; <a href="./references#CD011851-bbs2-0005" title="ACTRN12613000793718. TEXT messages to improve MEDication adherence &amp; Secondary prevention – TEXTMEDS [TEXT messages to improve MEDication adherence &amp; Secondary prevention in patients with acute coronary syndrome - TEXTMEDS]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364448&amp;isReview=true (first received 18 June 2013). ChowCK , KlimisH , ThiagalingamA , RedfernJ , HillisGS , BriegerD , et al. Text messages to improve medication adherence and secondary prevention after acute coronary syndrome: the TEXTMEDS randomized clinical trial. Circulation2022;145(19):1443-55. [DOI: 10.1161/CIRCULATIONAHA.121.056161]ChowCK , ThiagalingamA , SantoK , KokC , ThakkarJ , StepienS , et al. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol. BMJ Open2018;8:e019463. [DOI: 10.1136/bmjopen-2017-019463]">Chow 2022</a>), China (<a href="./references#CD011851-bbs2-0003" title="ChenC , LiX , KangY , LiuH , LiangYD , ZhangQ . Post-discharge short service message improves short-term clinical outcome and self-care behavior in Chinese patients with chronic heart failure. European Heart Journal2018;39(Suppl 1):797-8. [DOI: 10.1093/eurheartj/ehy563.P3770]ChenC , LiX , SunL , CaoS , KangY , HongL , et al. Post-discharge short message service improves short-term clinical outcome and self-care behaviour in chronic heart failure. ESC Heart Failure2019;6(1):164-73. [DOI: 10.1002/ehf2.12380]ChiCTR-INR-17012316. Effect of post-discharge text messages on clinical outcomes in patients with heart failure [Effect of post-discharge text messages on clinical outcomes in patients with heart failure]. trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR-INR-17012316 (first received 9 August 2018). LiX , ChenC , YouGY , ZhangQ . Post-discharge text messaging intervention improved clinical outcomes in patients with heart failure. European Heart Journal2016;37(Suppl 1):727-8. [DOI: 10.1093/eurheartj/ehw433]">Chen 2019</a>; <a href="./references#CD011851-bbs2-0007" title="FangR , LiX . Electronic messaging support service programs improve adherence to lipid-lowering therapy among outpatients with coronary artery disease: an exploratory randomised control study. Journal of Clinical Nursing2016;25(5-6):664-71. [DOI: 10.1111/jocn.12988]">Fang 2016</a>; <a href="./references#CD011851-bbs2-0008" title="HuoX , KrumholzHM , BaiX , SpatzES , DingQ , HorakP , et al. Effects of mobile text messaging on glycemic control in patients with coronary heart disease and diabetes mellitus: a randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(9):e005805. [DOI: 10.1161/CIRCOUTCOMES.119.005805]NCT02883842. Cardiovascular Health and Text Messaging-Diabetes Mellitus (CHAT-DM) Study [Effectiveness of text messaging on risk factors control and medication adherence among patients with Coronary Heart Disease and Diabetes in China: cardiovascular health andtext messaging-Diabetes Mellitus (CHAT-DM) study]. clinicaltrials.gov/ct2/show/NCT02883842 (first received 30 August 2016). ">Huo 2019</a>; <a href="./references#CD011851-bbs2-0012" title="NCT02793830. A mobile phone based medication reminder program [A mobile phone based medication reminder program for patients in China with coronary heart disease: a pilot study]. clinicaltrials.gov/ct2/show/NCT02793830 (first received 8 June 2016). NiZ , WuB , YangQ , YanLL , LiuC , ShawRJ . An mHealth intervention to improve medication adherence and health outcomes among patients with coronary heart disease: randomized controlled trial. Journal of Medical Internet Research2022;24(3):e27202. [DOI: 10.2196/27202]">Ni 2022</a>; <a href="./references#CD011851-bbs2-0018" title="HuoX , SpatzES , DingQ , HorakP , ZhengX , MastersC , et al. Design and rationale of the Cardiovascular Health and Text Messaging (CHAT) study and the CHAT-Diabetes Mellitus (CHAT-DM) study: two randomised controlled trials of text messaging to improve secondary prevention for coronary heart disease and diabetes. BMJ Open2017;7(12):e018302. [DOI: 10.1136/bmjopen-2017-018302]ZhengX , SpatzES , BaiX , HuoX , DingQ , HorakP , et al. Effect of text messaging on risk factor management in patients with coronary heart disease: the CHAT randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(4):e005616. [DOI: 10.1161/CIRCOUTCOMES.119.005616]">Zheng 2019</a>), Canada (<a href="./references#CD011851-bbs2-0013" title="NCT02783287. The impact of text messaging on medication adherence and exercise regimen among post-myocardial infarction patients. clinicaltrials.gov/ct2/show/NCT02783287 (first received 26 May 2016). PandeyA , ChoudhryN . An m-health application of daily text messages to address forgetfulness as contributor to non-adherence to medications post-myocardial infarction. Circulation2015;132:A18641. [DOI: 10.1161/circ.132.suppl_3.18641]PandeyA , KrummeAA , PatelT , ChoudhryNK . The impact of text messaging on medication adherence and exercise among postmyocardial infarction patients: randomized controlled pilot trial. JMIR mHealth and uHealth2017;5(8):e110. [DOI: 10.2196/mhealth.7144]PandeyAK , ChoudhryN . Text message reminders to address medication non-adherence in post-MI patients: a one year intervention study. Canadian Journal of Cardiology2014;30(10):S179. [DOI: 10.1016/j.cjca.2014.07.280]">Pandey 2017</a>; <a href="./references#CD011851-bbs2-0017" title="NCT02336919. The use of texting messaging to improve the hospital-to-community transition period in cardiovascular disease patients (Txt2Prevent) [The use of texting messaging to improve the hospital-to-community transition and prevent readmission in patients with cardiovascular disease (Txt2Prevent)]. clinicaltrials.gov/ct2/show/NCT02336919 (first received 13 January 2015). RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of SMS text messaging to improve the hospital-to-community transition in patients with acute coronary syndrome (Txt2Prevent): results from a pilot randomized controlled trial. JMIR mHealth and uHealth2021;9(5):e24530. [DOI: 10.2196/24530]RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of text messaging to improve the hospital-to-community transition in acute coronary syndrome patients (Txt2Prevent): intervention development and pilot randomized controlled trial protocol. JMIR Research Protocols2017;6(5):e91. [DOI: 10.2196/resprot.6968]">Ross 2021</a>), New Zealand (<a href="./references#CD011851-bbs2-0006" title="ACTRN12613000901707. Text4Heart: a text message and internet-based comprehensive cardiac rehabilitation intervention [A randomised controlled trial to determine the efficacy of a text message and Internet-based comprehensive cardiac rehabilitation programme to improve adherence to lifestyle change compared with usual care in New Zealand adults with a diagnosis of cardiovascular disease]. anzctr.org.au/ACTRN12613000901707.aspx (first received 9 August 2013). DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Improving coronary heart disease self-management using mobile technologies (Text4Heart): a randomised controlled trial protocol. Trials2014;15(71):1-9. [DOI: 10.1186/1745-6215-15-71]DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Text message and internet support for coronary heart disease self-management: results from the Text4Heart randomized controlled trial. Journal of Medical Internet Research2015;17(10):e237. [DOI: 10.2196/jmir.4944]">Dale 2015a</a>; <a href="./references#CD011851-bbs2-0011" title="ACTRN12616000422426. Text4Heart Partnership: a text messaging program to enhance self-management of cardiovascular disease [Text messaging to enhance self-management of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12616000422426 (first received 23 March 2016). MaddisonR , JiangY , StewartR , ScottT , KerrA , WhittakerR , et al. An intervention to improve medication adherence in people with heart disease (Text4HeartII): randomized controlled trial. JMIR mHealth and uHealth2021;9(6):e24952. [DOI: 10.2196/24952]MaddisonR , StewartR , DoughtyR , ScottT , KerrA , BenatarJ , et al. Text4Heart II - improving medication adherence in people with heart disease: a study protocol for a randomized controlled trial. Trials2018;19(1):70. [DOI: 10.1186/s13063-018-2468-z]">Maddison 2021</a>), Brazil (<a href="./references#CD011851-bbs2-0015" title="NCT03414190. Impact of text messages to promote secondary prevention after acute coronary syndrome [Impact of a mobile phone text messages intervention on the secondary prevention of cardiovascular events after acute coronary syndrome]. clinicaltrials.gov/show/NCT03414190 (first received 29 January 2018). PassagliaLG , BrantLC , NascimentoBR , RibeiroAL . Impact of text messages in a middle-income country to promote secondary prevention after acute coronary syndrome (IMPACS): a randomized trial. Medicine2019;98(22):e15681. [DOI: 10.1097/MD.0000000000015681]PassagliaLG , BrantLC , SilvaJL , NascimentoBR , RibeiroAL . Text messages to promote secondary prevention after acute coronary syndrome (IMPACS trial). International Journal of Cardiovascular Sciences2021;35(2):202-13. [DOI: 10.36660/ijcs.20200378]">Passaglia 2021</a>), Colombia (<a href="./references#CD011851-bbs2-0002" title="BermonA , UribeAF , Pérez-RiveroPF , Prieto-MerinoD , SaaibiJF , SilvaFA , et al. Efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: TXT2HEART Colombia randomized controlled trial. JMIR mHealth and uHealth2021;9(7):e25548. [DOI: 10.2196/25548]BermonA , Uribe-RodríguezAF , Pérez-RiveroPF , Prieto-MerinoD , RiveraDIC , GuioE , et al. Evaluation of the efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: the txt2heart Colombia randomised controlled trial protocol. BMJ Open2019;9:e028017. [DOI: 10.1136/ bmjopen-2018-028017]NCT03098186. TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention [TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention]. clinicaltrials.gov/ct2/show/NCT03098186 (first received 3 March 2017). ">Bermon 2021</a>), Korea (<a href="./references#CD011851-bbs2-0001" title="BaeJW , WooSI , LeeJ , ParkSD , KwonSW , ChoiSH , et al. mHealth interventions for lifestyle and risk factor modification in coronary heart disease: randomized controlled trial. JMIR mHealth and uHealth2021;9(9):e29928. [DOI: 10.2196/29928]KCT0005087. Effect of text messaging program on lifestyle and clinical outcomes in patients with cardiovascular disease. cris.nih.go.kr/cris/search/detailSearch.do/19282 (first received 11 September 2019). ">Bae 2021</a>), Malaysia (<a href="./references#CD011851-bbs2-0010" title="KhonsariS , SubramanianP , ChinnaK , LatifLA , LingLW , GholamiO . Effect of a reminder system using an automated short message service on medication adherence following acute coronary syndrome. European Journal of Cardiovascular Nursing2015;14(2):170-9. [DOI: 10.1177/1474515114521910]">Khonsari 2015</a>), Pakistan (<a href="./references#CD011851-bbs2-0009" title="KamalAK , ShaikQN , PashaO , AzamI , IslamM , MemonAA , et al. Improving medication adherence in stroke patients through Short Text Messages (SMS4Stroke)-study protocol for a randomized, controlled trial. BMC Neurology2015;15:157. [DOI: 10.1186/s12883-015-0413-2]KamalAK , ShaikhQ , PashaO , AzamI , IslamM , MemonAA , et al. A randomized controlled behavioral intervention trial to improve medication adherence in adult stroke patients with prescription tailored short messaging service (SMS)-SMS4Stroke study. BMC Neurolology2015;15:212. [DOI: 10.1186/s12883-015-0471-5]">Kamal 2015</a>), and the USA (<a href="./references#CD011851-bbs2-0014" title="ParkLG , Howie-EsquivelJ , ChungM , DracupK . A text messaging intervention improves medication adherence for patients with coronary heart disease: a randomized controlled trial. Circulation2013;128(Suppl 22):A15249. [DOI: 10.1161/circ.128.suppl_22.A15249]ParkLG , Howie-EsquivelJ , ChungML , DracupK . A text messaging intervention to promote medication adherence for patients with coronary heart disease: a randomized controlled trial. Patient Education and Counseling2014;94(2):261-8. [DOI: 10.1016/j.pec.2013.10.027]ParkLG , Howie-EsquivelJ , WhooleyMA , DracupK . Psychosocial factors and medication adherence among patients with coronary heart disease: a text messaging intervention. European Journal of Cardiovascular Nursing2015;14(3):264-73. [DOI: 10.1177/1474515114537024]">Park 2014a</a>). <a href="./references#CD011851-bbs2-0016" title="QuiliciJ , FugonL , BeguinS , MorangePE , BonnetJL , AlessiMC , et al. Effect of motivational mobile phone short message service on aspirin adherence after coronary stenting for acute coronary syndrome. International Journal of Cardiology2013;168(1):568-9. [DOI: 10.1016/j.ijcard.2013.01.252]">Quilici 2013</a> did not report the country in which the study was conducted, but the author affiliations suggest that it took place in France. Overall, the 18 included studies took place in 11 countries, including six high‐income countries (USA, Australia, Korea, Canada, New Zealand, and France), four upper‐middle‐income countries (China, Malaysia, Brazil, and Colombia), and one lower‐middle‐income country (Pakistan). None of the included studies were from low‐income countries. Of the 18 included studies, nine were conducted in high‐income countries (<a href="./references#CD011851-bbs2-0001" title="BaeJW , WooSI , LeeJ , ParkSD , KwonSW , ChoiSH , et al. mHealth interventions for lifestyle and risk factor modification in coronary heart disease: randomized controlled trial. JMIR mHealth and uHealth2021;9(9):e29928. [DOI: 10.2196/29928]KCT0005087. Effect of text messaging program on lifestyle and clinical outcomes in patients with cardiovascular disease. cris.nih.go.kr/cris/search/detailSearch.do/19282 (first received 11 September 2019). ">Bae 2021</a>; <a href="./references#CD011851-bbs2-0004" title="ACTRN12611000161921. Tobacco, EXercise and dieT MEssages (TEXT ME): the effect of semi-personalised lifestyle reminder text message intervention on cardiovascular disease risk [Tobacco, EXercise and dieT MEssages (TEXT ME): The effect of a semi-personalised lifestyle reminder text message intervention on cardiovascular risk factors in patients with cardiovascular disease and those who are at high risk of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12611000161921 (first received 3 February 2011). ChowCK , RedfernJ , HillisGS , ThakkarJ , SantoK , HackettML , et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA2015;314(12):1255-63. [DOI: 10.1001/jama.2015.10945]ChowCK , RedfernJ , ThiagalingamA , JanS , WhittakerR , HackettM , et al. Design and rationale of the tobacco, exercise and diet messages (TEXT ME) trial of a text message-based intervention for ongoing prevention of cardiovascular disease in people with coronary disease: a randomised controlled trial protocol. BMJ Open2012;2(1):e000606. [DOI: 10.1136/bmjopen-2011-000606]RedfernJ , SantoK , CooreyG , ThakkarJ , HackettM , ThiagalingamA , et al. Factors influencing engagement, perceived usefulness and behavioral mechanisms associated with a text message support program. PLOS ONE2016;11(10):e0163929. [DOI: 10.1371/journal.pone.0163929]ThakkarJ , RedfernJ , De KeizerL , ThiagalingamA , ChowC . Patient perceptions of text message-based intervention for secondary prevention of cardiovascular events. Heart, Lung and Circulation2013;22(Suppl 1):S264. [DOI: 10.1016/j.hlc.2013.05.630]ThakkarJ , RedfernJ , ThiagalingamA , ChowCK . Patterns, predictors and effects of texting intervention on physical activity in CHD – insights from the TEXT ME randomized clinical trial. European Journal of Preventive Cardiology2016;23(17):1894-902. [DOI: 10.1177/2047487316664190]">Chow 2015</a>; <a href="./references#CD011851-bbs2-0005" title="ACTRN12613000793718. TEXT messages to improve MEDication adherence &amp; Secondary prevention – TEXTMEDS [TEXT messages to improve MEDication adherence &amp; Secondary prevention in patients with acute coronary syndrome - TEXTMEDS]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364448&amp;isReview=true (first received 18 June 2013). ChowCK , KlimisH , ThiagalingamA , RedfernJ , HillisGS , BriegerD , et al. Text messages to improve medication adherence and secondary prevention after acute coronary syndrome: the TEXTMEDS randomized clinical trial. Circulation2022;145(19):1443-55. [DOI: 10.1161/CIRCULATIONAHA.121.056161]ChowCK , ThiagalingamA , SantoK , KokC , ThakkarJ , StepienS , et al. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol. BMJ Open2018;8:e019463. [DOI: 10.1136/bmjopen-2017-019463]">Chow 2022</a>; <a href="./references#CD011851-bbs2-0006" title="ACTRN12613000901707. Text4Heart: a text message and internet-based comprehensive cardiac rehabilitation intervention [A randomised controlled trial to determine the efficacy of a text message and Internet-based comprehensive cardiac rehabilitation programme to improve adherence to lifestyle change compared with usual care in New Zealand adults with a diagnosis of cardiovascular disease]. anzctr.org.au/ACTRN12613000901707.aspx (first received 9 August 2013). DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Improving coronary heart disease self-management using mobile technologies (Text4Heart): a randomised controlled trial protocol. Trials2014;15(71):1-9. [DOI: 10.1186/1745-6215-15-71]DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Text message and internet support for coronary heart disease self-management: results from the Text4Heart randomized controlled trial. Journal of Medical Internet Research2015;17(10):e237. [DOI: 10.2196/jmir.4944]">Dale 2015a</a>; <a href="./references#CD011851-bbs2-0011" title="ACTRN12616000422426. Text4Heart Partnership: a text messaging program to enhance self-management of cardiovascular disease [Text messaging to enhance self-management of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12616000422426 (first received 23 March 2016). MaddisonR , JiangY , StewartR , ScottT , KerrA , WhittakerR , et al. An intervention to improve medication adherence in people with heart disease (Text4HeartII): randomized controlled trial. JMIR mHealth and uHealth2021;9(6):e24952. [DOI: 10.2196/24952]MaddisonR , StewartR , DoughtyR , ScottT , KerrA , BenatarJ , et al. Text4Heart II - improving medication adherence in people with heart disease: a study protocol for a randomized controlled trial. Trials2018;19(1):70. [DOI: 10.1186/s13063-018-2468-z]">Maddison 2021</a>; <a href="./references#CD011851-bbs2-0013" title="NCT02783287. The impact of text messaging on medication adherence and exercise regimen among post-myocardial infarction patients. clinicaltrials.gov/ct2/show/NCT02783287 (first received 26 May 2016). PandeyA , ChoudhryN . An m-health application of daily text messages to address forgetfulness as contributor to non-adherence to medications post-myocardial infarction. Circulation2015;132:A18641. [DOI: 10.1161/circ.132.suppl_3.18641]PandeyA , KrummeAA , PatelT , ChoudhryNK . The impact of text messaging on medication adherence and exercise among postmyocardial infarction patients: randomized controlled pilot trial. JMIR mHealth and uHealth2017;5(8):e110. [DOI: 10.2196/mhealth.7144]PandeyAK , ChoudhryN . Text message reminders to address medication non-adherence in post-MI patients: a one year intervention study. Canadian Journal of Cardiology2014;30(10):S179. [DOI: 10.1016/j.cjca.2014.07.280]">Pandey 2017</a>; <a href="./references#CD011851-bbs2-0014" title="ParkLG , Howie-EsquivelJ , ChungM , DracupK . A text messaging intervention improves medication adherence for patients with coronary heart disease: a randomized controlled trial. Circulation2013;128(Suppl 22):A15249. [DOI: 10.1161/circ.128.suppl_22.A15249]ParkLG , Howie-EsquivelJ , ChungML , DracupK . A text messaging intervention to promote medication adherence for patients with coronary heart disease: a randomized controlled trial. Patient Education and Counseling2014;94(2):261-8. [DOI: 10.1016/j.pec.2013.10.027]ParkLG , Howie-EsquivelJ , WhooleyMA , DracupK . Psychosocial factors and medication adherence among patients with coronary heart disease: a text messaging intervention. European Journal of Cardiovascular Nursing2015;14(3):264-73. [DOI: 10.1177/1474515114537024]">Park 2014a</a>; <a href="./references#CD011851-bbs2-0016" title="QuiliciJ , FugonL , BeguinS , MorangePE , BonnetJL , AlessiMC , et al. Effect of motivational mobile phone short message service on aspirin adherence after coronary stenting for acute coronary syndrome. International Journal of Cardiology2013;168(1):568-9. [DOI: 10.1016/j.ijcard.2013.01.252]">Quilici 2013</a>; <a href="./references#CD011851-bbs2-0017" title="NCT02336919. The use of texting messaging to improve the hospital-to-community transition period in cardiovascular disease patients (Txt2Prevent) [The use of texting messaging to improve the hospital-to-community transition and prevent readmission in patients with cardiovascular disease (Txt2Prevent)]. clinicaltrials.gov/ct2/show/NCT02336919 (first received 13 January 2015). RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of SMS text messaging to improve the hospital-to-community transition in patients with acute coronary syndrome (Txt2Prevent): results from a pilot randomized controlled trial. JMIR mHealth and uHealth2021;9(5):e24530. [DOI: 10.2196/24530]RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of text messaging to improve the hospital-to-community transition in acute coronary syndrome patients (Txt2Prevent): intervention development and pilot randomized controlled trial protocol. JMIR Research Protocols2017;6(5):e91. [DOI: 10.2196/resprot.6968]">Ross 2021</a>), eight in upper‐middle‐income countries (<a href="./references#CD011851-bbs2-0002" title="BermonA , UribeAF , Pérez-RiveroPF , Prieto-MerinoD , SaaibiJF , SilvaFA , et al. Efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: TXT2HEART Colombia randomized controlled trial. JMIR mHealth and uHealth2021;9(7):e25548. [DOI: 10.2196/25548]BermonA , Uribe-RodríguezAF , Pérez-RiveroPF , Prieto-MerinoD , RiveraDIC , GuioE , et al. Evaluation of the efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: the txt2heart Colombia randomised controlled trial protocol. BMJ Open2019;9:e028017. [DOI: 10.1136/ bmjopen-2018-028017]NCT03098186. TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention [TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention]. clinicaltrials.gov/ct2/show/NCT03098186 (first received 3 March 2017). ">Bermon 2021</a>; <a href="./references#CD011851-bbs2-0003" title="ChenC , LiX , KangY , LiuH , LiangYD , ZhangQ . Post-discharge short service message improves short-term clinical outcome and self-care behavior in Chinese patients with chronic heart failure. European Heart Journal2018;39(Suppl 1):797-8. [DOI: 10.1093/eurheartj/ehy563.P3770]ChenC , LiX , SunL , CaoS , KangY , HongL , et al. Post-discharge short message service improves short-term clinical outcome and self-care behaviour in chronic heart failure. ESC Heart Failure2019;6(1):164-73. [DOI: 10.1002/ehf2.12380]ChiCTR-INR-17012316. Effect of post-discharge text messages on clinical outcomes in patients with heart failure [Effect of post-discharge text messages on clinical outcomes in patients with heart failure]. trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR-INR-17012316 (first received 9 August 2018). LiX , ChenC , YouGY , ZhangQ . Post-discharge text messaging intervention improved clinical outcomes in patients with heart failure. European Heart Journal2016;37(Suppl 1):727-8. [DOI: 10.1093/eurheartj/ehw433]">Chen 2019</a>; <a href="./references#CD011851-bbs2-0007" title="FangR , LiX . Electronic messaging support service programs improve adherence to lipid-lowering therapy among outpatients with coronary artery disease: an exploratory randomised control study. Journal of Clinical Nursing2016;25(5-6):664-71. [DOI: 10.1111/jocn.12988]">Fang 2016</a>; <a href="./references#CD011851-bbs2-0008" title="HuoX , KrumholzHM , BaiX , SpatzES , DingQ , HorakP , et al. Effects of mobile text messaging on glycemic control in patients with coronary heart disease and diabetes mellitus: a randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(9):e005805. [DOI: 10.1161/CIRCOUTCOMES.119.005805]NCT02883842. Cardiovascular Health and Text Messaging-Diabetes Mellitus (CHAT-DM) Study [Effectiveness of text messaging on risk factors control and medication adherence among patients with Coronary Heart Disease and Diabetes in China: cardiovascular health andtext messaging-Diabetes Mellitus (CHAT-DM) study]. clinicaltrials.gov/ct2/show/NCT02883842 (first received 30 August 2016). ">Huo 2019</a>; <a href="./references#CD011851-bbs2-0010" title="KhonsariS , SubramanianP , ChinnaK , LatifLA , LingLW , GholamiO . Effect of a reminder system using an automated short message service on medication adherence following acute coronary syndrome. European Journal of Cardiovascular Nursing2015;14(2):170-9. [DOI: 10.1177/1474515114521910]">Khonsari 2015</a>; <a href="./references#CD011851-bbs2-0012" title="NCT02793830. A mobile phone based medication reminder program [A mobile phone based medication reminder program for patients in China with coronary heart disease: a pilot study]. clinicaltrials.gov/ct2/show/NCT02793830 (first received 8 June 2016). NiZ , WuB , YangQ , YanLL , LiuC , ShawRJ . An mHealth intervention to improve medication adherence and health outcomes among patients with coronary heart disease: randomized controlled trial. Journal of Medical Internet Research2022;24(3):e27202. [DOI: 10.2196/27202]">Ni 2022</a>; <a href="./references#CD011851-bbs2-0015" title="NCT03414190. Impact of text messages to promote secondary prevention after acute coronary syndrome [Impact of a mobile phone text messages intervention on the secondary prevention of cardiovascular events after acute coronary syndrome]. clinicaltrials.gov/show/NCT03414190 (first received 29 January 2018). PassagliaLG , BrantLC , NascimentoBR , RibeiroAL . Impact of text messages in a middle-income country to promote secondary prevention after acute coronary syndrome (IMPACS): a randomized trial. Medicine2019;98(22):e15681. [DOI: 10.1097/MD.0000000000015681]PassagliaLG , BrantLC , SilvaJL , NascimentoBR , RibeiroAL . Text messages to promote secondary prevention after acute coronary syndrome (IMPACS trial). International Journal of Cardiovascular Sciences2021;35(2):202-13. [DOI: 10.36660/ijcs.20200378]">Passaglia 2021</a>; <a href="./references#CD011851-bbs2-0018" title="HuoX , SpatzES , DingQ , HorakP , ZhengX , MastersC , et al. Design and rationale of the Cardiovascular Health and Text Messaging (CHAT) study and the CHAT-Diabetes Mellitus (CHAT-DM) study: two randomised controlled trials of text messaging to improve secondary prevention for coronary heart disease and diabetes. BMJ Open2017;7(12):e018302. [DOI: 10.1136/bmjopen-2017-018302]ZhengX , SpatzES , BaiX , HuoX , DingQ , HorakP , et al. Effect of text messaging on risk factor management in patients with coronary heart disease: the CHAT randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(4):e005616. [DOI: 10.1161/CIRCOUTCOMES.119.005616]">Zheng 2019</a>), and one in a lower‐middle‐income country (<a href="./references#CD011851-bbs2-0009" title="KamalAK , ShaikQN , PashaO , AzamI , IslamM , MemonAA , et al. Improving medication adherence in stroke patients through Short Text Messages (SMS4Stroke)-study protocol for a randomized, controlled trial. BMC Neurology2015;15:157. [DOI: 10.1186/s12883-015-0413-2]KamalAK , ShaikhQ , PashaO , AzamI , IslamM , MemonAA , et al. A randomized controlled behavioral intervention trial to improve medication adherence in adult stroke patients with prescription tailored short messaging service (SMS)-SMS4Stroke study. BMC Neurolology2015;15:212. [DOI: 10.1186/s12883-015-0471-5]">Kamal 2015</a>). </p> </section> <section id="CD011851-sec-0045"> <h5 class="title">Development of SMS</h5> <p>All studies used text messaging as a central component of the intervention. The message content was predominantly medication reminders. Thirteen studies reported that the SMS was developed as a reminder to take their medications (<a href="./references#CD011851-bbs2-0001" title="BaeJW , WooSI , LeeJ , ParkSD , KwonSW , ChoiSH , et al. mHealth interventions for lifestyle and risk factor modification in coronary heart disease: randomized controlled trial. JMIR mHealth and uHealth2021;9(9):e29928. [DOI: 10.2196/29928]KCT0005087. Effect of text messaging program on lifestyle and clinical outcomes in patients with cardiovascular disease. cris.nih.go.kr/cris/search/detailSearch.do/19282 (first received 11 September 2019). ">Bae 2021</a>; <a href="./references#CD011851-bbs2-0003" title="ChenC , LiX , KangY , LiuH , LiangYD , ZhangQ . Post-discharge short service message improves short-term clinical outcome and self-care behavior in Chinese patients with chronic heart failure. European Heart Journal2018;39(Suppl 1):797-8. [DOI: 10.1093/eurheartj/ehy563.P3770]ChenC , LiX , SunL , CaoS , KangY , HongL , et al. Post-discharge short message service improves short-term clinical outcome and self-care behaviour in chronic heart failure. ESC Heart Failure2019;6(1):164-73. [DOI: 10.1002/ehf2.12380]ChiCTR-INR-17012316. Effect of post-discharge text messages on clinical outcomes in patients with heart failure [Effect of post-discharge text messages on clinical outcomes in patients with heart failure]. trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR-INR-17012316 (first received 9 August 2018). LiX , ChenC , YouGY , ZhangQ . Post-discharge text messaging intervention improved clinical outcomes in patients with heart failure. European Heart Journal2016;37(Suppl 1):727-8. [DOI: 10.1093/eurheartj/ehw433]">Chen 2019</a>; <a href="./references#CD011851-bbs2-0005" title="ACTRN12613000793718. TEXT messages to improve MEDication adherence &amp; Secondary prevention – TEXTMEDS [TEXT messages to improve MEDication adherence &amp; Secondary prevention in patients with acute coronary syndrome - TEXTMEDS]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364448&amp;isReview=true (first received 18 June 2013). ChowCK , KlimisH , ThiagalingamA , RedfernJ , HillisGS , BriegerD , et al. Text messages to improve medication adherence and secondary prevention after acute coronary syndrome: the TEXTMEDS randomized clinical trial. Circulation2022;145(19):1443-55. [DOI: 10.1161/CIRCULATIONAHA.121.056161]ChowCK , ThiagalingamA , SantoK , KokC , ThakkarJ , StepienS , et al. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol. BMJ Open2018;8:e019463. [DOI: 10.1136/bmjopen-2017-019463]">Chow 2022</a>; <a href="./references#CD011851-bbs2-0007" title="FangR , LiX . Electronic messaging support service programs improve adherence to lipid-lowering therapy among outpatients with coronary artery disease: an exploratory randomised control study. Journal of Clinical Nursing2016;25(5-6):664-71. [DOI: 10.1111/jocn.12988]">Fang 2016</a>; <a href="./references#CD011851-bbs2-0008" title="HuoX , KrumholzHM , BaiX , SpatzES , DingQ , HorakP , et al. Effects of mobile text messaging on glycemic control in patients with coronary heart disease and diabetes mellitus: a randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(9):e005805. [DOI: 10.1161/CIRCOUTCOMES.119.005805]NCT02883842. Cardiovascular Health and Text Messaging-Diabetes Mellitus (CHAT-DM) Study [Effectiveness of text messaging on risk factors control and medication adherence among patients with Coronary Heart Disease and Diabetes in China: cardiovascular health andtext messaging-Diabetes Mellitus (CHAT-DM) study]. clinicaltrials.gov/ct2/show/NCT02883842 (first received 30 August 2016). ">Huo 2019</a>; <a href="./references#CD011851-bbs2-0009" title="KamalAK , ShaikQN , PashaO , AzamI , IslamM , MemonAA , et al. Improving medication adherence in stroke patients through Short Text Messages (SMS4Stroke)-study protocol for a randomized, controlled trial. BMC Neurology2015;15:157. [DOI: 10.1186/s12883-015-0413-2]KamalAK , ShaikhQ , PashaO , AzamI , IslamM , MemonAA , et al. A randomized controlled behavioral intervention trial to improve medication adherence in adult stroke patients with prescription tailored short messaging service (SMS)-SMS4Stroke study. BMC Neurolology2015;15:212. [DOI: 10.1186/s12883-015-0471-5]">Kamal 2015</a>; <a href="./references#CD011851-bbs2-0010" title="KhonsariS , SubramanianP , ChinnaK , LatifLA , LingLW , GholamiO . Effect of a reminder system using an automated short message service on medication adherence following acute coronary syndrome. European Journal of Cardiovascular Nursing2015;14(2):170-9. [DOI: 10.1177/1474515114521910]">Khonsari 2015</a>; <a href="./references#CD011851-bbs2-0011" title="ACTRN12616000422426. Text4Heart Partnership: a text messaging program to enhance self-management of cardiovascular disease [Text messaging to enhance self-management of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12616000422426 (first received 23 March 2016). MaddisonR , JiangY , StewartR , ScottT , KerrA , WhittakerR , et al. An intervention to improve medication adherence in people with heart disease (Text4HeartII): randomized controlled trial. JMIR mHealth and uHealth2021;9(6):e24952. [DOI: 10.2196/24952]MaddisonR , StewartR , DoughtyR , ScottT , KerrA , BenatarJ , et al. Text4Heart II - improving medication adherence in people with heart disease: a study protocol for a randomized controlled trial. Trials2018;19(1):70. [DOI: 10.1186/s13063-018-2468-z]">Maddison 2021</a>; <a href="./references#CD011851-bbs2-0012" title="NCT02793830. A mobile phone based medication reminder program [A mobile phone based medication reminder program for patients in China with coronary heart disease: a pilot study]. clinicaltrials.gov/ct2/show/NCT02793830 (first received 8 June 2016). NiZ , WuB , YangQ , YanLL , LiuC , ShawRJ . An mHealth intervention to improve medication adherence and health outcomes among patients with coronary heart disease: randomized controlled trial. Journal of Medical Internet Research2022;24(3):e27202. [DOI: 10.2196/27202]">Ni 2022</a>; <a href="./references#CD011851-bbs2-0013" title="NCT02783287. The impact of text messaging on medication adherence and exercise regimen among post-myocardial infarction patients. clinicaltrials.gov/ct2/show/NCT02783287 (first received 26 May 2016). PandeyA , ChoudhryN . An m-health application of daily text messages to address forgetfulness as contributor to non-adherence to medications post-myocardial infarction. Circulation2015;132:A18641. [DOI: 10.1161/circ.132.suppl_3.18641]PandeyA , KrummeAA , PatelT , ChoudhryNK . The impact of text messaging on medication adherence and exercise among postmyocardial infarction patients: randomized controlled pilot trial. JMIR mHealth and uHealth2017;5(8):e110. [DOI: 10.2196/mhealth.7144]PandeyAK , ChoudhryN . Text message reminders to address medication non-adherence in post-MI patients: a one year intervention study. Canadian Journal of Cardiology2014;30(10):S179. [DOI: 10.1016/j.cjca.2014.07.280]">Pandey 2017</a>; <a href="./references#CD011851-bbs2-0014" title="ParkLG , Howie-EsquivelJ , ChungM , DracupK . A text messaging intervention improves medication adherence for patients with coronary heart disease: a randomized controlled trial. Circulation2013;128(Suppl 22):A15249. [DOI: 10.1161/circ.128.suppl_22.A15249]ParkLG , Howie-EsquivelJ , ChungML , DracupK . A text messaging intervention to promote medication adherence for patients with coronary heart disease: a randomized controlled trial. Patient Education and Counseling2014;94(2):261-8. [DOI: 10.1016/j.pec.2013.10.027]ParkLG , Howie-EsquivelJ , WhooleyMA , DracupK . Psychosocial factors and medication adherence among patients with coronary heart disease: a text messaging intervention. European Journal of Cardiovascular Nursing2015;14(3):264-73. [DOI: 10.1177/1474515114537024]">Park 2014a</a>; <a href="./references#CD011851-bbs2-0017" title="NCT02336919. The use of texting messaging to improve the hospital-to-community transition period in cardiovascular disease patients (Txt2Prevent) [The use of texting messaging to improve the hospital-to-community transition and prevent readmission in patients with cardiovascular disease (Txt2Prevent)]. clinicaltrials.gov/ct2/show/NCT02336919 (first received 13 January 2015). RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of SMS text messaging to improve the hospital-to-community transition in patients with acute coronary syndrome (Txt2Prevent): results from a pilot randomized controlled trial. JMIR mHealth and uHealth2021;9(5):e24530. [DOI: 10.2196/24530]RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of text messaging to improve the hospital-to-community transition in acute coronary syndrome patients (Txt2Prevent): intervention development and pilot randomized controlled trial protocol. JMIR Research Protocols2017;6(5):e91. [DOI: 10.2196/resprot.6968]">Ross 2021</a>; <a href="./references#CD011851-bbs2-0018" title="HuoX , SpatzES , DingQ , HorakP , ZhengX , MastersC , et al. Design and rationale of the Cardiovascular Health and Text Messaging (CHAT) study and the CHAT-Diabetes Mellitus (CHAT-DM) study: two randomised controlled trials of text messaging to improve secondary prevention for coronary heart disease and diabetes. BMJ Open2017;7(12):e018302. [DOI: 10.1136/bmjopen-2017-018302]ZhengX , SpatzES , BaiX , HuoX , DingQ , HorakP , et al. Effect of text messaging on risk factor management in patients with coronary heart disease: the CHAT randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(4):e005616. [DOI: 10.1161/CIRCOUTCOMES.119.005616]">Zheng 2019</a>). Of the 13 studies, 11 studies also included education or lifestyle modification information (e.g. healthy diet and physical activity) as part of the text messages in addition to the medication reminders. Two studies provided access to a supporting website as an additional intervention component (<a href="./references#CD011851-bbs2-0001" title="BaeJW , WooSI , LeeJ , ParkSD , KwonSW , ChoiSH , et al. mHealth interventions for lifestyle and risk factor modification in coronary heart disease: randomized controlled trial. JMIR mHealth and uHealth2021;9(9):e29928. [DOI: 10.2196/29928]KCT0005087. Effect of text messaging program on lifestyle and clinical outcomes in patients with cardiovascular disease. cris.nih.go.kr/cris/search/detailSearch.do/19282 (first received 11 September 2019). ">Bae 2021</a>; <a href="./references#CD011851-bbs2-0006" title="ACTRN12613000901707. Text4Heart: a text message and internet-based comprehensive cardiac rehabilitation intervention [A randomised controlled trial to determine the efficacy of a text message and Internet-based comprehensive cardiac rehabilitation programme to improve adherence to lifestyle change compared with usual care in New Zealand adults with a diagnosis of cardiovascular disease]. anzctr.org.au/ACTRN12613000901707.aspx (first received 9 August 2013). DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Improving coronary heart disease self-management using mobile technologies (Text4Heart): a randomised controlled trial protocol. Trials2014;15(71):1-9. [DOI: 10.1186/1745-6215-15-71]DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Text message and internet support for coronary heart disease self-management: results from the Text4Heart randomized controlled trial. Journal of Medical Internet Research2015;17(10):e237. [DOI: 10.2196/jmir.4944]">Dale 2015a</a>). Details regarding the development of SMS are summarised in <a href="#CD011851-tbl-0002">Table 1</a>. </p> <div class="table" id="CD011851-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">SMS development</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>SMS = reminder</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Description of process to design SMS</b> (e.g. did the authors describe the process used to construct the content of the text messages?) </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Evaluation of causes for non‐adherence</b> (e.g. did they evaluate causes for non‐adherence in the target population?) </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Used psychological theories to develop SMS</b> (e.g. were psychological theories used to develop the messages to target the identified behavioural determinants of non‐adherence?) </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Used behaviour change techniques to develop SMS</b> (e.g. were behaviour change techniques employed to develop the messages?) </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>SMS designed according to participant characteristics</b> (e.g. were different text messages developed according to participants' characteristics?) </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Pilot phase to evaluate clarity, grammar of SMS</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011851-bbs2-0001" title="BaeJW , WooSI , LeeJ , ParkSD , KwonSW , ChoiSH , et al. mHealth interventions for lifestyle and risk factor modification in coronary heart disease: randomized controlled trial. JMIR mHealth and uHealth2021;9(9):e29928. [DOI: 10.2196/29928]KCT0005087. Effect of text messaging program on lifestyle and clinical outcomes in patients with cardiovascular disease. cris.nih.go.kr/cris/search/detailSearch.do/19282 (first received 11 September 2019). ">Bae 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes, messages contain medication adherence contents</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes. “The contents of the SMS text messages were based on the Tobacco, Exercise, and Diet Messages (TEXTME) trial and the Australian Heart Foundation Healthy Living Guidelines. The cardiologists, nurses, clinical nutritionists, and preventive medicine experts reviewed the text messages in the TEXTME trial and modified them considering the Asian diet and culture.” (<a href="./references#CD011851-bbs2-0001" title="BaeJW , WooSI , LeeJ , ParkSD , KwonSW , ChoiSH , et al. mHealth interventions for lifestyle and risk factor modification in coronary heart disease: randomized controlled trial. JMIR mHealth and uHealth2021;9(9):e29928. [DOI: 10.2196/29928]KCT0005087. Effect of text messaging program on lifestyle and clinical outcomes in patients with cardiovascular disease. cris.nih.go.kr/cris/search/detailSearch.do/19282 (first received 11 September 2019). ">Bae 2021</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes. “The message sending program delivered semipersonalised text messages considering the smoking status and diet pattern of the participants ‐ vegetarian or not ‐ with their names.” (<a href="./references#CD011851-bbs2-0001" title="BaeJW , WooSI , LeeJ , ParkSD , KwonSW , ChoiSH , et al. mHealth interventions for lifestyle and risk factor modification in coronary heart disease: randomized controlled trial. JMIR mHealth and uHealth2021;9(9):e29928. [DOI: 10.2196/29928]KCT0005087. Effect of text messaging program on lifestyle and clinical outcomes in patients with cardiovascular disease. cris.nih.go.kr/cris/search/detailSearch.do/19282 (first received 11 September 2019). ">Bae 2021</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011851-bbs2-0002" title="BermonA , UribeAF , Pérez-RiveroPF , Prieto-MerinoD , SaaibiJF , SilvaFA , et al. Efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: TXT2HEART Colombia randomized controlled trial. JMIR mHealth and uHealth2021;9(7):e25548. [DOI: 10.2196/25548]BermonA , Uribe-RodríguezAF , Pérez-RiveroPF , Prieto-MerinoD , RiveraDIC , GuioE , et al. Evaluation of the efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: the txt2heart Colombia randomised controlled trial protocol. BMJ Open2019;9:e028017. [DOI: 10.1136/ bmjopen-2018-028017]NCT03098186. TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention [TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention]. clinicaltrials.gov/ct2/show/NCT03098186 (first received 3 March 2017). ">Bermon 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No, the text messages were not reminders for medication intake or appointments, but an intervention to increase awareness and commitment to medication taking. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes. “A protocol was carried out to determine the content, quantity, and frequency of SMS text messages through focus groups, validation of experts, user feedback, and pretest.” (<a href="./references#CD011851-bbs2-0002" title="BermonA , UribeAF , Pérez-RiveroPF , Prieto-MerinoD , SaaibiJF , SilvaFA , et al. Efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: TXT2HEART Colombia randomized controlled trial. JMIR mHealth and uHealth2021;9(7):e25548. [DOI: 10.2196/25548]BermonA , Uribe-RodríguezAF , Pérez-RiveroPF , Prieto-MerinoD , RiveraDIC , GuioE , et al. Evaluation of the efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: the txt2heart Colombia randomised controlled trial protocol. BMJ Open2019;9:e028017. [DOI: 10.1136/ bmjopen-2018-028017]NCT03098186. TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention [TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention]. clinicaltrials.gov/ct2/show/NCT03098186 (first received 3 March 2017). ">Bermon 2021</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes, based on the transtheoretical model of health behaviour change</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011851-bbs2-0003" title="ChenC , LiX , KangY , LiuH , LiangYD , ZhangQ . Post-discharge short service message improves short-term clinical outcome and self-care behavior in Chinese patients with chronic heart failure. European Heart Journal2018;39(Suppl 1):797-8. [DOI: 10.1093/eurheartj/ehy563.P3770]ChenC , LiX , SunL , CaoS , KangY , HongL , et al. Post-discharge short message service improves short-term clinical outcome and self-care behaviour in chronic heart failure. ESC Heart Failure2019;6(1):164-73. [DOI: 10.1002/ehf2.12380]ChiCTR-INR-17012316. Effect of post-discharge text messages on clinical outcomes in patients with heart failure [Effect of post-discharge text messages on clinical outcomes in patients with heart failure]. trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR-INR-17012316 (first received 9 August 2018). LiX , ChenC , YouGY , ZhangQ . Post-discharge text messaging intervention improved clinical outcomes in patients with heart failure. European Heart Journal2016;37(Suppl 1):727-8. [DOI: 10.1093/eurheartj/ehw433]">Chen 2019</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes, medication reminder</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes, all contents of text messages were pre‐written and reviewed by heart failure specialists and senior nursing specialists. The contents were developed based on heart failure diagnosis and management guidelines, evidence from review articles, and educational materials from Heart Failure Society of America. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011851-bbs2-0004" title="ACTRN12611000161921. Tobacco, EXercise and dieT MEssages (TEXT ME): the effect of semi-personalised lifestyle reminder text message intervention on cardiovascular disease risk [Tobacco, EXercise and dieT MEssages (TEXT ME): The effect of a semi-personalised lifestyle reminder text message intervention on cardiovascular risk factors in patients with cardiovascular disease and those who are at high risk of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12611000161921 (first received 3 February 2011). ChowCK , RedfernJ , HillisGS , ThakkarJ , SantoK , HackettML , et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA2015;314(12):1255-63. [DOI: 10.1001/jama.2015.10945]ChowCK , RedfernJ , ThiagalingamA , JanS , WhittakerR , HackettM , et al. Design and rationale of the tobacco, exercise and diet messages (TEXT ME) trial of a text message-based intervention for ongoing prevention of cardiovascular disease in people with coronary disease: a randomised controlled trial protocol. BMJ Open2012;2(1):e000606. [DOI: 10.1136/bmjopen-2011-000606]RedfernJ , SantoK , CooreyG , ThakkarJ , HackettM , ThiagalingamA , et al. Factors influencing engagement, perceived usefulness and behavioral mechanisms associated with a text message support program. PLOS ONE2016;11(10):e0163929. [DOI: 10.1371/journal.pone.0163929]ThakkarJ , RedfernJ , De KeizerL , ThiagalingamA , ChowC . Patient perceptions of text message-based intervention for secondary prevention of cardiovascular events. Heart, Lung and Circulation2013;22(Suppl 1):S264. [DOI: 10.1016/j.hlc.2013.05.630]ThakkarJ , RedfernJ , ThiagalingamA , ChowCK . Patterns, predictors and effects of texting intervention on physical activity in CHD – insights from the TEXT ME randomized clinical trial. European Journal of Preventive Cardiology2016;23(17):1894-902. [DOI: 10.1177/2047487316664190]">Chow 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes, a bank of messages was developed with input from investigators, clinicians, academics, and patients through a multistage iterative process. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes. “The message management program selected messages for each participant at random from the bank of messages from all relevant content areas as per the prespecified algorithms and using baseline data entered into the message management system. e.g. nonsmokers would not be sent smoking messages, and vegetarians would not be sent information about meat. Some messages were merged with patient’s preferred names.” (<a href="./references#CD011851-bbs2-0004" title="ACTRN12611000161921. Tobacco, EXercise and dieT MEssages (TEXT ME): the effect of semi-personalised lifestyle reminder text message intervention on cardiovascular disease risk [Tobacco, EXercise and dieT MEssages (TEXT ME): The effect of a semi-personalised lifestyle reminder text message intervention on cardiovascular risk factors in patients with cardiovascular disease and those who are at high risk of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12611000161921 (first received 3 February 2011). ChowCK , RedfernJ , HillisGS , ThakkarJ , SantoK , HackettML , et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA2015;314(12):1255-63. [DOI: 10.1001/jama.2015.10945]ChowCK , RedfernJ , ThiagalingamA , JanS , WhittakerR , HackettM , et al. Design and rationale of the tobacco, exercise and diet messages (TEXT ME) trial of a text message-based intervention for ongoing prevention of cardiovascular disease in people with coronary disease: a randomised controlled trial protocol. BMJ Open2012;2(1):e000606. [DOI: 10.1136/bmjopen-2011-000606]RedfernJ , SantoK , CooreyG , ThakkarJ , HackettM , ThiagalingamA , et al. Factors influencing engagement, perceived usefulness and behavioral mechanisms associated with a text message support program. PLOS ONE2016;11(10):e0163929. [DOI: 10.1371/journal.pone.0163929]ThakkarJ , RedfernJ , De KeizerL , ThiagalingamA , ChowC . Patient perceptions of text message-based intervention for secondary prevention of cardiovascular events. Heart, Lung and Circulation2013;22(Suppl 1):S264. [DOI: 10.1016/j.hlc.2013.05.630]ThakkarJ , RedfernJ , ThiagalingamA , ChowCK . Patterns, predictors and effects of texting intervention on physical activity in CHD – insights from the TEXT ME randomized clinical trial. European Journal of Preventive Cardiology2016;23(17):1894-902. [DOI: 10.1177/2047487316664190]">Chow 2015</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011851-bbs2-0005" title="ACTRN12613000793718. TEXT messages to improve MEDication adherence &amp; Secondary prevention – TEXTMEDS [TEXT messages to improve MEDication adherence &amp; Secondary prevention in patients with acute coronary syndrome - TEXTMEDS]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364448&amp;isReview=true (first received 18 June 2013). ChowCK , KlimisH , ThiagalingamA , RedfernJ , HillisGS , BriegerD , et al. Text messages to improve medication adherence and secondary prevention after acute coronary syndrome: the TEXTMEDS randomized clinical trial. Circulation2022;145(19):1443-55. [DOI: 10.1161/CIRCULATIONAHA.121.056161]ChowCK , ThiagalingamA , SantoK , KokC , ThakkarJ , StepienS , et al. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol. BMJ Open2018;8:e019463. [DOI: 10.1136/bmjopen-2017-019463]">Chow 2022</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes. The medication messages provided information about how medications worked, common side effects, and tips on how to take medication regularly. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes, the content of the messages was customised to participant characteristics such as medication class prescription, dietary habits (vegetarian or non‐vegetarian), and/or smoking status. Furthermore, messages were ‘personalised’, that is the preferred name of the participant was incorporated into some messages. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011851-bbs2-0006" title="ACTRN12613000901707. Text4Heart: a text message and internet-based comprehensive cardiac rehabilitation intervention [A randomised controlled trial to determine the efficacy of a text message and Internet-based comprehensive cardiac rehabilitation programme to improve adherence to lifestyle change compared with usual care in New Zealand adults with a diagnosis of cardiovascular disease]. anzctr.org.au/ACTRN12613000901707.aspx (first received 9 August 2013). DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Improving coronary heart disease self-management using mobile technologies (Text4Heart): a randomised controlled trial protocol. Trials2014;15(71):1-9. [DOI: 10.1186/1745-6215-15-71]DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Text message and internet support for coronary heart disease self-management: results from the Text4Heart randomized controlled trial. Journal of Medical Internet Research2015;17(10):e237. [DOI: 10.2196/jmir.4944]">Dale 2015a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>“We created and refined the Text4Heart intervention through formative and pretesting studies following the mHealth Development and Evaluation<br/>Framework.” (<a href="./references#CD011851-bbs2-0057" title="DaleLP , WhittakerR , EylesH , Ni MhurchuC , BallK , SmithN , et al. Cardiovascular disease self-management: pilot testing of an mHealth healthy eating program. Journal of Personalized Medicine2014;4(1):88-101. [DOI: 10.3390/jpm4010088]">Dale 2014a</a>) Also, another study that helped inform the physical activity component (<a href="./references#CD011851-bbs2-0059" title="DaleLP , WhittakerR , DixonR , StewartR , JiangY , CarterK , et al. Acceptability of a mobile health exercise-based cardiac rehabilitation intervention: a randomized trial. Journal of Cardiopulmonary Rehabilitation and Prevention2015;35(5):312-9. [DOI: 10.1097/HCR.0000000000000125]">Dale 2015b</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Messages were based on social cognitive theory and the common sense model (<a href="./references#CD011851-bbs2-0058" title="DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Improving coronary heart disease self management using mobile technologies (Text4Heart): a randomised controlled trial protocol. Trials2014;15(71):1-9. [DOI: 10.1186/1745-6215-15-71]">Dale 2014b</a>). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes. All messages were coded according to their theoretical construct and corresponding behaviour change techniques. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No, but participants could pick messages on the health behaviour they were most interested in changing (physical activity, healthy eating, smoking cessation, or stress management). Messages were also personalised with participant’s preferred name. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes, the healthy eating messages were pilot tested. Feedback from participants was used to refine the messages (<a href="./references#CD011851-bbs2-0057" title="DaleLP , WhittakerR , EylesH , Ni MhurchuC , BallK , SmithN , et al. Cardiovascular disease self-management: pilot testing of an mHealth healthy eating program. Journal of Personalized Medicine2014;4(1):88-101. [DOI: 10.3390/jpm4010088]">Dale 2014a</a>). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011851-bbs2-0007" title="FangR , LiX . Electronic messaging support service programs improve adherence to lipid-lowering therapy among outpatients with coronary artery disease: an exploratory randomised control study. Journal of Clinical Nursing2016;25(5-6):664-71. [DOI: 10.1111/jocn.12988]">Fang 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011851-bbs2-0008" title="HuoX , KrumholzHM , BaiX , SpatzES , DingQ , HorakP , et al. Effects of mobile text messaging on glycemic control in patients with coronary heart disease and diabetes mellitus: a randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(9):e005805. [DOI: 10.1161/CIRCOUTCOMES.119.005805]NCT02883842. Cardiovascular Health and Text Messaging-Diabetes Mellitus (CHAT-DM) Study [Effectiveness of text messaging on risk factors control and medication adherence among patients with Coronary Heart Disease and Diabetes in China: cardiovascular health andtext messaging-Diabetes Mellitus (CHAT-DM) study]. clinicaltrials.gov/ct2/show/NCT02883842 (first received 30 August 2016). ">Huo 2019</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes. “A multidisciplinary team of cardiologists, endocrinologists, psychologists, nurses, linguists, and patients developed the text message bank through a systematic and iterative approach. Messages were drafted based on existing evidence‐based guidelines and standards of care, and they incorporated behavioural change techniques to provide advice, motivation, and support.” (<a href="./references#CD011851-bbs2-0008" title="HuoX , KrumholzHM , BaiX , SpatzES , DingQ , HorakP , et al. Effects of mobile text messaging on glycemic control in patients with coronary heart disease and diabetes mellitus: a randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(9):e005805. [DOI: 10.1161/CIRCOUTCOMES.119.005805]NCT02883842. Cardiovascular Health and Text Messaging-Diabetes Mellitus (CHAT-DM) Study [Effectiveness of text messaging on risk factors control and medication adherence among patients with Coronary Heart Disease and Diabetes in China: cardiovascular health andtext messaging-Diabetes Mellitus (CHAT-DM) study]. clinicaltrials.gov/ct2/show/NCT02883842 (first received 30 August 2016). ">Huo 2019</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No. Some messages were personalised with the participant’s preferred name.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes. “A pilot study was conducted to elicit patient feedback on the messages, and the text bank was updated to improve clarity and practical usefulness. Messages were also modified to increase their applicability to the<br/>Chinese culture and compatibility with Chinese values. For example, some messages used aphorisms and catchy rhyme schemes to make them more appealing to patients.” (<a href="./references#CD011851-bbs2-0008" title="HuoX , KrumholzHM , BaiX , SpatzES , DingQ , HorakP , et al. Effects of mobile text messaging on glycemic control in patients with coronary heart disease and diabetes mellitus: a randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(9):e005805. [DOI: 10.1161/CIRCOUTCOMES.119.005805]NCT02883842. Cardiovascular Health and Text Messaging-Diabetes Mellitus (CHAT-DM) Study [Effectiveness of text messaging on risk factors control and medication adherence among patients with Coronary Heart Disease and Diabetes in China: cardiovascular health andtext messaging-Diabetes Mellitus (CHAT-DM) study]. clinicaltrials.gov/ct2/show/NCT02883842 (first received 30 August 2016). ">Huo 2019</a>) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011851-bbs2-0009" title="KamalAK , ShaikQN , PashaO , AzamI , IslamM , MemonAA , et al. Improving medication adherence in stroke patients through Short Text Messages (SMS4Stroke)-study protocol for a randomized, controlled trial. BMC Neurology2015;15:157. [DOI: 10.1186/s12883-015-0413-2]KamalAK , ShaikhQ , PashaO , AzamI , IslamM , MemonAA , et al. A randomized controlled behavioral intervention trial to improve medication adherence in adult stroke patients with prescription tailored short messaging service (SMS)-SMS4Stroke study. BMC Neurolology2015;15:212. [DOI: 10.1186/s12883-015-0471-5]">Kamal 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011851-bbs2-0010" title="KhonsariS , SubramanianP , ChinnaK , LatifLA , LingLW , GholamiO . Effect of a reminder system using an automated short message service on medication adherence following acute coronary syndrome. European Journal of Cardiovascular Nursing2015;14(2):170-9. [DOI: 10.1177/1474515114521910]">Khonsari 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The content of the text messages was based on the WHO multidimensional adherence model (<a href="./references#CD011851-bbs2-0106" title="World Health Organization. Chapter V - Towards the solution. In: Adherence to Long-Term Therapies: Evidence for Action. World Health Organization, 2003:27-38. [ ISBN: 9241545992]">WHO 2003</a>). In constructing the content of the text messages, the study authors focused on the most common reasons for medication non‐adherence based on the WHO model that were unintentional on the patient’s part (forgetfulness and carelessness with medication usage), and included a therapy‐related dimension (misunderstanding of treatment instructions: meds name, dosage and timing) (<a href="./references#CD011851-bbs2-0069" title="GadkariAS , McHorneyCA . Unintentional non-adherence to chronic prescription medications: how unintentional is it really. BMC Health Services Research2012;12:98. [DOI: 10.1186/1472-6963-12-98]">Gadkari 2012</a>). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>According to the study methods, participants were recruited during an admission for<br/>ACS prior to discharge from the cardiology ward. This means that all participants were primarily diagnosed with ACS without any experience of taking cardiac medications.<br/>Evaluating causes for non‐adherence<br/>in the target population was therefore not applicable. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The WHO multidimensional adherence model that guided this study included many different aspects to describe medication non‐adherence behaviour, including psychological factors (<a href="./references#CD011851-bbs2-0106" title="World Health Organization. Chapter V - Towards the solution. In: Adherence to Long-Term Therapies: Evidence for Action. World Health Organization, 2003:27-38. [ ISBN: 9241545992]">WHO 2003</a>). It is<br/>emphasised that no single determinant is responsible for non‐adherence to treatment because the adherence phenomenon is multidimensional and results from the interplay of 5 sets of factors (dimensions), including: </p> <p>A. social and economic factors;<br/>B. therapy‐related factors;<br/>C. condition‐related factors;<br/>D. healthcare team and system‐related factors; and<br/>E. patient‐related factors. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Development of the automated SMS reminder system in this study was useful for deploying spaced repetition strategies via text messaging. Basically, spaced repetition strategy posits that instruction which is repeated at intervals has a great impact on improving a behaviour (<a href="./references#CD011851-bbs2-0063" title="EbbinghausH . Über das Gedächtnis: Untersuchungen zur experimentellen Psychologie. Leipzig: Dunker, 1885. [OCLC: (OCoLC)5876733]">Ebbinghaus 1885</a>). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The intervention was piloted with 10 cardiac patients during the first stage of the study. During this phase, a variety of test scenarios and clarity of SMS content were analysed. Text messages were further modified to achieve the desired functions. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011851-bbs2-0011" title="ACTRN12616000422426. Text4Heart Partnership: a text messaging program to enhance self-management of cardiovascular disease [Text messaging to enhance self-management of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12616000422426 (first received 23 March 2016). MaddisonR , JiangY , StewartR , ScottT , KerrA , WhittakerR , et al. An intervention to improve medication adherence in people with heart disease (Text4HeartII): randomized controlled trial. JMIR mHealth and uHealth2021;9(6):e24952. [DOI: 10.2196/24952]MaddisonR , StewartR , DoughtyR , ScottT , KerrA , BenatarJ , et al. Text4Heart II - improving medication adherence in people with heart disease: a study protocol for a randomized controlled trial. Trials2018;19(1):70. [DOI: 10.1186/s13063-018-2468-z]">Maddison 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes. All message content was grounded in psychological theory (Common Sense Model). “The content was focused on modifying people’s perceptions of the symptoms, timeline, cause, consequences, personal control over, and the ability of treatment to prevent cardiovascular disease as well as altering the key mediators of behaviour change, including self‐efficacy, social support, and motivation.” (<a href="./references#CD011851-bbs2-0011" title="ACTRN12616000422426. Text4Heart Partnership: a text messaging program to enhance self-management of cardiovascular disease [Text messaging to enhance self-management of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12616000422426 (first received 23 March 2016). MaddisonR , JiangY , StewartR , ScottT , KerrA , WhittakerR , et al. An intervention to improve medication adherence in people with heart disease (Text4HeartII): randomized controlled trial. JMIR mHealth and uHealth2021;9(6):e24952. [DOI: 10.2196/24952]MaddisonR , StewartR , DoughtyR , ScottT , KerrA , BenatarJ , et al. Text4Heart II - improving medication adherence in people with heart disease: a study protocol for a randomized controlled trial. Trials2018;19(1):70. [DOI: 10.1186/s13063-018-2468-z]">Maddison 2021</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes. All message content was grounded in behaviour change (social cognitive) theory. “The content was focused on modifying people’s perceptions of the symptoms, timeline, cause, consequences, personal control over, and the ability of treatment to prevent cardiovascular disease as well as altering the key mediators of behaviour change, including self‐efficacy, social support, and motivation.” (<a href="./references#CD011851-bbs2-0011" title="ACTRN12616000422426. Text4Heart Partnership: a text messaging program to enhance self-management of cardiovascular disease [Text messaging to enhance self-management of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12616000422426 (first received 23 March 2016). MaddisonR , JiangY , StewartR , ScottT , KerrA , WhittakerR , et al. An intervention to improve medication adherence in people with heart disease (Text4HeartII): randomized controlled trial. JMIR mHealth and uHealth2021;9(6):e24952. [DOI: 10.2196/24952]MaddisonR , StewartR , DoughtyR , ScottT , KerrA , BenatarJ , et al. Text4Heart II - improving medication adherence in people with heart disease: a study protocol for a randomized controlled trial. Trials2018;19(1):70. [DOI: 10.1186/s13063-018-2468-z]">Maddison 2021</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes. The content of messages was based on the original Text4Heart pilot programme, with some modifications. Message content from weeks 12 to 24 was modified to promote maintenance of the behaviours and relapse prevention. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011851-bbs2-0012" title="NCT02793830. A mobile phone based medication reminder program [A mobile phone based medication reminder program for patients in China with coronary heart disease: a pilot study]. clinicaltrials.gov/ct2/show/NCT02793830 (first received 8 June 2016). NiZ , WuB , YangQ , YanLL , LiuC , ShawRJ . An mHealth intervention to improve medication adherence and health outcomes among patients with coronary heart disease: randomized controlled trial. Journal of Medical Internet Research2022;24(3):e27202. [DOI: 10.2196/27202]">Ni 2022</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes, message reminders</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes, personalised reminders</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes. The interventions were refined based on the pilot study.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011851-bbs2-0013" title="NCT02783287. The impact of text messaging on medication adherence and exercise regimen among post-myocardial infarction patients. clinicaltrials.gov/ct2/show/NCT02783287 (first received 26 May 2016). PandeyA , ChoudhryN . An m-health application of daily text messages to address forgetfulness as contributor to non-adherence to medications post-myocardial infarction. Circulation2015;132:A18641. [DOI: 10.1161/circ.132.suppl_3.18641]PandeyA , KrummeAA , PatelT , ChoudhryNK . The impact of text messaging on medication adherence and exercise among postmyocardial infarction patients: randomized controlled pilot trial. JMIR mHealth and uHealth2017;5(8):e110. [DOI: 10.2196/mhealth.7144]PandeyAK , ChoudhryN . Text message reminders to address medication non-adherence in post-MI patients: a one year intervention study. Canadian Journal of Cardiology2014;30(10):S179. [DOI: 10.1016/j.cjca.2014.07.280]">Pandey 2017</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes, medication reminders</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011851-bbs2-0014" title="ParkLG , Howie-EsquivelJ , ChungM , DracupK . A text messaging intervention improves medication adherence for patients with coronary heart disease: a randomized controlled trial. Circulation2013;128(Suppl 22):A15249. [DOI: 10.1161/circ.128.suppl_22.A15249]ParkLG , Howie-EsquivelJ , ChungML , DracupK . A text messaging intervention to promote medication adherence for patients with coronary heart disease: a randomized controlled trial. Patient Education and Counseling2014;94(2):261-8. [DOI: 10.1016/j.pec.2013.10.027]ParkLG , Howie-EsquivelJ , WhooleyMA , DracupK . Psychosocial factors and medication adherence among patients with coronary heart disease: a text messaging intervention. European Journal of Cardiovascular Nursing2015;14(3):264-73. [DOI: 10.1177/1474515114537024]">Park 2014a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011851-bbs2-0015" title="NCT03414190. Impact of text messages to promote secondary prevention after acute coronary syndrome [Impact of a mobile phone text messages intervention on the secondary prevention of cardiovascular events after acute coronary syndrome]. clinicaltrials.gov/show/NCT03414190 (first received 29 January 2018). PassagliaLG , BrantLC , NascimentoBR , RibeiroAL . Impact of text messages in a middle-income country to promote secondary prevention after acute coronary syndrome (IMPACS): a randomized trial. Medicine2019;98(22):e15681. [DOI: 10.1097/MD.0000000000015681]PassagliaLG , BrantLC , SilvaJL , NascimentoBR , RibeiroAL . Text messages to promote secondary prevention after acute coronary syndrome (IMPACS trial). International Journal of Cardiovascular Sciences2021;35(2):202-13. [DOI: 10.36660/ijcs.20200378]">Passaglia 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes, text messages were developed by the research group, and reviewed by individuals not involved in the study to check for language issues and evaluation of understanding. The content of the messages was based on the Brazilian Society of Cardiology Guidelines. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No, semi‐personalised</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A pilot study was conducted to test the software developed and the initial acceptability of text messages sent. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011851-bbs2-0016" title="QuiliciJ , FugonL , BeguinS , MorangePE , BonnetJL , AlessiMC , et al. Effect of motivational mobile phone short message service on aspirin adherence after coronary stenting for acute coronary syndrome. International Journal of Cardiology2013;168(1):568-9. [DOI: 10.1016/j.ijcard.2013.01.252]">Quilici 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011851-bbs2-0017" title="NCT02336919. The use of texting messaging to improve the hospital-to-community transition period in cardiovascular disease patients (Txt2Prevent) [The use of texting messaging to improve the hospital-to-community transition and prevent readmission in patients with cardiovascular disease (Txt2Prevent)]. clinicaltrials.gov/ct2/show/NCT02336919 (first received 13 January 2015). RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of SMS text messaging to improve the hospital-to-community transition in patients with acute coronary syndrome (Txt2Prevent): results from a pilot randomized controlled trial. JMIR mHealth and uHealth2021;9(5):e24530. [DOI: 10.2196/24530]RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of text messaging to improve the hospital-to-community transition in acute coronary syndrome patients (Txt2Prevent): intervention development and pilot randomized controlled trial protocol. JMIR Research Protocols2017;6(5):e91. [DOI: 10.2196/resprot.6968]">Ross 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes, medication reminders</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes. The content of the text messages was developed by a clinical advisory committee (including cardiologists, a general practitioner, a community pharmacist, a cardiac nurse specialist, patient‐users, a programmer, a benefits evaluation specialist, and researchers). Messages were further revised based on the guiding principles, discharge materials, and interviews with patients. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>“Instead of conforming to a single one of the many branded theories of behaviour change, the intervention reflects a set of cross‐cutting theoretical domains; the themes in the messages relate to concerns about knowledge, skills, roles and identity, beliefs about capabilities (eg, self‐efficacy), beliefs about consequences, motivation, attention and decision processes (e.g. cues to action such as reminders), environmental context and resources, social influences, emotion, and action plans.” (<a href="./references#CD011851-bbs2-0017" title="NCT02336919. The use of texting messaging to improve the hospital-to-community transition period in cardiovascular disease patients (Txt2Prevent) [The use of texting messaging to improve the hospital-to-community transition and prevent readmission in patients with cardiovascular disease (Txt2Prevent)]. clinicaltrials.gov/ct2/show/NCT02336919 (first received 13 January 2015). RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of SMS text messaging to improve the hospital-to-community transition in patients with acute coronary syndrome (Txt2Prevent): results from a pilot randomized controlled trial. JMIR mHealth and uHealth2021;9(5):e24530. [DOI: 10.2196/24530]RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of text messaging to improve the hospital-to-community transition in acute coronary syndrome patients (Txt2Prevent): intervention development and pilot randomized controlled trial protocol. JMIR Research Protocols2017;6(5):e91. [DOI: 10.2196/resprot.6968]">Ross 2021</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>“Instead of conforming to a single one of the many branded theories of behaviour change, the intervention reflects a set of cross‐cutting theoretical domains; the themes in the messages relate to concerns about knowledge, skills, roles and identity, beliefs about capabilities (eg, self‐efficacy), beliefs about consequences, motivation, attention and decision processes (e.g. cues to action such as reminders), environmental context and resources, social influences, emotion, and action plans.” (<a href="./references#CD011851-bbs2-0017" title="NCT02336919. The use of texting messaging to improve the hospital-to-community transition period in cardiovascular disease patients (Txt2Prevent) [The use of texting messaging to improve the hospital-to-community transition and prevent readmission in patients with cardiovascular disease (Txt2Prevent)]. clinicaltrials.gov/ct2/show/NCT02336919 (first received 13 January 2015). RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of SMS text messaging to improve the hospital-to-community transition in patients with acute coronary syndrome (Txt2Prevent): results from a pilot randomized controlled trial. JMIR mHealth and uHealth2021;9(5):e24530. [DOI: 10.2196/24530]RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of text messaging to improve the hospital-to-community transition in acute coronary syndrome patients (Txt2Prevent): intervention development and pilot randomized controlled trial protocol. JMIR Research Protocols2017;6(5):e91. [DOI: 10.2196/resprot.6968]">Ross 2021</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No, but participants received different SMS text messages on 2 occasions based on their smoking status. No other aspects were personalised. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes, this was a pilot study.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011851-bbs2-0018" title="HuoX , SpatzES , DingQ , HorakP , ZhengX , MastersC , et al. Design and rationale of the Cardiovascular Health and Text Messaging (CHAT) study and the CHAT-Diabetes Mellitus (CHAT-DM) study: two randomised controlled trials of text messaging to improve secondary prevention for coronary heart disease and diabetes. BMJ Open2017;7(12):e018302. [DOI: 10.1136/bmjopen-2017-018302]ZhengX , SpatzES , BaiX , HuoX , DingQ , HorakP , et al. Effect of text messaging on risk factor management in patients with coronary heart disease: the CHAT randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(4):e005616. [DOI: 10.1161/CIRCOUTCOMES.119.005616]">Zheng 2019</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes, it reminded people to take their medications and follow‐up.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes. “A multidisciplinary team of cardiologists, endocrinologists, psychologists, nurses, linguists, and patients developed the text message bank through a systematic and iterative approach.” (<a href="./references#CD011851-bbs2-0008" title="HuoX , KrumholzHM , BaiX , SpatzES , DingQ , HorakP , et al. Effects of mobile text messaging on glycemic control in patients with coronary heart disease and diabetes mellitus: a randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(9):e005805. [DOI: 10.1161/CIRCOUTCOMES.119.005805]NCT02883842. Cardiovascular Health and Text Messaging-Diabetes Mellitus (CHAT-DM) Study [Effectiveness of text messaging on risk factors control and medication adherence among patients with Coronary Heart Disease and Diabetes in China: cardiovascular health andtext messaging-Diabetes Mellitus (CHAT-DM) study]. clinicaltrials.gov/ct2/show/NCT02883842 (first received 30 August 2016). ">Huo 2019</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No, but semi‐personalised with participants' preferred name</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes. To make the messages more simple, culturally adaptable, and easy to understand, a user test and pilot study were conducted to collect patient feedback on the text bank messages. </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>ACS: acute coronary syndrome; SMS: short message service; WHO: World Health Organization</p> </div> </div> <p>Four studies specified that the automated computer program from which the messages were sent was developed particularly for this study (<a href="./references#CD011851-bbs2-0004" title="ACTRN12611000161921. Tobacco, EXercise and dieT MEssages (TEXT ME): the effect of semi-personalised lifestyle reminder text message intervention on cardiovascular disease risk [Tobacco, EXercise and dieT MEssages (TEXT ME): The effect of a semi-personalised lifestyle reminder text message intervention on cardiovascular risk factors in patients with cardiovascular disease and those who are at high risk of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12611000161921 (first received 3 February 2011). ChowCK , RedfernJ , HillisGS , ThakkarJ , SantoK , HackettML , et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA2015;314(12):1255-63. [DOI: 10.1001/jama.2015.10945]ChowCK , RedfernJ , ThiagalingamA , JanS , WhittakerR , HackettM , et al. Design and rationale of the tobacco, exercise and diet messages (TEXT ME) trial of a text message-based intervention for ongoing prevention of cardiovascular disease in people with coronary disease: a randomised controlled trial protocol. BMJ Open2012;2(1):e000606. [DOI: 10.1136/bmjopen-2011-000606]RedfernJ , SantoK , CooreyG , ThakkarJ , HackettM , ThiagalingamA , et al. Factors influencing engagement, perceived usefulness and behavioral mechanisms associated with a text message support program. PLOS ONE2016;11(10):e0163929. [DOI: 10.1371/journal.pone.0163929]ThakkarJ , RedfernJ , De KeizerL , ThiagalingamA , ChowC . Patient perceptions of text message-based intervention for secondary prevention of cardiovascular events. Heart, Lung and Circulation2013;22(Suppl 1):S264. [DOI: 10.1016/j.hlc.2013.05.630]ThakkarJ , RedfernJ , ThiagalingamA , ChowCK . Patterns, predictors and effects of texting intervention on physical activity in CHD – insights from the TEXT ME randomized clinical trial. European Journal of Preventive Cardiology2016;23(17):1894-902. [DOI: 10.1177/2047487316664190]">Chow 2015</a>; <a href="./references#CD011851-bbs2-0005" title="ACTRN12613000793718. TEXT messages to improve MEDication adherence &amp; Secondary prevention – TEXTMEDS [TEXT messages to improve MEDication adherence &amp; Secondary prevention in patients with acute coronary syndrome - TEXTMEDS]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364448&amp;isReview=true (first received 18 June 2013). ChowCK , KlimisH , ThiagalingamA , RedfernJ , HillisGS , BriegerD , et al. Text messages to improve medication adherence and secondary prevention after acute coronary syndrome: the TEXTMEDS randomized clinical trial. Circulation2022;145(19):1443-55. [DOI: 10.1161/CIRCULATIONAHA.121.056161]ChowCK , ThiagalingamA , SantoK , KokC , ThakkarJ , StepienS , et al. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol. BMJ Open2018;8:e019463. [DOI: 10.1136/bmjopen-2017-019463]">Chow 2022</a>; <a href="./references#CD011851-bbs2-0013" title="NCT02783287. The impact of text messaging on medication adherence and exercise regimen among post-myocardial infarction patients. clinicaltrials.gov/ct2/show/NCT02783287 (first received 26 May 2016). PandeyA , ChoudhryN . An m-health application of daily text messages to address forgetfulness as contributor to non-adherence to medications post-myocardial infarction. Circulation2015;132:A18641. [DOI: 10.1161/circ.132.suppl_3.18641]PandeyA , KrummeAA , PatelT , ChoudhryNK . The impact of text messaging on medication adherence and exercise among postmyocardial infarction patients: randomized controlled pilot trial. JMIR mHealth and uHealth2017;5(8):e110. [DOI: 10.2196/mhealth.7144]PandeyAK , ChoudhryN . Text message reminders to address medication non-adherence in post-MI patients: a one year intervention study. Canadian Journal of Cardiology2014;30(10):S179. [DOI: 10.1016/j.cjca.2014.07.280]">Pandey 2017</a>; <a href="./references#CD011851-bbs2-0015" title="NCT03414190. Impact of text messages to promote secondary prevention after acute coronary syndrome [Impact of a mobile phone text messages intervention on the secondary prevention of cardiovascular events after acute coronary syndrome]. clinicaltrials.gov/show/NCT03414190 (first received 29 January 2018). PassagliaLG , BrantLC , NascimentoBR , RibeiroAL . Impact of text messages in a middle-income country to promote secondary prevention after acute coronary syndrome (IMPACS): a randomized trial. Medicine2019;98(22):e15681. [DOI: 10.1097/MD.0000000000015681]PassagliaLG , BrantLC , SilvaJL , NascimentoBR , RibeiroAL . Text messages to promote secondary prevention after acute coronary syndrome (IMPACS trial). International Journal of Cardiovascular Sciences2021;35(2):202-13. [DOI: 10.36660/ijcs.20200378]">Passaglia 2021</a>). Eleven other studies stated that an automated system was used (<a href="./references#CD011851-bbs2-0001" title="BaeJW , WooSI , LeeJ , ParkSD , KwonSW , ChoiSH , et al. mHealth interventions for lifestyle and risk factor modification in coronary heart disease: randomized controlled trial. JMIR mHealth and uHealth2021;9(9):e29928. [DOI: 10.2196/29928]KCT0005087. Effect of text messaging program on lifestyle and clinical outcomes in patients with cardiovascular disease. cris.nih.go.kr/cris/search/detailSearch.do/19282 (first received 11 September 2019). ">Bae 2021</a>; <a href="./references#CD011851-bbs2-0002" title="BermonA , UribeAF , Pérez-RiveroPF , Prieto-MerinoD , SaaibiJF , SilvaFA , et al. Efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: TXT2HEART Colombia randomized controlled trial. JMIR mHealth and uHealth2021;9(7):e25548. [DOI: 10.2196/25548]BermonA , Uribe-RodríguezAF , Pérez-RiveroPF , Prieto-MerinoD , RiveraDIC , GuioE , et al. Evaluation of the efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: the txt2heart Colombia randomised controlled trial protocol. BMJ Open2019;9:e028017. [DOI: 10.1136/ bmjopen-2018-028017]NCT03098186. TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention [TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention]. clinicaltrials.gov/ct2/show/NCT03098186 (first received 3 March 2017). ">Bermon 2021</a>; <a href="./references#CD011851-bbs2-0003" title="ChenC , LiX , KangY , LiuH , LiangYD , ZhangQ . Post-discharge short service message improves short-term clinical outcome and self-care behavior in Chinese patients with chronic heart failure. European Heart Journal2018;39(Suppl 1):797-8. [DOI: 10.1093/eurheartj/ehy563.P3770]ChenC , LiX , SunL , CaoS , KangY , HongL , et al. Post-discharge short message service improves short-term clinical outcome and self-care behaviour in chronic heart failure. ESC Heart Failure2019;6(1):164-73. [DOI: 10.1002/ehf2.12380]ChiCTR-INR-17012316. Effect of post-discharge text messages on clinical outcomes in patients with heart failure [Effect of post-discharge text messages on clinical outcomes in patients with heart failure]. trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR-INR-17012316 (first received 9 August 2018). LiX , ChenC , YouGY , ZhangQ . Post-discharge text messaging intervention improved clinical outcomes in patients with heart failure. European Heart Journal2016;37(Suppl 1):727-8. [DOI: 10.1093/eurheartj/ehw433]">Chen 2019</a>; <a href="./references#CD011851-bbs2-0006" title="ACTRN12613000901707. Text4Heart: a text message and internet-based comprehensive cardiac rehabilitation intervention [A randomised controlled trial to determine the efficacy of a text message and Internet-based comprehensive cardiac rehabilitation programme to improve adherence to lifestyle change compared with usual care in New Zealand adults with a diagnosis of cardiovascular disease]. anzctr.org.au/ACTRN12613000901707.aspx (first received 9 August 2013). DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Improving coronary heart disease self-management using mobile technologies (Text4Heart): a randomised controlled trial protocol. Trials2014;15(71):1-9. [DOI: 10.1186/1745-6215-15-71]DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Text message and internet support for coronary heart disease self-management: results from the Text4Heart randomized controlled trial. Journal of Medical Internet Research2015;17(10):e237. [DOI: 10.2196/jmir.4944]">Dale 2015a</a>; <a href="./references#CD011851-bbs2-0007" title="FangR , LiX . Electronic messaging support service programs improve adherence to lipid-lowering therapy among outpatients with coronary artery disease: an exploratory randomised control study. Journal of Clinical Nursing2016;25(5-6):664-71. [DOI: 10.1111/jocn.12988]">Fang 2016</a>; <a href="./references#CD011851-bbs2-0008" title="HuoX , KrumholzHM , BaiX , SpatzES , DingQ , HorakP , et al. Effects of mobile text messaging on glycemic control in patients with coronary heart disease and diabetes mellitus: a randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(9):e005805. [DOI: 10.1161/CIRCOUTCOMES.119.005805]NCT02883842. Cardiovascular Health and Text Messaging-Diabetes Mellitus (CHAT-DM) Study [Effectiveness of text messaging on risk factors control and medication adherence among patients with Coronary Heart Disease and Diabetes in China: cardiovascular health andtext messaging-Diabetes Mellitus (CHAT-DM) study]. clinicaltrials.gov/ct2/show/NCT02883842 (first received 30 August 2016). ">Huo 2019</a>; <a href="./references#CD011851-bbs2-0009" title="KamalAK , ShaikQN , PashaO , AzamI , IslamM , MemonAA , et al. Improving medication adherence in stroke patients through Short Text Messages (SMS4Stroke)-study protocol for a randomized, controlled trial. BMC Neurology2015;15:157. [DOI: 10.1186/s12883-015-0413-2]KamalAK , ShaikhQ , PashaO , AzamI , IslamM , MemonAA , et al. A randomized controlled behavioral intervention trial to improve medication adherence in adult stroke patients with prescription tailored short messaging service (SMS)-SMS4Stroke study. BMC Neurolology2015;15:212. [DOI: 10.1186/s12883-015-0471-5]">Kamal 2015</a>; <a href="./references#CD011851-bbs2-0010" title="KhonsariS , SubramanianP , ChinnaK , LatifLA , LingLW , GholamiO . Effect of a reminder system using an automated short message service on medication adherence following acute coronary syndrome. European Journal of Cardiovascular Nursing2015;14(2):170-9. [DOI: 10.1177/1474515114521910]">Khonsari 2015</a>; <a href="./references#CD011851-bbs2-0011" title="ACTRN12616000422426. Text4Heart Partnership: a text messaging program to enhance self-management of cardiovascular disease [Text messaging to enhance self-management of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12616000422426 (first received 23 March 2016). MaddisonR , JiangY , StewartR , ScottT , KerrA , WhittakerR , et al. An intervention to improve medication adherence in people with heart disease (Text4HeartII): randomized controlled trial. JMIR mHealth and uHealth2021;9(6):e24952. [DOI: 10.2196/24952]MaddisonR , StewartR , DoughtyR , ScottT , KerrA , BenatarJ , et al. Text4Heart II - improving medication adherence in people with heart disease: a study protocol for a randomized controlled trial. Trials2018;19(1):70. [DOI: 10.1186/s13063-018-2468-z]">Maddison 2021</a>; <a href="./references#CD011851-bbs2-0014" title="ParkLG , Howie-EsquivelJ , ChungM , DracupK . A text messaging intervention improves medication adherence for patients with coronary heart disease: a randomized controlled trial. Circulation2013;128(Suppl 22):A15249. [DOI: 10.1161/circ.128.suppl_22.A15249]ParkLG , Howie-EsquivelJ , ChungML , DracupK . A text messaging intervention to promote medication adherence for patients with coronary heart disease: a randomized controlled trial. Patient Education and Counseling2014;94(2):261-8. [DOI: 10.1016/j.pec.2013.10.027]ParkLG , Howie-EsquivelJ , WhooleyMA , DracupK . Psychosocial factors and medication adherence among patients with coronary heart disease: a text messaging intervention. European Journal of Cardiovascular Nursing2015;14(3):264-73. [DOI: 10.1177/1474515114537024]">Park 2014a</a>; <a href="./references#CD011851-bbs2-0018" title="HuoX , SpatzES , DingQ , HorakP , ZhengX , MastersC , et al. Design and rationale of the Cardiovascular Health and Text Messaging (CHAT) study and the CHAT-Diabetes Mellitus (CHAT-DM) study: two randomised controlled trials of text messaging to improve secondary prevention for coronary heart disease and diabetes. BMJ Open2017;7(12):e018302. [DOI: 10.1136/bmjopen-2017-018302]ZhengX , SpatzES , BaiX , HuoX , DingQ , HorakP , et al. Effect of text messaging on risk factor management in patients with coronary heart disease: the CHAT randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(4):e005616. [DOI: 10.1161/CIRCOUTCOMES.119.005616]">Zheng 2019</a>), which can also be assumed for two remaining studies whilst not explicitly stated (<a href="./references#CD011851-bbs2-0016" title="QuiliciJ , FugonL , BeguinS , MorangePE , BonnetJL , AlessiMC , et al. Effect of motivational mobile phone short message service on aspirin adherence after coronary stenting for acute coronary syndrome. International Journal of Cardiology2013;168(1):568-9. [DOI: 10.1016/j.ijcard.2013.01.252]">Quilici 2013</a>; <a href="./references#CD011851-bbs2-0017" title="NCT02336919. The use of texting messaging to improve the hospital-to-community transition period in cardiovascular disease patients (Txt2Prevent) [The use of texting messaging to improve the hospital-to-community transition and prevent readmission in patients with cardiovascular disease (Txt2Prevent)]. clinicaltrials.gov/ct2/show/NCT02336919 (first received 13 January 2015). RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of SMS text messaging to improve the hospital-to-community transition in patients with acute coronary syndrome (Txt2Prevent): results from a pilot randomized controlled trial. JMIR mHealth and uHealth2021;9(5):e24530. [DOI: 10.2196/24530]RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of text messaging to improve the hospital-to-community transition in acute coronary syndrome patients (Txt2Prevent): intervention development and pilot randomized controlled trial protocol. JMIR Research Protocols2017;6(5):e91. [DOI: 10.2196/resprot.6968]">Ross 2021</a>). One study used a mobile app to send messages and was not automated (<a href="./references#CD011851-bbs2-0012" title="NCT02793830. A mobile phone based medication reminder program [A mobile phone based medication reminder program for patients in China with coronary heart disease: a pilot study]. clinicaltrials.gov/ct2/show/NCT02793830 (first received 8 June 2016). NiZ , WuB , YangQ , YanLL , LiuC , ShawRJ . An mHealth intervention to improve medication adherence and health outcomes among patients with coronary heart disease: randomized controlled trial. Journal of Medical Internet Research2022;24(3):e27202. [DOI: 10.2196/27202]">Ni 2022</a>). In <a href="./references#CD011851-bbs2-0012" title="NCT02793830. A mobile phone based medication reminder program [A mobile phone based medication reminder program for patients in China with coronary heart disease: a pilot study]. clinicaltrials.gov/ct2/show/NCT02793830 (first received 8 June 2016). NiZ , WuB , YangQ , YanLL , LiuC , ShawRJ . An mHealth intervention to improve medication adherence and health outcomes among patients with coronary heart disease: randomized controlled trial. Journal of Medical Internet Research2022;24(3):e27202. [DOI: 10.2196/27202]">Ni 2022</a>, the study co‐ordinator sent the medication reminders and educational materials through Message Express (a message saving and delivery app) on an encrypted external device. </p> <p>Seven studies reported on the psychological theory and behaviour change techniques used in the development of their text messages (<a href="./references#CD011851-bbs2-0004" title="ACTRN12611000161921. Tobacco, EXercise and dieT MEssages (TEXT ME): the effect of semi-personalised lifestyle reminder text message intervention on cardiovascular disease risk [Tobacco, EXercise and dieT MEssages (TEXT ME): The effect of a semi-personalised lifestyle reminder text message intervention on cardiovascular risk factors in patients with cardiovascular disease and those who are at high risk of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12611000161921 (first received 3 February 2011). ChowCK , RedfernJ , HillisGS , ThakkarJ , SantoK , HackettML , et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA2015;314(12):1255-63. [DOI: 10.1001/jama.2015.10945]ChowCK , RedfernJ , ThiagalingamA , JanS , WhittakerR , HackettM , et al. Design and rationale of the tobacco, exercise and diet messages (TEXT ME) trial of a text message-based intervention for ongoing prevention of cardiovascular disease in people with coronary disease: a randomised controlled trial protocol. BMJ Open2012;2(1):e000606. [DOI: 10.1136/bmjopen-2011-000606]RedfernJ , SantoK , CooreyG , ThakkarJ , HackettM , ThiagalingamA , et al. Factors influencing engagement, perceived usefulness and behavioral mechanisms associated with a text message support program. PLOS ONE2016;11(10):e0163929. [DOI: 10.1371/journal.pone.0163929]ThakkarJ , RedfernJ , De KeizerL , ThiagalingamA , ChowC . Patient perceptions of text message-based intervention for secondary prevention of cardiovascular events. Heart, Lung and Circulation2013;22(Suppl 1):S264. [DOI: 10.1016/j.hlc.2013.05.630]ThakkarJ , RedfernJ , ThiagalingamA , ChowCK . Patterns, predictors and effects of texting intervention on physical activity in CHD – insights from the TEXT ME randomized clinical trial. European Journal of Preventive Cardiology2016;23(17):1894-902. [DOI: 10.1177/2047487316664190]">Chow 2015</a>; <a href="./references#CD011851-bbs2-0005" title="ACTRN12613000793718. TEXT messages to improve MEDication adherence &amp; Secondary prevention – TEXTMEDS [TEXT messages to improve MEDication adherence &amp; Secondary prevention in patients with acute coronary syndrome - TEXTMEDS]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364448&amp;isReview=true (first received 18 June 2013). ChowCK , KlimisH , ThiagalingamA , RedfernJ , HillisGS , BriegerD , et al. Text messages to improve medication adherence and secondary prevention after acute coronary syndrome: the TEXTMEDS randomized clinical trial. Circulation2022;145(19):1443-55. [DOI: 10.1161/CIRCULATIONAHA.121.056161]ChowCK , ThiagalingamA , SantoK , KokC , ThakkarJ , StepienS , et al. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol. BMJ Open2018;8:e019463. [DOI: 10.1136/bmjopen-2017-019463]">Chow 2022</a>; <a href="./references#CD011851-bbs2-0006" title="ACTRN12613000901707. Text4Heart: a text message and internet-based comprehensive cardiac rehabilitation intervention [A randomised controlled trial to determine the efficacy of a text message and Internet-based comprehensive cardiac rehabilitation programme to improve adherence to lifestyle change compared with usual care in New Zealand adults with a diagnosis of cardiovascular disease]. anzctr.org.au/ACTRN12613000901707.aspx (first received 9 August 2013). DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Improving coronary heart disease self-management using mobile technologies (Text4Heart): a randomised controlled trial protocol. Trials2014;15(71):1-9. [DOI: 10.1186/1745-6215-15-71]DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Text message and internet support for coronary heart disease self-management: results from the Text4Heart randomized controlled trial. Journal of Medical Internet Research2015;17(10):e237. [DOI: 10.2196/jmir.4944]">Dale 2015a</a>; <a href="./references#CD011851-bbs2-0009" title="KamalAK , ShaikQN , PashaO , AzamI , IslamM , MemonAA , et al. Improving medication adherence in stroke patients through Short Text Messages (SMS4Stroke)-study protocol for a randomized, controlled trial. BMC Neurology2015;15:157. [DOI: 10.1186/s12883-015-0413-2]KamalAK , ShaikhQ , PashaO , AzamI , IslamM , MemonAA , et al. A randomized controlled behavioral intervention trial to improve medication adherence in adult stroke patients with prescription tailored short messaging service (SMS)-SMS4Stroke study. BMC Neurolology2015;15:212. [DOI: 10.1186/s12883-015-0471-5]">Kamal 2015</a>; <a href="./references#CD011851-bbs2-0010" title="KhonsariS , SubramanianP , ChinnaK , LatifLA , LingLW , GholamiO . Effect of a reminder system using an automated short message service on medication adherence following acute coronary syndrome. European Journal of Cardiovascular Nursing2015;14(2):170-9. [DOI: 10.1177/1474515114521910]">Khonsari 2015</a>; <a href="./references#CD011851-bbs2-0011" title="ACTRN12616000422426. Text4Heart Partnership: a text messaging program to enhance self-management of cardiovascular disease [Text messaging to enhance self-management of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12616000422426 (first received 23 March 2016). MaddisonR , JiangY , StewartR , ScottT , KerrA , WhittakerR , et al. An intervention to improve medication adherence in people with heart disease (Text4HeartII): randomized controlled trial. JMIR mHealth and uHealth2021;9(6):e24952. [DOI: 10.2196/24952]MaddisonR , StewartR , DoughtyR , ScottT , KerrA , BenatarJ , et al. Text4Heart II - improving medication adherence in people with heart disease: a study protocol for a randomized controlled trial. Trials2018;19(1):70. [DOI: 10.1186/s13063-018-2468-z]">Maddison 2021</a>; <a href="./references#CD011851-bbs2-0017" title="NCT02336919. The use of texting messaging to improve the hospital-to-community transition period in cardiovascular disease patients (Txt2Prevent) [The use of texting messaging to improve the hospital-to-community transition and prevent readmission in patients with cardiovascular disease (Txt2Prevent)]. clinicaltrials.gov/ct2/show/NCT02336919 (first received 13 January 2015). RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of SMS text messaging to improve the hospital-to-community transition in patients with acute coronary syndrome (Txt2Prevent): results from a pilot randomized controlled trial. JMIR mHealth and uHealth2021;9(5):e24530. [DOI: 10.2196/24530]RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of text messaging to improve the hospital-to-community transition in acute coronary syndrome patients (Txt2Prevent): intervention development and pilot randomized controlled trial protocol. JMIR Research Protocols2017;6(5):e91. [DOI: 10.2196/resprot.6968]">Ross 2021</a>), with <a href="./references#CD011851-bbs2-0004" title="ACTRN12611000161921. Tobacco, EXercise and dieT MEssages (TEXT ME): the effect of semi-personalised lifestyle reminder text message intervention on cardiovascular disease risk [Tobacco, EXercise and dieT MEssages (TEXT ME): The effect of a semi-personalised lifestyle reminder text message intervention on cardiovascular risk factors in patients with cardiovascular disease and those who are at high risk of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12611000161921 (first received 3 February 2011). ChowCK , RedfernJ , HillisGS , ThakkarJ , SantoK , HackettML , et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA2015;314(12):1255-63. [DOI: 10.1001/jama.2015.10945]ChowCK , RedfernJ , ThiagalingamA , JanS , WhittakerR , HackettM , et al. Design and rationale of the tobacco, exercise and diet messages (TEXT ME) trial of a text message-based intervention for ongoing prevention of cardiovascular disease in people with coronary disease: a randomised controlled trial protocol. BMJ Open2012;2(1):e000606. [DOI: 10.1136/bmjopen-2011-000606]RedfernJ , SantoK , CooreyG , ThakkarJ , HackettM , ThiagalingamA , et al. Factors influencing engagement, perceived usefulness and behavioral mechanisms associated with a text message support program. PLOS ONE2016;11(10):e0163929. [DOI: 10.1371/journal.pone.0163929]ThakkarJ , RedfernJ , De KeizerL , ThiagalingamA , ChowC . Patient perceptions of text message-based intervention for secondary prevention of cardiovascular events. Heart, Lung and Circulation2013;22(Suppl 1):S264. [DOI: 10.1016/j.hlc.2013.05.630]ThakkarJ , RedfernJ , ThiagalingamA , ChowCK . Patterns, predictors and effects of texting intervention on physical activity in CHD – insights from the TEXT ME randomized clinical trial. European Journal of Preventive Cardiology2016;23(17):1894-902. [DOI: 10.1177/2047487316664190]">Chow 2015</a> also having an extensive co‐design and development process published (<a href="./references#CD011851-bbs2-0089" title="RedfernJ , ThiagalingamA , JanS , WhittakerR , HackettML , MooneyJ , et al. Development of a set of mobile phone text messages designed for prevention of recurrent cardiovascular events. European Journal of Preventive Cardiology2014;21(4):492-9. [DOI: 10.1177/2047487312449416]">Redfern 2014</a>) (<a href="#CD011851-tbl-0002">Table 1</a>). Four studies only used behaviour change techniques to develop their text messages without stating a psychological theory (<a href="./references#CD011851-bbs2-0002" title="BermonA , UribeAF , Pérez-RiveroPF , Prieto-MerinoD , SaaibiJF , SilvaFA , et al. Efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: TXT2HEART Colombia randomized controlled trial. JMIR mHealth and uHealth2021;9(7):e25548. [DOI: 10.2196/25548]BermonA , Uribe-RodríguezAF , Pérez-RiveroPF , Prieto-MerinoD , RiveraDIC , GuioE , et al. Evaluation of the efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: the txt2heart Colombia randomised controlled trial protocol. BMJ Open2019;9:e028017. [DOI: 10.1136/ bmjopen-2018-028017]NCT03098186. TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention [TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention]. clinicaltrials.gov/ct2/show/NCT03098186 (first received 3 March 2017). ">Bermon 2021</a>; <a href="./references#CD011851-bbs2-0008" title="HuoX , KrumholzHM , BaiX , SpatzES , DingQ , HorakP , et al. Effects of mobile text messaging on glycemic control in patients with coronary heart disease and diabetes mellitus: a randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(9):e005805. [DOI: 10.1161/CIRCOUTCOMES.119.005805]NCT02883842. Cardiovascular Health and Text Messaging-Diabetes Mellitus (CHAT-DM) Study [Effectiveness of text messaging on risk factors control and medication adherence among patients with Coronary Heart Disease and Diabetes in China: cardiovascular health andtext messaging-Diabetes Mellitus (CHAT-DM) study]. clinicaltrials.gov/ct2/show/NCT02883842 (first received 30 August 2016). ">Huo 2019</a>; <a href="./references#CD011851-bbs2-0014" title="ParkLG , Howie-EsquivelJ , ChungM , DracupK . A text messaging intervention improves medication adherence for patients with coronary heart disease: a randomized controlled trial. Circulation2013;128(Suppl 22):A15249. [DOI: 10.1161/circ.128.suppl_22.A15249]ParkLG , Howie-EsquivelJ , ChungML , DracupK . A text messaging intervention to promote medication adherence for patients with coronary heart disease: a randomized controlled trial. Patient Education and Counseling2014;94(2):261-8. [DOI: 10.1016/j.pec.2013.10.027]ParkLG , Howie-EsquivelJ , WhooleyMA , DracupK . Psychosocial factors and medication adherence among patients with coronary heart disease: a text messaging intervention. European Journal of Cardiovascular Nursing2015;14(3):264-73. [DOI: 10.1177/1474515114537024]">Park 2014a</a>; <a href="./references#CD011851-bbs2-0018" title="HuoX , SpatzES , DingQ , HorakP , ZhengX , MastersC , et al. Design and rationale of the Cardiovascular Health and Text Messaging (CHAT) study and the CHAT-Diabetes Mellitus (CHAT-DM) study: two randomised controlled trials of text messaging to improve secondary prevention for coronary heart disease and diabetes. BMJ Open2017;7(12):e018302. [DOI: 10.1136/bmjopen-2017-018302]ZhengX , SpatzES , BaiX , HuoX , DingQ , HorakP , et al. Effect of text messaging on risk factor management in patients with coronary heart disease: the CHAT randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(4):e005616. [DOI: 10.1161/CIRCOUTCOMES.119.005616]">Zheng 2019</a>). The other seven studies did not specify whether the text messages were supported by theoretical framework. </p> <p>Nine studies tailored the text messages to the participants' name (<a href="./references#CD011851-bbs2-0001" title="BaeJW , WooSI , LeeJ , ParkSD , KwonSW , ChoiSH , et al. mHealth interventions for lifestyle and risk factor modification in coronary heart disease: randomized controlled trial. JMIR mHealth and uHealth2021;9(9):e29928. [DOI: 10.2196/29928]KCT0005087. Effect of text messaging program on lifestyle and clinical outcomes in patients with cardiovascular disease. cris.nih.go.kr/cris/search/detailSearch.do/19282 (first received 11 September 2019). ">Bae 2021</a>; <a href="./references#CD011851-bbs2-0004" title="ACTRN12611000161921. Tobacco, EXercise and dieT MEssages (TEXT ME): the effect of semi-personalised lifestyle reminder text message intervention on cardiovascular disease risk [Tobacco, EXercise and dieT MEssages (TEXT ME): The effect of a semi-personalised lifestyle reminder text message intervention on cardiovascular risk factors in patients with cardiovascular disease and those who are at high risk of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12611000161921 (first received 3 February 2011). ChowCK , RedfernJ , HillisGS , ThakkarJ , SantoK , HackettML , et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA2015;314(12):1255-63. [DOI: 10.1001/jama.2015.10945]ChowCK , RedfernJ , ThiagalingamA , JanS , WhittakerR , HackettM , et al. Design and rationale of the tobacco, exercise and diet messages (TEXT ME) trial of a text message-based intervention for ongoing prevention of cardiovascular disease in people with coronary disease: a randomised controlled trial protocol. BMJ Open2012;2(1):e000606. [DOI: 10.1136/bmjopen-2011-000606]RedfernJ , SantoK , CooreyG , ThakkarJ , HackettM , ThiagalingamA , et al. Factors influencing engagement, perceived usefulness and behavioral mechanisms associated with a text message support program. PLOS ONE2016;11(10):e0163929. [DOI: 10.1371/journal.pone.0163929]ThakkarJ , RedfernJ , De KeizerL , ThiagalingamA , ChowC . Patient perceptions of text message-based intervention for secondary prevention of cardiovascular events. Heart, Lung and Circulation2013;22(Suppl 1):S264. [DOI: 10.1016/j.hlc.2013.05.630]ThakkarJ , RedfernJ , ThiagalingamA , ChowCK . Patterns, predictors and effects of texting intervention on physical activity in CHD – insights from the TEXT ME randomized clinical trial. European Journal of Preventive Cardiology2016;23(17):1894-902. [DOI: 10.1177/2047487316664190]">Chow 2015</a>; <a href="./references#CD011851-bbs2-0005" title="ACTRN12613000793718. TEXT messages to improve MEDication adherence &amp; Secondary prevention – TEXTMEDS [TEXT messages to improve MEDication adherence &amp; Secondary prevention in patients with acute coronary syndrome - TEXTMEDS]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364448&amp;isReview=true (first received 18 June 2013). ChowCK , KlimisH , ThiagalingamA , RedfernJ , HillisGS , BriegerD , et al. Text messages to improve medication adherence and secondary prevention after acute coronary syndrome: the TEXTMEDS randomized clinical trial. Circulation2022;145(19):1443-55. [DOI: 10.1161/CIRCULATIONAHA.121.056161]ChowCK , ThiagalingamA , SantoK , KokC , ThakkarJ , StepienS , et al. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol. BMJ Open2018;8:e019463. [DOI: 10.1136/bmjopen-2017-019463]">Chow 2022</a>; <a href="./references#CD011851-bbs2-0006" title="ACTRN12613000901707. Text4Heart: a text message and internet-based comprehensive cardiac rehabilitation intervention [A randomised controlled trial to determine the efficacy of a text message and Internet-based comprehensive cardiac rehabilitation programme to improve adherence to lifestyle change compared with usual care in New Zealand adults with a diagnosis of cardiovascular disease]. anzctr.org.au/ACTRN12613000901707.aspx (first received 9 August 2013). DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Improving coronary heart disease self-management using mobile technologies (Text4Heart): a randomised controlled trial protocol. Trials2014;15(71):1-9. [DOI: 10.1186/1745-6215-15-71]DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Text message and internet support for coronary heart disease self-management: results from the Text4Heart randomized controlled trial. Journal of Medical Internet Research2015;17(10):e237. [DOI: 10.2196/jmir.4944]">Dale 2015a</a>; <a href="./references#CD011851-bbs2-0008" title="HuoX , KrumholzHM , BaiX , SpatzES , DingQ , HorakP , et al. Effects of mobile text messaging on glycemic control in patients with coronary heart disease and diabetes mellitus: a randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(9):e005805. [DOI: 10.1161/CIRCOUTCOMES.119.005805]NCT02883842. Cardiovascular Health and Text Messaging-Diabetes Mellitus (CHAT-DM) Study [Effectiveness of text messaging on risk factors control and medication adherence among patients with Coronary Heart Disease and Diabetes in China: cardiovascular health andtext messaging-Diabetes Mellitus (CHAT-DM) study]. clinicaltrials.gov/ct2/show/NCT02883842 (first received 30 August 2016). ">Huo 2019</a>; <a href="./references#CD011851-bbs2-0010" title="KhonsariS , SubramanianP , ChinnaK , LatifLA , LingLW , GholamiO . Effect of a reminder system using an automated short message service on medication adherence following acute coronary syndrome. European Journal of Cardiovascular Nursing2015;14(2):170-9. [DOI: 10.1177/1474515114521910]">Khonsari 2015</a>; <a href="./references#CD011851-bbs2-0011" title="ACTRN12616000422426. Text4Heart Partnership: a text messaging program to enhance self-management of cardiovascular disease [Text messaging to enhance self-management of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12616000422426 (first received 23 March 2016). MaddisonR , JiangY , StewartR , ScottT , KerrA , WhittakerR , et al. An intervention to improve medication adherence in people with heart disease (Text4HeartII): randomized controlled trial. JMIR mHealth and uHealth2021;9(6):e24952. [DOI: 10.2196/24952]MaddisonR , StewartR , DoughtyR , ScottT , KerrA , BenatarJ , et al. Text4Heart II - improving medication adherence in people with heart disease: a study protocol for a randomized controlled trial. Trials2018;19(1):70. [DOI: 10.1186/s13063-018-2468-z]">Maddison 2021</a>; <a href="./references#CD011851-bbs2-0014" title="ParkLG , Howie-EsquivelJ , ChungM , DracupK . A text messaging intervention improves medication adherence for patients with coronary heart disease: a randomized controlled trial. Circulation2013;128(Suppl 22):A15249. [DOI: 10.1161/circ.128.suppl_22.A15249]ParkLG , Howie-EsquivelJ , ChungML , DracupK . A text messaging intervention to promote medication adherence for patients with coronary heart disease: a randomized controlled trial. Patient Education and Counseling2014;94(2):261-8. [DOI: 10.1016/j.pec.2013.10.027]ParkLG , Howie-EsquivelJ , WhooleyMA , DracupK . Psychosocial factors and medication adherence among patients with coronary heart disease: a text messaging intervention. European Journal of Cardiovascular Nursing2015;14(3):264-73. [DOI: 10.1177/1474515114537024]">Park 2014a</a>; <a href="./references#CD011851-bbs2-0018" title="HuoX , SpatzES , DingQ , HorakP , ZhengX , MastersC , et al. Design and rationale of the Cardiovascular Health and Text Messaging (CHAT) study and the CHAT-Diabetes Mellitus (CHAT-DM) study: two randomised controlled trials of text messaging to improve secondary prevention for coronary heart disease and diabetes. BMJ Open2017;7(12):e018302. [DOI: 10.1136/bmjopen-2017-018302]ZhengX , SpatzES , BaiX , HuoX , DingQ , HorakP , et al. Effect of text messaging on risk factor management in patients with coronary heart disease: the CHAT randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(4):e005616. [DOI: 10.1161/CIRCOUTCOMES.119.005616]">Zheng 2019</a>). Four studies customised messages according to patients’ medication profile or appointment schedule (<a href="./references#CD011851-bbs2-0005" title="ACTRN12613000793718. TEXT messages to improve MEDication adherence &amp; Secondary prevention – TEXTMEDS [TEXT messages to improve MEDication adherence &amp; Secondary prevention in patients with acute coronary syndrome - TEXTMEDS]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364448&amp;isReview=true (first received 18 June 2013). ChowCK , KlimisH , ThiagalingamA , RedfernJ , HillisGS , BriegerD , et al. Text messages to improve medication adherence and secondary prevention after acute coronary syndrome: the TEXTMEDS randomized clinical trial. Circulation2022;145(19):1443-55. [DOI: 10.1161/CIRCULATIONAHA.121.056161]ChowCK , ThiagalingamA , SantoK , KokC , ThakkarJ , StepienS , et al. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol. BMJ Open2018;8:e019463. [DOI: 10.1136/bmjopen-2017-019463]">Chow 2022</a>; <a href="./references#CD011851-bbs2-0009" title="KamalAK , ShaikQN , PashaO , AzamI , IslamM , MemonAA , et al. Improving medication adherence in stroke patients through Short Text Messages (SMS4Stroke)-study protocol for a randomized, controlled trial. BMC Neurology2015;15:157. [DOI: 10.1186/s12883-015-0413-2]KamalAK , ShaikhQ , PashaO , AzamI , IslamM , MemonAA , et al. A randomized controlled behavioral intervention trial to improve medication adherence in adult stroke patients with prescription tailored short messaging service (SMS)-SMS4Stroke study. BMC Neurolology2015;15:212. [DOI: 10.1186/s12883-015-0471-5]">Kamal 2015</a>; <a href="./references#CD011851-bbs2-0010" title="KhonsariS , SubramanianP , ChinnaK , LatifLA , LingLW , GholamiO . Effect of a reminder system using an automated short message service on medication adherence following acute coronary syndrome. European Journal of Cardiovascular Nursing2015;14(2):170-9. [DOI: 10.1177/1474515114521910]">Khonsari 2015</a>; <a href="./references#CD011851-bbs2-0014" title="ParkLG , Howie-EsquivelJ , ChungM , DracupK . A text messaging intervention improves medication adherence for patients with coronary heart disease: a randomized controlled trial. Circulation2013;128(Suppl 22):A15249. [DOI: 10.1161/circ.128.suppl_22.A15249]ParkLG , Howie-EsquivelJ , ChungML , DracupK . A text messaging intervention to promote medication adherence for patients with coronary heart disease: a randomized controlled trial. Patient Education and Counseling2014;94(2):261-8. [DOI: 10.1016/j.pec.2013.10.027]ParkLG , Howie-EsquivelJ , WhooleyMA , DracupK . Psychosocial factors and medication adherence among patients with coronary heart disease: a text messaging intervention. European Journal of Cardiovascular Nursing2015;14(3):264-73. [DOI: 10.1177/1474515114537024]">Park 2014a</a>). Six studies delivered semi‐personalised text messages based on a consideration of CVD risk factors of participants ‐ smoking status or dietary habits pattern (<a href="./references#CD011851-bbs2-0001" title="BaeJW , WooSI , LeeJ , ParkSD , KwonSW , ChoiSH , et al. mHealth interventions for lifestyle and risk factor modification in coronary heart disease: randomized controlled trial. JMIR mHealth and uHealth2021;9(9):e29928. [DOI: 10.2196/29928]KCT0005087. Effect of text messaging program on lifestyle and clinical outcomes in patients with cardiovascular disease. cris.nih.go.kr/cris/search/detailSearch.do/19282 (first received 11 September 2019). ">Bae 2021</a>; <a href="./references#CD011851-bbs2-0004" title="ACTRN12611000161921. Tobacco, EXercise and dieT MEssages (TEXT ME): the effect of semi-personalised lifestyle reminder text message intervention on cardiovascular disease risk [Tobacco, EXercise and dieT MEssages (TEXT ME): The effect of a semi-personalised lifestyle reminder text message intervention on cardiovascular risk factors in patients with cardiovascular disease and those who are at high risk of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12611000161921 (first received 3 February 2011). ChowCK , RedfernJ , HillisGS , ThakkarJ , SantoK , HackettML , et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA2015;314(12):1255-63. [DOI: 10.1001/jama.2015.10945]ChowCK , RedfernJ , ThiagalingamA , JanS , WhittakerR , HackettM , et al. Design and rationale of the tobacco, exercise and diet messages (TEXT ME) trial of a text message-based intervention for ongoing prevention of cardiovascular disease in people with coronary disease: a randomised controlled trial protocol. BMJ Open2012;2(1):e000606. [DOI: 10.1136/bmjopen-2011-000606]RedfernJ , SantoK , CooreyG , ThakkarJ , HackettM , ThiagalingamA , et al. Factors influencing engagement, perceived usefulness and behavioral mechanisms associated with a text message support program. PLOS ONE2016;11(10):e0163929. [DOI: 10.1371/journal.pone.0163929]ThakkarJ , RedfernJ , De KeizerL , ThiagalingamA , ChowC . Patient perceptions of text message-based intervention for secondary prevention of cardiovascular events. Heart, Lung and Circulation2013;22(Suppl 1):S264. [DOI: 10.1016/j.hlc.2013.05.630]ThakkarJ , RedfernJ , ThiagalingamA , ChowCK . Patterns, predictors and effects of texting intervention on physical activity in CHD – insights from the TEXT ME randomized clinical trial. European Journal of Preventive Cardiology2016;23(17):1894-902. [DOI: 10.1177/2047487316664190]">Chow 2015</a>; <a href="./references#CD011851-bbs2-0005" title="ACTRN12613000793718. TEXT messages to improve MEDication adherence &amp; Secondary prevention – TEXTMEDS [TEXT messages to improve MEDication adherence &amp; Secondary prevention in patients with acute coronary syndrome - TEXTMEDS]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364448&amp;isReview=true (first received 18 June 2013). ChowCK , KlimisH , ThiagalingamA , RedfernJ , HillisGS , BriegerD , et al. Text messages to improve medication adherence and secondary prevention after acute coronary syndrome: the TEXTMEDS randomized clinical trial. Circulation2022;145(19):1443-55. [DOI: 10.1161/CIRCULATIONAHA.121.056161]ChowCK , ThiagalingamA , SantoK , KokC , ThakkarJ , StepienS , et al. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol. BMJ Open2018;8:e019463. [DOI: 10.1136/bmjopen-2017-019463]">Chow 2022</a>; <a href="./references#CD011851-bbs2-0011" title="ACTRN12616000422426. Text4Heart Partnership: a text messaging program to enhance self-management of cardiovascular disease [Text messaging to enhance self-management of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12616000422426 (first received 23 March 2016). MaddisonR , JiangY , StewartR , ScottT , KerrA , WhittakerR , et al. An intervention to improve medication adherence in people with heart disease (Text4HeartII): randomized controlled trial. JMIR mHealth and uHealth2021;9(6):e24952. [DOI: 10.2196/24952]MaddisonR , StewartR , DoughtyR , ScottT , KerrA , BenatarJ , et al. Text4Heart II - improving medication adherence in people with heart disease: a study protocol for a randomized controlled trial. Trials2018;19(1):70. [DOI: 10.1186/s13063-018-2468-z]">Maddison 2021</a>; <a href="./references#CD011851-bbs2-0015" title="NCT03414190. Impact of text messages to promote secondary prevention after acute coronary syndrome [Impact of a mobile phone text messages intervention on the secondary prevention of cardiovascular events after acute coronary syndrome]. clinicaltrials.gov/show/NCT03414190 (first received 29 January 2018). PassagliaLG , BrantLC , NascimentoBR , RibeiroAL . Impact of text messages in a middle-income country to promote secondary prevention after acute coronary syndrome (IMPACS): a randomized trial. Medicine2019;98(22):e15681. [DOI: 10.1097/MD.0000000000015681]PassagliaLG , BrantLC , SilvaJL , NascimentoBR , RibeiroAL . Text messages to promote secondary prevention after acute coronary syndrome (IMPACS trial). International Journal of Cardiovascular Sciences2021;35(2):202-13. [DOI: 10.36660/ijcs.20200378]">Passaglia 2021</a>; <a href="./references#CD011851-bbs2-0017" title="NCT02336919. The use of texting messaging to improve the hospital-to-community transition period in cardiovascular disease patients (Txt2Prevent) [The use of texting messaging to improve the hospital-to-community transition and prevent readmission in patients with cardiovascular disease (Txt2Prevent)]. clinicaltrials.gov/ct2/show/NCT02336919 (first received 13 January 2015). RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of SMS text messaging to improve the hospital-to-community transition in patients with acute coronary syndrome (Txt2Prevent): results from a pilot randomized controlled trial. JMIR mHealth and uHealth2021;9(5):e24530. [DOI: 10.2196/24530]RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of text messaging to improve the hospital-to-community transition in acute coronary syndrome patients (Txt2Prevent): intervention development and pilot randomized controlled trial protocol. JMIR Research Protocols2017;6(5):e91. [DOI: 10.2196/resprot.6968]">Ross 2021</a>). Two studies stated that the messages were personalised without any further details provided (<a href="./references#CD011851-bbs2-0012" title="NCT02793830. A mobile phone based medication reminder program [A mobile phone based medication reminder program for patients in China with coronary heart disease: a pilot study]. clinicaltrials.gov/ct2/show/NCT02793830 (first received 8 June 2016). NiZ , WuB , YangQ , YanLL , LiuC , ShawRJ . An mHealth intervention to improve medication adherence and health outcomes among patients with coronary heart disease: randomized controlled trial. Journal of Medical Internet Research2022;24(3):e27202. [DOI: 10.2196/27202]">Ni 2022</a>; <a href="./references#CD011851-bbs2-0016" title="QuiliciJ , FugonL , BeguinS , MorangePE , BonnetJL , AlessiMC , et al. Effect of motivational mobile phone short message service on aspirin adherence after coronary stenting for acute coronary syndrome. International Journal of Cardiology2013;168(1):568-9. [DOI: 10.1016/j.ijcard.2013.01.252]">Quilici 2013</a>). Two studies did not provide information on whether the messages were tailored (<a href="./references#CD011851-bbs2-0007" title="FangR , LiX . Electronic messaging support service programs improve adherence to lipid-lowering therapy among outpatients with coronary artery disease: an exploratory randomised control study. Journal of Clinical Nursing2016;25(5-6):664-71. [DOI: 10.1111/jocn.12988]">Fang 2016</a>; <a href="./references#CD011851-bbs2-0013" title="NCT02783287. The impact of text messaging on medication adherence and exercise regimen among post-myocardial infarction patients. clinicaltrials.gov/ct2/show/NCT02783287 (first received 26 May 2016). PandeyA , ChoudhryN . An m-health application of daily text messages to address forgetfulness as contributor to non-adherence to medications post-myocardial infarction. Circulation2015;132:A18641. [DOI: 10.1161/circ.132.suppl_3.18641]PandeyA , KrummeAA , PatelT , ChoudhryNK . The impact of text messaging on medication adherence and exercise among postmyocardial infarction patients: randomized controlled pilot trial. JMIR mHealth and uHealth2017;5(8):e110. [DOI: 10.2196/mhealth.7144]PandeyAK , ChoudhryN . Text message reminders to address medication non-adherence in post-MI patients: a one year intervention study. Canadian Journal of Cardiology2014;30(10):S179. [DOI: 10.1016/j.cjca.2014.07.280]">Pandey 2017</a>). Two studies stated that text messages were not customised according to patient characteristics, and only standardised texts were sent (<a href="./references#CD011851-bbs2-0002" title="BermonA , UribeAF , Pérez-RiveroPF , Prieto-MerinoD , SaaibiJF , SilvaFA , et al. Efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: TXT2HEART Colombia randomized controlled trial. JMIR mHealth and uHealth2021;9(7):e25548. [DOI: 10.2196/25548]BermonA , Uribe-RodríguezAF , Pérez-RiveroPF , Prieto-MerinoD , RiveraDIC , GuioE , et al. Evaluation of the efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: the txt2heart Colombia randomised controlled trial protocol. BMJ Open2019;9:e028017. [DOI: 10.1136/ bmjopen-2018-028017]NCT03098186. TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention [TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention]. clinicaltrials.gov/ct2/show/NCT03098186 (first received 3 March 2017). ">Bermon 2021</a>; <a href="./references#CD011851-bbs2-0003" title="ChenC , LiX , KangY , LiuH , LiangYD , ZhangQ . Post-discharge short service message improves short-term clinical outcome and self-care behavior in Chinese patients with chronic heart failure. European Heart Journal2018;39(Suppl 1):797-8. [DOI: 10.1093/eurheartj/ehy563.P3770]ChenC , LiX , SunL , CaoS , KangY , HongL , et al. Post-discharge short message service improves short-term clinical outcome and self-care behaviour in chronic heart failure. ESC Heart Failure2019;6(1):164-73. [DOI: 10.1002/ehf2.12380]ChiCTR-INR-17012316. Effect of post-discharge text messages on clinical outcomes in patients with heart failure [Effect of post-discharge text messages on clinical outcomes in patients with heart failure]. trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR-INR-17012316 (first received 9 August 2018). LiX , ChenC , YouGY , ZhangQ . Post-discharge text messaging intervention improved clinical outcomes in patients with heart failure. European Heart Journal2016;37(Suppl 1):727-8. [DOI: 10.1093/eurheartj/ehw433]">Chen 2019</a>). </p> <p>Four studies stated that bi‐directional text messaging was employed, and a response from the participants was required (<a href="./references#CD011851-bbs2-0005" title="ACTRN12613000793718. TEXT messages to improve MEDication adherence &amp; Secondary prevention – TEXTMEDS [TEXT messages to improve MEDication adherence &amp; Secondary prevention in patients with acute coronary syndrome - TEXTMEDS]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364448&amp;isReview=true (first received 18 June 2013). ChowCK , KlimisH , ThiagalingamA , RedfernJ , HillisGS , BriegerD , et al. Text messages to improve medication adherence and secondary prevention after acute coronary syndrome: the TEXTMEDS randomized clinical trial. Circulation2022;145(19):1443-55. [DOI: 10.1161/CIRCULATIONAHA.121.056161]ChowCK , ThiagalingamA , SantoK , KokC , ThakkarJ , StepienS , et al. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol. BMJ Open2018;8:e019463. [DOI: 10.1136/bmjopen-2017-019463]">Chow 2022</a>; <a href="./references#CD011851-bbs2-0006" title="ACTRN12613000901707. Text4Heart: a text message and internet-based comprehensive cardiac rehabilitation intervention [A randomised controlled trial to determine the efficacy of a text message and Internet-based comprehensive cardiac rehabilitation programme to improve adherence to lifestyle change compared with usual care in New Zealand adults with a diagnosis of cardiovascular disease]. anzctr.org.au/ACTRN12613000901707.aspx (first received 9 August 2013). DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Improving coronary heart disease self-management using mobile technologies (Text4Heart): a randomised controlled trial protocol. Trials2014;15(71):1-9. [DOI: 10.1186/1745-6215-15-71]DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Text message and internet support for coronary heart disease self-management: results from the Text4Heart randomized controlled trial. Journal of Medical Internet Research2015;17(10):e237. [DOI: 10.2196/jmir.4944]">Dale 2015a</a>; <a href="./references#CD011851-bbs2-0009" title="KamalAK , ShaikQN , PashaO , AzamI , IslamM , MemonAA , et al. Improving medication adherence in stroke patients through Short Text Messages (SMS4Stroke)-study protocol for a randomized, controlled trial. BMC Neurology2015;15:157. [DOI: 10.1186/s12883-015-0413-2]KamalAK , ShaikhQ , PashaO , AzamI , IslamM , MemonAA , et al. A randomized controlled behavioral intervention trial to improve medication adherence in adult stroke patients with prescription tailored short messaging service (SMS)-SMS4Stroke study. BMC Neurolology2015;15:212. [DOI: 10.1186/s12883-015-0471-5]">Kamal 2015</a>; <a href="./references#CD011851-bbs2-0014" title="ParkLG , Howie-EsquivelJ , ChungM , DracupK . A text messaging intervention improves medication adherence for patients with coronary heart disease: a randomized controlled trial. Circulation2013;128(Suppl 22):A15249. [DOI: 10.1161/circ.128.suppl_22.A15249]ParkLG , Howie-EsquivelJ , ChungML , DracupK . A text messaging intervention to promote medication adherence for patients with coronary heart disease: a randomized controlled trial. Patient Education and Counseling2014;94(2):261-8. [DOI: 10.1016/j.pec.2013.10.027]ParkLG , Howie-EsquivelJ , WhooleyMA , DracupK . Psychosocial factors and medication adherence among patients with coronary heart disease: a text messaging intervention. European Journal of Cardiovascular Nursing2015;14(3):264-73. [DOI: 10.1177/1474515114537024]">Park 2014a</a>). Nine studies stated that unidirectional text messaging was employed (<a href="./references#CD011851-bbs2-0001" title="BaeJW , WooSI , LeeJ , ParkSD , KwonSW , ChoiSH , et al. mHealth interventions for lifestyle and risk factor modification in coronary heart disease: randomized controlled trial. JMIR mHealth and uHealth2021;9(9):e29928. [DOI: 10.2196/29928]KCT0005087. Effect of text messaging program on lifestyle and clinical outcomes in patients with cardiovascular disease. cris.nih.go.kr/cris/search/detailSearch.do/19282 (first received 11 September 2019). ">Bae 2021</a>; <a href="./references#CD011851-bbs2-0002" title="BermonA , UribeAF , Pérez-RiveroPF , Prieto-MerinoD , SaaibiJF , SilvaFA , et al. Efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: TXT2HEART Colombia randomized controlled trial. JMIR mHealth and uHealth2021;9(7):e25548. [DOI: 10.2196/25548]BermonA , Uribe-RodríguezAF , Pérez-RiveroPF , Prieto-MerinoD , RiveraDIC , GuioE , et al. Evaluation of the efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: the txt2heart Colombia randomised controlled trial protocol. BMJ Open2019;9:e028017. [DOI: 10.1136/ bmjopen-2018-028017]NCT03098186. TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention [TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention]. clinicaltrials.gov/ct2/show/NCT03098186 (first received 3 March 2017). ">Bermon 2021</a>; <a href="./references#CD011851-bbs2-0003" title="ChenC , LiX , KangY , LiuH , LiangYD , ZhangQ . Post-discharge short service message improves short-term clinical outcome and self-care behavior in Chinese patients with chronic heart failure. European Heart Journal2018;39(Suppl 1):797-8. [DOI: 10.1093/eurheartj/ehy563.P3770]ChenC , LiX , SunL , CaoS , KangY , HongL , et al. Post-discharge short message service improves short-term clinical outcome and self-care behaviour in chronic heart failure. ESC Heart Failure2019;6(1):164-73. [DOI: 10.1002/ehf2.12380]ChiCTR-INR-17012316. Effect of post-discharge text messages on clinical outcomes in patients with heart failure [Effect of post-discharge text messages on clinical outcomes in patients with heart failure]. trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR-INR-17012316 (first received 9 August 2018). LiX , ChenC , YouGY , ZhangQ . Post-discharge text messaging intervention improved clinical outcomes in patients with heart failure. European Heart Journal2016;37(Suppl 1):727-8. [DOI: 10.1093/eurheartj/ehw433]">Chen 2019</a>; <a href="./references#CD011851-bbs2-0004" title="ACTRN12611000161921. Tobacco, EXercise and dieT MEssages (TEXT ME): the effect of semi-personalised lifestyle reminder text message intervention on cardiovascular disease risk [Tobacco, EXercise and dieT MEssages (TEXT ME): The effect of a semi-personalised lifestyle reminder text message intervention on cardiovascular risk factors in patients with cardiovascular disease and those who are at high risk of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12611000161921 (first received 3 February 2011). ChowCK , RedfernJ , HillisGS , ThakkarJ , SantoK , HackettML , et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA2015;314(12):1255-63. [DOI: 10.1001/jama.2015.10945]ChowCK , RedfernJ , ThiagalingamA , JanS , WhittakerR , HackettM , et al. Design and rationale of the tobacco, exercise and diet messages (TEXT ME) trial of a text message-based intervention for ongoing prevention of cardiovascular disease in people with coronary disease: a randomised controlled trial protocol. BMJ Open2012;2(1):e000606. [DOI: 10.1136/bmjopen-2011-000606]RedfernJ , SantoK , CooreyG , ThakkarJ , HackettM , ThiagalingamA , et al. Factors influencing engagement, perceived usefulness and behavioral mechanisms associated with a text message support program. PLOS ONE2016;11(10):e0163929. [DOI: 10.1371/journal.pone.0163929]ThakkarJ , RedfernJ , De KeizerL , ThiagalingamA , ChowC . Patient perceptions of text message-based intervention for secondary prevention of cardiovascular events. Heart, Lung and Circulation2013;22(Suppl 1):S264. [DOI: 10.1016/j.hlc.2013.05.630]ThakkarJ , RedfernJ , ThiagalingamA , ChowCK . Patterns, predictors and effects of texting intervention on physical activity in CHD – insights from the TEXT ME randomized clinical trial. European Journal of Preventive Cardiology2016;23(17):1894-902. [DOI: 10.1177/2047487316664190]">Chow 2015</a>; <a href="./references#CD011851-bbs2-0010" title="KhonsariS , SubramanianP , ChinnaK , LatifLA , LingLW , GholamiO . Effect of a reminder system using an automated short message service on medication adherence following acute coronary syndrome. European Journal of Cardiovascular Nursing2015;14(2):170-9. [DOI: 10.1177/1474515114521910]">Khonsari 2015</a>; <a href="./references#CD011851-bbs2-0011" title="ACTRN12616000422426. Text4Heart Partnership: a text messaging program to enhance self-management of cardiovascular disease [Text messaging to enhance self-management of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12616000422426 (first received 23 March 2016). MaddisonR , JiangY , StewartR , ScottT , KerrA , WhittakerR , et al. An intervention to improve medication adherence in people with heart disease (Text4HeartII): randomized controlled trial. JMIR mHealth and uHealth2021;9(6):e24952. [DOI: 10.2196/24952]MaddisonR , StewartR , DoughtyR , ScottT , KerrA , BenatarJ , et al. Text4Heart II - improving medication adherence in people with heart disease: a study protocol for a randomized controlled trial. Trials2018;19(1):70. [DOI: 10.1186/s13063-018-2468-z]">Maddison 2021</a>; <a href="./references#CD011851-bbs2-0013" title="NCT02783287. The impact of text messaging on medication adherence and exercise regimen among post-myocardial infarction patients. clinicaltrials.gov/ct2/show/NCT02783287 (first received 26 May 2016). PandeyA , ChoudhryN . An m-health application of daily text messages to address forgetfulness as contributor to non-adherence to medications post-myocardial infarction. Circulation2015;132:A18641. [DOI: 10.1161/circ.132.suppl_3.18641]PandeyA , KrummeAA , PatelT , ChoudhryNK . The impact of text messaging on medication adherence and exercise among postmyocardial infarction patients: randomized controlled pilot trial. JMIR mHealth and uHealth2017;5(8):e110. [DOI: 10.2196/mhealth.7144]PandeyAK , ChoudhryN . Text message reminders to address medication non-adherence in post-MI patients: a one year intervention study. Canadian Journal of Cardiology2014;30(10):S179. [DOI: 10.1016/j.cjca.2014.07.280]">Pandey 2017</a>; <a href="./references#CD011851-bbs2-0015" title="NCT03414190. Impact of text messages to promote secondary prevention after acute coronary syndrome [Impact of a mobile phone text messages intervention on the secondary prevention of cardiovascular events after acute coronary syndrome]. clinicaltrials.gov/show/NCT03414190 (first received 29 January 2018). PassagliaLG , BrantLC , NascimentoBR , RibeiroAL . Impact of text messages in a middle-income country to promote secondary prevention after acute coronary syndrome (IMPACS): a randomized trial. Medicine2019;98(22):e15681. [DOI: 10.1097/MD.0000000000015681]PassagliaLG , BrantLC , SilvaJL , NascimentoBR , RibeiroAL . Text messages to promote secondary prevention after acute coronary syndrome (IMPACS trial). International Journal of Cardiovascular Sciences2021;35(2):202-13. [DOI: 10.36660/ijcs.20200378]">Passaglia 2021</a>; <a href="./references#CD011851-bbs2-0017" title="NCT02336919. The use of texting messaging to improve the hospital-to-community transition period in cardiovascular disease patients (Txt2Prevent) [The use of texting messaging to improve the hospital-to-community transition and prevent readmission in patients with cardiovascular disease (Txt2Prevent)]. clinicaltrials.gov/ct2/show/NCT02336919 (first received 13 January 2015). RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of SMS text messaging to improve the hospital-to-community transition in patients with acute coronary syndrome (Txt2Prevent): results from a pilot randomized controlled trial. JMIR mHealth and uHealth2021;9(5):e24530. [DOI: 10.2196/24530]RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of text messaging to improve the hospital-to-community transition in acute coronary syndrome patients (Txt2Prevent): intervention development and pilot randomized controlled trial protocol. JMIR Research Protocols2017;6(5):e91. [DOI: 10.2196/resprot.6968]">Ross 2021</a>). Two studies stated that messages were predominately unidirectional, with some messages assessing medication usage and blood pressure/glucose level measurements bidirectional (<a href="./references#CD011851-bbs2-0008" title="HuoX , KrumholzHM , BaiX , SpatzES , DingQ , HorakP , et al. Effects of mobile text messaging on glycemic control in patients with coronary heart disease and diabetes mellitus: a randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(9):e005805. [DOI: 10.1161/CIRCOUTCOMES.119.005805]NCT02883842. Cardiovascular Health and Text Messaging-Diabetes Mellitus (CHAT-DM) Study [Effectiveness of text messaging on risk factors control and medication adherence among patients with Coronary Heart Disease and Diabetes in China: cardiovascular health andtext messaging-Diabetes Mellitus (CHAT-DM) study]. clinicaltrials.gov/ct2/show/NCT02883842 (first received 30 August 2016). ">Huo 2019</a>; <a href="./references#CD011851-bbs2-0018" title="HuoX , SpatzES , DingQ , HorakP , ZhengX , MastersC , et al. Design and rationale of the Cardiovascular Health and Text Messaging (CHAT) study and the CHAT-Diabetes Mellitus (CHAT-DM) study: two randomised controlled trials of text messaging to improve secondary prevention for coronary heart disease and diabetes. BMJ Open2017;7(12):e018302. [DOI: 10.1136/bmjopen-2017-018302]ZhengX , SpatzES , BaiX , HuoX , DingQ , HorakP , et al. Effect of text messaging on risk factor management in patients with coronary heart disease: the CHAT randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(4):e005616. [DOI: 10.1161/CIRCOUTCOMES.119.005616]">Zheng 2019</a>). Three studies did not provide information on whether the messages were bi‐directional or unidirectional (<a href="./references#CD011851-bbs2-0007" title="FangR , LiX . Electronic messaging support service programs improve adherence to lipid-lowering therapy among outpatients with coronary artery disease: an exploratory randomised control study. Journal of Clinical Nursing2016;25(5-6):664-71. [DOI: 10.1111/jocn.12988]">Fang 2016</a>; <a href="./references#CD011851-bbs2-0012" title="NCT02793830. A mobile phone based medication reminder program [A mobile phone based medication reminder program for patients in China with coronary heart disease: a pilot study]. clinicaltrials.gov/ct2/show/NCT02793830 (first received 8 June 2016). NiZ , WuB , YangQ , YanLL , LiuC , ShawRJ . An mHealth intervention to improve medication adherence and health outcomes among patients with coronary heart disease: randomized controlled trial. Journal of Medical Internet Research2022;24(3):e27202. [DOI: 10.2196/27202]">Ni 2022</a>; <a href="./references#CD011851-bbs2-0016" title="QuiliciJ , FugonL , BeguinS , MorangePE , BonnetJL , AlessiMC , et al. Effect of motivational mobile phone short message service on aspirin adherence after coronary stenting for acute coronary syndrome. International Journal of Cardiology2013;168(1):568-9. [DOI: 10.1016/j.ijcard.2013.01.252]">Quilici 2013</a>). </p> <p>Thirteen studies provided details on the template texts used for the text messages (<a href="./references#CD011851-bbs2-0003" title="ChenC , LiX , KangY , LiuH , LiangYD , ZhangQ . Post-discharge short service message improves short-term clinical outcome and self-care behavior in Chinese patients with chronic heart failure. European Heart Journal2018;39(Suppl 1):797-8. [DOI: 10.1093/eurheartj/ehy563.P3770]ChenC , LiX , SunL , CaoS , KangY , HongL , et al. Post-discharge short message service improves short-term clinical outcome and self-care behaviour in chronic heart failure. ESC Heart Failure2019;6(1):164-73. [DOI: 10.1002/ehf2.12380]ChiCTR-INR-17012316. Effect of post-discharge text messages on clinical outcomes in patients with heart failure [Effect of post-discharge text messages on clinical outcomes in patients with heart failure]. trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR-INR-17012316 (first received 9 August 2018). LiX , ChenC , YouGY , ZhangQ . Post-discharge text messaging intervention improved clinical outcomes in patients with heart failure. European Heart Journal2016;37(Suppl 1):727-8. [DOI: 10.1093/eurheartj/ehw433]">Chen 2019</a>; <a href="./references#CD011851-bbs2-0004" title="ACTRN12611000161921. Tobacco, EXercise and dieT MEssages (TEXT ME): the effect of semi-personalised lifestyle reminder text message intervention on cardiovascular disease risk [Tobacco, EXercise and dieT MEssages (TEXT ME): The effect of a semi-personalised lifestyle reminder text message intervention on cardiovascular risk factors in patients with cardiovascular disease and those who are at high risk of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12611000161921 (first received 3 February 2011). ChowCK , RedfernJ , HillisGS , ThakkarJ , SantoK , HackettML , et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA2015;314(12):1255-63. [DOI: 10.1001/jama.2015.10945]ChowCK , RedfernJ , ThiagalingamA , JanS , WhittakerR , HackettM , et al. Design and rationale of the tobacco, exercise and diet messages (TEXT ME) trial of a text message-based intervention for ongoing prevention of cardiovascular disease in people with coronary disease: a randomised controlled trial protocol. BMJ Open2012;2(1):e000606. [DOI: 10.1136/bmjopen-2011-000606]RedfernJ , SantoK , CooreyG , ThakkarJ , HackettM , ThiagalingamA , et al. Factors influencing engagement, perceived usefulness and behavioral mechanisms associated with a text message support program. PLOS ONE2016;11(10):e0163929. [DOI: 10.1371/journal.pone.0163929]ThakkarJ , RedfernJ , De KeizerL , ThiagalingamA , ChowC . Patient perceptions of text message-based intervention for secondary prevention of cardiovascular events. Heart, Lung and Circulation2013;22(Suppl 1):S264. [DOI: 10.1016/j.hlc.2013.05.630]ThakkarJ , RedfernJ , ThiagalingamA , ChowCK . Patterns, predictors and effects of texting intervention on physical activity in CHD – insights from the TEXT ME randomized clinical trial. European Journal of Preventive Cardiology2016;23(17):1894-902. [DOI: 10.1177/2047487316664190]">Chow 2015</a>; <a href="./references#CD011851-bbs2-0005" title="ACTRN12613000793718. TEXT messages to improve MEDication adherence &amp; Secondary prevention – TEXTMEDS [TEXT messages to improve MEDication adherence &amp; Secondary prevention in patients with acute coronary syndrome - TEXTMEDS]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364448&amp;isReview=true (first received 18 June 2013). ChowCK , KlimisH , ThiagalingamA , RedfernJ , HillisGS , BriegerD , et al. Text messages to improve medication adherence and secondary prevention after acute coronary syndrome: the TEXTMEDS randomized clinical trial. Circulation2022;145(19):1443-55. [DOI: 10.1161/CIRCULATIONAHA.121.056161]ChowCK , ThiagalingamA , SantoK , KokC , ThakkarJ , StepienS , et al. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol. BMJ Open2018;8:e019463. [DOI: 10.1136/bmjopen-2017-019463]">Chow 2022</a>; <a href="./references#CD011851-bbs2-0006" title="ACTRN12613000901707. Text4Heart: a text message and internet-based comprehensive cardiac rehabilitation intervention [A randomised controlled trial to determine the efficacy of a text message and Internet-based comprehensive cardiac rehabilitation programme to improve adherence to lifestyle change compared with usual care in New Zealand adults with a diagnosis of cardiovascular disease]. anzctr.org.au/ACTRN12613000901707.aspx (first received 9 August 2013). DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Improving coronary heart disease self-management using mobile technologies (Text4Heart): a randomised controlled trial protocol. Trials2014;15(71):1-9. [DOI: 10.1186/1745-6215-15-71]DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Text message and internet support for coronary heart disease self-management: results from the Text4Heart randomized controlled trial. Journal of Medical Internet Research2015;17(10):e237. [DOI: 10.2196/jmir.4944]">Dale 2015a</a>; <a href="./references#CD011851-bbs2-0008" title="HuoX , KrumholzHM , BaiX , SpatzES , DingQ , HorakP , et al. Effects of mobile text messaging on glycemic control in patients with coronary heart disease and diabetes mellitus: a randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(9):e005805. [DOI: 10.1161/CIRCOUTCOMES.119.005805]NCT02883842. Cardiovascular Health and Text Messaging-Diabetes Mellitus (CHAT-DM) Study [Effectiveness of text messaging on risk factors control and medication adherence among patients with Coronary Heart Disease and Diabetes in China: cardiovascular health andtext messaging-Diabetes Mellitus (CHAT-DM) study]. clinicaltrials.gov/ct2/show/NCT02883842 (first received 30 August 2016). ">Huo 2019</a>; <a href="./references#CD011851-bbs2-0010" title="KhonsariS , SubramanianP , ChinnaK , LatifLA , LingLW , GholamiO . Effect of a reminder system using an automated short message service on medication adherence following acute coronary syndrome. European Journal of Cardiovascular Nursing2015;14(2):170-9. [DOI: 10.1177/1474515114521910]">Khonsari 2015</a>; <a href="./references#CD011851-bbs2-0011" title="ACTRN12616000422426. Text4Heart Partnership: a text messaging program to enhance self-management of cardiovascular disease [Text messaging to enhance self-management of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12616000422426 (first received 23 March 2016). MaddisonR , JiangY , StewartR , ScottT , KerrA , WhittakerR , et al. An intervention to improve medication adherence in people with heart disease (Text4HeartII): randomized controlled trial. JMIR mHealth and uHealth2021;9(6):e24952. [DOI: 10.2196/24952]MaddisonR , StewartR , DoughtyR , ScottT , KerrA , BenatarJ , et al. Text4Heart II - improving medication adherence in people with heart disease: a study protocol for a randomized controlled trial. Trials2018;19(1):70. [DOI: 10.1186/s13063-018-2468-z]">Maddison 2021</a>; <a href="./references#CD011851-bbs2-0012" title="NCT02793830. A mobile phone based medication reminder program [A mobile phone based medication reminder program for patients in China with coronary heart disease: a pilot study]. clinicaltrials.gov/ct2/show/NCT02793830 (first received 8 June 2016). NiZ , WuB , YangQ , YanLL , LiuC , ShawRJ . An mHealth intervention to improve medication adherence and health outcomes among patients with coronary heart disease: randomized controlled trial. Journal of Medical Internet Research2022;24(3):e27202. [DOI: 10.2196/27202]">Ni 2022</a>; <a href="./references#CD011851-bbs2-0013" title="NCT02783287. The impact of text messaging on medication adherence and exercise regimen among post-myocardial infarction patients. clinicaltrials.gov/ct2/show/NCT02783287 (first received 26 May 2016). PandeyA , ChoudhryN . An m-health application of daily text messages to address forgetfulness as contributor to non-adherence to medications post-myocardial infarction. Circulation2015;132:A18641. [DOI: 10.1161/circ.132.suppl_3.18641]PandeyA , KrummeAA , PatelT , ChoudhryNK . The impact of text messaging on medication adherence and exercise among postmyocardial infarction patients: randomized controlled pilot trial. JMIR mHealth and uHealth2017;5(8):e110. [DOI: 10.2196/mhealth.7144]PandeyAK , ChoudhryN . Text message reminders to address medication non-adherence in post-MI patients: a one year intervention study. Canadian Journal of Cardiology2014;30(10):S179. [DOI: 10.1016/j.cjca.2014.07.280]">Pandey 2017</a>; <a href="./references#CD011851-bbs2-0014" title="ParkLG , Howie-EsquivelJ , ChungM , DracupK . A text messaging intervention improves medication adherence for patients with coronary heart disease: a randomized controlled trial. Circulation2013;128(Suppl 22):A15249. [DOI: 10.1161/circ.128.suppl_22.A15249]ParkLG , Howie-EsquivelJ , ChungML , DracupK . A text messaging intervention to promote medication adherence for patients with coronary heart disease: a randomized controlled trial. Patient Education and Counseling2014;94(2):261-8. [DOI: 10.1016/j.pec.2013.10.027]ParkLG , Howie-EsquivelJ , WhooleyMA , DracupK . Psychosocial factors and medication adherence among patients with coronary heart disease: a text messaging intervention. European Journal of Cardiovascular Nursing2015;14(3):264-73. [DOI: 10.1177/1474515114537024]">Park 2014a</a>; <a href="./references#CD011851-bbs2-0015" title="NCT03414190. Impact of text messages to promote secondary prevention after acute coronary syndrome [Impact of a mobile phone text messages intervention on the secondary prevention of cardiovascular events after acute coronary syndrome]. clinicaltrials.gov/show/NCT03414190 (first received 29 January 2018). PassagliaLG , BrantLC , NascimentoBR , RibeiroAL . Impact of text messages in a middle-income country to promote secondary prevention after acute coronary syndrome (IMPACS): a randomized trial. Medicine2019;98(22):e15681. [DOI: 10.1097/MD.0000000000015681]PassagliaLG , BrantLC , SilvaJL , NascimentoBR , RibeiroAL . Text messages to promote secondary prevention after acute coronary syndrome (IMPACS trial). International Journal of Cardiovascular Sciences2021;35(2):202-13. [DOI: 10.36660/ijcs.20200378]">Passaglia 2021</a>; <a href="./references#CD011851-bbs2-0017" title="NCT02336919. The use of texting messaging to improve the hospital-to-community transition period in cardiovascular disease patients (Txt2Prevent) [The use of texting messaging to improve the hospital-to-community transition and prevent readmission in patients with cardiovascular disease (Txt2Prevent)]. clinicaltrials.gov/ct2/show/NCT02336919 (first received 13 January 2015). RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of SMS text messaging to improve the hospital-to-community transition in patients with acute coronary syndrome (Txt2Prevent): results from a pilot randomized controlled trial. JMIR mHealth and uHealth2021;9(5):e24530. [DOI: 10.2196/24530]RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of text messaging to improve the hospital-to-community transition in acute coronary syndrome patients (Txt2Prevent): intervention development and pilot randomized controlled trial protocol. JMIR Research Protocols2017;6(5):e91. [DOI: 10.2196/resprot.6968]">Ross 2021</a>; <a href="./references#CD011851-bbs2-0018" title="HuoX , SpatzES , DingQ , HorakP , ZhengX , MastersC , et al. Design and rationale of the Cardiovascular Health and Text Messaging (CHAT) study and the CHAT-Diabetes Mellitus (CHAT-DM) study: two randomised controlled trials of text messaging to improve secondary prevention for coronary heart disease and diabetes. BMJ Open2017;7(12):e018302. [DOI: 10.1136/bmjopen-2017-018302]ZhengX , SpatzES , BaiX , HuoX , DingQ , HorakP , et al. Effect of text messaging on risk factor management in patients with coronary heart disease: the CHAT randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(4):e005616. [DOI: 10.1161/CIRCOUTCOMES.119.005616]">Zheng 2019</a>). Ten studies reported that a pilot programme was previously conducted before the formal randomised controlled study (<a href="./references#CD011851-bbs2-0002" title="BermonA , UribeAF , Pérez-RiveroPF , Prieto-MerinoD , SaaibiJF , SilvaFA , et al. Efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: TXT2HEART Colombia randomized controlled trial. JMIR mHealth and uHealth2021;9(7):e25548. [DOI: 10.2196/25548]BermonA , Uribe-RodríguezAF , Pérez-RiveroPF , Prieto-MerinoD , RiveraDIC , GuioE , et al. Evaluation of the efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: the txt2heart Colombia randomised controlled trial protocol. BMJ Open2019;9:e028017. [DOI: 10.1136/ bmjopen-2018-028017]NCT03098186. TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention [TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention]. clinicaltrials.gov/ct2/show/NCT03098186 (first received 3 March 2017). ">Bermon 2021</a>; <a href="./references#CD011851-bbs2-0005" title="ACTRN12613000793718. TEXT messages to improve MEDication adherence &amp; Secondary prevention – TEXTMEDS [TEXT messages to improve MEDication adherence &amp; Secondary prevention in patients with acute coronary syndrome - TEXTMEDS]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364448&amp;isReview=true (first received 18 June 2013). ChowCK , KlimisH , ThiagalingamA , RedfernJ , HillisGS , BriegerD , et al. Text messages to improve medication adherence and secondary prevention after acute coronary syndrome: the TEXTMEDS randomized clinical trial. Circulation2022;145(19):1443-55. [DOI: 10.1161/CIRCULATIONAHA.121.056161]ChowCK , ThiagalingamA , SantoK , KokC , ThakkarJ , StepienS , et al. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol. BMJ Open2018;8:e019463. [DOI: 10.1136/bmjopen-2017-019463]">Chow 2022</a>; <a href="./references#CD011851-bbs2-0006" title="ACTRN12613000901707. Text4Heart: a text message and internet-based comprehensive cardiac rehabilitation intervention [A randomised controlled trial to determine the efficacy of a text message and Internet-based comprehensive cardiac rehabilitation programme to improve adherence to lifestyle change compared with usual care in New Zealand adults with a diagnosis of cardiovascular disease]. anzctr.org.au/ACTRN12613000901707.aspx (first received 9 August 2013). DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Improving coronary heart disease self-management using mobile technologies (Text4Heart): a randomised controlled trial protocol. Trials2014;15(71):1-9. [DOI: 10.1186/1745-6215-15-71]DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Text message and internet support for coronary heart disease self-management: results from the Text4Heart randomized controlled trial. Journal of Medical Internet Research2015;17(10):e237. [DOI: 10.2196/jmir.4944]">Dale 2015a</a>; <a href="./references#CD011851-bbs2-0008" title="HuoX , KrumholzHM , BaiX , SpatzES , DingQ , HorakP , et al. Effects of mobile text messaging on glycemic control in patients with coronary heart disease and diabetes mellitus: a randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(9):e005805. [DOI: 10.1161/CIRCOUTCOMES.119.005805]NCT02883842. Cardiovascular Health and Text Messaging-Diabetes Mellitus (CHAT-DM) Study [Effectiveness of text messaging on risk factors control and medication adherence among patients with Coronary Heart Disease and Diabetes in China: cardiovascular health andtext messaging-Diabetes Mellitus (CHAT-DM) study]. clinicaltrials.gov/ct2/show/NCT02883842 (first received 30 August 2016). ">Huo 2019</a>; <a href="./references#CD011851-bbs2-0009" title="KamalAK , ShaikQN , PashaO , AzamI , IslamM , MemonAA , et al. Improving medication adherence in stroke patients through Short Text Messages (SMS4Stroke)-study protocol for a randomized, controlled trial. BMC Neurology2015;15:157. [DOI: 10.1186/s12883-015-0413-2]KamalAK , ShaikhQ , PashaO , AzamI , IslamM , MemonAA , et al. A randomized controlled behavioral intervention trial to improve medication adherence in adult stroke patients with prescription tailored short messaging service (SMS)-SMS4Stroke study. BMC Neurolology2015;15:212. [DOI: 10.1186/s12883-015-0471-5]">Kamal 2015</a>; <a href="./references#CD011851-bbs2-0010" title="KhonsariS , SubramanianP , ChinnaK , LatifLA , LingLW , GholamiO . Effect of a reminder system using an automated short message service on medication adherence following acute coronary syndrome. European Journal of Cardiovascular Nursing2015;14(2):170-9. [DOI: 10.1177/1474515114521910]">Khonsari 2015</a>; <a href="./references#CD011851-bbs2-0011" title="ACTRN12616000422426. Text4Heart Partnership: a text messaging program to enhance self-management of cardiovascular disease [Text messaging to enhance self-management of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12616000422426 (first received 23 March 2016). MaddisonR , JiangY , StewartR , ScottT , KerrA , WhittakerR , et al. An intervention to improve medication adherence in people with heart disease (Text4HeartII): randomized controlled trial. JMIR mHealth and uHealth2021;9(6):e24952. [DOI: 10.2196/24952]MaddisonR , StewartR , DoughtyR , ScottT , KerrA , BenatarJ , et al. Text4Heart II - improving medication adherence in people with heart disease: a study protocol for a randomized controlled trial. Trials2018;19(1):70. [DOI: 10.1186/s13063-018-2468-z]">Maddison 2021</a>; <a href="./references#CD011851-bbs2-0012" title="NCT02793830. A mobile phone based medication reminder program [A mobile phone based medication reminder program for patients in China with coronary heart disease: a pilot study]. clinicaltrials.gov/ct2/show/NCT02793830 (first received 8 June 2016). NiZ , WuB , YangQ , YanLL , LiuC , ShawRJ . An mHealth intervention to improve medication adherence and health outcomes among patients with coronary heart disease: randomized controlled trial. Journal of Medical Internet Research2022;24(3):e27202. [DOI: 10.2196/27202]">Ni 2022</a>; <a href="./references#CD011851-bbs2-0015" title="NCT03414190. Impact of text messages to promote secondary prevention after acute coronary syndrome [Impact of a mobile phone text messages intervention on the secondary prevention of cardiovascular events after acute coronary syndrome]. clinicaltrials.gov/show/NCT03414190 (first received 29 January 2018). PassagliaLG , BrantLC , NascimentoBR , RibeiroAL . Impact of text messages in a middle-income country to promote secondary prevention after acute coronary syndrome (IMPACS): a randomized trial. Medicine2019;98(22):e15681. [DOI: 10.1097/MD.0000000000015681]PassagliaLG , BrantLC , SilvaJL , NascimentoBR , RibeiroAL . Text messages to promote secondary prevention after acute coronary syndrome (IMPACS trial). International Journal of Cardiovascular Sciences2021;35(2):202-13. [DOI: 10.36660/ijcs.20200378]">Passaglia 2021</a>; <a href="./references#CD011851-bbs2-0018" title="HuoX , SpatzES , DingQ , HorakP , ZhengX , MastersC , et al. Design and rationale of the Cardiovascular Health and Text Messaging (CHAT) study and the CHAT-Diabetes Mellitus (CHAT-DM) study: two randomised controlled trials of text messaging to improve secondary prevention for coronary heart disease and diabetes. BMJ Open2017;7(12):e018302. [DOI: 10.1136/bmjopen-2017-018302]ZhengX , SpatzES , BaiX , HuoX , DingQ , HorakP , et al. Effect of text messaging on risk factor management in patients with coronary heart disease: the CHAT randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(4):e005616. [DOI: 10.1161/CIRCOUTCOMES.119.005616]">Zheng 2019</a>). <a href="./references#CD011851-bbs2-0017" title="NCT02336919. The use of texting messaging to improve the hospital-to-community transition period in cardiovascular disease patients (Txt2Prevent) [The use of texting messaging to improve the hospital-to-community transition and prevent readmission in patients with cardiovascular disease (Txt2Prevent)]. clinicaltrials.gov/ct2/show/NCT02336919 (first received 13 January 2015). RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of SMS text messaging to improve the hospital-to-community transition in patients with acute coronary syndrome (Txt2Prevent): results from a pilot randomized controlled trial. JMIR mHealth and uHealth2021;9(5):e24530. [DOI: 10.2196/24530]RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of text messaging to improve the hospital-to-community transition in acute coronary syndrome patients (Txt2Prevent): intervention development and pilot randomized controlled trial protocol. JMIR Research Protocols2017;6(5):e91. [DOI: 10.2196/resprot.6968]">Ross 2021</a> and <a href="./references#CD011851-bbs2-0016" title="QuiliciJ , FugonL , BeguinS , MorangePE , BonnetJL , AlessiMC , et al. Effect of motivational mobile phone short message service on aspirin adherence after coronary stenting for acute coronary syndrome. International Journal of Cardiology2013;168(1):568-9. [DOI: 10.1016/j.ijcard.2013.01.252]">Quilici 2013</a> were pilot studies only. <a href="./references#CD011851-bbs2-0007" title="FangR , LiX . Electronic messaging support service programs improve adherence to lipid-lowering therapy among outpatients with coronary artery disease: an exploratory randomised control study. Journal of Clinical Nursing2016;25(5-6):664-71. [DOI: 10.1111/jocn.12988]">Fang 2016</a> did not discuss the method or timing of the SMS in the paper. </p> </section> <section id="CD011851-sec-0046"> <h5 class="title">Interventions</h5> <p>The duration of the intervention ranged from one month (<a href="./references#CD011851-bbs2-0003" title="ChenC , LiX , KangY , LiuH , LiangYD , ZhangQ . Post-discharge short service message improves short-term clinical outcome and self-care behavior in Chinese patients with chronic heart failure. European Heart Journal2018;39(Suppl 1):797-8. [DOI: 10.1093/eurheartj/ehy563.P3770]ChenC , LiX , SunL , CaoS , KangY , HongL , et al. Post-discharge short message service improves short-term clinical outcome and self-care behaviour in chronic heart failure. ESC Heart Failure2019;6(1):164-73. [DOI: 10.1002/ehf2.12380]ChiCTR-INR-17012316. Effect of post-discharge text messages on clinical outcomes in patients with heart failure [Effect of post-discharge text messages on clinical outcomes in patients with heart failure]. trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR-INR-17012316 (first received 9 August 2018). LiX , ChenC , YouGY , ZhangQ . Post-discharge text messaging intervention improved clinical outcomes in patients with heart failure. European Heart Journal2016;37(Suppl 1):727-8. [DOI: 10.1093/eurheartj/ehw433]">Chen 2019</a>; <a href="./references#CD011851-bbs2-0014" title="ParkLG , Howie-EsquivelJ , ChungM , DracupK . A text messaging intervention improves medication adherence for patients with coronary heart disease: a randomized controlled trial. Circulation2013;128(Suppl 22):A15249. [DOI: 10.1161/circ.128.suppl_22.A15249]ParkLG , Howie-EsquivelJ , ChungML , DracupK . A text messaging intervention to promote medication adherence for patients with coronary heart disease: a randomized controlled trial. Patient Education and Counseling2014;94(2):261-8. [DOI: 10.1016/j.pec.2013.10.027]ParkLG , Howie-EsquivelJ , WhooleyMA , DracupK . Psychosocial factors and medication adherence among patients with coronary heart disease: a text messaging intervention. European Journal of Cardiovascular Nursing2015;14(3):264-73. [DOI: 10.1177/1474515114537024]">Park 2014a</a>; <a href="./references#CD011851-bbs2-0016" title="QuiliciJ , FugonL , BeguinS , MorangePE , BonnetJL , AlessiMC , et al. Effect of motivational mobile phone short message service on aspirin adherence after coronary stenting for acute coronary syndrome. International Journal of Cardiology2013;168(1):568-9. [DOI: 10.1016/j.ijcard.2013.01.252]">Quilici 2013</a>) to 12 months (<a href="./references#CD011851-bbs2-0002" title="BermonA , UribeAF , Pérez-RiveroPF , Prieto-MerinoD , SaaibiJF , SilvaFA , et al. Efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: TXT2HEART Colombia randomized controlled trial. JMIR mHealth and uHealth2021;9(7):e25548. [DOI: 10.2196/25548]BermonA , Uribe-RodríguezAF , Pérez-RiveroPF , Prieto-MerinoD , RiveraDIC , GuioE , et al. Evaluation of the efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: the txt2heart Colombia randomised controlled trial protocol. BMJ Open2019;9:e028017. [DOI: 10.1136/ bmjopen-2018-028017]NCT03098186. TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention [TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention]. clinicaltrials.gov/ct2/show/NCT03098186 (first received 3 March 2017). ">Bermon 2021</a>; <a href="./references#CD011851-bbs2-0005" title="ACTRN12613000793718. TEXT messages to improve MEDication adherence &amp; Secondary prevention – TEXTMEDS [TEXT messages to improve MEDication adherence &amp; Secondary prevention in patients with acute coronary syndrome - TEXTMEDS]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364448&amp;isReview=true (first received 18 June 2013). ChowCK , KlimisH , ThiagalingamA , RedfernJ , HillisGS , BriegerD , et al. Text messages to improve medication adherence and secondary prevention after acute coronary syndrome: the TEXTMEDS randomized clinical trial. Circulation2022;145(19):1443-55. [DOI: 10.1161/CIRCULATIONAHA.121.056161]ChowCK , ThiagalingamA , SantoK , KokC , ThakkarJ , StepienS , et al. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol. BMJ Open2018;8:e019463. [DOI: 10.1136/bmjopen-2017-019463]">Chow 2022</a>; <a href="./references#CD011851-bbs2-0013" title="NCT02783287. The impact of text messaging on medication adherence and exercise regimen among post-myocardial infarction patients. clinicaltrials.gov/ct2/show/NCT02783287 (first received 26 May 2016). PandeyA , ChoudhryN . An m-health application of daily text messages to address forgetfulness as contributor to non-adherence to medications post-myocardial infarction. Circulation2015;132:A18641. [DOI: 10.1161/circ.132.suppl_3.18641]PandeyA , KrummeAA , PatelT , ChoudhryNK . The impact of text messaging on medication adherence and exercise among postmyocardial infarction patients: randomized controlled pilot trial. JMIR mHealth and uHealth2017;5(8):e110. [DOI: 10.2196/mhealth.7144]PandeyAK , ChoudhryN . Text message reminders to address medication non-adherence in post-MI patients: a one year intervention study. Canadian Journal of Cardiology2014;30(10):S179. [DOI: 10.1016/j.cjca.2014.07.280]">Pandey 2017</a>). Duration of intervention was six months in eight studies (<a href="./references#CD011851-bbs2-0001" title="BaeJW , WooSI , LeeJ , ParkSD , KwonSW , ChoiSH , et al. mHealth interventions for lifestyle and risk factor modification in coronary heart disease: randomized controlled trial. JMIR mHealth and uHealth2021;9(9):e29928. [DOI: 10.2196/29928]KCT0005087. Effect of text messaging program on lifestyle and clinical outcomes in patients with cardiovascular disease. cris.nih.go.kr/cris/search/detailSearch.do/19282 (first received 11 September 2019). ">Bae 2021</a>; <a href="./references#CD011851-bbs2-0004" title="ACTRN12611000161921. Tobacco, EXercise and dieT MEssages (TEXT ME): the effect of semi-personalised lifestyle reminder text message intervention on cardiovascular disease risk [Tobacco, EXercise and dieT MEssages (TEXT ME): The effect of a semi-personalised lifestyle reminder text message intervention on cardiovascular risk factors in patients with cardiovascular disease and those who are at high risk of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12611000161921 (first received 3 February 2011). ChowCK , RedfernJ , HillisGS , ThakkarJ , SantoK , HackettML , et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA2015;314(12):1255-63. [DOI: 10.1001/jama.2015.10945]ChowCK , RedfernJ , ThiagalingamA , JanS , WhittakerR , HackettM , et al. Design and rationale of the tobacco, exercise and diet messages (TEXT ME) trial of a text message-based intervention for ongoing prevention of cardiovascular disease in people with coronary disease: a randomised controlled trial protocol. BMJ Open2012;2(1):e000606. [DOI: 10.1136/bmjopen-2011-000606]RedfernJ , SantoK , CooreyG , ThakkarJ , HackettM , ThiagalingamA , et al. Factors influencing engagement, perceived usefulness and behavioral mechanisms associated with a text message support program. PLOS ONE2016;11(10):e0163929. [DOI: 10.1371/journal.pone.0163929]ThakkarJ , RedfernJ , De KeizerL , ThiagalingamA , ChowC . Patient perceptions of text message-based intervention for secondary prevention of cardiovascular events. Heart, Lung and Circulation2013;22(Suppl 1):S264. [DOI: 10.1016/j.hlc.2013.05.630]ThakkarJ , RedfernJ , ThiagalingamA , ChowCK . Patterns, predictors and effects of texting intervention on physical activity in CHD – insights from the TEXT ME randomized clinical trial. European Journal of Preventive Cardiology2016;23(17):1894-902. [DOI: 10.1177/2047487316664190]">Chow 2015</a>; <a href="./references#CD011851-bbs2-0006" title="ACTRN12613000901707. Text4Heart: a text message and internet-based comprehensive cardiac rehabilitation intervention [A randomised controlled trial to determine the efficacy of a text message and Internet-based comprehensive cardiac rehabilitation programme to improve adherence to lifestyle change compared with usual care in New Zealand adults with a diagnosis of cardiovascular disease]. anzctr.org.au/ACTRN12613000901707.aspx (first received 9 August 2013). DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Improving coronary heart disease self-management using mobile technologies (Text4Heart): a randomised controlled trial protocol. Trials2014;15(71):1-9. [DOI: 10.1186/1745-6215-15-71]DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Text message and internet support for coronary heart disease self-management: results from the Text4Heart randomized controlled trial. Journal of Medical Internet Research2015;17(10):e237. [DOI: 10.2196/jmir.4944]">Dale 2015a</a>; <a href="./references#CD011851-bbs2-0007" title="FangR , LiX . Electronic messaging support service programs improve adherence to lipid-lowering therapy among outpatients with coronary artery disease: an exploratory randomised control study. Journal of Clinical Nursing2016;25(5-6):664-71. [DOI: 10.1111/jocn.12988]">Fang 2016</a>; <a href="./references#CD011851-bbs2-0008" title="HuoX , KrumholzHM , BaiX , SpatzES , DingQ , HorakP , et al. Effects of mobile text messaging on glycemic control in patients with coronary heart disease and diabetes mellitus: a randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(9):e005805. [DOI: 10.1161/CIRCOUTCOMES.119.005805]NCT02883842. Cardiovascular Health and Text Messaging-Diabetes Mellitus (CHAT-DM) Study [Effectiveness of text messaging on risk factors control and medication adherence among patients with Coronary Heart Disease and Diabetes in China: cardiovascular health andtext messaging-Diabetes Mellitus (CHAT-DM) study]. clinicaltrials.gov/ct2/show/NCT02883842 (first received 30 August 2016). ">Huo 2019</a>; <a href="./references#CD011851-bbs2-0011" title="ACTRN12616000422426. Text4Heart Partnership: a text messaging program to enhance self-management of cardiovascular disease [Text messaging to enhance self-management of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12616000422426 (first received 23 March 2016). MaddisonR , JiangY , StewartR , ScottT , KerrA , WhittakerR , et al. An intervention to improve medication adherence in people with heart disease (Text4HeartII): randomized controlled trial. JMIR mHealth and uHealth2021;9(6):e24952. [DOI: 10.2196/24952]MaddisonR , StewartR , DoughtyR , ScottT , KerrA , BenatarJ , et al. Text4Heart II - improving medication adherence in people with heart disease: a study protocol for a randomized controlled trial. Trials2018;19(1):70. [DOI: 10.1186/s13063-018-2468-z]">Maddison 2021</a>; <a href="./references#CD011851-bbs2-0015" title="NCT03414190. Impact of text messages to promote secondary prevention after acute coronary syndrome [Impact of a mobile phone text messages intervention on the secondary prevention of cardiovascular events after acute coronary syndrome]. clinicaltrials.gov/show/NCT03414190 (first received 29 January 2018). PassagliaLG , BrantLC , NascimentoBR , RibeiroAL . Impact of text messages in a middle-income country to promote secondary prevention after acute coronary syndrome (IMPACS): a randomized trial. Medicine2019;98(22):e15681. [DOI: 10.1097/MD.0000000000015681]PassagliaLG , BrantLC , SilvaJL , NascimentoBR , RibeiroAL . Text messages to promote secondary prevention after acute coronary syndrome (IMPACS trial). International Journal of Cardiovascular Sciences2021;35(2):202-13. [DOI: 10.36660/ijcs.20200378]">Passaglia 2021</a>; <a href="./references#CD011851-bbs2-0018" title="HuoX , SpatzES , DingQ , HorakP , ZhengX , MastersC , et al. Design and rationale of the Cardiovascular Health and Text Messaging (CHAT) study and the CHAT-Diabetes Mellitus (CHAT-DM) study: two randomised controlled trials of text messaging to improve secondary prevention for coronary heart disease and diabetes. BMJ Open2017;7(12):e018302. [DOI: 10.1136/bmjopen-2017-018302]ZhengX , SpatzES , BaiX , HuoX , DingQ , HorakP , et al. Effect of text messaging on risk factor management in patients with coronary heart disease: the CHAT randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(4):e005616. [DOI: 10.1161/CIRCOUTCOMES.119.005616]">Zheng 2019</a>), two months in four studies (<a href="./references#CD011851-bbs2-0009" title="KamalAK , ShaikQN , PashaO , AzamI , IslamM , MemonAA , et al. Improving medication adherence in stroke patients through Short Text Messages (SMS4Stroke)-study protocol for a randomized, controlled trial. BMC Neurology2015;15:157. [DOI: 10.1186/s12883-015-0413-2]KamalAK , ShaikhQ , PashaO , AzamI , IslamM , MemonAA , et al. A randomized controlled behavioral intervention trial to improve medication adherence in adult stroke patients with prescription tailored short messaging service (SMS)-SMS4Stroke study. BMC Neurolology2015;15:212. [DOI: 10.1186/s12883-015-0471-5]">Kamal 2015</a>; <a href="./references#CD011851-bbs2-0010" title="KhonsariS , SubramanianP , ChinnaK , LatifLA , LingLW , GholamiO . Effect of a reminder system using an automated short message service on medication adherence following acute coronary syndrome. European Journal of Cardiovascular Nursing2015;14(2):170-9. [DOI: 10.1177/1474515114521910]">Khonsari 2015</a>; <a href="./references#CD011851-bbs2-0012" title="NCT02793830. A mobile phone based medication reminder program [A mobile phone based medication reminder program for patients in China with coronary heart disease: a pilot study]. clinicaltrials.gov/ct2/show/NCT02793830 (first received 8 June 2016). NiZ , WuB , YangQ , YanLL , LiuC , ShawRJ . An mHealth intervention to improve medication adherence and health outcomes among patients with coronary heart disease: randomized controlled trial. Journal of Medical Internet Research2022;24(3):e27202. [DOI: 10.2196/27202]">Ni 2022</a>; <a href="./references#CD011851-bbs2-0017" title="NCT02336919. The use of texting messaging to improve the hospital-to-community transition period in cardiovascular disease patients (Txt2Prevent) [The use of texting messaging to improve the hospital-to-community transition and prevent readmission in patients with cardiovascular disease (Txt2Prevent)]. clinicaltrials.gov/ct2/show/NCT02336919 (first received 13 January 2015). RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of SMS text messaging to improve the hospital-to-community transition in patients with acute coronary syndrome (Txt2Prevent): results from a pilot randomized controlled trial. JMIR mHealth and uHealth2021;9(5):e24530. [DOI: 10.2196/24530]RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of text messaging to improve the hospital-to-community transition in acute coronary syndrome patients (Txt2Prevent): intervention development and pilot randomized controlled trial protocol. JMIR Research Protocols2017;6(5):e91. [DOI: 10.2196/resprot.6968]">Ross 2021</a>), 12 months in three studies (<a href="./references#CD011851-bbs2-0002" title="BermonA , UribeAF , Pérez-RiveroPF , Prieto-MerinoD , SaaibiJF , SilvaFA , et al. Efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: TXT2HEART Colombia randomized controlled trial. JMIR mHealth and uHealth2021;9(7):e25548. [DOI: 10.2196/25548]BermonA , Uribe-RodríguezAF , Pérez-RiveroPF , Prieto-MerinoD , RiveraDIC , GuioE , et al. Evaluation of the efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: the txt2heart Colombia randomised controlled trial protocol. BMJ Open2019;9:e028017. [DOI: 10.1136/ bmjopen-2018-028017]NCT03098186. TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention [TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention]. clinicaltrials.gov/ct2/show/NCT03098186 (first received 3 March 2017). ">Bermon 2021</a>; <a href="./references#CD011851-bbs2-0005" title="ACTRN12613000793718. TEXT messages to improve MEDication adherence &amp; Secondary prevention – TEXTMEDS [TEXT messages to improve MEDication adherence &amp; Secondary prevention in patients with acute coronary syndrome - TEXTMEDS]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364448&amp;isReview=true (first received 18 June 2013). ChowCK , KlimisH , ThiagalingamA , RedfernJ , HillisGS , BriegerD , et al. Text messages to improve medication adherence and secondary prevention after acute coronary syndrome: the TEXTMEDS randomized clinical trial. Circulation2022;145(19):1443-55. [DOI: 10.1161/CIRCULATIONAHA.121.056161]ChowCK , ThiagalingamA , SantoK , KokC , ThakkarJ , StepienS , et al. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol. BMJ Open2018;8:e019463. [DOI: 10.1136/bmjopen-2017-019463]">Chow 2022</a>; <a href="./references#CD011851-bbs2-0013" title="NCT02783287. The impact of text messaging on medication adherence and exercise regimen among post-myocardial infarction patients. clinicaltrials.gov/ct2/show/NCT02783287 (first received 26 May 2016). PandeyA , ChoudhryN . An m-health application of daily text messages to address forgetfulness as contributor to non-adherence to medications post-myocardial infarction. Circulation2015;132:A18641. [DOI: 10.1161/circ.132.suppl_3.18641]PandeyA , KrummeAA , PatelT , ChoudhryNK . The impact of text messaging on medication adherence and exercise among postmyocardial infarction patients: randomized controlled pilot trial. JMIR mHealth and uHealth2017;5(8):e110. [DOI: 10.2196/mhealth.7144]PandeyAK , ChoudhryN . Text message reminders to address medication non-adherence in post-MI patients: a one year intervention study. Canadian Journal of Cardiology2014;30(10):S179. [DOI: 10.1016/j.cjca.2014.07.280]">Pandey 2017</a>), and one month in three studies (<a href="./references#CD011851-bbs2-0003" title="ChenC , LiX , KangY , LiuH , LiangYD , ZhangQ . Post-discharge short service message improves short-term clinical outcome and self-care behavior in Chinese patients with chronic heart failure. European Heart Journal2018;39(Suppl 1):797-8. [DOI: 10.1093/eurheartj/ehy563.P3770]ChenC , LiX , SunL , CaoS , KangY , HongL , et al. Post-discharge short message service improves short-term clinical outcome and self-care behaviour in chronic heart failure. ESC Heart Failure2019;6(1):164-73. [DOI: 10.1002/ehf2.12380]ChiCTR-INR-17012316. Effect of post-discharge text messages on clinical outcomes in patients with heart failure [Effect of post-discharge text messages on clinical outcomes in patients with heart failure]. trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR-INR-17012316 (first received 9 August 2018). LiX , ChenC , YouGY , ZhangQ . Post-discharge text messaging intervention improved clinical outcomes in patients with heart failure. European Heart Journal2016;37(Suppl 1):727-8. [DOI: 10.1093/eurheartj/ehw433]">Chen 2019</a>; <a href="./references#CD011851-bbs2-0014" title="ParkLG , Howie-EsquivelJ , ChungM , DracupK . A text messaging intervention improves medication adherence for patients with coronary heart disease: a randomized controlled trial. Circulation2013;128(Suppl 22):A15249. [DOI: 10.1161/circ.128.suppl_22.A15249]ParkLG , Howie-EsquivelJ , ChungML , DracupK . A text messaging intervention to promote medication adherence for patients with coronary heart disease: a randomized controlled trial. Patient Education and Counseling2014;94(2):261-8. [DOI: 10.1016/j.pec.2013.10.027]ParkLG , Howie-EsquivelJ , WhooleyMA , DracupK . Psychosocial factors and medication adherence among patients with coronary heart disease: a text messaging intervention. European Journal of Cardiovascular Nursing2015;14(3):264-73. [DOI: 10.1177/1474515114537024]">Park 2014a</a>; <a href="./references#CD011851-bbs2-0016" title="QuiliciJ , FugonL , BeguinS , MorangePE , BonnetJL , AlessiMC , et al. Effect of motivational mobile phone short message service on aspirin adherence after coronary stenting for acute coronary syndrome. International Journal of Cardiology2013;168(1):568-9. [DOI: 10.1016/j.ijcard.2013.01.252]">Quilici 2013</a>). The mean duration of intervention was five months. </p> <p>The frequency of text messaging delivery varied from twice daily to once weekly. Twelve studies sent text messages at a fixed frequency, including once daily (<a href="./references#CD011851-bbs2-0009" title="KamalAK , ShaikQN , PashaO , AzamI , IslamM , MemonAA , et al. Improving medication adherence in stroke patients through Short Text Messages (SMS4Stroke)-study protocol for a randomized, controlled trial. BMC Neurology2015;15:157. [DOI: 10.1186/s12883-015-0413-2]KamalAK , ShaikhQ , PashaO , AzamI , IslamM , MemonAA , et al. A randomized controlled behavioral intervention trial to improve medication adherence in adult stroke patients with prescription tailored short messaging service (SMS)-SMS4Stroke study. BMC Neurolology2015;15:212. [DOI: 10.1186/s12883-015-0471-5]">Kamal 2015</a>; <a href="./references#CD011851-bbs2-0010" title="KhonsariS , SubramanianP , ChinnaK , LatifLA , LingLW , GholamiO . Effect of a reminder system using an automated short message service on medication adherence following acute coronary syndrome. European Journal of Cardiovascular Nursing2015;14(2):170-9. [DOI: 10.1177/1474515114521910]">Khonsari 2015</a>; <a href="./references#CD011851-bbs2-0011" title="ACTRN12616000422426. Text4Heart Partnership: a text messaging program to enhance self-management of cardiovascular disease [Text messaging to enhance self-management of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12616000422426 (first received 23 March 2016). MaddisonR , JiangY , StewartR , ScottT , KerrA , WhittakerR , et al. An intervention to improve medication adherence in people with heart disease (Text4HeartII): randomized controlled trial. JMIR mHealth and uHealth2021;9(6):e24952. [DOI: 10.2196/24952]MaddisonR , StewartR , DoughtyR , ScottT , KerrA , BenatarJ , et al. Text4Heart II - improving medication adherence in people with heart disease: a study protocol for a randomized controlled trial. Trials2018;19(1):70. [DOI: 10.1186/s13063-018-2468-z]">Maddison 2021</a>; <a href="./references#CD011851-bbs2-0012" title="NCT02793830. A mobile phone based medication reminder program [A mobile phone based medication reminder program for patients in China with coronary heart disease: a pilot study]. clinicaltrials.gov/ct2/show/NCT02793830 (first received 8 June 2016). NiZ , WuB , YangQ , YanLL , LiuC , ShawRJ . An mHealth intervention to improve medication adherence and health outcomes among patients with coronary heart disease: randomized controlled trial. Journal of Medical Internet Research2022;24(3):e27202. [DOI: 10.2196/27202]">Ni 2022</a>; <a href="./references#CD011851-bbs2-0013" title="NCT02783287. The impact of text messaging on medication adherence and exercise regimen among post-myocardial infarction patients. clinicaltrials.gov/ct2/show/NCT02783287 (first received 26 May 2016). PandeyA , ChoudhryN . An m-health application of daily text messages to address forgetfulness as contributor to non-adherence to medications post-myocardial infarction. Circulation2015;132:A18641. [DOI: 10.1161/circ.132.suppl_3.18641]PandeyA , KrummeAA , PatelT , ChoudhryNK . The impact of text messaging on medication adherence and exercise among postmyocardial infarction patients: randomized controlled pilot trial. JMIR mHealth and uHealth2017;5(8):e110. [DOI: 10.2196/mhealth.7144]PandeyAK , ChoudhryN . Text message reminders to address medication non-adherence in post-MI patients: a one year intervention study. Canadian Journal of Cardiology2014;30(10):S179. [DOI: 10.1016/j.cjca.2014.07.280]">Pandey 2017</a>; <a href="./references#CD011851-bbs2-0016" title="QuiliciJ , FugonL , BeguinS , MorangePE , BonnetJL , AlessiMC , et al. Effect of motivational mobile phone short message service on aspirin adherence after coronary stenting for acute coronary syndrome. International Journal of Cardiology2013;168(1):568-9. [DOI: 10.1016/j.ijcard.2013.01.252]">Quilici 2013</a>), once per week (<a href="./references#CD011851-bbs2-0003" title="ChenC , LiX , KangY , LiuH , LiangYD , ZhangQ . Post-discharge short service message improves short-term clinical outcome and self-care behavior in Chinese patients with chronic heart failure. European Heart Journal2018;39(Suppl 1):797-8. [DOI: 10.1093/eurheartj/ehy563.P3770]ChenC , LiX , SunL , CaoS , KangY , HongL , et al. Post-discharge short message service improves short-term clinical outcome and self-care behaviour in chronic heart failure. ESC Heart Failure2019;6(1):164-73. [DOI: 10.1002/ehf2.12380]ChiCTR-INR-17012316. Effect of post-discharge text messages on clinical outcomes in patients with heart failure [Effect of post-discharge text messages on clinical outcomes in patients with heart failure]. trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR-INR-17012316 (first received 9 August 2018). LiX , ChenC , YouGY , ZhangQ . Post-discharge text messaging intervention improved clinical outcomes in patients with heart failure. European Heart Journal2016;37(Suppl 1):727-8. [DOI: 10.1093/eurheartj/ehw433]">Chen 2019</a>; <a href="./references#CD011851-bbs2-0015" title="NCT03414190. Impact of text messages to promote secondary prevention after acute coronary syndrome [Impact of a mobile phone text messages intervention on the secondary prevention of cardiovascular events after acute coronary syndrome]. clinicaltrials.gov/show/NCT03414190 (first received 29 January 2018). PassagliaLG , BrantLC , NascimentoBR , RibeiroAL . Impact of text messages in a middle-income country to promote secondary prevention after acute coronary syndrome (IMPACS): a randomized trial. Medicine2019;98(22):e15681. [DOI: 10.1097/MD.0000000000015681]PassagliaLG , BrantLC , SilvaJL , NascimentoBR , RibeiroAL . Text messages to promote secondary prevention after acute coronary syndrome (IMPACS trial). International Journal of Cardiovascular Sciences2021;35(2):202-13. [DOI: 10.36660/ijcs.20200378]">Passaglia 2021</a>; <a href="./references#CD011851-bbs2-0018" title="HuoX , SpatzES , DingQ , HorakP , ZhengX , MastersC , et al. Design and rationale of the Cardiovascular Health and Text Messaging (CHAT) study and the CHAT-Diabetes Mellitus (CHAT-DM) study: two randomised controlled trials of text messaging to improve secondary prevention for coronary heart disease and diabetes. BMJ Open2017;7(12):e018302. [DOI: 10.1136/bmjopen-2017-018302]ZhengX , SpatzES , BaiX , HuoX , DingQ , HorakP , et al. Effect of text messaging on risk factor management in patients with coronary heart disease: the CHAT randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(4):e005616. [DOI: 10.1161/CIRCOUTCOMES.119.005616]">Zheng 2019</a>), four times per week (<a href="./references#CD011851-bbs2-0001" title="BaeJW , WooSI , LeeJ , ParkSD , KwonSW , ChoiSH , et al. mHealth interventions for lifestyle and risk factor modification in coronary heart disease: randomized controlled trial. JMIR mHealth and uHealth2021;9(9):e29928. [DOI: 10.2196/29928]KCT0005087. Effect of text messaging program on lifestyle and clinical outcomes in patients with cardiovascular disease. cris.nih.go.kr/cris/search/detailSearch.do/19282 (first received 11 September 2019). ">Bae 2021</a>; <a href="./references#CD011851-bbs2-0004" title="ACTRN12611000161921. Tobacco, EXercise and dieT MEssages (TEXT ME): the effect of semi-personalised lifestyle reminder text message intervention on cardiovascular disease risk [Tobacco, EXercise and dieT MEssages (TEXT ME): The effect of a semi-personalised lifestyle reminder text message intervention on cardiovascular risk factors in patients with cardiovascular disease and those who are at high risk of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12611000161921 (first received 3 February 2011). ChowCK , RedfernJ , HillisGS , ThakkarJ , SantoK , HackettML , et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA2015;314(12):1255-63. [DOI: 10.1001/jama.2015.10945]ChowCK , RedfernJ , ThiagalingamA , JanS , WhittakerR , HackettM , et al. Design and rationale of the tobacco, exercise and diet messages (TEXT ME) trial of a text message-based intervention for ongoing prevention of cardiovascular disease in people with coronary disease: a randomised controlled trial protocol. BMJ Open2012;2(1):e000606. [DOI: 10.1136/bmjopen-2011-000606]RedfernJ , SantoK , CooreyG , ThakkarJ , HackettM , ThiagalingamA , et al. Factors influencing engagement, perceived usefulness and behavioral mechanisms associated with a text message support program. PLOS ONE2016;11(10):e0163929. [DOI: 10.1371/journal.pone.0163929]ThakkarJ , RedfernJ , De KeizerL , ThiagalingamA , ChowC . Patient perceptions of text message-based intervention for secondary prevention of cardiovascular events. Heart, Lung and Circulation2013;22(Suppl 1):S264. [DOI: 10.1016/j.hlc.2013.05.630]ThakkarJ , RedfernJ , ThiagalingamA , ChowCK . Patterns, predictors and effects of texting intervention on physical activity in CHD – insights from the TEXT ME randomized clinical trial. European Journal of Preventive Cardiology2016;23(17):1894-902. [DOI: 10.1177/2047487316664190]">Chow 2015</a>), and six times per week (<a href="./references#CD011851-bbs2-0008" title="HuoX , KrumholzHM , BaiX , SpatzES , DingQ , HorakP , et al. Effects of mobile text messaging on glycemic control in patients with coronary heart disease and diabetes mellitus: a randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(9):e005805. [DOI: 10.1161/CIRCOUTCOMES.119.005805]NCT02883842. Cardiovascular Health and Text Messaging-Diabetes Mellitus (CHAT-DM) Study [Effectiveness of text messaging on risk factors control and medication adherence among patients with Coronary Heart Disease and Diabetes in China: cardiovascular health andtext messaging-Diabetes Mellitus (CHAT-DM) study]. clinicaltrials.gov/ct2/show/NCT02883842 (first received 30 August 2016). ">Huo 2019</a>). The remaining studies sent messages at a variable frequency. <a href="./references#CD011851-bbs2-0014" title="ParkLG , Howie-EsquivelJ , ChungM , DracupK . A text messaging intervention improves medication adherence for patients with coronary heart disease: a randomized controlled trial. Circulation2013;128(Suppl 22):A15249. [DOI: 10.1161/circ.128.suppl_22.A15249]ParkLG , Howie-EsquivelJ , ChungML , DracupK . A text messaging intervention to promote medication adherence for patients with coronary heart disease: a randomized controlled trial. Patient Education and Counseling2014;94(2):261-8. [DOI: 10.1016/j.pec.2013.10.027]ParkLG , Howie-EsquivelJ , WhooleyMA , DracupK . Psychosocial factors and medication adherence among patients with coronary heart disease: a text messaging intervention. European Journal of Cardiovascular Nursing2015;14(3):264-73. [DOI: 10.1177/1474515114537024]">Park 2014a</a> sent educational messages three times a week and medication reminders twice a day. <a href="./references#CD011851-bbs2-0006" title="ACTRN12613000901707. Text4Heart: a text message and internet-based comprehensive cardiac rehabilitation intervention [A randomised controlled trial to determine the efficacy of a text message and Internet-based comprehensive cardiac rehabilitation programme to improve adherence to lifestyle change compared with usual care in New Zealand adults with a diagnosis of cardiovascular disease]. anzctr.org.au/ACTRN12613000901707.aspx (first received 9 August 2013). DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Improving coronary heart disease self-management using mobile technologies (Text4Heart): a randomised controlled trial protocol. Trials2014;15(71):1-9. [DOI: 10.1186/1745-6215-15-71]DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Text message and internet support for coronary heart disease self-management: results from the Text4Heart randomized controlled trial. Journal of Medical Internet Research2015;17(10):e237. [DOI: 10.2196/jmir.4944]">Dale 2015a</a> sent daily text messages from week zero to 12 weeks, which were reduced in week 13 to week 24 to five messages a week. <a href="./references#CD011851-bbs2-0017" title="NCT02336919. The use of texting messaging to improve the hospital-to-community transition period in cardiovascular disease patients (Txt2Prevent) [The use of texting messaging to improve the hospital-to-community transition and prevent readmission in patients with cardiovascular disease (Txt2Prevent)]. clinicaltrials.gov/ct2/show/NCT02336919 (first received 13 January 2015). RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of SMS text messaging to improve the hospital-to-community transition in patients with acute coronary syndrome (Txt2Prevent): results from a pilot randomized controlled trial. JMIR mHealth and uHealth2021;9(5):e24530. [DOI: 10.2196/24530]RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of text messaging to improve the hospital-to-community transition in acute coronary syndrome patients (Txt2Prevent): intervention development and pilot randomized controlled trial protocol. JMIR Research Protocols2017;6(5):e91. [DOI: 10.2196/resprot.6968]">Ross 2021</a> sent daily text messages for 36 days, and then every other day until day 60. <a href="./references#CD011851-bbs2-0002" title="BermonA , UribeAF , Pérez-RiveroPF , Prieto-MerinoD , SaaibiJF , SilvaFA , et al. Efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: TXT2HEART Colombia randomized controlled trial. JMIR mHealth and uHealth2021;9(7):e25548. [DOI: 10.2196/25548]BermonA , Uribe-RodríguezAF , Pérez-RiveroPF , Prieto-MerinoD , RiveraDIC , GuioE , et al. Evaluation of the efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: the txt2heart Colombia randomised controlled trial protocol. BMJ Open2019;9:e028017. [DOI: 10.1136/ bmjopen-2018-028017]NCT03098186. TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention [TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention]. clinicaltrials.gov/ct2/show/NCT03098186 (first received 3 March 2017). ">Bermon 2021</a> sent daily text messages in the first four weeks, which was gradually reduced to five messages per week in week 5, three messages per week from week 6 to week 8, and one message from week 8 until week 52. <a href="./references#CD011851-bbs2-0005" title="ACTRN12613000793718. TEXT messages to improve MEDication adherence &amp; Secondary prevention – TEXTMEDS [TEXT messages to improve MEDication adherence &amp; Secondary prevention in patients with acute coronary syndrome - TEXTMEDS]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364448&amp;isReview=true (first received 18 June 2013). ChowCK , KlimisH , ThiagalingamA , RedfernJ , HillisGS , BriegerD , et al. Text messages to improve medication adherence and secondary prevention after acute coronary syndrome: the TEXTMEDS randomized clinical trial. Circulation2022;145(19):1443-55. [DOI: 10.1161/CIRCULATIONAHA.121.056161]ChowCK , ThiagalingamA , SantoK , KokC , ThakkarJ , StepienS , et al. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol. BMJ Open2018;8:e019463. [DOI: 10.1136/bmjopen-2017-019463]">Chow 2022</a> sent four messages per week for the first six months, which was then decreased to three messages per week over the subsequent six months. One study did not report on message frequency (<a href="./references#CD011851-bbs2-0007" title="FangR , LiX . Electronic messaging support service programs improve adherence to lipid-lowering therapy among outpatients with coronary artery disease: an exploratory randomised control study. Journal of Clinical Nursing2016;25(5-6):664-71. [DOI: 10.1111/jocn.12988]">Fang 2016</a>). </p> <p>The control group included usual care in all 18 studies. However, usual care was not clearly described in nine of the included studies (<a href="./references#CD011851-bbs2-0003" title="ChenC , LiX , KangY , LiuH , LiangYD , ZhangQ . Post-discharge short service message improves short-term clinical outcome and self-care behavior in Chinese patients with chronic heart failure. European Heart Journal2018;39(Suppl 1):797-8. [DOI: 10.1093/eurheartj/ehy563.P3770]ChenC , LiX , SunL , CaoS , KangY , HongL , et al. Post-discharge short message service improves short-term clinical outcome and self-care behaviour in chronic heart failure. ESC Heart Failure2019;6(1):164-73. [DOI: 10.1002/ehf2.12380]ChiCTR-INR-17012316. Effect of post-discharge text messages on clinical outcomes in patients with heart failure [Effect of post-discharge text messages on clinical outcomes in patients with heart failure]. trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR-INR-17012316 (first received 9 August 2018). LiX , ChenC , YouGY , ZhangQ . Post-discharge text messaging intervention improved clinical outcomes in patients with heart failure. European Heart Journal2016;37(Suppl 1):727-8. [DOI: 10.1093/eurheartj/ehw433]">Chen 2019</a>; <a href="./references#CD011851-bbs2-0005" title="ACTRN12613000793718. TEXT messages to improve MEDication adherence &amp; Secondary prevention – TEXTMEDS [TEXT messages to improve MEDication adherence &amp; Secondary prevention in patients with acute coronary syndrome - TEXTMEDS]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364448&amp;isReview=true (first received 18 June 2013). ChowCK , KlimisH , ThiagalingamA , RedfernJ , HillisGS , BriegerD , et al. Text messages to improve medication adherence and secondary prevention after acute coronary syndrome: the TEXTMEDS randomized clinical trial. Circulation2022;145(19):1443-55. [DOI: 10.1161/CIRCULATIONAHA.121.056161]ChowCK , ThiagalingamA , SantoK , KokC , ThakkarJ , StepienS , et al. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol. BMJ Open2018;8:e019463. [DOI: 10.1136/bmjopen-2017-019463]">Chow 2022</a>; <a href="./references#CD011851-bbs2-0008" title="HuoX , KrumholzHM , BaiX , SpatzES , DingQ , HorakP , et al. Effects of mobile text messaging on glycemic control in patients with coronary heart disease and diabetes mellitus: a randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(9):e005805. [DOI: 10.1161/CIRCOUTCOMES.119.005805]NCT02883842. Cardiovascular Health and Text Messaging-Diabetes Mellitus (CHAT-DM) Study [Effectiveness of text messaging on risk factors control and medication adherence among patients with Coronary Heart Disease and Diabetes in China: cardiovascular health andtext messaging-Diabetes Mellitus (CHAT-DM) study]. clinicaltrials.gov/ct2/show/NCT02883842 (first received 30 August 2016). ">Huo 2019</a>; <a href="./references#CD011851-bbs2-0013" title="NCT02783287. The impact of text messaging on medication adherence and exercise regimen among post-myocardial infarction patients. clinicaltrials.gov/ct2/show/NCT02783287 (first received 26 May 2016). PandeyA , ChoudhryN . An m-health application of daily text messages to address forgetfulness as contributor to non-adherence to medications post-myocardial infarction. Circulation2015;132:A18641. [DOI: 10.1161/circ.132.suppl_3.18641]PandeyA , KrummeAA , PatelT , ChoudhryNK . The impact of text messaging on medication adherence and exercise among postmyocardial infarction patients: randomized controlled pilot trial. JMIR mHealth and uHealth2017;5(8):e110. [DOI: 10.2196/mhealth.7144]PandeyAK , ChoudhryN . Text message reminders to address medication non-adherence in post-MI patients: a one year intervention study. Canadian Journal of Cardiology2014;30(10):S179. [DOI: 10.1016/j.cjca.2014.07.280]">Pandey 2017</a>; <a href="./references#CD011851-bbs2-0014" title="ParkLG , Howie-EsquivelJ , ChungM , DracupK . A text messaging intervention improves medication adherence for patients with coronary heart disease: a randomized controlled trial. Circulation2013;128(Suppl 22):A15249. [DOI: 10.1161/circ.128.suppl_22.A15249]ParkLG , Howie-EsquivelJ , ChungML , DracupK . A text messaging intervention to promote medication adherence for patients with coronary heart disease: a randomized controlled trial. Patient Education and Counseling2014;94(2):261-8. [DOI: 10.1016/j.pec.2013.10.027]ParkLG , Howie-EsquivelJ , WhooleyMA , DracupK . Psychosocial factors and medication adherence among patients with coronary heart disease: a text messaging intervention. European Journal of Cardiovascular Nursing2015;14(3):264-73. [DOI: 10.1177/1474515114537024]">Park 2014a</a>; <a href="./references#CD011851-bbs2-0015" title="NCT03414190. Impact of text messages to promote secondary prevention after acute coronary syndrome [Impact of a mobile phone text messages intervention on the secondary prevention of cardiovascular events after acute coronary syndrome]. clinicaltrials.gov/show/NCT03414190 (first received 29 January 2018). PassagliaLG , BrantLC , NascimentoBR , RibeiroAL . Impact of text messages in a middle-income country to promote secondary prevention after acute coronary syndrome (IMPACS): a randomized trial. Medicine2019;98(22):e15681. [DOI: 10.1097/MD.0000000000015681]PassagliaLG , BrantLC , SilvaJL , NascimentoBR , RibeiroAL . Text messages to promote secondary prevention after acute coronary syndrome (IMPACS trial). International Journal of Cardiovascular Sciences2021;35(2):202-13. [DOI: 10.36660/ijcs.20200378]">Passaglia 2021</a>; <a href="./references#CD011851-bbs2-0016" title="QuiliciJ , FugonL , BeguinS , MorangePE , BonnetJL , AlessiMC , et al. Effect of motivational mobile phone short message service on aspirin adherence after coronary stenting for acute coronary syndrome. International Journal of Cardiology2013;168(1):568-9. [DOI: 10.1016/j.ijcard.2013.01.252]">Quilici 2013</a>; <a href="./references#CD011851-bbs2-0017" title="NCT02336919. The use of texting messaging to improve the hospital-to-community transition period in cardiovascular disease patients (Txt2Prevent) [The use of texting messaging to improve the hospital-to-community transition and prevent readmission in patients with cardiovascular disease (Txt2Prevent)]. clinicaltrials.gov/ct2/show/NCT02336919 (first received 13 January 2015). RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of SMS text messaging to improve the hospital-to-community transition in patients with acute coronary syndrome (Txt2Prevent): results from a pilot randomized controlled trial. JMIR mHealth and uHealth2021;9(5):e24530. [DOI: 10.2196/24530]RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of text messaging to improve the hospital-to-community transition in acute coronary syndrome patients (Txt2Prevent): intervention development and pilot randomized controlled trial protocol. JMIR Research Protocols2017;6(5):e91. [DOI: 10.2196/resprot.6968]">Ross 2021</a>; <a href="./references#CD011851-bbs2-0018" title="HuoX , SpatzES , DingQ , HorakP , ZhengX , MastersC , et al. Design and rationale of the Cardiovascular Health and Text Messaging (CHAT) study and the CHAT-Diabetes Mellitus (CHAT-DM) study: two randomised controlled trials of text messaging to improve secondary prevention for coronary heart disease and diabetes. BMJ Open2017;7(12):e018302. [DOI: 10.1136/bmjopen-2017-018302]ZhengX , SpatzES , BaiX , HuoX , DingQ , HorakP , et al. Effect of text messaging on risk factor management in patients with coronary heart disease: the CHAT randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(4):e005616. [DOI: 10.1161/CIRCOUTCOMES.119.005616]">Zheng 2019</a>). Although the definition of usual care was provided in the remaining nine studies, the definition of usual care varied across studies. Usual care in <a href="./references#CD011851-bbs2-0001" title="BaeJW , WooSI , LeeJ , ParkSD , KwonSW , ChoiSH , et al. mHealth interventions for lifestyle and risk factor modification in coronary heart disease: randomized controlled trial. JMIR mHealth and uHealth2021;9(9):e29928. [DOI: 10.2196/29928]KCT0005087. Effect of text messaging program on lifestyle and clinical outcomes in patients with cardiovascular disease. cris.nih.go.kr/cris/search/detailSearch.do/19282 (first received 11 September 2019). ">Bae 2021</a> included regular follow‐up at the outpatient clinic and education on cardiovascular health and risk factors. The usual care group in <a href="./references#CD011851-bbs2-0002" title="BermonA , UribeAF , Pérez-RiveroPF , Prieto-MerinoD , SaaibiJF , SilvaFA , et al. Efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: TXT2HEART Colombia randomized controlled trial. JMIR mHealth and uHealth2021;9(7):e25548. [DOI: 10.2196/25548]BermonA , Uribe-RodríguezAF , Pérez-RiveroPF , Prieto-MerinoD , RiveraDIC , GuioE , et al. Evaluation of the efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: the txt2heart Colombia randomised controlled trial protocol. BMJ Open2019;9:e028017. [DOI: 10.1136/ bmjopen-2018-028017]NCT03098186. TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention [TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention]. clinicaltrials.gov/ct2/show/NCT03098186 (first received 3 March 2017). ">Bermon 2021</a> received text messages for reminding of participation in the study. <a href="./references#CD011851-bbs2-0004" title="ACTRN12611000161921. Tobacco, EXercise and dieT MEssages (TEXT ME): the effect of semi-personalised lifestyle reminder text message intervention on cardiovascular disease risk [Tobacco, EXercise and dieT MEssages (TEXT ME): The effect of a semi-personalised lifestyle reminder text message intervention on cardiovascular risk factors in patients with cardiovascular disease and those who are at high risk of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12611000161921 (first received 3 February 2011). ChowCK , RedfernJ , HillisGS , ThakkarJ , SantoK , HackettML , et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA2015;314(12):1255-63. [DOI: 10.1001/jama.2015.10945]ChowCK , RedfernJ , ThiagalingamA , JanS , WhittakerR , HackettM , et al. Design and rationale of the tobacco, exercise and diet messages (TEXT ME) trial of a text message-based intervention for ongoing prevention of cardiovascular disease in people with coronary disease: a randomised controlled trial protocol. BMJ Open2012;2(1):e000606. [DOI: 10.1136/bmjopen-2011-000606]RedfernJ , SantoK , CooreyG , ThakkarJ , HackettM , ThiagalingamA , et al. Factors influencing engagement, perceived usefulness and behavioral mechanisms associated with a text message support program. PLOS ONE2016;11(10):e0163929. [DOI: 10.1371/journal.pone.0163929]ThakkarJ , RedfernJ , De KeizerL , ThiagalingamA , ChowC . Patient perceptions of text message-based intervention for secondary prevention of cardiovascular events. Heart, Lung and Circulation2013;22(Suppl 1):S264. [DOI: 10.1016/j.hlc.2013.05.630]ThakkarJ , RedfernJ , ThiagalingamA , ChowCK . Patterns, predictors and effects of texting intervention on physical activity in CHD – insights from the TEXT ME randomized clinical trial. European Journal of Preventive Cardiology2016;23(17):1894-902. [DOI: 10.1177/2047487316664190]">Chow 2015</a> defined usual care as community follow‐up and referral to inpatient cardiac rehabilitation. The usual care group in <a href="./references#CD011851-bbs2-0007" title="FangR , LiX . Electronic messaging support service programs improve adherence to lipid-lowering therapy among outpatients with coronary artery disease: an exploratory randomised control study. Journal of Clinical Nursing2016;25(5-6):664-71. [DOI: 10.1111/jocn.12988]">Fang 2016</a> received monthly phone calls, and in <a href="./references#CD011851-bbs2-0009" title="KamalAK , ShaikQN , PashaO , AzamI , IslamM , MemonAA , et al. Improving medication adherence in stroke patients through Short Text Messages (SMS4Stroke)-study protocol for a randomized, controlled trial. BMC Neurology2015;15:157. [DOI: 10.1186/s12883-015-0413-2]KamalAK , ShaikhQ , PashaO , AzamI , IslamM , MemonAA , et al. A randomized controlled behavioral intervention trial to improve medication adherence in adult stroke patients with prescription tailored short messaging service (SMS)-SMS4Stroke study. BMC Neurolology2015;15:212. [DOI: 10.1186/s12883-015-0471-5]">Kamal 2015</a> received regular follow‐up visits with neurologist. In <a href="./references#CD011851-bbs2-0012" title="NCT02793830. A mobile phone based medication reminder program [A mobile phone based medication reminder program for patients in China with coronary heart disease: a pilot study]. clinicaltrials.gov/ct2/show/NCT02793830 (first received 8 June 2016). NiZ , WuB , YangQ , YanLL , LiuC , ShawRJ . An mHealth intervention to improve medication adherence and health outcomes among patients with coronary heart disease: randomized controlled trial. Journal of Medical Internet Research2022;24(3):e27202. [DOI: 10.2196/27202]">Ni 2022</a>, the usual care group received educational materials from WeChat. Usual care in <a href="./references#CD011851-bbs2-0006" title="ACTRN12613000901707. Text4Heart: a text message and internet-based comprehensive cardiac rehabilitation intervention [A randomised controlled trial to determine the efficacy of a text message and Internet-based comprehensive cardiac rehabilitation programme to improve adherence to lifestyle change compared with usual care in New Zealand adults with a diagnosis of cardiovascular disease]. anzctr.org.au/ACTRN12613000901707.aspx (first received 9 August 2013). DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Improving coronary heart disease self-management using mobile technologies (Text4Heart): a randomised controlled trial protocol. Trials2014;15(71):1-9. [DOI: 10.1186/1745-6215-15-71]DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Text message and internet support for coronary heart disease self-management: results from the Text4Heart randomized controlled trial. Journal of Medical Internet Research2015;17(10):e237. [DOI: 10.2196/jmir.4944]">Dale 2015a</a> and <a href="./references#CD011851-bbs2-0011" title="ACTRN12616000422426. Text4Heart Partnership: a text messaging program to enhance self-management of cardiovascular disease [Text messaging to enhance self-management of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12616000422426 (first received 23 March 2016). MaddisonR , JiangY , StewartR , ScottT , KerrA , WhittakerR , et al. An intervention to improve medication adherence in people with heart disease (Text4HeartII): randomized controlled trial. JMIR mHealth and uHealth2021;9(6):e24952. [DOI: 10.2196/24952]MaddisonR , StewartR , DoughtyR , ScottT , KerrA , BenatarJ , et al. Text4Heart II - improving medication adherence in people with heart disease: a study protocol for a randomized controlled trial. Trials2018;19(1):70. [DOI: 10.1186/s13063-018-2468-z]">Maddison 2021</a> consisted of an outpatient cardiac rehabilitation programme involving health education and supervised exercise. In <a href="./references#CD011851-bbs2-0010" title="KhonsariS , SubramanianP , ChinnaK , LatifLA , LingLW , GholamiO . Effect of a reminder system using an automated short message service on medication adherence following acute coronary syndrome. European Journal of Cardiovascular Nursing2015;14(2):170-9. [DOI: 10.1177/1474515114521910]">Khonsari 2015</a>, usual care referred to cardiac rehabilitation and follow‐up appointments with the cardiologists. </p> </section> <section id="CD011851-sec-0047"> <h5 class="title">Outcomes</h5> <section id="CD011851-sec-0048"> <h6 class="title">Primary outcomes</h6> <p>All included studies measured medication adherence. Five studies measured the overall adherence to several prescribed medications (<a href="./references#CD011851-bbs2-0002" title="BermonA , UribeAF , Pérez-RiveroPF , Prieto-MerinoD , SaaibiJF , SilvaFA , et al. Efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: TXT2HEART Colombia randomized controlled trial. JMIR mHealth and uHealth2021;9(7):e25548. [DOI: 10.2196/25548]BermonA , Uribe-RodríguezAF , Pérez-RiveroPF , Prieto-MerinoD , RiveraDIC , GuioE , et al. Evaluation of the efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: the txt2heart Colombia randomised controlled trial protocol. BMJ Open2019;9:e028017. [DOI: 10.1136/ bmjopen-2018-028017]NCT03098186. TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention [TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention]. clinicaltrials.gov/ct2/show/NCT03098186 (first received 3 March 2017). ">Bermon 2021</a>; <a href="./references#CD011851-bbs2-0005" title="ACTRN12613000793718. TEXT messages to improve MEDication adherence &amp; Secondary prevention – TEXTMEDS [TEXT messages to improve MEDication adherence &amp; Secondary prevention in patients with acute coronary syndrome - TEXTMEDS]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364448&amp;isReview=true (first received 18 June 2013). ChowCK , KlimisH , ThiagalingamA , RedfernJ , HillisGS , BriegerD , et al. Text messages to improve medication adherence and secondary prevention after acute coronary syndrome: the TEXTMEDS randomized clinical trial. Circulation2022;145(19):1443-55. [DOI: 10.1161/CIRCULATIONAHA.121.056161]ChowCK , ThiagalingamA , SantoK , KokC , ThakkarJ , StepienS , et al. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol. BMJ Open2018;8:e019463. [DOI: 10.1136/bmjopen-2017-019463]">Chow 2022</a>; <a href="./references#CD011851-bbs2-0010" title="KhonsariS , SubramanianP , ChinnaK , LatifLA , LingLW , GholamiO . Effect of a reminder system using an automated short message service on medication adherence following acute coronary syndrome. European Journal of Cardiovascular Nursing2015;14(2):170-9. [DOI: 10.1177/1474515114521910]">Khonsari 2015</a>; <a href="./references#CD011851-bbs2-0011" title="ACTRN12616000422426. Text4Heart Partnership: a text messaging program to enhance self-management of cardiovascular disease [Text messaging to enhance self-management of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12616000422426 (first received 23 March 2016). MaddisonR , JiangY , StewartR , ScottT , KerrA , WhittakerR , et al. An intervention to improve medication adherence in people with heart disease (Text4HeartII): randomized controlled trial. JMIR mHealth and uHealth2021;9(6):e24952. [DOI: 10.2196/24952]MaddisonR , StewartR , DoughtyR , ScottT , KerrA , BenatarJ , et al. Text4Heart II - improving medication adherence in people with heart disease: a study protocol for a randomized controlled trial. Trials2018;19(1):70. [DOI: 10.1186/s13063-018-2468-z]">Maddison 2021</a>; <a href="./references#CD011851-bbs2-0013" title="NCT02783287. The impact of text messaging on medication adherence and exercise regimen among post-myocardial infarction patients. clinicaltrials.gov/ct2/show/NCT02783287 (first received 26 May 2016). PandeyA , ChoudhryN . An m-health application of daily text messages to address forgetfulness as contributor to non-adherence to medications post-myocardial infarction. Circulation2015;132:A18641. [DOI: 10.1161/circ.132.suppl_3.18641]PandeyA , KrummeAA , PatelT , ChoudhryNK . The impact of text messaging on medication adherence and exercise among postmyocardial infarction patients: randomized controlled pilot trial. JMIR mHealth and uHealth2017;5(8):e110. [DOI: 10.2196/mhealth.7144]PandeyAK , ChoudhryN . Text message reminders to address medication non-adherence in post-MI patients: a one year intervention study. Canadian Journal of Cardiology2014;30(10):S179. [DOI: 10.1016/j.cjca.2014.07.280]">Pandey 2017</a>). <a href="./references#CD011851-bbs2-0013" title="NCT02783287. The impact of text messaging on medication adherence and exercise regimen among post-myocardial infarction patients. clinicaltrials.gov/ct2/show/NCT02783287 (first received 26 May 2016). PandeyA , ChoudhryN . An m-health application of daily text messages to address forgetfulness as contributor to non-adherence to medications post-myocardial infarction. Circulation2015;132:A18641. [DOI: 10.1161/circ.132.suppl_3.18641]PandeyA , KrummeAA , PatelT , ChoudhryNK . The impact of text messaging on medication adherence and exercise among postmyocardial infarction patients: randomized controlled pilot trial. JMIR mHealth and uHealth2017;5(8):e110. [DOI: 10.2196/mhealth.7144]PandeyAK , ChoudhryN . Text message reminders to address medication non-adherence in post-MI patients: a one year intervention study. Canadian Journal of Cardiology2014;30(10):S179. [DOI: 10.1016/j.cjca.2014.07.280]">Pandey 2017</a> included participants on a once‐daily regimen of aspirin, a beta‐blocker, an angiotensin converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB), and a statin using self‐reported logs. Most participants in <a href="./references#CD011851-bbs2-0010" title="KhonsariS , SubramanianP , ChinnaK , LatifLA , LingLW , GholamiO . Effect of a reminder system using an automated short message service on medication adherence following acute coronary syndrome. European Journal of Cardiovascular Nursing2015;14(2):170-9. [DOI: 10.1177/1474515114521910]">Khonsari 2015</a> were on five or more daily medications, and adherence was measured using the Morisky Medication Adherence Scale. <a href="./references#CD011851-bbs2-0011" title="ACTRN12616000422426. Text4Heart Partnership: a text messaging program to enhance self-management of cardiovascular disease [Text messaging to enhance self-management of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12616000422426 (first received 23 March 2016). MaddisonR , JiangY , StewartR , ScottT , KerrA , WhittakerR , et al. An intervention to improve medication adherence in people with heart disease (Text4HeartII): randomized controlled trial. JMIR mHealth and uHealth2021;9(6):e24952. [DOI: 10.2196/24952]MaddisonR , StewartR , DoughtyR , ScottT , KerrA , BenatarJ , et al. Text4Heart II - improving medication adherence in people with heart disease: a study protocol for a randomized controlled trial. Trials2018;19(1):70. [DOI: 10.1186/s13063-018-2468-z]">Maddison 2021</a> measured overall adherence to all three medication classes (aspirin, statin, and blood pressure‐lowering medication) and to all four medication classes (aspirin, statin, beta‐blocker, and ACEI/ARB) and adherence to each medication class (statin, aspirin, beta‐blocker, ACEI/ARB) via self‐reported Morisky Medication Adherence Scale. <a href="./references#CD011851-bbs2-0002" title="BermonA , UribeAF , Pérez-RiveroPF , Prieto-MerinoD , SaaibiJF , SilvaFA , et al. Efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: TXT2HEART Colombia randomized controlled trial. JMIR mHealth and uHealth2021;9(7):e25548. [DOI: 10.2196/25548]BermonA , Uribe-RodríguezAF , Pérez-RiveroPF , Prieto-MerinoD , RiveraDIC , GuioE , et al. Evaluation of the efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: the txt2heart Colombia randomised controlled trial protocol. BMJ Open2019;9:e028017. [DOI: 10.1136/ bmjopen-2018-028017]NCT03098186. TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention [TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention]. clinicaltrials.gov/ct2/show/NCT03098186 (first received 3 March 2017). ">Bermon 2021</a> measured self‐reported adherence to cardiovascular medications used in secondary prevention with the Medication Adherence Report Scale‐5 (MARS‐5) questionnaire. In contrast to those studies merely using subjective measures, <a href="./references#CD011851-bbs2-0005" title="ACTRN12613000793718. TEXT messages to improve MEDication adherence &amp; Secondary prevention – TEXTMEDS [TEXT messages to improve MEDication adherence &amp; Secondary prevention in patients with acute coronary syndrome - TEXTMEDS]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364448&amp;isReview=true (first received 18 June 2013). ChowCK , KlimisH , ThiagalingamA , RedfernJ , HillisGS , BriegerD , et al. Text messages to improve medication adherence and secondary prevention after acute coronary syndrome: the TEXTMEDS randomized clinical trial. Circulation2022;145(19):1443-55. [DOI: 10.1161/CIRCULATIONAHA.121.056161]ChowCK , ThiagalingamA , SantoK , KokC , ThakkarJ , StepienS , et al. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol. BMJ Open2018;8:e019463. [DOI: 10.1136/bmjopen-2017-019463]">Chow 2022</a> used a multi‐measure approach including a combination of subjective and objective measures of medication adherence to reduce subjectivity. The subjective measures included measurement of overall adherence to five medication classes (aspirin, beta‐blocker, ACEI/ARB, statin, second antiplatelet) and adherence to each class separately, by self‐reported approach. Objective measures included extraction of prescriptions filled from linked Pharmaceutical Benefits Scheme (PBS) database to validate the self‐reported medication adherence (<a href="./references#CD011851-bbs2-0061" title="Department of Health and Aged Care. Pharmaceutical Benefits Scheme (PBS). www.pbs.gov.au/pbs/home (accessed 30 August 2023).">Department of Health and Aged Care 2023</a>), making it distinct from other studies. </p> <p>Three studies only measured adherence to a single medication class. <a href="./references#CD011851-bbs2-0014" title="ParkLG , Howie-EsquivelJ , ChungM , DracupK . A text messaging intervention improves medication adherence for patients with coronary heart disease: a randomized controlled trial. Circulation2013;128(Suppl 22):A15249. [DOI: 10.1161/circ.128.suppl_22.A15249]ParkLG , Howie-EsquivelJ , ChungML , DracupK . A text messaging intervention to promote medication adherence for patients with coronary heart disease: a randomized controlled trial. Patient Education and Counseling2014;94(2):261-8. [DOI: 10.1016/j.pec.2013.10.027]ParkLG , Howie-EsquivelJ , WhooleyMA , DracupK . Psychosocial factors and medication adherence among patients with coronary heart disease: a text messaging intervention. European Journal of Cardiovascular Nursing2015;14(3):264-73. [DOI: 10.1177/1474515114537024]">Park 2014a</a> measured adherence to antiplatelet and statin medications separately, using both electronic pill bottles and self‐reported adherence. <a href="./references#CD011851-bbs2-0007" title="FangR , LiX . Electronic messaging support service programs improve adherence to lipid-lowering therapy among outpatients with coronary artery disease: an exploratory randomised control study. Journal of Clinical Nursing2016;25(5-6):664-71. [DOI: 10.1111/jocn.12988]">Fang 2016</a> only looked at adherence to statins by four‐item Morisky Medication Adherence Scale. <a href="./references#CD011851-bbs2-0016" title="QuiliciJ , FugonL , BeguinS , MorangePE , BonnetJL , AlessiMC , et al. Effect of motivational mobile phone short message service on aspirin adherence after coronary stenting for acute coronary syndrome. International Journal of Cardiology2013;168(1):568-9. [DOI: 10.1016/j.ijcard.2013.01.252]">Quilici 2013</a> measured aspirin adherence using a self‐reported adherence approach. </p> <p>Seven studies did not specify which medications the participants were taking and to which medication adherence was measured, but specified that it used self‐reported medication adherence (<a href="./references#CD011851-bbs2-0001" title="BaeJW , WooSI , LeeJ , ParkSD , KwonSW , ChoiSH , et al. mHealth interventions for lifestyle and risk factor modification in coronary heart disease: randomized controlled trial. JMIR mHealth and uHealth2021;9(9):e29928. [DOI: 10.2196/29928]KCT0005087. Effect of text messaging program on lifestyle and clinical outcomes in patients with cardiovascular disease. cris.nih.go.kr/cris/search/detailSearch.do/19282 (first received 11 September 2019). ">Bae 2021</a>; <a href="./references#CD011851-bbs2-0003" title="ChenC , LiX , KangY , LiuH , LiangYD , ZhangQ . Post-discharge short service message improves short-term clinical outcome and self-care behavior in Chinese patients with chronic heart failure. European Heart Journal2018;39(Suppl 1):797-8. [DOI: 10.1093/eurheartj/ehy563.P3770]ChenC , LiX , SunL , CaoS , KangY , HongL , et al. Post-discharge short message service improves short-term clinical outcome and self-care behaviour in chronic heart failure. ESC Heart Failure2019;6(1):164-73. [DOI: 10.1002/ehf2.12380]ChiCTR-INR-17012316. Effect of post-discharge text messages on clinical outcomes in patients with heart failure [Effect of post-discharge text messages on clinical outcomes in patients with heart failure]. trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR-INR-17012316 (first received 9 August 2018). LiX , ChenC , YouGY , ZhangQ . Post-discharge text messaging intervention improved clinical outcomes in patients with heart failure. European Heart Journal2016;37(Suppl 1):727-8. [DOI: 10.1093/eurheartj/ehw433]">Chen 2019</a>; <a href="./references#CD011851-bbs2-0006" title="ACTRN12613000901707. Text4Heart: a text message and internet-based comprehensive cardiac rehabilitation intervention [A randomised controlled trial to determine the efficacy of a text message and Internet-based comprehensive cardiac rehabilitation programme to improve adherence to lifestyle change compared with usual care in New Zealand adults with a diagnosis of cardiovascular disease]. anzctr.org.au/ACTRN12613000901707.aspx (first received 9 August 2013). DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Improving coronary heart disease self-management using mobile technologies (Text4Heart): a randomised controlled trial protocol. Trials2014;15(71):1-9. [DOI: 10.1186/1745-6215-15-71]DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Text message and internet support for coronary heart disease self-management: results from the Text4Heart randomized controlled trial. Journal of Medical Internet Research2015;17(10):e237. [DOI: 10.2196/jmir.4944]">Dale 2015a</a>; <a href="./references#CD011851-bbs2-0009" title="KamalAK , ShaikQN , PashaO , AzamI , IslamM , MemonAA , et al. Improving medication adherence in stroke patients through Short Text Messages (SMS4Stroke)-study protocol for a randomized, controlled trial. BMC Neurology2015;15:157. [DOI: 10.1186/s12883-015-0413-2]KamalAK , ShaikhQ , PashaO , AzamI , IslamM , MemonAA , et al. A randomized controlled behavioral intervention trial to improve medication adherence in adult stroke patients with prescription tailored short messaging service (SMS)-SMS4Stroke study. BMC Neurolology2015;15:212. [DOI: 10.1186/s12883-015-0471-5]">Kamal 2015</a>; <a href="./references#CD011851-bbs2-0012" title="NCT02793830. A mobile phone based medication reminder program [A mobile phone based medication reminder program for patients in China with coronary heart disease: a pilot study]. clinicaltrials.gov/ct2/show/NCT02793830 (first received 8 June 2016). NiZ , WuB , YangQ , YanLL , LiuC , ShawRJ . An mHealth intervention to improve medication adherence and health outcomes among patients with coronary heart disease: randomized controlled trial. Journal of Medical Internet Research2022;24(3):e27202. [DOI: 10.2196/27202]">Ni 2022</a>; <a href="./references#CD011851-bbs2-0015" title="NCT03414190. Impact of text messages to promote secondary prevention after acute coronary syndrome [Impact of a mobile phone text messages intervention on the secondary prevention of cardiovascular events after acute coronary syndrome]. clinicaltrials.gov/show/NCT03414190 (first received 29 January 2018). PassagliaLG , BrantLC , NascimentoBR , RibeiroAL . Impact of text messages in a middle-income country to promote secondary prevention after acute coronary syndrome (IMPACS): a randomized trial. Medicine2019;98(22):e15681. [DOI: 10.1097/MD.0000000000015681]PassagliaLG , BrantLC , SilvaJL , NascimentoBR , RibeiroAL . Text messages to promote secondary prevention after acute coronary syndrome (IMPACS trial). International Journal of Cardiovascular Sciences2021;35(2):202-13. [DOI: 10.36660/ijcs.20200378]">Passaglia 2021</a>; <a href="./references#CD011851-bbs2-0017" title="NCT02336919. The use of texting messaging to improve the hospital-to-community transition period in cardiovascular disease patients (Txt2Prevent) [The use of texting messaging to improve the hospital-to-community transition and prevent readmission in patients with cardiovascular disease (Txt2Prevent)]. clinicaltrials.gov/ct2/show/NCT02336919 (first received 13 January 2015). RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of SMS text messaging to improve the hospital-to-community transition in patients with acute coronary syndrome (Txt2Prevent): results from a pilot randomized controlled trial. JMIR mHealth and uHealth2021;9(5):e24530. [DOI: 10.2196/24530]RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of text messaging to improve the hospital-to-community transition in acute coronary syndrome patients (Txt2Prevent): intervention development and pilot randomized controlled trial protocol. JMIR Research Protocols2017;6(5):e91. [DOI: 10.2196/resprot.6968]">Ross 2021</a>). </p> <p>Three studies reported prescribed medication, including ACEI/ARB, aspirin, beta‐blocker, and statin, and all of these four medications (<a href="./references#CD011851-bbs2-0004" title="ACTRN12611000161921. Tobacco, EXercise and dieT MEssages (TEXT ME): the effect of semi-personalised lifestyle reminder text message intervention on cardiovascular disease risk [Tobacco, EXercise and dieT MEssages (TEXT ME): The effect of a semi-personalised lifestyle reminder text message intervention on cardiovascular risk factors in patients with cardiovascular disease and those who are at high risk of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12611000161921 (first received 3 February 2011). ChowCK , RedfernJ , HillisGS , ThakkarJ , SantoK , HackettML , et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA2015;314(12):1255-63. [DOI: 10.1001/jama.2015.10945]ChowCK , RedfernJ , ThiagalingamA , JanS , WhittakerR , HackettM , et al. Design and rationale of the tobacco, exercise and diet messages (TEXT ME) trial of a text message-based intervention for ongoing prevention of cardiovascular disease in people with coronary disease: a randomised controlled trial protocol. BMJ Open2012;2(1):e000606. [DOI: 10.1136/bmjopen-2011-000606]RedfernJ , SantoK , CooreyG , ThakkarJ , HackettM , ThiagalingamA , et al. Factors influencing engagement, perceived usefulness and behavioral mechanisms associated with a text message support program. PLOS ONE2016;11(10):e0163929. [DOI: 10.1371/journal.pone.0163929]ThakkarJ , RedfernJ , De KeizerL , ThiagalingamA , ChowC . Patient perceptions of text message-based intervention for secondary prevention of cardiovascular events. Heart, Lung and Circulation2013;22(Suppl 1):S264. [DOI: 10.1016/j.hlc.2013.05.630]ThakkarJ , RedfernJ , ThiagalingamA , ChowCK . Patterns, predictors and effects of texting intervention on physical activity in CHD – insights from the TEXT ME randomized clinical trial. European Journal of Preventive Cardiology2016;23(17):1894-902. [DOI: 10.1177/2047487316664190]">Chow 2015</a>; <a href="./references#CD011851-bbs2-0008" title="HuoX , KrumholzHM , BaiX , SpatzES , DingQ , HorakP , et al. Effects of mobile text messaging on glycemic control in patients with coronary heart disease and diabetes mellitus: a randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(9):e005805. [DOI: 10.1161/CIRCOUTCOMES.119.005805]NCT02883842. Cardiovascular Health and Text Messaging-Diabetes Mellitus (CHAT-DM) Study [Effectiveness of text messaging on risk factors control and medication adherence among patients with Coronary Heart Disease and Diabetes in China: cardiovascular health andtext messaging-Diabetes Mellitus (CHAT-DM) study]. clinicaltrials.gov/ct2/show/NCT02883842 (first received 30 August 2016). ">Huo 2019</a>; <a href="./references#CD011851-bbs2-0018" title="HuoX , SpatzES , DingQ , HorakP , ZhengX , MastersC , et al. Design and rationale of the Cardiovascular Health and Text Messaging (CHAT) study and the CHAT-Diabetes Mellitus (CHAT-DM) study: two randomised controlled trials of text messaging to improve secondary prevention for coronary heart disease and diabetes. BMJ Open2017;7(12):e018302. [DOI: 10.1136/bmjopen-2017-018302]ZhengX , SpatzES , BaiX , HuoX , DingQ , HorakP , et al. Effect of text messaging on risk factor management in patients with coronary heart disease: the CHAT randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(4):e005616. [DOI: 10.1161/CIRCOUTCOMES.119.005616]">Zheng 2019</a>). </p> <p>Medication adherence was measured via subjective assessment in 15 of the 18 included studies. In the other three studies, medication adherence was measured and validated via objective measures, including medication possession ratio (MPR) (<a href="./references#CD011851-bbs2-0011" title="ACTRN12616000422426. Text4Heart Partnership: a text messaging program to enhance self-management of cardiovascular disease [Text messaging to enhance self-management of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12616000422426 (first received 23 March 2016). MaddisonR , JiangY , StewartR , ScottT , KerrA , WhittakerR , et al. An intervention to improve medication adherence in people with heart disease (Text4HeartII): randomized controlled trial. JMIR mHealth and uHealth2021;9(6):e24952. [DOI: 10.2196/24952]MaddisonR , StewartR , DoughtyR , ScottT , KerrA , BenatarJ , et al. Text4Heart II - improving medication adherence in people with heart disease: a study protocol for a randomized controlled trial. Trials2018;19(1):70. [DOI: 10.1186/s13063-018-2468-z]">Maddison 2021</a>), medication event monitoring system (<a href="./references#CD011851-bbs2-0014" title="ParkLG , Howie-EsquivelJ , ChungM , DracupK . A text messaging intervention improves medication adherence for patients with coronary heart disease: a randomized controlled trial. Circulation2013;128(Suppl 22):A15249. [DOI: 10.1161/circ.128.suppl_22.A15249]ParkLG , Howie-EsquivelJ , ChungML , DracupK . A text messaging intervention to promote medication adherence for patients with coronary heart disease: a randomized controlled trial. Patient Education and Counseling2014;94(2):261-8. [DOI: 10.1016/j.pec.2013.10.027]ParkLG , Howie-EsquivelJ , WhooleyMA , DracupK . Psychosocial factors and medication adherence among patients with coronary heart disease: a text messaging intervention. European Journal of Cardiovascular Nursing2015;14(3):264-73. [DOI: 10.1177/1474515114537024]">Park 2014a</a>), and data linkage with PBS database (<a href="./references#CD011851-bbs2-0005" title="ACTRN12613000793718. TEXT messages to improve MEDication adherence &amp; Secondary prevention – TEXTMEDS [TEXT messages to improve MEDication adherence &amp; Secondary prevention in patients with acute coronary syndrome - TEXTMEDS]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364448&amp;isReview=true (first received 18 June 2013). ChowCK , KlimisH , ThiagalingamA , RedfernJ , HillisGS , BriegerD , et al. Text messages to improve medication adherence and secondary prevention after acute coronary syndrome: the TEXTMEDS randomized clinical trial. Circulation2022;145(19):1443-55. [DOI: 10.1161/CIRCULATIONAHA.121.056161]ChowCK , ThiagalingamA , SantoK , KokC , ThakkarJ , StepienS , et al. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol. BMJ Open2018;8:e019463. [DOI: 10.1136/bmjopen-2017-019463]">Chow 2022</a>). </p> <p>Four studies reported on fatal cardiovascular events (<a href="./references#CD011851-bbs2-0002" title="BermonA , UribeAF , Pérez-RiveroPF , Prieto-MerinoD , SaaibiJF , SilvaFA , et al. Efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: TXT2HEART Colombia randomized controlled trial. JMIR mHealth and uHealth2021;9(7):e25548. [DOI: 10.2196/25548]BermonA , Uribe-RodríguezAF , Pérez-RiveroPF , Prieto-MerinoD , RiveraDIC , GuioE , et al. Evaluation of the efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: the txt2heart Colombia randomised controlled trial protocol. BMJ Open2019;9:e028017. [DOI: 10.1136/ bmjopen-2018-028017]NCT03098186. TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention [TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention]. clinicaltrials.gov/ct2/show/NCT03098186 (first received 3 March 2017). ">Bermon 2021</a>; <a href="./references#CD011851-bbs2-0003" title="ChenC , LiX , KangY , LiuH , LiangYD , ZhangQ . Post-discharge short service message improves short-term clinical outcome and self-care behavior in Chinese patients with chronic heart failure. European Heart Journal2018;39(Suppl 1):797-8. [DOI: 10.1093/eurheartj/ehy563.P3770]ChenC , LiX , SunL , CaoS , KangY , HongL , et al. Post-discharge short message service improves short-term clinical outcome and self-care behaviour in chronic heart failure. ESC Heart Failure2019;6(1):164-73. [DOI: 10.1002/ehf2.12380]ChiCTR-INR-17012316. Effect of post-discharge text messages on clinical outcomes in patients with heart failure [Effect of post-discharge text messages on clinical outcomes in patients with heart failure]. trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR-INR-17012316 (first received 9 August 2018). LiX , ChenC , YouGY , ZhangQ . Post-discharge text messaging intervention improved clinical outcomes in patients with heart failure. European Heart Journal2016;37(Suppl 1):727-8. [DOI: 10.1093/eurheartj/ehw433]">Chen 2019</a>; <a href="./references#CD011851-bbs2-0010" title="KhonsariS , SubramanianP , ChinnaK , LatifLA , LingLW , GholamiO . Effect of a reminder system using an automated short message service on medication adherence following acute coronary syndrome. European Journal of Cardiovascular Nursing2015;14(2):170-9. [DOI: 10.1177/1474515114521910]">Khonsari 2015</a>; <a href="./references#CD011851-bbs2-0015" title="NCT03414190. Impact of text messages to promote secondary prevention after acute coronary syndrome [Impact of a mobile phone text messages intervention on the secondary prevention of cardiovascular events after acute coronary syndrome]. clinicaltrials.gov/show/NCT03414190 (first received 29 January 2018). PassagliaLG , BrantLC , NascimentoBR , RibeiroAL . Impact of text messages in a middle-income country to promote secondary prevention after acute coronary syndrome (IMPACS): a randomized trial. Medicine2019;98(22):e15681. [DOI: 10.1097/MD.0000000000015681]PassagliaLG , BrantLC , SilvaJL , NascimentoBR , RibeiroAL . Text messages to promote secondary prevention after acute coronary syndrome (IMPACS trial). International Journal of Cardiovascular Sciences2021;35(2):202-13. [DOI: 10.36660/ijcs.20200378]">Passaglia 2021</a>). </p> <p>One study reported non‐fatal cardiovascular events and combined CVD event (<a href="./references#CD011851-bbs2-0005" title="ACTRN12613000793718. TEXT messages to improve MEDication adherence &amp; Secondary prevention – TEXTMEDS [TEXT messages to improve MEDication adherence &amp; Secondary prevention in patients with acute coronary syndrome - TEXTMEDS]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364448&amp;isReview=true (first received 18 June 2013). ChowCK , KlimisH , ThiagalingamA , RedfernJ , HillisGS , BriegerD , et al. Text messages to improve medication adherence and secondary prevention after acute coronary syndrome: the TEXTMEDS randomized clinical trial. Circulation2022;145(19):1443-55. [DOI: 10.1161/CIRCULATIONAHA.121.056161]ChowCK , ThiagalingamA , SantoK , KokC , ThakkarJ , StepienS , et al. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol. BMJ Open2018;8:e019463. [DOI: 10.1136/bmjopen-2017-019463]">Chow 2022</a>). </p> </section> <section id="CD011851-sec-0049"> <h6 class="title">Secondary outcomes</h6> <p>Ten studies provided outcome data for our secondary outcome of blood pressure (<a href="./references#CD011851-bbs2-0001" title="BaeJW , WooSI , LeeJ , ParkSD , KwonSW , ChoiSH , et al. mHealth interventions for lifestyle and risk factor modification in coronary heart disease: randomized controlled trial. JMIR mHealth and uHealth2021;9(9):e29928. [DOI: 10.2196/29928]KCT0005087. Effect of text messaging program on lifestyle and clinical outcomes in patients with cardiovascular disease. cris.nih.go.kr/cris/search/detailSearch.do/19282 (first received 11 September 2019). ">Bae 2021</a>; <a href="./references#CD011851-bbs2-0002" title="BermonA , UribeAF , Pérez-RiveroPF , Prieto-MerinoD , SaaibiJF , SilvaFA , et al. Efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: TXT2HEART Colombia randomized controlled trial. JMIR mHealth and uHealth2021;9(7):e25548. [DOI: 10.2196/25548]BermonA , Uribe-RodríguezAF , Pérez-RiveroPF , Prieto-MerinoD , RiveraDIC , GuioE , et al. Evaluation of the efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: the txt2heart Colombia randomised controlled trial protocol. BMJ Open2019;9:e028017. [DOI: 10.1136/ bmjopen-2018-028017]NCT03098186. TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention [TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention]. clinicaltrials.gov/ct2/show/NCT03098186 (first received 3 March 2017). ">Bermon 2021</a>; <a href="./references#CD011851-bbs2-0004" title="ACTRN12611000161921. Tobacco, EXercise and dieT MEssages (TEXT ME): the effect of semi-personalised lifestyle reminder text message intervention on cardiovascular disease risk [Tobacco, EXercise and dieT MEssages (TEXT ME): The effect of a semi-personalised lifestyle reminder text message intervention on cardiovascular risk factors in patients with cardiovascular disease and those who are at high risk of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12611000161921 (first received 3 February 2011). ChowCK , RedfernJ , HillisGS , ThakkarJ , SantoK , HackettML , et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA2015;314(12):1255-63. [DOI: 10.1001/jama.2015.10945]ChowCK , RedfernJ , ThiagalingamA , JanS , WhittakerR , HackettM , et al. Design and rationale of the tobacco, exercise and diet messages (TEXT ME) trial of a text message-based intervention for ongoing prevention of cardiovascular disease in people with coronary disease: a randomised controlled trial protocol. BMJ Open2012;2(1):e000606. [DOI: 10.1136/bmjopen-2011-000606]RedfernJ , SantoK , CooreyG , ThakkarJ , HackettM , ThiagalingamA , et al. Factors influencing engagement, perceived usefulness and behavioral mechanisms associated with a text message support program. PLOS ONE2016;11(10):e0163929. [DOI: 10.1371/journal.pone.0163929]ThakkarJ , RedfernJ , De KeizerL , ThiagalingamA , ChowC . Patient perceptions of text message-based intervention for secondary prevention of cardiovascular events. Heart, Lung and Circulation2013;22(Suppl 1):S264. [DOI: 10.1016/j.hlc.2013.05.630]ThakkarJ , RedfernJ , ThiagalingamA , ChowCK . Patterns, predictors and effects of texting intervention on physical activity in CHD – insights from the TEXT ME randomized clinical trial. European Journal of Preventive Cardiology2016;23(17):1894-902. [DOI: 10.1177/2047487316664190]">Chow 2015</a>; <a href="./references#CD011851-bbs2-0005" title="ACTRN12613000793718. TEXT messages to improve MEDication adherence &amp; Secondary prevention – TEXTMEDS [TEXT messages to improve MEDication adherence &amp; Secondary prevention in patients with acute coronary syndrome - TEXTMEDS]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364448&amp;isReview=true (first received 18 June 2013). ChowCK , KlimisH , ThiagalingamA , RedfernJ , HillisGS , BriegerD , et al. Text messages to improve medication adherence and secondary prevention after acute coronary syndrome: the TEXTMEDS randomized clinical trial. Circulation2022;145(19):1443-55. [DOI: 10.1161/CIRCULATIONAHA.121.056161]ChowCK , ThiagalingamA , SantoK , KokC , ThakkarJ , StepienS , et al. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol. BMJ Open2018;8:e019463. [DOI: 10.1136/bmjopen-2017-019463]">Chow 2022</a>; <a href="./references#CD011851-bbs2-0006" title="ACTRN12613000901707. Text4Heart: a text message and internet-based comprehensive cardiac rehabilitation intervention [A randomised controlled trial to determine the efficacy of a text message and Internet-based comprehensive cardiac rehabilitation programme to improve adherence to lifestyle change compared with usual care in New Zealand adults with a diagnosis of cardiovascular disease]. anzctr.org.au/ACTRN12613000901707.aspx (first received 9 August 2013). DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Improving coronary heart disease self-management using mobile technologies (Text4Heart): a randomised controlled trial protocol. Trials2014;15(71):1-9. [DOI: 10.1186/1745-6215-15-71]DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Text message and internet support for coronary heart disease self-management: results from the Text4Heart randomized controlled trial. Journal of Medical Internet Research2015;17(10):e237. [DOI: 10.2196/jmir.4944]">Dale 2015a</a>; <a href="./references#CD011851-bbs2-0008" title="HuoX , KrumholzHM , BaiX , SpatzES , DingQ , HorakP , et al. Effects of mobile text messaging on glycemic control in patients with coronary heart disease and diabetes mellitus: a randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(9):e005805. [DOI: 10.1161/CIRCOUTCOMES.119.005805]NCT02883842. Cardiovascular Health and Text Messaging-Diabetes Mellitus (CHAT-DM) Study [Effectiveness of text messaging on risk factors control and medication adherence among patients with Coronary Heart Disease and Diabetes in China: cardiovascular health andtext messaging-Diabetes Mellitus (CHAT-DM) study]. clinicaltrials.gov/ct2/show/NCT02883842 (first received 30 August 2016). ">Huo 2019</a>; <a href="./references#CD011851-bbs2-0009" title="KamalAK , ShaikQN , PashaO , AzamI , IslamM , MemonAA , et al. Improving medication adherence in stroke patients through Short Text Messages (SMS4Stroke)-study protocol for a randomized, controlled trial. BMC Neurology2015;15:157. [DOI: 10.1186/s12883-015-0413-2]KamalAK , ShaikhQ , PashaO , AzamI , IslamM , MemonAA , et al. A randomized controlled behavioral intervention trial to improve medication adherence in adult stroke patients with prescription tailored short messaging service (SMS)-SMS4Stroke study. BMC Neurolology2015;15:212. [DOI: 10.1186/s12883-015-0471-5]">Kamal 2015</a>; <a href="./references#CD011851-bbs2-0012" title="NCT02793830. A mobile phone based medication reminder program [A mobile phone based medication reminder program for patients in China with coronary heart disease: a pilot study]. clinicaltrials.gov/ct2/show/NCT02793830 (first received 8 June 2016). NiZ , WuB , YangQ , YanLL , LiuC , ShawRJ . An mHealth intervention to improve medication adherence and health outcomes among patients with coronary heart disease: randomized controlled trial. Journal of Medical Internet Research2022;24(3):e27202. [DOI: 10.2196/27202]">Ni 2022</a>; <a href="./references#CD011851-bbs2-0015" title="NCT03414190. Impact of text messages to promote secondary prevention after acute coronary syndrome [Impact of a mobile phone text messages intervention on the secondary prevention of cardiovascular events after acute coronary syndrome]. clinicaltrials.gov/show/NCT03414190 (first received 29 January 2018). PassagliaLG , BrantLC , NascimentoBR , RibeiroAL . Impact of text messages in a middle-income country to promote secondary prevention after acute coronary syndrome (IMPACS): a randomized trial. Medicine2019;98(22):e15681. [DOI: 10.1097/MD.0000000000015681]PassagliaLG , BrantLC , SilvaJL , NascimentoBR , RibeiroAL . Text messages to promote secondary prevention after acute coronary syndrome (IMPACS trial). International Journal of Cardiovascular Sciences2021;35(2):202-13. [DOI: 10.36660/ijcs.20200378]">Passaglia 2021</a>; <a href="./references#CD011851-bbs2-0018" title="HuoX , SpatzES , DingQ , HorakP , ZhengX , MastersC , et al. Design and rationale of the Cardiovascular Health and Text Messaging (CHAT) study and the CHAT-Diabetes Mellitus (CHAT-DM) study: two randomised controlled trials of text messaging to improve secondary prevention for coronary heart disease and diabetes. BMJ Open2017;7(12):e018302. [DOI: 10.1136/bmjopen-2017-018302]ZhengX , SpatzES , BaiX , HuoX , DingQ , HorakP , et al. Effect of text messaging on risk factor management in patients with coronary heart disease: the CHAT randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(4):e005616. [DOI: 10.1161/CIRCOUTCOMES.119.005616]">Zheng 2019</a>), and eight studies reported on LDL cholesterol (<a href="./references#CD011851-bbs2-0001" title="BaeJW , WooSI , LeeJ , ParkSD , KwonSW , ChoiSH , et al. mHealth interventions for lifestyle and risk factor modification in coronary heart disease: randomized controlled trial. JMIR mHealth and uHealth2021;9(9):e29928. [DOI: 10.2196/29928]KCT0005087. Effect of text messaging program on lifestyle and clinical outcomes in patients with cardiovascular disease. cris.nih.go.kr/cris/search/detailSearch.do/19282 (first received 11 September 2019). ">Bae 2021</a>; <a href="./references#CD011851-bbs2-0002" title="BermonA , UribeAF , Pérez-RiveroPF , Prieto-MerinoD , SaaibiJF , SilvaFA , et al. Efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: TXT2HEART Colombia randomized controlled trial. JMIR mHealth and uHealth2021;9(7):e25548. [DOI: 10.2196/25548]BermonA , Uribe-RodríguezAF , Pérez-RiveroPF , Prieto-MerinoD , RiveraDIC , GuioE , et al. Evaluation of the efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: the txt2heart Colombia randomised controlled trial protocol. BMJ Open2019;9:e028017. [DOI: 10.1136/ bmjopen-2018-028017]NCT03098186. TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention [TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention]. clinicaltrials.gov/ct2/show/NCT03098186 (first received 3 March 2017). ">Bermon 2021</a>; <a href="./references#CD011851-bbs2-0004" title="ACTRN12611000161921. Tobacco, EXercise and dieT MEssages (TEXT ME): the effect of semi-personalised lifestyle reminder text message intervention on cardiovascular disease risk [Tobacco, EXercise and dieT MEssages (TEXT ME): The effect of a semi-personalised lifestyle reminder text message intervention on cardiovascular risk factors in patients with cardiovascular disease and those who are at high risk of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12611000161921 (first received 3 February 2011). ChowCK , RedfernJ , HillisGS , ThakkarJ , SantoK , HackettML , et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA2015;314(12):1255-63. [DOI: 10.1001/jama.2015.10945]ChowCK , RedfernJ , ThiagalingamA , JanS , WhittakerR , HackettM , et al. Design and rationale of the tobacco, exercise and diet messages (TEXT ME) trial of a text message-based intervention for ongoing prevention of cardiovascular disease in people with coronary disease: a randomised controlled trial protocol. BMJ Open2012;2(1):e000606. [DOI: 10.1136/bmjopen-2011-000606]RedfernJ , SantoK , CooreyG , ThakkarJ , HackettM , ThiagalingamA , et al. Factors influencing engagement, perceived usefulness and behavioral mechanisms associated with a text message support program. PLOS ONE2016;11(10):e0163929. [DOI: 10.1371/journal.pone.0163929]ThakkarJ , RedfernJ , De KeizerL , ThiagalingamA , ChowC . Patient perceptions of text message-based intervention for secondary prevention of cardiovascular events. Heart, Lung and Circulation2013;22(Suppl 1):S264. [DOI: 10.1016/j.hlc.2013.05.630]ThakkarJ , RedfernJ , ThiagalingamA , ChowCK . Patterns, predictors and effects of texting intervention on physical activity in CHD – insights from the TEXT ME randomized clinical trial. European Journal of Preventive Cardiology2016;23(17):1894-902. [DOI: 10.1177/2047487316664190]">Chow 2015</a>; <a href="./references#CD011851-bbs2-0005" title="ACTRN12613000793718. TEXT messages to improve MEDication adherence &amp; Secondary prevention – TEXTMEDS [TEXT messages to improve MEDication adherence &amp; Secondary prevention in patients with acute coronary syndrome - TEXTMEDS]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364448&amp;isReview=true (first received 18 June 2013). ChowCK , KlimisH , ThiagalingamA , RedfernJ , HillisGS , BriegerD , et al. Text messages to improve medication adherence and secondary prevention after acute coronary syndrome: the TEXTMEDS randomized clinical trial. Circulation2022;145(19):1443-55. [DOI: 10.1161/CIRCULATIONAHA.121.056161]ChowCK , ThiagalingamA , SantoK , KokC , ThakkarJ , StepienS , et al. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol. BMJ Open2018;8:e019463. [DOI: 10.1136/bmjopen-2017-019463]">Chow 2022</a>; <a href="./references#CD011851-bbs2-0006" title="ACTRN12613000901707. Text4Heart: a text message and internet-based comprehensive cardiac rehabilitation intervention [A randomised controlled trial to determine the efficacy of a text message and Internet-based comprehensive cardiac rehabilitation programme to improve adherence to lifestyle change compared with usual care in New Zealand adults with a diagnosis of cardiovascular disease]. anzctr.org.au/ACTRN12613000901707.aspx (first received 9 August 2013). DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Improving coronary heart disease self-management using mobile technologies (Text4Heart): a randomised controlled trial protocol. Trials2014;15(71):1-9. [DOI: 10.1186/1745-6215-15-71]DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Text message and internet support for coronary heart disease self-management: results from the Text4Heart randomized controlled trial. Journal of Medical Internet Research2015;17(10):e237. [DOI: 10.2196/jmir.4944]">Dale 2015a</a>; <a href="./references#CD011851-bbs2-0008" title="HuoX , KrumholzHM , BaiX , SpatzES , DingQ , HorakP , et al. Effects of mobile text messaging on glycemic control in patients with coronary heart disease and diabetes mellitus: a randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(9):e005805. [DOI: 10.1161/CIRCOUTCOMES.119.005805]NCT02883842. Cardiovascular Health and Text Messaging-Diabetes Mellitus (CHAT-DM) Study [Effectiveness of text messaging on risk factors control and medication adherence among patients with Coronary Heart Disease and Diabetes in China: cardiovascular health andtext messaging-Diabetes Mellitus (CHAT-DM) study]. clinicaltrials.gov/ct2/show/NCT02883842 (first received 30 August 2016). ">Huo 2019</a>; <a href="./references#CD011851-bbs2-0015" title="NCT03414190. Impact of text messages to promote secondary prevention after acute coronary syndrome [Impact of a mobile phone text messages intervention on the secondary prevention of cardiovascular events after acute coronary syndrome]. clinicaltrials.gov/show/NCT03414190 (first received 29 January 2018). PassagliaLG , BrantLC , NascimentoBR , RibeiroAL . Impact of text messages in a middle-income country to promote secondary prevention after acute coronary syndrome (IMPACS): a randomized trial. Medicine2019;98(22):e15681. [DOI: 10.1097/MD.0000000000015681]PassagliaLG , BrantLC , SilvaJL , NascimentoBR , RibeiroAL . Text messages to promote secondary prevention after acute coronary syndrome (IMPACS trial). International Journal of Cardiovascular Sciences2021;35(2):202-13. [DOI: 10.36660/ijcs.20200378]">Passaglia 2021</a>; <a href="./references#CD011851-bbs2-0018" title="HuoX , SpatzES , DingQ , HorakP , ZhengX , MastersC , et al. Design and rationale of the Cardiovascular Health and Text Messaging (CHAT) study and the CHAT-Diabetes Mellitus (CHAT-DM) study: two randomised controlled trials of text messaging to improve secondary prevention for coronary heart disease and diabetes. BMJ Open2017;7(12):e018302. [DOI: 10.1136/bmjopen-2017-018302]ZhengX , SpatzES , BaiX , HuoX , DingQ , HorakP , et al. Effect of text messaging on risk factor management in patients with coronary heart disease: the CHAT randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(4):e005616. [DOI: 10.1161/CIRCOUTCOMES.119.005616]">Zheng 2019</a>). Five studies reported on heart rate (<a href="./references#CD011851-bbs2-0002" title="BermonA , UribeAF , Pérez-RiveroPF , Prieto-MerinoD , SaaibiJF , SilvaFA , et al. Efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: TXT2HEART Colombia randomized controlled trial. JMIR mHealth and uHealth2021;9(7):e25548. [DOI: 10.2196/25548]BermonA , Uribe-RodríguezAF , Pérez-RiveroPF , Prieto-MerinoD , RiveraDIC , GuioE , et al. Evaluation of the efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: the txt2heart Colombia randomised controlled trial protocol. BMJ Open2019;9:e028017. [DOI: 10.1136/ bmjopen-2018-028017]NCT03098186. TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention [TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention]. clinicaltrials.gov/ct2/show/NCT03098186 (first received 3 March 2017). ">Bermon 2021</a>; <a href="./references#CD011851-bbs2-0004" title="ACTRN12611000161921. Tobacco, EXercise and dieT MEssages (TEXT ME): the effect of semi-personalised lifestyle reminder text message intervention on cardiovascular disease risk [Tobacco, EXercise and dieT MEssages (TEXT ME): The effect of a semi-personalised lifestyle reminder text message intervention on cardiovascular risk factors in patients with cardiovascular disease and those who are at high risk of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12611000161921 (first received 3 February 2011). ChowCK , RedfernJ , HillisGS , ThakkarJ , SantoK , HackettML , et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA2015;314(12):1255-63. [DOI: 10.1001/jama.2015.10945]ChowCK , RedfernJ , ThiagalingamA , JanS , WhittakerR , HackettM , et al. Design and rationale of the tobacco, exercise and diet messages (TEXT ME) trial of a text message-based intervention for ongoing prevention of cardiovascular disease in people with coronary disease: a randomised controlled trial protocol. BMJ Open2012;2(1):e000606. [DOI: 10.1136/bmjopen-2011-000606]RedfernJ , SantoK , CooreyG , ThakkarJ , HackettM , ThiagalingamA , et al. Factors influencing engagement, perceived usefulness and behavioral mechanisms associated with a text message support program. PLOS ONE2016;11(10):e0163929. [DOI: 10.1371/journal.pone.0163929]ThakkarJ , RedfernJ , De KeizerL , ThiagalingamA , ChowC . Patient perceptions of text message-based intervention for secondary prevention of cardiovascular events. Heart, Lung and Circulation2013;22(Suppl 1):S264. [DOI: 10.1016/j.hlc.2013.05.630]ThakkarJ , RedfernJ , ThiagalingamA , ChowCK . Patterns, predictors and effects of texting intervention on physical activity in CHD – insights from the TEXT ME randomized clinical trial. European Journal of Preventive Cardiology2016;23(17):1894-902. [DOI: 10.1177/2047487316664190]">Chow 2015</a>; <a href="./references#CD011851-bbs2-0005" title="ACTRN12613000793718. TEXT messages to improve MEDication adherence &amp; Secondary prevention – TEXTMEDS [TEXT messages to improve MEDication adherence &amp; Secondary prevention in patients with acute coronary syndrome - TEXTMEDS]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364448&amp;isReview=true (first received 18 June 2013). ChowCK , KlimisH , ThiagalingamA , RedfernJ , HillisGS , BriegerD , et al. Text messages to improve medication adherence and secondary prevention after acute coronary syndrome: the TEXTMEDS randomized clinical trial. Circulation2022;145(19):1443-55. [DOI: 10.1161/CIRCULATIONAHA.121.056161]ChowCK , ThiagalingamA , SantoK , KokC , ThakkarJ , StepienS , et al. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol. BMJ Open2018;8:e019463. [DOI: 10.1136/bmjopen-2017-019463]">Chow 2022</a>; <a href="./references#CD011851-bbs2-0012" title="NCT02793830. A mobile phone based medication reminder program [A mobile phone based medication reminder program for patients in China with coronary heart disease: a pilot study]. clinicaltrials.gov/ct2/show/NCT02793830 (first received 8 June 2016). NiZ , WuB , YangQ , YanLL , LiuC , ShawRJ . An mHealth intervention to improve medication adherence and health outcomes among patients with coronary heart disease: randomized controlled trial. Journal of Medical Internet Research2022;24(3):e27202. [DOI: 10.2196/27202]">Ni 2022</a>; <a href="./references#CD011851-bbs2-0015" title="NCT03414190. Impact of text messages to promote secondary prevention after acute coronary syndrome [Impact of a mobile phone text messages intervention on the secondary prevention of cardiovascular events after acute coronary syndrome]. clinicaltrials.gov/show/NCT03414190 (first received 29 January 2018). PassagliaLG , BrantLC , NascimentoBR , RibeiroAL . Impact of text messages in a middle-income country to promote secondary prevention after acute coronary syndrome (IMPACS): a randomized trial. Medicine2019;98(22):e15681. [DOI: 10.1097/MD.0000000000015681]PassagliaLG , BrantLC , SilvaJL , NascimentoBR , RibeiroAL . Text messages to promote secondary prevention after acute coronary syndrome (IMPACS trial). International Journal of Cardiovascular Sciences2021;35(2):202-13. [DOI: 10.36660/ijcs.20200378]">Passaglia 2021</a>). </p> <p>Thirteen studies reported patient‐reported experience regarding satisfaction, utility, and acceptability of the intervention (<a href="./references#CD011851-bbs2-0001" title="BaeJW , WooSI , LeeJ , ParkSD , KwonSW , ChoiSH , et al. mHealth interventions for lifestyle and risk factor modification in coronary heart disease: randomized controlled trial. JMIR mHealth and uHealth2021;9(9):e29928. [DOI: 10.2196/29928]KCT0005087. Effect of text messaging program on lifestyle and clinical outcomes in patients with cardiovascular disease. cris.nih.go.kr/cris/search/detailSearch.do/19282 (first received 11 September 2019). ">Bae 2021</a>; <a href="./references#CD011851-bbs2-0004" title="ACTRN12611000161921. Tobacco, EXercise and dieT MEssages (TEXT ME): the effect of semi-personalised lifestyle reminder text message intervention on cardiovascular disease risk [Tobacco, EXercise and dieT MEssages (TEXT ME): The effect of a semi-personalised lifestyle reminder text message intervention on cardiovascular risk factors in patients with cardiovascular disease and those who are at high risk of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12611000161921 (first received 3 February 2011). ChowCK , RedfernJ , HillisGS , ThakkarJ , SantoK , HackettML , et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA2015;314(12):1255-63. [DOI: 10.1001/jama.2015.10945]ChowCK , RedfernJ , ThiagalingamA , JanS , WhittakerR , HackettM , et al. Design and rationale of the tobacco, exercise and diet messages (TEXT ME) trial of a text message-based intervention for ongoing prevention of cardiovascular disease in people with coronary disease: a randomised controlled trial protocol. BMJ Open2012;2(1):e000606. [DOI: 10.1136/bmjopen-2011-000606]RedfernJ , SantoK , CooreyG , ThakkarJ , HackettM , ThiagalingamA , et al. Factors influencing engagement, perceived usefulness and behavioral mechanisms associated with a text message support program. PLOS ONE2016;11(10):e0163929. [DOI: 10.1371/journal.pone.0163929]ThakkarJ , RedfernJ , De KeizerL , ThiagalingamA , ChowC . Patient perceptions of text message-based intervention for secondary prevention of cardiovascular events. Heart, Lung and Circulation2013;22(Suppl 1):S264. [DOI: 10.1016/j.hlc.2013.05.630]ThakkarJ , RedfernJ , ThiagalingamA , ChowCK . Patterns, predictors and effects of texting intervention on physical activity in CHD – insights from the TEXT ME randomized clinical trial. European Journal of Preventive Cardiology2016;23(17):1894-902. [DOI: 10.1177/2047487316664190]">Chow 2015</a>; <a href="./references#CD011851-bbs2-0005" title="ACTRN12613000793718. TEXT messages to improve MEDication adherence &amp; Secondary prevention – TEXTMEDS [TEXT messages to improve MEDication adherence &amp; Secondary prevention in patients with acute coronary syndrome - TEXTMEDS]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364448&amp;isReview=true (first received 18 June 2013). ChowCK , KlimisH , ThiagalingamA , RedfernJ , HillisGS , BriegerD , et al. Text messages to improve medication adherence and secondary prevention after acute coronary syndrome: the TEXTMEDS randomized clinical trial. Circulation2022;145(19):1443-55. [DOI: 10.1161/CIRCULATIONAHA.121.056161]ChowCK , ThiagalingamA , SantoK , KokC , ThakkarJ , StepienS , et al. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol. BMJ Open2018;8:e019463. [DOI: 10.1136/bmjopen-2017-019463]">Chow 2022</a>; <a href="./references#CD011851-bbs2-0006" title="ACTRN12613000901707. Text4Heart: a text message and internet-based comprehensive cardiac rehabilitation intervention [A randomised controlled trial to determine the efficacy of a text message and Internet-based comprehensive cardiac rehabilitation programme to improve adherence to lifestyle change compared with usual care in New Zealand adults with a diagnosis of cardiovascular disease]. anzctr.org.au/ACTRN12613000901707.aspx (first received 9 August 2013). DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Improving coronary heart disease self-management using mobile technologies (Text4Heart): a randomised controlled trial protocol. Trials2014;15(71):1-9. [DOI: 10.1186/1745-6215-15-71]DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Text message and internet support for coronary heart disease self-management: results from the Text4Heart randomized controlled trial. Journal of Medical Internet Research2015;17(10):e237. [DOI: 10.2196/jmir.4944]">Dale 2015a</a>; <a href="./references#CD011851-bbs2-0008" title="HuoX , KrumholzHM , BaiX , SpatzES , DingQ , HorakP , et al. Effects of mobile text messaging on glycemic control in patients with coronary heart disease and diabetes mellitus: a randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(9):e005805. [DOI: 10.1161/CIRCOUTCOMES.119.005805]NCT02883842. Cardiovascular Health and Text Messaging-Diabetes Mellitus (CHAT-DM) Study [Effectiveness of text messaging on risk factors control and medication adherence among patients with Coronary Heart Disease and Diabetes in China: cardiovascular health andtext messaging-Diabetes Mellitus (CHAT-DM) study]. clinicaltrials.gov/ct2/show/NCT02883842 (first received 30 August 2016). ">Huo 2019</a>; <a href="./references#CD011851-bbs2-0009" title="KamalAK , ShaikQN , PashaO , AzamI , IslamM , MemonAA , et al. Improving medication adherence in stroke patients through Short Text Messages (SMS4Stroke)-study protocol for a randomized, controlled trial. BMC Neurology2015;15:157. [DOI: 10.1186/s12883-015-0413-2]KamalAK , ShaikhQ , PashaO , AzamI , IslamM , MemonAA , et al. A randomized controlled behavioral intervention trial to improve medication adherence in adult stroke patients with prescription tailored short messaging service (SMS)-SMS4Stroke study. BMC Neurolology2015;15:212. [DOI: 10.1186/s12883-015-0471-5]">Kamal 2015</a>; <a href="./references#CD011851-bbs2-0010" title="KhonsariS , SubramanianP , ChinnaK , LatifLA , LingLW , GholamiO . Effect of a reminder system using an automated short message service on medication adherence following acute coronary syndrome. European Journal of Cardiovascular Nursing2015;14(2):170-9. [DOI: 10.1177/1474515114521910]">Khonsari 2015</a>; <a href="./references#CD011851-bbs2-0011" title="ACTRN12616000422426. Text4Heart Partnership: a text messaging program to enhance self-management of cardiovascular disease [Text messaging to enhance self-management of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12616000422426 (first received 23 March 2016). MaddisonR , JiangY , StewartR , ScottT , KerrA , WhittakerR , et al. An intervention to improve medication adherence in people with heart disease (Text4HeartII): randomized controlled trial. JMIR mHealth and uHealth2021;9(6):e24952. [DOI: 10.2196/24952]MaddisonR , StewartR , DoughtyR , ScottT , KerrA , BenatarJ , et al. Text4Heart II - improving medication adherence in people with heart disease: a study protocol for a randomized controlled trial. Trials2018;19(1):70. [DOI: 10.1186/s13063-018-2468-z]">Maddison 2021</a>; <a href="./references#CD011851-bbs2-0014" title="ParkLG , Howie-EsquivelJ , ChungM , DracupK . A text messaging intervention improves medication adherence for patients with coronary heart disease: a randomized controlled trial. Circulation2013;128(Suppl 22):A15249. [DOI: 10.1161/circ.128.suppl_22.A15249]ParkLG , Howie-EsquivelJ , ChungML , DracupK . A text messaging intervention to promote medication adherence for patients with coronary heart disease: a randomized controlled trial. Patient Education and Counseling2014;94(2):261-8. [DOI: 10.1016/j.pec.2013.10.027]ParkLG , Howie-EsquivelJ , WhooleyMA , DracupK . Psychosocial factors and medication adherence among patients with coronary heart disease: a text messaging intervention. European Journal of Cardiovascular Nursing2015;14(3):264-73. [DOI: 10.1177/1474515114537024]">Park 2014a</a>; <a href="./references#CD011851-bbs2-0015" title="NCT03414190. Impact of text messages to promote secondary prevention after acute coronary syndrome [Impact of a mobile phone text messages intervention on the secondary prevention of cardiovascular events after acute coronary syndrome]. clinicaltrials.gov/show/NCT03414190 (first received 29 January 2018). PassagliaLG , BrantLC , NascimentoBR , RibeiroAL . Impact of text messages in a middle-income country to promote secondary prevention after acute coronary syndrome (IMPACS): a randomized trial. Medicine2019;98(22):e15681. [DOI: 10.1097/MD.0000000000015681]PassagliaLG , BrantLC , SilvaJL , NascimentoBR , RibeiroAL . Text messages to promote secondary prevention after acute coronary syndrome (IMPACS trial). International Journal of Cardiovascular Sciences2021;35(2):202-13. [DOI: 10.36660/ijcs.20200378]">Passaglia 2021</a>; <a href="./references#CD011851-bbs2-0016" title="QuiliciJ , FugonL , BeguinS , MorangePE , BonnetJL , AlessiMC , et al. Effect of motivational mobile phone short message service on aspirin adherence after coronary stenting for acute coronary syndrome. International Journal of Cardiology2013;168(1):568-9. [DOI: 10.1016/j.ijcard.2013.01.252]">Quilici 2013</a>; <a href="./references#CD011851-bbs2-0017" title="NCT02336919. The use of texting messaging to improve the hospital-to-community transition period in cardiovascular disease patients (Txt2Prevent) [The use of texting messaging to improve the hospital-to-community transition and prevent readmission in patients with cardiovascular disease (Txt2Prevent)]. clinicaltrials.gov/ct2/show/NCT02336919 (first received 13 January 2015). RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of SMS text messaging to improve the hospital-to-community transition in patients with acute coronary syndrome (Txt2Prevent): results from a pilot randomized controlled trial. JMIR mHealth and uHealth2021;9(5):e24530. [DOI: 10.2196/24530]RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of text messaging to improve the hospital-to-community transition in acute coronary syndrome patients (Txt2Prevent): intervention development and pilot randomized controlled trial protocol. JMIR Research Protocols2017;6(5):e91. [DOI: 10.2196/resprot.6968]">Ross 2021</a>; <a href="./references#CD011851-bbs2-0018" title="HuoX , SpatzES , DingQ , HorakP , ZhengX , MastersC , et al. Design and rationale of the Cardiovascular Health and Text Messaging (CHAT) study and the CHAT-Diabetes Mellitus (CHAT-DM) study: two randomised controlled trials of text messaging to improve secondary prevention for coronary heart disease and diabetes. BMJ Open2017;7(12):e018302. [DOI: 10.1136/bmjopen-2017-018302]ZhengX , SpatzES , BaiX , HuoX , DingQ , HorakP , et al. Effect of text messaging on risk factor management in patients with coronary heart disease: the CHAT randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(4):e005616. [DOI: 10.1161/CIRCOUTCOMES.119.005616]">Zheng 2019</a>). Only one study measured adverse effects by reporting road traffic crashes (<a href="./references#CD011851-bbs2-0002" title="BermonA , UribeAF , Pérez-RiveroPF , Prieto-MerinoD , SaaibiJF , SilvaFA , et al. Efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: TXT2HEART Colombia randomized controlled trial. JMIR mHealth and uHealth2021;9(7):e25548. [DOI: 10.2196/25548]BermonA , Uribe-RodríguezAF , Pérez-RiveroPF , Prieto-MerinoD , RiveraDIC , GuioE , et al. Evaluation of the efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: the txt2heart Colombia randomised controlled trial protocol. BMJ Open2019;9:e028017. [DOI: 10.1136/ bmjopen-2018-028017]NCT03098186. TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention [TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention]. clinicaltrials.gov/ct2/show/NCT03098186 (first received 3 March 2017). ">Bermon 2021</a>). None of the included studies reported repetitive thumb strain as an adverse effect. </p> <p>Four studies did not report on any of our secondary outcomes (<a href="./references#CD011851-bbs2-0003" title="ChenC , LiX , KangY , LiuH , LiangYD , ZhangQ . Post-discharge short service message improves short-term clinical outcome and self-care behavior in Chinese patients with chronic heart failure. European Heart Journal2018;39(Suppl 1):797-8. [DOI: 10.1093/eurheartj/ehy563.P3770]ChenC , LiX , SunL , CaoS , KangY , HongL , et al. Post-discharge short message service improves short-term clinical outcome and self-care behaviour in chronic heart failure. ESC Heart Failure2019;6(1):164-73. [DOI: 10.1002/ehf2.12380]ChiCTR-INR-17012316. Effect of post-discharge text messages on clinical outcomes in patients with heart failure [Effect of post-discharge text messages on clinical outcomes in patients with heart failure]. trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR-INR-17012316 (first received 9 August 2018). LiX , ChenC , YouGY , ZhangQ . Post-discharge text messaging intervention improved clinical outcomes in patients with heart failure. European Heart Journal2016;37(Suppl 1):727-8. [DOI: 10.1093/eurheartj/ehw433]">Chen 2019</a>; <a href="./references#CD011851-bbs2-0007" title="FangR , LiX . Electronic messaging support service programs improve adherence to lipid-lowering therapy among outpatients with coronary artery disease: an exploratory randomised control study. Journal of Clinical Nursing2016;25(5-6):664-71. [DOI: 10.1111/jocn.12988]">Fang 2016</a>; <a href="./references#CD011851-bbs2-0010" title="KhonsariS , SubramanianP , ChinnaK , LatifLA , LingLW , GholamiO . Effect of a reminder system using an automated short message service on medication adherence following acute coronary syndrome. European Journal of Cardiovascular Nursing2015;14(2):170-9. [DOI: 10.1177/1474515114521910]">Khonsari 2015</a>; <a href="./references#CD011851-bbs2-0013" title="NCT02783287. The impact of text messaging on medication adherence and exercise regimen among post-myocardial infarction patients. clinicaltrials.gov/ct2/show/NCT02783287 (first received 26 May 2016). PandeyA , ChoudhryN . An m-health application of daily text messages to address forgetfulness as contributor to non-adherence to medications post-myocardial infarction. Circulation2015;132:A18641. [DOI: 10.1161/circ.132.suppl_3.18641]PandeyA , KrummeAA , PatelT , ChoudhryNK . The impact of text messaging on medication adherence and exercise among postmyocardial infarction patients: randomized controlled pilot trial. JMIR mHealth and uHealth2017;5(8):e110. [DOI: 10.2196/mhealth.7144]PandeyAK , ChoudhryN . Text message reminders to address medication non-adherence in post-MI patients: a one year intervention study. Canadian Journal of Cardiology2014;30(10):S179. [DOI: 10.1016/j.cjca.2014.07.280]">Pandey 2017</a>). None of the included studies reported on urinary 11‐dehydrothromboxane B2. </p> </section> </section> <section id="CD011851-sec-0050"> <h5 class="title">Funding</h5> <p>Eleven studies reported the source of funding (<a href="./references#CD011851-bbs2-0001" title="BaeJW , WooSI , LeeJ , ParkSD , KwonSW , ChoiSH , et al. mHealth interventions for lifestyle and risk factor modification in coronary heart disease: randomized controlled trial. JMIR mHealth and uHealth2021;9(9):e29928. [DOI: 10.2196/29928]KCT0005087. Effect of text messaging program on lifestyle and clinical outcomes in patients with cardiovascular disease. cris.nih.go.kr/cris/search/detailSearch.do/19282 (first received 11 September 2019). ">Bae 2021</a>; <a href="./references#CD011851-bbs2-0002" title="BermonA , UribeAF , Pérez-RiveroPF , Prieto-MerinoD , SaaibiJF , SilvaFA , et al. Efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: TXT2HEART Colombia randomized controlled trial. JMIR mHealth and uHealth2021;9(7):e25548. [DOI: 10.2196/25548]BermonA , Uribe-RodríguezAF , Pérez-RiveroPF , Prieto-MerinoD , RiveraDIC , GuioE , et al. Evaluation of the efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: the txt2heart Colombia randomised controlled trial protocol. BMJ Open2019;9:e028017. [DOI: 10.1136/ bmjopen-2018-028017]NCT03098186. TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention [TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention]. clinicaltrials.gov/ct2/show/NCT03098186 (first received 3 March 2017). ">Bermon 2021</a>; <a href="./references#CD011851-bbs2-0004" title="ACTRN12611000161921. Tobacco, EXercise and dieT MEssages (TEXT ME): the effect of semi-personalised lifestyle reminder text message intervention on cardiovascular disease risk [Tobacco, EXercise and dieT MEssages (TEXT ME): The effect of a semi-personalised lifestyle reminder text message intervention on cardiovascular risk factors in patients with cardiovascular disease and those who are at high risk of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12611000161921 (first received 3 February 2011). ChowCK , RedfernJ , HillisGS , ThakkarJ , SantoK , HackettML , et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA2015;314(12):1255-63. [DOI: 10.1001/jama.2015.10945]ChowCK , RedfernJ , ThiagalingamA , JanS , WhittakerR , HackettM , et al. Design and rationale of the tobacco, exercise and diet messages (TEXT ME) trial of a text message-based intervention for ongoing prevention of cardiovascular disease in people with coronary disease: a randomised controlled trial protocol. BMJ Open2012;2(1):e000606. [DOI: 10.1136/bmjopen-2011-000606]RedfernJ , SantoK , CooreyG , ThakkarJ , HackettM , ThiagalingamA , et al. Factors influencing engagement, perceived usefulness and behavioral mechanisms associated with a text message support program. PLOS ONE2016;11(10):e0163929. [DOI: 10.1371/journal.pone.0163929]ThakkarJ , RedfernJ , De KeizerL , ThiagalingamA , ChowC . Patient perceptions of text message-based intervention for secondary prevention of cardiovascular events. Heart, Lung and Circulation2013;22(Suppl 1):S264. [DOI: 10.1016/j.hlc.2013.05.630]ThakkarJ , RedfernJ , ThiagalingamA , ChowCK . Patterns, predictors and effects of texting intervention on physical activity in CHD – insights from the TEXT ME randomized clinical trial. European Journal of Preventive Cardiology2016;23(17):1894-902. [DOI: 10.1177/2047487316664190]">Chow 2015</a>; <a href="./references#CD011851-bbs2-0005" title="ACTRN12613000793718. TEXT messages to improve MEDication adherence &amp; Secondary prevention – TEXTMEDS [TEXT messages to improve MEDication adherence &amp; Secondary prevention in patients with acute coronary syndrome - TEXTMEDS]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364448&amp;isReview=true (first received 18 June 2013). ChowCK , KlimisH , ThiagalingamA , RedfernJ , HillisGS , BriegerD , et al. Text messages to improve medication adherence and secondary prevention after acute coronary syndrome: the TEXTMEDS randomized clinical trial. Circulation2022;145(19):1443-55. [DOI: 10.1161/CIRCULATIONAHA.121.056161]ChowCK , ThiagalingamA , SantoK , KokC , ThakkarJ , StepienS , et al. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol. BMJ Open2018;8:e019463. [DOI: 10.1136/bmjopen-2017-019463]">Chow 2022</a>; <a href="./references#CD011851-bbs2-0006" title="ACTRN12613000901707. Text4Heart: a text message and internet-based comprehensive cardiac rehabilitation intervention [A randomised controlled trial to determine the efficacy of a text message and Internet-based comprehensive cardiac rehabilitation programme to improve adherence to lifestyle change compared with usual care in New Zealand adults with a diagnosis of cardiovascular disease]. anzctr.org.au/ACTRN12613000901707.aspx (first received 9 August 2013). DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Improving coronary heart disease self-management using mobile technologies (Text4Heart): a randomised controlled trial protocol. Trials2014;15(71):1-9. [DOI: 10.1186/1745-6215-15-71]DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Text message and internet support for coronary heart disease self-management: results from the Text4Heart randomized controlled trial. Journal of Medical Internet Research2015;17(10):e237. [DOI: 10.2196/jmir.4944]">Dale 2015a</a>; <a href="./references#CD011851-bbs2-0008" title="HuoX , KrumholzHM , BaiX , SpatzES , DingQ , HorakP , et al. Effects of mobile text messaging on glycemic control in patients with coronary heart disease and diabetes mellitus: a randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(9):e005805. [DOI: 10.1161/CIRCOUTCOMES.119.005805]NCT02883842. Cardiovascular Health and Text Messaging-Diabetes Mellitus (CHAT-DM) Study [Effectiveness of text messaging on risk factors control and medication adherence among patients with Coronary Heart Disease and Diabetes in China: cardiovascular health andtext messaging-Diabetes Mellitus (CHAT-DM) study]. clinicaltrials.gov/ct2/show/NCT02883842 (first received 30 August 2016). ">Huo 2019</a>; <a href="./references#CD011851-bbs2-0011" title="ACTRN12616000422426. Text4Heart Partnership: a text messaging program to enhance self-management of cardiovascular disease [Text messaging to enhance self-management of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12616000422426 (first received 23 March 2016). MaddisonR , JiangY , StewartR , ScottT , KerrA , WhittakerR , et al. An intervention to improve medication adherence in people with heart disease (Text4HeartII): randomized controlled trial. JMIR mHealth and uHealth2021;9(6):e24952. [DOI: 10.2196/24952]MaddisonR , StewartR , DoughtyR , ScottT , KerrA , BenatarJ , et al. Text4Heart II - improving medication adherence in people with heart disease: a study protocol for a randomized controlled trial. Trials2018;19(1):70. [DOI: 10.1186/s13063-018-2468-z]">Maddison 2021</a>; <a href="./references#CD011851-bbs2-0012" title="NCT02793830. A mobile phone based medication reminder program [A mobile phone based medication reminder program for patients in China with coronary heart disease: a pilot study]. clinicaltrials.gov/ct2/show/NCT02793830 (first received 8 June 2016). NiZ , WuB , YangQ , YanLL , LiuC , ShawRJ . An mHealth intervention to improve medication adherence and health outcomes among patients with coronary heart disease: randomized controlled trial. Journal of Medical Internet Research2022;24(3):e27202. [DOI: 10.2196/27202]">Ni 2022</a>; <a href="./references#CD011851-bbs2-0014" title="ParkLG , Howie-EsquivelJ , ChungM , DracupK . A text messaging intervention improves medication adherence for patients with coronary heart disease: a randomized controlled trial. Circulation2013;128(Suppl 22):A15249. [DOI: 10.1161/circ.128.suppl_22.A15249]ParkLG , Howie-EsquivelJ , ChungML , DracupK . A text messaging intervention to promote medication adherence for patients with coronary heart disease: a randomized controlled trial. Patient Education and Counseling2014;94(2):261-8. [DOI: 10.1016/j.pec.2013.10.027]ParkLG , Howie-EsquivelJ , WhooleyMA , DracupK . Psychosocial factors and medication adherence among patients with coronary heart disease: a text messaging intervention. European Journal of Cardiovascular Nursing2015;14(3):264-73. [DOI: 10.1177/1474515114537024]">Park 2014a</a>; <a href="./references#CD011851-bbs2-0017" title="NCT02336919. The use of texting messaging to improve the hospital-to-community transition period in cardiovascular disease patients (Txt2Prevent) [The use of texting messaging to improve the hospital-to-community transition and prevent readmission in patients with cardiovascular disease (Txt2Prevent)]. clinicaltrials.gov/ct2/show/NCT02336919 (first received 13 January 2015). RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of SMS text messaging to improve the hospital-to-community transition in patients with acute coronary syndrome (Txt2Prevent): results from a pilot randomized controlled trial. JMIR mHealth and uHealth2021;9(5):e24530. [DOI: 10.2196/24530]RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of text messaging to improve the hospital-to-community transition in acute coronary syndrome patients (Txt2Prevent): intervention development and pilot randomized controlled trial protocol. JMIR Research Protocols2017;6(5):e91. [DOI: 10.2196/resprot.6968]">Ross 2021</a>; <a href="./references#CD011851-bbs2-0018" title="HuoX , SpatzES , DingQ , HorakP , ZhengX , MastersC , et al. Design and rationale of the Cardiovascular Health and Text Messaging (CHAT) study and the CHAT-Diabetes Mellitus (CHAT-DM) study: two randomised controlled trials of text messaging to improve secondary prevention for coronary heart disease and diabetes. BMJ Open2017;7(12):e018302. [DOI: 10.1136/bmjopen-2017-018302]ZhengX , SpatzES , BaiX , HuoX , DingQ , HorakP , et al. Effect of text messaging on risk factor management in patients with coronary heart disease: the CHAT randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(4):e005616. [DOI: 10.1161/CIRCOUTCOMES.119.005616]">Zheng 2019</a>). Three studies stated that no specific funding was received (<a href="./references#CD011851-bbs2-0009" title="KamalAK , ShaikQN , PashaO , AzamI , IslamM , MemonAA , et al. Improving medication adherence in stroke patients through Short Text Messages (SMS4Stroke)-study protocol for a randomized, controlled trial. BMC Neurology2015;15:157. [DOI: 10.1186/s12883-015-0413-2]KamalAK , ShaikhQ , PashaO , AzamI , IslamM , MemonAA , et al. A randomized controlled behavioral intervention trial to improve medication adherence in adult stroke patients with prescription tailored short messaging service (SMS)-SMS4Stroke study. BMC Neurolology2015;15:212. [DOI: 10.1186/s12883-015-0471-5]">Kamal 2015</a>; <a href="./references#CD011851-bbs2-0010" title="KhonsariS , SubramanianP , ChinnaK , LatifLA , LingLW , GholamiO . Effect of a reminder system using an automated short message service on medication adherence following acute coronary syndrome. European Journal of Cardiovascular Nursing2015;14(2):170-9. [DOI: 10.1177/1474515114521910]">Khonsari 2015</a>; <a href="./references#CD011851-bbs2-0015" title="NCT03414190. Impact of text messages to promote secondary prevention after acute coronary syndrome [Impact of a mobile phone text messages intervention on the secondary prevention of cardiovascular events after acute coronary syndrome]. clinicaltrials.gov/show/NCT03414190 (first received 29 January 2018). PassagliaLG , BrantLC , NascimentoBR , RibeiroAL . Impact of text messages in a middle-income country to promote secondary prevention after acute coronary syndrome (IMPACS): a randomized trial. Medicine2019;98(22):e15681. [DOI: 10.1097/MD.0000000000015681]PassagliaLG , BrantLC , SilvaJL , NascimentoBR , RibeiroAL . Text messages to promote secondary prevention after acute coronary syndrome (IMPACS trial). International Journal of Cardiovascular Sciences2021;35(2):202-13. [DOI: 10.36660/ijcs.20200378]">Passaglia 2021</a>). Four studies did not report if funding was received (<a href="./references#CD011851-bbs2-0003" title="ChenC , LiX , KangY , LiuH , LiangYD , ZhangQ . Post-discharge short service message improves short-term clinical outcome and self-care behavior in Chinese patients with chronic heart failure. European Heart Journal2018;39(Suppl 1):797-8. [DOI: 10.1093/eurheartj/ehy563.P3770]ChenC , LiX , SunL , CaoS , KangY , HongL , et al. Post-discharge short message service improves short-term clinical outcome and self-care behaviour in chronic heart failure. ESC Heart Failure2019;6(1):164-73. [DOI: 10.1002/ehf2.12380]ChiCTR-INR-17012316. Effect of post-discharge text messages on clinical outcomes in patients with heart failure [Effect of post-discharge text messages on clinical outcomes in patients with heart failure]. trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR-INR-17012316 (first received 9 August 2018). LiX , ChenC , YouGY , ZhangQ . Post-discharge text messaging intervention improved clinical outcomes in patients with heart failure. European Heart Journal2016;37(Suppl 1):727-8. [DOI: 10.1093/eurheartj/ehw433]">Chen 2019</a>; <a href="./references#CD011851-bbs2-0007" title="FangR , LiX . Electronic messaging support service programs improve adherence to lipid-lowering therapy among outpatients with coronary artery disease: an exploratory randomised control study. Journal of Clinical Nursing2016;25(5-6):664-71. [DOI: 10.1111/jocn.12988]">Fang 2016</a>; <a href="./references#CD011851-bbs2-0013" title="NCT02783287. The impact of text messaging on medication adherence and exercise regimen among post-myocardial infarction patients. clinicaltrials.gov/ct2/show/NCT02783287 (first received 26 May 2016). PandeyA , ChoudhryN . An m-health application of daily text messages to address forgetfulness as contributor to non-adherence to medications post-myocardial infarction. Circulation2015;132:A18641. [DOI: 10.1161/circ.132.suppl_3.18641]PandeyA , KrummeAA , PatelT , ChoudhryNK . The impact of text messaging on medication adherence and exercise among postmyocardial infarction patients: randomized controlled pilot trial. JMIR mHealth and uHealth2017;5(8):e110. [DOI: 10.2196/mhealth.7144]PandeyAK , ChoudhryN . Text message reminders to address medication non-adherence in post-MI patients: a one year intervention study. Canadian Journal of Cardiology2014;30(10):S179. [DOI: 10.1016/j.cjca.2014.07.280]">Pandey 2017</a>; <a href="./references#CD011851-bbs2-0016" title="QuiliciJ , FugonL , BeguinS , MorangePE , BonnetJL , AlessiMC , et al. Effect of motivational mobile phone short message service on aspirin adherence after coronary stenting for acute coronary syndrome. International Journal of Cardiology2013;168(1):568-9. [DOI: 10.1016/j.ijcard.2013.01.252]">Quilici 2013</a>). </p> </section> </section> <section id="CD011851-sec-0051"> <h4 class="title">Excluded studies</h4> <p>We excluded 12,197 reports based on title and abstract. We excluded a further 18 studies (20 reports) following full‐text screening. The reasons for exclusion of each study are presented in the <a href="./references#CD011851-sec-0112" title="">Characteristics of excluded studies</a> table. There were four studies that never set out to measure any outcomes of interest (<a href="./references#CD011851-bbs2-0025" title="FoccardiG , VecchiatoM , NeunhaeusererD , MezzaroM , QuintoG , BattistaF , et al. Effectiveness of text messaging as an incentive to maintain physical activity after cardiac rehabilitation: a randomized controlled pilot study. International Journal of Environmental Research and Public Health2021;18(12):6645. [DOI: 10.3390/ijerph18126645]">Foccardi 2021</a>; <a href="./references#CD011851-bbs2-0030" title="MoradiA , MoeiniM , SaneiH . The effect of interactive text message follow-up on health promoting lifestyle of patients with acute coronary syndrome. Iranian Journal of Nursing and Midwifery Research2017;22(4):287-93. [DOI: 10.4103/ijnmr.IJNMR_89_16]">Moradi 2017</a>; <a href="./references#CD011851-bbs2-0031" title="RohdeLE , Hoffmann FilhoCR , RoverMM , Rabelo-SilvaER , LopezL , PassosLCS , et al. Design of a multifaceted strategy based on automated text messaging in patients with recent heart failure admission. ESC Heart Failure2021;8(6):5523-30. [DOI: 10.1002/ehf2.13516]">Rohde 2021</a>; <a href="./references#CD011851-bbs2-0033" title="SantoK , HyunK , deKeizerL , ThiagalingamA , HillisGS , ChalmersJ , et al. The effects of a lifestyle-focused text-messaging intervention on adherence to dietary guideline recommendations in patients with coronary heart disease: an analysis of the TEXT ME study. International Journal of Behavioral Nutrition and Physical Activity2018;15(1):45. [DOI: 10.1186/s12966-018-0677-1]">Santo 2018</a>), and four studies were non‐randomised or single‐arm trials (<a href="./references#CD011851-bbs2-0022" title="CarrilloA , HuffmanJC , KimS , MasseyCN , LeglerSR , CelanoCM . An adaptive text message intervention to promote well-being and health behavior adherence for patients with cardiovascular disease: intervention design and preliminary results. Journal of the Academy of Consultation-Liaison Psychiatry2021;62(6):617-24. [DOI: 10.1016/j.jaclp.2021.06.001]">Carrillo 2021</a>; <a href="./references#CD011851-bbs2-0023" title="ChenS , GongE , KaziDS , GatesAB , BaiR , FuH , et al. Using mobile health intervention to improve secondary prevention of coronary heart diseases in China: mixed-methods feasibility study. JMIR mHealth and uHealth2018;6(1):e9. [DOI: 10.2196/mhealth.7849]">Chen 2018</a>; <a href="./references#CD011851-bbs2-0028" title="LeglerS , CelanoCM , BealeEE , HoeppnerBB , HuffmanJC . Use of text messages to increase positive affect and promote physical activity in patients with heart disease: the promoting activity in cardiac patients via text messages (PACT) pilot study. Current Psychology2020;39:648-55. [DOI: 10.1007/s12144-018-9785-y]">Legler 2020</a>; <a href="./references#CD011851-bbs2-0036" title="ZhaoYY , DangFP , ZhaiTT , LiHJ , WangRJ , RenJJ . The effect of text message reminders on medication adherence among patients with coronary heart disease: a systematic review and meta-analysis. Medicine2019;98(52):e18353. [DOI: 10.1097/MD.0000000000018353]">Zhao 2019</a>). We excluded four studies because of ineligible intervention (e.g. text messaging was not a central component of a multicomponent intervention) (<a href="./references#CD011851-bbs2-0027" title="IRCT20180911041002N. Effect of patient education and follow up with short massage on patient's therapeutic adherence with heart disease. trialsearch.who.int/Trial2.aspx?TrialID=IRCT20180911041002N1 (first received 22 January 2019). ">IRCT20180911041002N</a>; <a href="./references#CD011851-bbs2-0032" title="SantoK , ChowCK , ThiagalingamA , RogersK , ChalmersJ , RedfernJ . MEDication reminder APPs to improve medication adherence in Coronary Heart Disease (MedApp-CHD) Study: a randomised controlled trial protocol. BMJ Open2017;7(10):e017540. [DOI: 10.1136/bmjopen-2017-017540]SantoK , SingletonA , RogersK , ThiagalingamA , ChalmersJ , ChowCK , et al. Medication reminder applications to improve adherence in coronary heart disease: a randomised clinical trial. Heart2019;105(4):323-9. [DOI: 10.1136/heartjnl-2018-313479]">Santo 2017</a>; <a href="./references#CD011851-bbs2-0034" title="WangJ , ZengZ , DongR , ShengJ , LaiY , YuJ , et al. Efficacy of a WeChat based intervention to adherence to secondary prevention in patients undergoing coronary artery bypass graft in China: a randomized controlled trial. Journal of Telemedicine and Telecare2020;28(9):653-66. [DOI: 10.1177/1357633X20960639]">Wang 2020</a>; <a href="./references#CD011851-bbs2-0035" title="YanLL , GongE , GuW , TurnerEL , GallisJA , ZhouY . Effectiveness of a primary care-based integrated mobile health intervention for stroke management in rural China (SINEMA): a cluster-randomized controlled trial. PLOS Medicine2021;18(4):e1003582. [DOI: 10.1371/journal.pmed.1003582]">Yan 2021</a>). We excluded the remaining six studies because they did not fulfil the inclusion criteria for cardiovascular disease (<a href="./references#CD011851-bbs2-0019" title="AcevedoM , VarletaP , Casas-CorderoC , BerríosA , NavarreteC , ValentinoG , et al. Mobile-phone text messaging to promote ideal cardiovascular health in women. Open Heart2023;10(1):e002214. [DOI: 10.1136/openhrt-2022-002214]">Acevedo 2023</a>; <a href="./references#CD011851-bbs2-0020" title="Akhu-ZaheyaLM , ShiyabWY . The effect of short message system (SMS) reminder on adherence to a healthy diet, medication, and cessation of smoking among adult patients with cardiovascular diseases. International Journal of Medical Informatics2017;98:65-75. [DOI: 10.1016/j.ijmedinf.2016.12.003]">Akhu‐Zaheya 2017</a>; <a href="./references#CD011851-bbs2-0021" title="Brar PrayagaR , JeongEW , FegerE , NobleHK , KmiecM , PrayagaRS . Improving refill adherence in Medicare patients with tailored and interactive mobile text messaging: pilot study. JMIR mHealth and uHealth2018;6(1):e30. [DOI: 10.2196/mhealth.8930]">Brar 2018</a>; <a href="./references#CD011851-bbs2-0024" title="CheungNW , RedfernJ , ThiagalingamA , HngTM , IslamSMS , HaiderR , et al. Text messaging support for patients with diabetes or coronary artery disease (SupportMe): protocol for a pragmatic randomised controlled trial. BMJ Open2019;9(6):e025923. [DOI: 10.1136/bmjopen-2018-025923]CheungNW , RedfernJ , ThiagalingamA , HngTM , MarschnerS , HaiderR , et al. Effect of mobile phone text messaging self-management support for patients with diabetes or coronary heart disease in a chronic disease management program (SupportMe) on blood pressure: pragmatic randomized controlled trial. Journal of Medical Internet Research 2023;25:e38275. [DOI: 10.2196/38275]">Cheung 2019</a>; <a href="./references#CD011851-bbs2-0026" title="HaramiovaZ , StaskoM , HulinM , TesarT , KuzelovaM , MoriskyDM . The effectiveness of daily SMS reminders in pharmaceutical care of older adults on improving patients' adherence to antihypertensive medication (SPPA): study protocol for a randomized controlled trial. Trials2017;18(1):334. [DOI: 10.1186/s13063-017-2063-8]">Haramiova 2017</a>; <a href="./references#CD011851-bbs2-0029" title="LuongP , GloriosoTJ , GrunwaldGK , PetersonP , AllenLA , KhannaA , et al. Text message medication adherence reminders automated and delivered at scale across two institutions: testing the nudge system: pilot study. Circulation Cardiovascular Quality and Outcomes2021;14(5):e007015. [DOI: 10.1161/CIRCOUTCOMES.120.007015]">Luong 2021</a>). </p> <section id="CD011851-sec-0052"> <h5 class="title">Ongoing studies</h5> <p>We identified nine ongoing studies (<a href="./references#CD011851-bbs2-0037" title="ACTRN12621000754842. Efficacy and safety of adjunctive virtual models of care in the secondary prevention of cardiovascular events in adults discharged from hospital after myocardial infarction or decompensated heart failure. anzctr.org.au/ACTRN12621000754842.aspx (first received 16 June 2021). ">ACTRN12621000754842</a>; <a href="./references#CD011851-bbs2-0038" title="CTRI/2021/06/034463. Drug adherence in persons after stunting and the effect of text messages on drug adherence. trialsearch.who.int/Trial2.aspx?TrialID=CTRI/2021/06/034463 (first received 29 June 2021). ">CTRI/2021/06/034463</a>; <a href="./references#CD011851-bbs2-0039" title="CTRI/2021/10/037432. Prevention of secondary stroke by risk factor control and medication adherence. trialsearch.who.int/Trial2.aspx?TrialID=CTRI/2021/10/037432 (first received 21 October 2021). ">CTRI/2021/10/037432</a>; <a href="./references#CD011851-bbs2-0040" title="IRCT2014050617596N1. Comparison of telephone and SMS follow up on treatment regimen adherence in patients with coronary artery bypass surgery. trialsearch.who.int/Trial2.aspx?TrialID=IRCT2014050617596N1 (first received 7 August 2014). ">IRCT2014050617596N1</a>; <a href="./references#CD011851-bbs2-0041" title="IRCT2016011025937N1. The effect of follow up using short message service on illness perception and medication adherence in patients under coronary angioplasty. trialsearch.who.int/Trial2.aspx?TrialID=IRCT2016011025937N1 (first received 20 February 2016). ">IRCT2016011025937N1</a>; <a href="./references#CD011851-bbs2-0042" title="IRCT2016081125937N2. Effect of a reminder system on medication adherence. trialsearch.who.int/Trial2.aspx?TrialID=IRCT2016081125937N2 (first received 29 August 2016). ">IRCT2016081125937N2</a>; <a href="./references#CD011851-bbs2-0043" title="ISRCTN10549665. Improving medication taking in patients with coronary heart disease using a mobile health technology, a feasibility study. www.isrctn.com/ISRCTN10549665 (first received 26 November 2019). [DOI: 10.1186/ISRCTN10549665]">ISRCTN10549665</a>; <a href="./references#CD011851-bbs2-0044" title="NCT03022669. Mobile health strategies for veterans. clinicaltrials.gov/study/NCT03022669 (first received 16 January 2017). ParkLG , CollinsEG , ShimJK , WhooleyMA . Comparing mobile health strategies to improve medication adherence for veterans with coronary heart disease (Mobile4Meds): protocol for a mixed-methods study. JMIR Research Protocols2017;6(7):e134. [DOI: 10.2196/resprot.7327]">Park 2017</a>; <a href="./references#CD011851-bbs2-0045" title="ACTRN12616001167459. Impact of integrated text messaging (ITM) on the efficacy of rehabilitation programs for chronic respiratory and cardiovascular disease. anzctr.org.au/ACTRN12616001167459.aspx (first received 26 August 2016). RedfernJ , HyunK , SingletonA , HafizN , RaesideR , SpencerL , et al. ITM support for patients with chronic respiratory and cardiovascular diseases: a protocol for a randomised controlled trial. BMJ Open2019;9(3):e023863. [DOI: 10.1136/bmjopen-2018-023863]">Redfern 2019</a>). Three were from high‐income countries (225 participants, USA, <a href="./references#CD011851-bbs2-0044" title="NCT03022669. Mobile health strategies for veterans. clinicaltrials.gov/study/NCT03022669 (first received 16 January 2017). ParkLG , CollinsEG , ShimJK , WhooleyMA . Comparing mobile health strategies to improve medication adherence for veterans with coronary heart disease (Mobile4Meds): protocol for a mixed-methods study. JMIR Research Protocols2017;6(7):e134. [DOI: 10.2196/resprot.7327]">Park 2017</a>; 310 participants, Australia, <a href="./references#CD011851-bbs2-0045" title="ACTRN12616001167459. Impact of integrated text messaging (ITM) on the efficacy of rehabilitation programs for chronic respiratory and cardiovascular disease. anzctr.org.au/ACTRN12616001167459.aspx (first received 26 August 2016). RedfernJ , HyunK , SingletonA , HafizN , RaesideR , SpencerL , et al. ITM support for patients with chronic respiratory and cardiovascular diseases: a protocol for a randomised controlled trial. BMJ Open2019;9(3):e023863. [DOI: 10.1136/bmjopen-2018-023863]">Redfern 2019</a>; 2500 participants, Australia, <a href="./references#CD011851-bbs2-0037" title="ACTRN12621000754842. Efficacy and safety of adjunctive virtual models of care in the secondary prevention of cardiovascular events in adults discharged from hospital after myocardial infarction or decompensated heart failure. anzctr.org.au/ACTRN12621000754842.aspx (first received 16 June 2021). ">ACTRN12621000754842</a>), and six were from lower‐middle‐income countries (300 participants, India, <a href="./references#CD011851-bbs2-0038" title="CTRI/2021/06/034463. Drug adherence in persons after stunting and the effect of text messages on drug adherence. trialsearch.who.int/Trial2.aspx?TrialID=CTRI/2021/06/034463 (first received 29 June 2021). ">CTRI/2021/06/034463</a>; 1200 participants, India <a href="./references#CD011851-bbs2-0039" title="CTRI/2021/10/037432. Prevention of secondary stroke by risk factor control and medication adherence. trialsearch.who.int/Trial2.aspx?TrialID=CTRI/2021/10/037432 (first received 21 October 2021). ">CTRI/2021/10/037432</a>; 90 participants, Iran, <a href="./references#CD011851-bbs2-0040" title="IRCT2014050617596N1. Comparison of telephone and SMS follow up on treatment regimen adherence in patients with coronary artery bypass surgery. trialsearch.who.int/Trial2.aspx?TrialID=IRCT2014050617596N1 (first received 7 August 2014). ">IRCT2014050617596N1</a>; 116 participants, Iran, <a href="./references#CD011851-bbs2-0041" title="IRCT2016011025937N1. The effect of follow up using short message service on illness perception and medication adherence in patients under coronary angioplasty. trialsearch.who.int/Trial2.aspx?TrialID=IRCT2016011025937N1 (first received 20 February 2016). ">IRCT2016011025937N1</a>; 116 participants, Iran, <a href="./references#CD011851-bbs2-0042" title="IRCT2016081125937N2. Effect of a reminder system on medication adherence. trialsearch.who.int/Trial2.aspx?TrialID=IRCT2016081125937N2 (first received 29 August 2016). ">IRCT2016081125937N2</a>; 78 participants, Iran, <a href="./references#CD011851-bbs2-0043" title="ISRCTN10549665. Improving medication taking in patients with coronary heart disease using a mobile health technology, a feasibility study. www.isrctn.com/ISRCTN10549665 (first received 26 November 2019). [DOI: 10.1186/ISRCTN10549665]">ISRCTN10549665</a>). Details can be found in the <a href="./references#CD011851-sec-0113" title="">Characteristics of ongoing studies</a> table. </p> </section> </section> </section> <section id="CD011851-sec-0053"> <h3 class="title">Risk of bias in included studies</h3> <p>Details are provided for each study in the risk of bias tables in <a href="./references#CD011851-sec-0111" title="">Characteristics of included studies</a> and in <a href="#CD011851-fig-0002">Figure 2</a> and <a href="#CD011851-fig-0003">Figure 3</a>. Overall, studies were assessed as having high or unclear bias across multiple domains, and the certainty of the evidence was deemed to be low or very low (<a href="./full#CD011851-tbl-0001">summary of findings Table 1</a>). </p> <div class="figure" id="CD011851-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD011851-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_n/nCD011851-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD011851-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD011851-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_n/nCD011851-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD011851-sec-0054"> <h4 class="title">Allocation</h4> <p>Fifteen studies reported adequate random sequence generation and were judged to be of low risk of bias for this domain (<a href="./references#CD011851-bbs2-0001" title="BaeJW , WooSI , LeeJ , ParkSD , KwonSW , ChoiSH , et al. mHealth interventions for lifestyle and risk factor modification in coronary heart disease: randomized controlled trial. JMIR mHealth and uHealth2021;9(9):e29928. [DOI: 10.2196/29928]KCT0005087. Effect of text messaging program on lifestyle and clinical outcomes in patients with cardiovascular disease. cris.nih.go.kr/cris/search/detailSearch.do/19282 (first received 11 September 2019). ">Bae 2021</a>; <a href="./references#CD011851-bbs2-0002" title="BermonA , UribeAF , Pérez-RiveroPF , Prieto-MerinoD , SaaibiJF , SilvaFA , et al. Efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: TXT2HEART Colombia randomized controlled trial. JMIR mHealth and uHealth2021;9(7):e25548. [DOI: 10.2196/25548]BermonA , Uribe-RodríguezAF , Pérez-RiveroPF , Prieto-MerinoD , RiveraDIC , GuioE , et al. Evaluation of the efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: the txt2heart Colombia randomised controlled trial protocol. BMJ Open2019;9:e028017. [DOI: 10.1136/ bmjopen-2018-028017]NCT03098186. TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention [TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention]. clinicaltrials.gov/ct2/show/NCT03098186 (first received 3 March 2017). ">Bermon 2021</a>; <a href="./references#CD011851-bbs2-0003" title="ChenC , LiX , KangY , LiuH , LiangYD , ZhangQ . Post-discharge short service message improves short-term clinical outcome and self-care behavior in Chinese patients with chronic heart failure. European Heart Journal2018;39(Suppl 1):797-8. [DOI: 10.1093/eurheartj/ehy563.P3770]ChenC , LiX , SunL , CaoS , KangY , HongL , et al. Post-discharge short message service improves short-term clinical outcome and self-care behaviour in chronic heart failure. ESC Heart Failure2019;6(1):164-73. [DOI: 10.1002/ehf2.12380]ChiCTR-INR-17012316. Effect of post-discharge text messages on clinical outcomes in patients with heart failure [Effect of post-discharge text messages on clinical outcomes in patients with heart failure]. trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR-INR-17012316 (first received 9 August 2018). LiX , ChenC , YouGY , ZhangQ . Post-discharge text messaging intervention improved clinical outcomes in patients with heart failure. European Heart Journal2016;37(Suppl 1):727-8. [DOI: 10.1093/eurheartj/ehw433]">Chen 2019</a>; <a href="./references#CD011851-bbs2-0004" title="ACTRN12611000161921. Tobacco, EXercise and dieT MEssages (TEXT ME): the effect of semi-personalised lifestyle reminder text message intervention on cardiovascular disease risk [Tobacco, EXercise and dieT MEssages (TEXT ME): The effect of a semi-personalised lifestyle reminder text message intervention on cardiovascular risk factors in patients with cardiovascular disease and those who are at high risk of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12611000161921 (first received 3 February 2011). ChowCK , RedfernJ , HillisGS , ThakkarJ , SantoK , HackettML , et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA2015;314(12):1255-63. [DOI: 10.1001/jama.2015.10945]ChowCK , RedfernJ , ThiagalingamA , JanS , WhittakerR , HackettM , et al. Design and rationale of the tobacco, exercise and diet messages (TEXT ME) trial of a text message-based intervention for ongoing prevention of cardiovascular disease in people with coronary disease: a randomised controlled trial protocol. BMJ Open2012;2(1):e000606. [DOI: 10.1136/bmjopen-2011-000606]RedfernJ , SantoK , CooreyG , ThakkarJ , HackettM , ThiagalingamA , et al. Factors influencing engagement, perceived usefulness and behavioral mechanisms associated with a text message support program. PLOS ONE2016;11(10):e0163929. [DOI: 10.1371/journal.pone.0163929]ThakkarJ , RedfernJ , De KeizerL , ThiagalingamA , ChowC . Patient perceptions of text message-based intervention for secondary prevention of cardiovascular events. Heart, Lung and Circulation2013;22(Suppl 1):S264. [DOI: 10.1016/j.hlc.2013.05.630]ThakkarJ , RedfernJ , ThiagalingamA , ChowCK . Patterns, predictors and effects of texting intervention on physical activity in CHD – insights from the TEXT ME randomized clinical trial. European Journal of Preventive Cardiology2016;23(17):1894-902. [DOI: 10.1177/2047487316664190]">Chow 2015</a>; <a href="./references#CD011851-bbs2-0005" title="ACTRN12613000793718. TEXT messages to improve MEDication adherence &amp; Secondary prevention – TEXTMEDS [TEXT messages to improve MEDication adherence &amp; Secondary prevention in patients with acute coronary syndrome - TEXTMEDS]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364448&amp;isReview=true (first received 18 June 2013). ChowCK , KlimisH , ThiagalingamA , RedfernJ , HillisGS , BriegerD , et al. Text messages to improve medication adherence and secondary prevention after acute coronary syndrome: the TEXTMEDS randomized clinical trial. Circulation2022;145(19):1443-55. [DOI: 10.1161/CIRCULATIONAHA.121.056161]ChowCK , ThiagalingamA , SantoK , KokC , ThakkarJ , StepienS , et al. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol. BMJ Open2018;8:e019463. [DOI: 10.1136/bmjopen-2017-019463]">Chow 2022</a>; <a href="./references#CD011851-bbs2-0006" title="ACTRN12613000901707. Text4Heart: a text message and internet-based comprehensive cardiac rehabilitation intervention [A randomised controlled trial to determine the efficacy of a text message and Internet-based comprehensive cardiac rehabilitation programme to improve adherence to lifestyle change compared with usual care in New Zealand adults with a diagnosis of cardiovascular disease]. anzctr.org.au/ACTRN12613000901707.aspx (first received 9 August 2013). DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Improving coronary heart disease self-management using mobile technologies (Text4Heart): a randomised controlled trial protocol. Trials2014;15(71):1-9. [DOI: 10.1186/1745-6215-15-71]DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Text message and internet support for coronary heart disease self-management: results from the Text4Heart randomized controlled trial. Journal of Medical Internet Research2015;17(10):e237. [DOI: 10.2196/jmir.4944]">Dale 2015a</a>; <a href="./references#CD011851-bbs2-0007" title="FangR , LiX . Electronic messaging support service programs improve adherence to lipid-lowering therapy among outpatients with coronary artery disease: an exploratory randomised control study. Journal of Clinical Nursing2016;25(5-6):664-71. [DOI: 10.1111/jocn.12988]">Fang 2016</a>; <a href="./references#CD011851-bbs2-0008" title="HuoX , KrumholzHM , BaiX , SpatzES , DingQ , HorakP , et al. Effects of mobile text messaging on glycemic control in patients with coronary heart disease and diabetes mellitus: a randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(9):e005805. [DOI: 10.1161/CIRCOUTCOMES.119.005805]NCT02883842. Cardiovascular Health and Text Messaging-Diabetes Mellitus (CHAT-DM) Study [Effectiveness of text messaging on risk factors control and medication adherence among patients with Coronary Heart Disease and Diabetes in China: cardiovascular health andtext messaging-Diabetes Mellitus (CHAT-DM) study]. clinicaltrials.gov/ct2/show/NCT02883842 (first received 30 August 2016). ">Huo 2019</a>; <a href="./references#CD011851-bbs2-0009" title="KamalAK , ShaikQN , PashaO , AzamI , IslamM , MemonAA , et al. Improving medication adherence in stroke patients through Short Text Messages (SMS4Stroke)-study protocol for a randomized, controlled trial. BMC Neurology2015;15:157. [DOI: 10.1186/s12883-015-0413-2]KamalAK , ShaikhQ , PashaO , AzamI , IslamM , MemonAA , et al. A randomized controlled behavioral intervention trial to improve medication adherence in adult stroke patients with prescription tailored short messaging service (SMS)-SMS4Stroke study. BMC Neurolology2015;15:212. [DOI: 10.1186/s12883-015-0471-5]">Kamal 2015</a>; <a href="./references#CD011851-bbs2-0011" title="ACTRN12616000422426. Text4Heart Partnership: a text messaging program to enhance self-management of cardiovascular disease [Text messaging to enhance self-management of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12616000422426 (first received 23 March 2016). MaddisonR , JiangY , StewartR , ScottT , KerrA , WhittakerR , et al. An intervention to improve medication adherence in people with heart disease (Text4HeartII): randomized controlled trial. JMIR mHealth and uHealth2021;9(6):e24952. [DOI: 10.2196/24952]MaddisonR , StewartR , DoughtyR , ScottT , KerrA , BenatarJ , et al. Text4Heart II - improving medication adherence in people with heart disease: a study protocol for a randomized controlled trial. Trials2018;19(1):70. [DOI: 10.1186/s13063-018-2468-z]">Maddison 2021</a>; <a href="./references#CD011851-bbs2-0012" title="NCT02793830. A mobile phone based medication reminder program [A mobile phone based medication reminder program for patients in China with coronary heart disease: a pilot study]. clinicaltrials.gov/ct2/show/NCT02793830 (first received 8 June 2016). NiZ , WuB , YangQ , YanLL , LiuC , ShawRJ . An mHealth intervention to improve medication adherence and health outcomes among patients with coronary heart disease: randomized controlled trial. Journal of Medical Internet Research2022;24(3):e27202. [DOI: 10.2196/27202]">Ni 2022</a>; <a href="./references#CD011851-bbs2-0014" title="ParkLG , Howie-EsquivelJ , ChungM , DracupK . A text messaging intervention improves medication adherence for patients with coronary heart disease: a randomized controlled trial. Circulation2013;128(Suppl 22):A15249. [DOI: 10.1161/circ.128.suppl_22.A15249]ParkLG , Howie-EsquivelJ , ChungML , DracupK . A text messaging intervention to promote medication adherence for patients with coronary heart disease: a randomized controlled trial. Patient Education and Counseling2014;94(2):261-8. [DOI: 10.1016/j.pec.2013.10.027]ParkLG , Howie-EsquivelJ , WhooleyMA , DracupK . Psychosocial factors and medication adherence among patients with coronary heart disease: a text messaging intervention. European Journal of Cardiovascular Nursing2015;14(3):264-73. [DOI: 10.1177/1474515114537024]">Park 2014a</a>; <a href="./references#CD011851-bbs2-0015" title="NCT03414190. Impact of text messages to promote secondary prevention after acute coronary syndrome [Impact of a mobile phone text messages intervention on the secondary prevention of cardiovascular events after acute coronary syndrome]. clinicaltrials.gov/show/NCT03414190 (first received 29 January 2018). PassagliaLG , BrantLC , NascimentoBR , RibeiroAL . Impact of text messages in a middle-income country to promote secondary prevention after acute coronary syndrome (IMPACS): a randomized trial. Medicine2019;98(22):e15681. [DOI: 10.1097/MD.0000000000015681]PassagliaLG , BrantLC , SilvaJL , NascimentoBR , RibeiroAL . Text messages to promote secondary prevention after acute coronary syndrome (IMPACS trial). International Journal of Cardiovascular Sciences2021;35(2):202-13. [DOI: 10.36660/ijcs.20200378]">Passaglia 2021</a>; <a href="./references#CD011851-bbs2-0017" title="NCT02336919. The use of texting messaging to improve the hospital-to-community transition period in cardiovascular disease patients (Txt2Prevent) [The use of texting messaging to improve the hospital-to-community transition and prevent readmission in patients with cardiovascular disease (Txt2Prevent)]. clinicaltrials.gov/ct2/show/NCT02336919 (first received 13 January 2015). RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of SMS text messaging to improve the hospital-to-community transition in patients with acute coronary syndrome (Txt2Prevent): results from a pilot randomized controlled trial. JMIR mHealth and uHealth2021;9(5):e24530. [DOI: 10.2196/24530]RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of text messaging to improve the hospital-to-community transition in acute coronary syndrome patients (Txt2Prevent): intervention development and pilot randomized controlled trial protocol. JMIR Research Protocols2017;6(5):e91. [DOI: 10.2196/resprot.6968]">Ross 2021</a>; <a href="./references#CD011851-bbs2-0018" title="HuoX , SpatzES , DingQ , HorakP , ZhengX , MastersC , et al. Design and rationale of the Cardiovascular Health and Text Messaging (CHAT) study and the CHAT-Diabetes Mellitus (CHAT-DM) study: two randomised controlled trials of text messaging to improve secondary prevention for coronary heart disease and diabetes. BMJ Open2017;7(12):e018302. [DOI: 10.1136/bmjopen-2017-018302]ZhengX , SpatzES , BaiX , HuoX , DingQ , HorakP , et al. Effect of text messaging on risk factor management in patients with coronary heart disease: the CHAT randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(4):e005616. [DOI: 10.1161/CIRCOUTCOMES.119.005616]">Zheng 2019</a>). We assessed three studies that provided insufficient information as at unclear risk of bias (<a href="./references#CD011851-bbs2-0010" title="KhonsariS , SubramanianP , ChinnaK , LatifLA , LingLW , GholamiO . Effect of a reminder system using an automated short message service on medication adherence following acute coronary syndrome. European Journal of Cardiovascular Nursing2015;14(2):170-9. [DOI: 10.1177/1474515114521910]">Khonsari 2015</a>; <a href="./references#CD011851-bbs2-0013" title="NCT02783287. The impact of text messaging on medication adherence and exercise regimen among post-myocardial infarction patients. clinicaltrials.gov/ct2/show/NCT02783287 (first received 26 May 2016). PandeyA , ChoudhryN . An m-health application of daily text messages to address forgetfulness as contributor to non-adherence to medications post-myocardial infarction. Circulation2015;132:A18641. [DOI: 10.1161/circ.132.suppl_3.18641]PandeyA , KrummeAA , PatelT , ChoudhryNK . The impact of text messaging on medication adherence and exercise among postmyocardial infarction patients: randomized controlled pilot trial. JMIR mHealth and uHealth2017;5(8):e110. [DOI: 10.2196/mhealth.7144]PandeyAK , ChoudhryN . Text message reminders to address medication non-adherence in post-MI patients: a one year intervention study. Canadian Journal of Cardiology2014;30(10):S179. [DOI: 10.1016/j.cjca.2014.07.280]">Pandey 2017</a>; <a href="./references#CD011851-bbs2-0016" title="QuiliciJ , FugonL , BeguinS , MorangePE , BonnetJL , AlessiMC , et al. Effect of motivational mobile phone short message service on aspirin adherence after coronary stenting for acute coronary syndrome. International Journal of Cardiology2013;168(1):568-9. [DOI: 10.1016/j.ijcard.2013.01.252]">Quilici 2013</a>). No studies were at high risk of bias for random sequence generation. </p> <p>Eight studies reported adequate allocation concealment and were judged to be of low risk of bias for this domain (<a href="./references#CD011851-bbs2-0002" title="BermonA , UribeAF , Pérez-RiveroPF , Prieto-MerinoD , SaaibiJF , SilvaFA , et al. Efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: TXT2HEART Colombia randomized controlled trial. JMIR mHealth and uHealth2021;9(7):e25548. [DOI: 10.2196/25548]BermonA , Uribe-RodríguezAF , Pérez-RiveroPF , Prieto-MerinoD , RiveraDIC , GuioE , et al. Evaluation of the efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: the txt2heart Colombia randomised controlled trial protocol. BMJ Open2019;9:e028017. [DOI: 10.1136/ bmjopen-2018-028017]NCT03098186. TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention [TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention]. clinicaltrials.gov/ct2/show/NCT03098186 (first received 3 March 2017). ">Bermon 2021</a>; <a href="./references#CD011851-bbs2-0004" title="ACTRN12611000161921. Tobacco, EXercise and dieT MEssages (TEXT ME): the effect of semi-personalised lifestyle reminder text message intervention on cardiovascular disease risk [Tobacco, EXercise and dieT MEssages (TEXT ME): The effect of a semi-personalised lifestyle reminder text message intervention on cardiovascular risk factors in patients with cardiovascular disease and those who are at high risk of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12611000161921 (first received 3 February 2011). ChowCK , RedfernJ , HillisGS , ThakkarJ , SantoK , HackettML , et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA2015;314(12):1255-63. [DOI: 10.1001/jama.2015.10945]ChowCK , RedfernJ , ThiagalingamA , JanS , WhittakerR , HackettM , et al. Design and rationale of the tobacco, exercise and diet messages (TEXT ME) trial of a text message-based intervention for ongoing prevention of cardiovascular disease in people with coronary disease: a randomised controlled trial protocol. BMJ Open2012;2(1):e000606. [DOI: 10.1136/bmjopen-2011-000606]RedfernJ , SantoK , CooreyG , ThakkarJ , HackettM , ThiagalingamA , et al. Factors influencing engagement, perceived usefulness and behavioral mechanisms associated with a text message support program. PLOS ONE2016;11(10):e0163929. [DOI: 10.1371/journal.pone.0163929]ThakkarJ , RedfernJ , De KeizerL , ThiagalingamA , ChowC . Patient perceptions of text message-based intervention for secondary prevention of cardiovascular events. Heart, Lung and Circulation2013;22(Suppl 1):S264. [DOI: 10.1016/j.hlc.2013.05.630]ThakkarJ , RedfernJ , ThiagalingamA , ChowCK . Patterns, predictors and effects of texting intervention on physical activity in CHD – insights from the TEXT ME randomized clinical trial. European Journal of Preventive Cardiology2016;23(17):1894-902. [DOI: 10.1177/2047487316664190]">Chow 2015</a>; <a href="./references#CD011851-bbs2-0005" title="ACTRN12613000793718. TEXT messages to improve MEDication adherence &amp; Secondary prevention – TEXTMEDS [TEXT messages to improve MEDication adherence &amp; Secondary prevention in patients with acute coronary syndrome - TEXTMEDS]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364448&amp;isReview=true (first received 18 June 2013). ChowCK , KlimisH , ThiagalingamA , RedfernJ , HillisGS , BriegerD , et al. Text messages to improve medication adherence and secondary prevention after acute coronary syndrome: the TEXTMEDS randomized clinical trial. Circulation2022;145(19):1443-55. [DOI: 10.1161/CIRCULATIONAHA.121.056161]ChowCK , ThiagalingamA , SantoK , KokC , ThakkarJ , StepienS , et al. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol. BMJ Open2018;8:e019463. [DOI: 10.1136/bmjopen-2017-019463]">Chow 2022</a>; <a href="./references#CD011851-bbs2-0006" title="ACTRN12613000901707. Text4Heart: a text message and internet-based comprehensive cardiac rehabilitation intervention [A randomised controlled trial to determine the efficacy of a text message and Internet-based comprehensive cardiac rehabilitation programme to improve adherence to lifestyle change compared with usual care in New Zealand adults with a diagnosis of cardiovascular disease]. anzctr.org.au/ACTRN12613000901707.aspx (first received 9 August 2013). DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Improving coronary heart disease self-management using mobile technologies (Text4Heart): a randomised controlled trial protocol. Trials2014;15(71):1-9. [DOI: 10.1186/1745-6215-15-71]DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Text message and internet support for coronary heart disease self-management: results from the Text4Heart randomized controlled trial. Journal of Medical Internet Research2015;17(10):e237. [DOI: 10.2196/jmir.4944]">Dale 2015a</a>; <a href="./references#CD011851-bbs2-0009" title="KamalAK , ShaikQN , PashaO , AzamI , IslamM , MemonAA , et al. Improving medication adherence in stroke patients through Short Text Messages (SMS4Stroke)-study protocol for a randomized, controlled trial. BMC Neurology2015;15:157. [DOI: 10.1186/s12883-015-0413-2]KamalAK , ShaikhQ , PashaO , AzamI , IslamM , MemonAA , et al. A randomized controlled behavioral intervention trial to improve medication adherence in adult stroke patients with prescription tailored short messaging service (SMS)-SMS4Stroke study. BMC Neurolology2015;15:212. [DOI: 10.1186/s12883-015-0471-5]">Kamal 2015</a>; <a href="./references#CD011851-bbs2-0011" title="ACTRN12616000422426. Text4Heart Partnership: a text messaging program to enhance self-management of cardiovascular disease [Text messaging to enhance self-management of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12616000422426 (first received 23 March 2016). MaddisonR , JiangY , StewartR , ScottT , KerrA , WhittakerR , et al. An intervention to improve medication adherence in people with heart disease (Text4HeartII): randomized controlled trial. JMIR mHealth and uHealth2021;9(6):e24952. [DOI: 10.2196/24952]MaddisonR , StewartR , DoughtyR , ScottT , KerrA , BenatarJ , et al. Text4Heart II - improving medication adherence in people with heart disease: a study protocol for a randomized controlled trial. Trials2018;19(1):70. [DOI: 10.1186/s13063-018-2468-z]">Maddison 2021</a>; <a href="./references#CD011851-bbs2-0014" title="ParkLG , Howie-EsquivelJ , ChungM , DracupK . A text messaging intervention improves medication adherence for patients with coronary heart disease: a randomized controlled trial. Circulation2013;128(Suppl 22):A15249. [DOI: 10.1161/circ.128.suppl_22.A15249]ParkLG , Howie-EsquivelJ , ChungML , DracupK . A text messaging intervention to promote medication adherence for patients with coronary heart disease: a randomized controlled trial. Patient Education and Counseling2014;94(2):261-8. [DOI: 10.1016/j.pec.2013.10.027]ParkLG , Howie-EsquivelJ , WhooleyMA , DracupK . Psychosocial factors and medication adherence among patients with coronary heart disease: a text messaging intervention. European Journal of Cardiovascular Nursing2015;14(3):264-73. [DOI: 10.1177/1474515114537024]">Park 2014a</a>; <a href="./references#CD011851-bbs2-0017" title="NCT02336919. The use of texting messaging to improve the hospital-to-community transition period in cardiovascular disease patients (Txt2Prevent) [The use of texting messaging to improve the hospital-to-community transition and prevent readmission in patients with cardiovascular disease (Txt2Prevent)]. clinicaltrials.gov/ct2/show/NCT02336919 (first received 13 January 2015). RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of SMS text messaging to improve the hospital-to-community transition in patients with acute coronary syndrome (Txt2Prevent): results from a pilot randomized controlled trial. JMIR mHealth and uHealth2021;9(5):e24530. [DOI: 10.2196/24530]RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of text messaging to improve the hospital-to-community transition in acute coronary syndrome patients (Txt2Prevent): intervention development and pilot randomized controlled trial protocol. JMIR Research Protocols2017;6(5):e91. [DOI: 10.2196/resprot.6968]">Ross 2021</a>). We assessed nine studies that provided insufficient information as at unclear risk of bias (<a href="./references#CD011851-bbs2-0001" title="BaeJW , WooSI , LeeJ , ParkSD , KwonSW , ChoiSH , et al. mHealth interventions for lifestyle and risk factor modification in coronary heart disease: randomized controlled trial. JMIR mHealth and uHealth2021;9(9):e29928. [DOI: 10.2196/29928]KCT0005087. Effect of text messaging program on lifestyle and clinical outcomes in patients with cardiovascular disease. cris.nih.go.kr/cris/search/detailSearch.do/19282 (first received 11 September 2019). ">Bae 2021</a>; <a href="./references#CD011851-bbs2-0003" title="ChenC , LiX , KangY , LiuH , LiangYD , ZhangQ . Post-discharge short service message improves short-term clinical outcome and self-care behavior in Chinese patients with chronic heart failure. European Heart Journal2018;39(Suppl 1):797-8. [DOI: 10.1093/eurheartj/ehy563.P3770]ChenC , LiX , SunL , CaoS , KangY , HongL , et al. Post-discharge short message service improves short-term clinical outcome and self-care behaviour in chronic heart failure. ESC Heart Failure2019;6(1):164-73. [DOI: 10.1002/ehf2.12380]ChiCTR-INR-17012316. Effect of post-discharge text messages on clinical outcomes in patients with heart failure [Effect of post-discharge text messages on clinical outcomes in patients with heart failure]. trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR-INR-17012316 (first received 9 August 2018). LiX , ChenC , YouGY , ZhangQ . Post-discharge text messaging intervention improved clinical outcomes in patients with heart failure. European Heart Journal2016;37(Suppl 1):727-8. [DOI: 10.1093/eurheartj/ehw433]">Chen 2019</a>; <a href="./references#CD011851-bbs2-0007" title="FangR , LiX . Electronic messaging support service programs improve adherence to lipid-lowering therapy among outpatients with coronary artery disease: an exploratory randomised control study. Journal of Clinical Nursing2016;25(5-6):664-71. [DOI: 10.1111/jocn.12988]">Fang 2016</a>; <a href="./references#CD011851-bbs2-0008" title="HuoX , KrumholzHM , BaiX , SpatzES , DingQ , HorakP , et al. Effects of mobile text messaging on glycemic control in patients with coronary heart disease and diabetes mellitus: a randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(9):e005805. [DOI: 10.1161/CIRCOUTCOMES.119.005805]NCT02883842. Cardiovascular Health and Text Messaging-Diabetes Mellitus (CHAT-DM) Study [Effectiveness of text messaging on risk factors control and medication adherence among patients with Coronary Heart Disease and Diabetes in China: cardiovascular health andtext messaging-Diabetes Mellitus (CHAT-DM) study]. clinicaltrials.gov/ct2/show/NCT02883842 (first received 30 August 2016). ">Huo 2019</a>; <a href="./references#CD011851-bbs2-0010" title="KhonsariS , SubramanianP , ChinnaK , LatifLA , LingLW , GholamiO . Effect of a reminder system using an automated short message service on medication adherence following acute coronary syndrome. European Journal of Cardiovascular Nursing2015;14(2):170-9. [DOI: 10.1177/1474515114521910]">Khonsari 2015</a>; <a href="./references#CD011851-bbs2-0013" title="NCT02783287. The impact of text messaging on medication adherence and exercise regimen among post-myocardial infarction patients. clinicaltrials.gov/ct2/show/NCT02783287 (first received 26 May 2016). PandeyA , ChoudhryN . An m-health application of daily text messages to address forgetfulness as contributor to non-adherence to medications post-myocardial infarction. Circulation2015;132:A18641. [DOI: 10.1161/circ.132.suppl_3.18641]PandeyA , KrummeAA , PatelT , ChoudhryNK . The impact of text messaging on medication adherence and exercise among postmyocardial infarction patients: randomized controlled pilot trial. JMIR mHealth and uHealth2017;5(8):e110. [DOI: 10.2196/mhealth.7144]PandeyAK , ChoudhryN . Text message reminders to address medication non-adherence in post-MI patients: a one year intervention study. Canadian Journal of Cardiology2014;30(10):S179. [DOI: 10.1016/j.cjca.2014.07.280]">Pandey 2017</a>; <a href="./references#CD011851-bbs2-0015" title="NCT03414190. Impact of text messages to promote secondary prevention after acute coronary syndrome [Impact of a mobile phone text messages intervention on the secondary prevention of cardiovascular events after acute coronary syndrome]. clinicaltrials.gov/show/NCT03414190 (first received 29 January 2018). PassagliaLG , BrantLC , NascimentoBR , RibeiroAL . Impact of text messages in a middle-income country to promote secondary prevention after acute coronary syndrome (IMPACS): a randomized trial. Medicine2019;98(22):e15681. [DOI: 10.1097/MD.0000000000015681]PassagliaLG , BrantLC , SilvaJL , NascimentoBR , RibeiroAL . Text messages to promote secondary prevention after acute coronary syndrome (IMPACS trial). International Journal of Cardiovascular Sciences2021;35(2):202-13. [DOI: 10.36660/ijcs.20200378]">Passaglia 2021</a>; <a href="./references#CD011851-bbs2-0016" title="QuiliciJ , FugonL , BeguinS , MorangePE , BonnetJL , AlessiMC , et al. Effect of motivational mobile phone short message service on aspirin adherence after coronary stenting for acute coronary syndrome. International Journal of Cardiology2013;168(1):568-9. [DOI: 10.1016/j.ijcard.2013.01.252]">Quilici 2013</a>; <a href="./references#CD011851-bbs2-0018" title="HuoX , SpatzES , DingQ , HorakP , ZhengX , MastersC , et al. Design and rationale of the Cardiovascular Health and Text Messaging (CHAT) study and the CHAT-Diabetes Mellitus (CHAT-DM) study: two randomised controlled trials of text messaging to improve secondary prevention for coronary heart disease and diabetes. BMJ Open2017;7(12):e018302. [DOI: 10.1136/bmjopen-2017-018302]ZhengX , SpatzES , BaiX , HuoX , DingQ , HorakP , et al. Effect of text messaging on risk factor management in patients with coronary heart disease: the CHAT randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(4):e005616. [DOI: 10.1161/CIRCOUTCOMES.119.005616]">Zheng 2019</a>). We judged <a href="./references#CD011851-bbs2-0012" title="NCT02793830. A mobile phone based medication reminder program [A mobile phone based medication reminder program for patients in China with coronary heart disease: a pilot study]. clinicaltrials.gov/ct2/show/NCT02793830 (first received 8 June 2016). NiZ , WuB , YangQ , YanLL , LiuC , ShawRJ . An mHealth intervention to improve medication adherence and health outcomes among patients with coronary heart disease: randomized controlled trial. Journal of Medical Internet Research2022;24(3):e27202. [DOI: 10.2196/27202]">Ni 2022</a> to be at high risk of bias because generation of the random allocation sequence, enrolment of participants, and assignment of participants to intervention were all conducted by the first author. </p> </section> <section id="CD011851-sec-0055"> <h4 class="title">Blinding</h4> <p>Whilst blinding of participants is not possible with this intervention, blinding of outcome assessors could have been done. Three studies clearly stated that no blinding of outcome assessors occurred and were therefore deemed as at high risk of bias (<a href="./references#CD011851-bbs2-0006" title="ACTRN12613000901707. Text4Heart: a text message and internet-based comprehensive cardiac rehabilitation intervention [A randomised controlled trial to determine the efficacy of a text message and Internet-based comprehensive cardiac rehabilitation programme to improve adherence to lifestyle change compared with usual care in New Zealand adults with a diagnosis of cardiovascular disease]. anzctr.org.au/ACTRN12613000901707.aspx (first received 9 August 2013). DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Improving coronary heart disease self-management using mobile technologies (Text4Heart): a randomised controlled trial protocol. Trials2014;15(71):1-9. [DOI: 10.1186/1745-6215-15-71]DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Text message and internet support for coronary heart disease self-management: results from the Text4Heart randomized controlled trial. Journal of Medical Internet Research2015;17(10):e237. [DOI: 10.2196/jmir.4944]">Dale 2015a</a>; <a href="./references#CD011851-bbs2-0010" title="KhonsariS , SubramanianP , ChinnaK , LatifLA , LingLW , GholamiO . Effect of a reminder system using an automated short message service on medication adherence following acute coronary syndrome. European Journal of Cardiovascular Nursing2015;14(2):170-9. [DOI: 10.1177/1474515114521910]">Khonsari 2015</a>; <a href="./references#CD011851-bbs2-0012" title="NCT02793830. A mobile phone based medication reminder program [A mobile phone based medication reminder program for patients in China with coronary heart disease: a pilot study]. clinicaltrials.gov/ct2/show/NCT02793830 (first received 8 June 2016). NiZ , WuB , YangQ , YanLL , LiuC , ShawRJ . An mHealth intervention to improve medication adherence and health outcomes among patients with coronary heart disease: randomized controlled trial. Journal of Medical Internet Research2022;24(3):e27202. [DOI: 10.2196/27202]">Ni 2022</a>). Seven studies did not report on this domain and were assessed as at unclear risk of bias (<a href="./references#CD011851-bbs2-0003" title="ChenC , LiX , KangY , LiuH , LiangYD , ZhangQ . Post-discharge short service message improves short-term clinical outcome and self-care behavior in Chinese patients with chronic heart failure. European Heart Journal2018;39(Suppl 1):797-8. [DOI: 10.1093/eurheartj/ehy563.P3770]ChenC , LiX , SunL , CaoS , KangY , HongL , et al. Post-discharge short message service improves short-term clinical outcome and self-care behaviour in chronic heart failure. ESC Heart Failure2019;6(1):164-73. [DOI: 10.1002/ehf2.12380]ChiCTR-INR-17012316. Effect of post-discharge text messages on clinical outcomes in patients with heart failure [Effect of post-discharge text messages on clinical outcomes in patients with heart failure]. trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR-INR-17012316 (first received 9 August 2018). LiX , ChenC , YouGY , ZhangQ . Post-discharge text messaging intervention improved clinical outcomes in patients with heart failure. European Heart Journal2016;37(Suppl 1):727-8. [DOI: 10.1093/eurheartj/ehw433]">Chen 2019</a>; <a href="./references#CD011851-bbs2-0007" title="FangR , LiX . Electronic messaging support service programs improve adherence to lipid-lowering therapy among outpatients with coronary artery disease: an exploratory randomised control study. Journal of Clinical Nursing2016;25(5-6):664-71. [DOI: 10.1111/jocn.12988]">Fang 2016</a>; <a href="./references#CD011851-bbs2-0009" title="KamalAK , ShaikQN , PashaO , AzamI , IslamM , MemonAA , et al. Improving medication adherence in stroke patients through Short Text Messages (SMS4Stroke)-study protocol for a randomized, controlled trial. BMC Neurology2015;15:157. [DOI: 10.1186/s12883-015-0413-2]KamalAK , ShaikhQ , PashaO , AzamI , IslamM , MemonAA , et al. A randomized controlled behavioral intervention trial to improve medication adherence in adult stroke patients with prescription tailored short messaging service (SMS)-SMS4Stroke study. BMC Neurolology2015;15:212. [DOI: 10.1186/s12883-015-0471-5]">Kamal 2015</a>; <a href="./references#CD011851-bbs2-0011" title="ACTRN12616000422426. Text4Heart Partnership: a text messaging program to enhance self-management of cardiovascular disease [Text messaging to enhance self-management of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12616000422426 (first received 23 March 2016). MaddisonR , JiangY , StewartR , ScottT , KerrA , WhittakerR , et al. An intervention to improve medication adherence in people with heart disease (Text4HeartII): randomized controlled trial. JMIR mHealth and uHealth2021;9(6):e24952. [DOI: 10.2196/24952]MaddisonR , StewartR , DoughtyR , ScottT , KerrA , BenatarJ , et al. Text4Heart II - improving medication adherence in people with heart disease: a study protocol for a randomized controlled trial. Trials2018;19(1):70. [DOI: 10.1186/s13063-018-2468-z]">Maddison 2021</a>; <a href="./references#CD011851-bbs2-0013" title="NCT02783287. The impact of text messaging on medication adherence and exercise regimen among post-myocardial infarction patients. clinicaltrials.gov/ct2/show/NCT02783287 (first received 26 May 2016). PandeyA , ChoudhryN . An m-health application of daily text messages to address forgetfulness as contributor to non-adherence to medications post-myocardial infarction. Circulation2015;132:A18641. [DOI: 10.1161/circ.132.suppl_3.18641]PandeyA , KrummeAA , PatelT , ChoudhryNK . The impact of text messaging on medication adherence and exercise among postmyocardial infarction patients: randomized controlled pilot trial. JMIR mHealth and uHealth2017;5(8):e110. [DOI: 10.2196/mhealth.7144]PandeyAK , ChoudhryN . Text message reminders to address medication non-adherence in post-MI patients: a one year intervention study. Canadian Journal of Cardiology2014;30(10):S179. [DOI: 10.1016/j.cjca.2014.07.280]">Pandey 2017</a>; <a href="./references#CD011851-bbs2-0014" title="ParkLG , Howie-EsquivelJ , ChungM , DracupK . A text messaging intervention improves medication adherence for patients with coronary heart disease: a randomized controlled trial. Circulation2013;128(Suppl 22):A15249. [DOI: 10.1161/circ.128.suppl_22.A15249]ParkLG , Howie-EsquivelJ , ChungML , DracupK . A text messaging intervention to promote medication adherence for patients with coronary heart disease: a randomized controlled trial. Patient Education and Counseling2014;94(2):261-8. [DOI: 10.1016/j.pec.2013.10.027]ParkLG , Howie-EsquivelJ , WhooleyMA , DracupK . Psychosocial factors and medication adherence among patients with coronary heart disease: a text messaging intervention. European Journal of Cardiovascular Nursing2015;14(3):264-73. [DOI: 10.1177/1474515114537024]">Park 2014a</a>; <a href="./references#CD011851-bbs2-0016" title="QuiliciJ , FugonL , BeguinS , MorangePE , BonnetJL , AlessiMC , et al. Effect of motivational mobile phone short message service on aspirin adherence after coronary stenting for acute coronary syndrome. International Journal of Cardiology2013;168(1):568-9. [DOI: 10.1016/j.ijcard.2013.01.252]">Quilici 2013</a>). Eight studies clearly stated that outcome assessors were not aware of the study group assignment and were therefore rated as at low risk of bias (<a href="./references#CD011851-bbs2-0001" title="BaeJW , WooSI , LeeJ , ParkSD , KwonSW , ChoiSH , et al. mHealth interventions for lifestyle and risk factor modification in coronary heart disease: randomized controlled trial. JMIR mHealth and uHealth2021;9(9):e29928. [DOI: 10.2196/29928]KCT0005087. Effect of text messaging program on lifestyle and clinical outcomes in patients with cardiovascular disease. cris.nih.go.kr/cris/search/detailSearch.do/19282 (first received 11 September 2019). ">Bae 2021</a>; <a href="./references#CD011851-bbs2-0002" title="BermonA , UribeAF , Pérez-RiveroPF , Prieto-MerinoD , SaaibiJF , SilvaFA , et al. Efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: TXT2HEART Colombia randomized controlled trial. JMIR mHealth and uHealth2021;9(7):e25548. [DOI: 10.2196/25548]BermonA , Uribe-RodríguezAF , Pérez-RiveroPF , Prieto-MerinoD , RiveraDIC , GuioE , et al. Evaluation of the efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: the txt2heart Colombia randomised controlled trial protocol. BMJ Open2019;9:e028017. [DOI: 10.1136/ bmjopen-2018-028017]NCT03098186. TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention [TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention]. clinicaltrials.gov/ct2/show/NCT03098186 (first received 3 March 2017). ">Bermon 2021</a>; <a href="./references#CD011851-bbs2-0004" title="ACTRN12611000161921. Tobacco, EXercise and dieT MEssages (TEXT ME): the effect of semi-personalised lifestyle reminder text message intervention on cardiovascular disease risk [Tobacco, EXercise and dieT MEssages (TEXT ME): The effect of a semi-personalised lifestyle reminder text message intervention on cardiovascular risk factors in patients with cardiovascular disease and those who are at high risk of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12611000161921 (first received 3 February 2011). ChowCK , RedfernJ , HillisGS , ThakkarJ , SantoK , HackettML , et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA2015;314(12):1255-63. [DOI: 10.1001/jama.2015.10945]ChowCK , RedfernJ , ThiagalingamA , JanS , WhittakerR , HackettM , et al. Design and rationale of the tobacco, exercise and diet messages (TEXT ME) trial of a text message-based intervention for ongoing prevention of cardiovascular disease in people with coronary disease: a randomised controlled trial protocol. BMJ Open2012;2(1):e000606. [DOI: 10.1136/bmjopen-2011-000606]RedfernJ , SantoK , CooreyG , ThakkarJ , HackettM , ThiagalingamA , et al. Factors influencing engagement, perceived usefulness and behavioral mechanisms associated with a text message support program. PLOS ONE2016;11(10):e0163929. [DOI: 10.1371/journal.pone.0163929]ThakkarJ , RedfernJ , De KeizerL , ThiagalingamA , ChowC . Patient perceptions of text message-based intervention for secondary prevention of cardiovascular events. Heart, Lung and Circulation2013;22(Suppl 1):S264. [DOI: 10.1016/j.hlc.2013.05.630]ThakkarJ , RedfernJ , ThiagalingamA , ChowCK . Patterns, predictors and effects of texting intervention on physical activity in CHD – insights from the TEXT ME randomized clinical trial. European Journal of Preventive Cardiology2016;23(17):1894-902. [DOI: 10.1177/2047487316664190]">Chow 2015</a>; <a href="./references#CD011851-bbs2-0005" title="ACTRN12613000793718. TEXT messages to improve MEDication adherence &amp; Secondary prevention – TEXTMEDS [TEXT messages to improve MEDication adherence &amp; Secondary prevention in patients with acute coronary syndrome - TEXTMEDS]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364448&amp;isReview=true (first received 18 June 2013). ChowCK , KlimisH , ThiagalingamA , RedfernJ , HillisGS , BriegerD , et al. Text messages to improve medication adherence and secondary prevention after acute coronary syndrome: the TEXTMEDS randomized clinical trial. Circulation2022;145(19):1443-55. [DOI: 10.1161/CIRCULATIONAHA.121.056161]ChowCK , ThiagalingamA , SantoK , KokC , ThakkarJ , StepienS , et al. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol. BMJ Open2018;8:e019463. [DOI: 10.1136/bmjopen-2017-019463]">Chow 2022</a>; <a href="./references#CD011851-bbs2-0008" title="HuoX , KrumholzHM , BaiX , SpatzES , DingQ , HorakP , et al. Effects of mobile text messaging on glycemic control in patients with coronary heart disease and diabetes mellitus: a randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(9):e005805. [DOI: 10.1161/CIRCOUTCOMES.119.005805]NCT02883842. Cardiovascular Health and Text Messaging-Diabetes Mellitus (CHAT-DM) Study [Effectiveness of text messaging on risk factors control and medication adherence among patients with Coronary Heart Disease and Diabetes in China: cardiovascular health andtext messaging-Diabetes Mellitus (CHAT-DM) study]. clinicaltrials.gov/ct2/show/NCT02883842 (first received 30 August 2016). ">Huo 2019</a>; <a href="./references#CD011851-bbs2-0015" title="NCT03414190. Impact of text messages to promote secondary prevention after acute coronary syndrome [Impact of a mobile phone text messages intervention on the secondary prevention of cardiovascular events after acute coronary syndrome]. clinicaltrials.gov/show/NCT03414190 (first received 29 January 2018). PassagliaLG , BrantLC , NascimentoBR , RibeiroAL . Impact of text messages in a middle-income country to promote secondary prevention after acute coronary syndrome (IMPACS): a randomized trial. Medicine2019;98(22):e15681. [DOI: 10.1097/MD.0000000000015681]PassagliaLG , BrantLC , SilvaJL , NascimentoBR , RibeiroAL . Text messages to promote secondary prevention after acute coronary syndrome (IMPACS trial). International Journal of Cardiovascular Sciences2021;35(2):202-13. [DOI: 10.36660/ijcs.20200378]">Passaglia 2021</a>; <a href="./references#CD011851-bbs2-0017" title="NCT02336919. The use of texting messaging to improve the hospital-to-community transition period in cardiovascular disease patients (Txt2Prevent) [The use of texting messaging to improve the hospital-to-community transition and prevent readmission in patients with cardiovascular disease (Txt2Prevent)]. clinicaltrials.gov/ct2/show/NCT02336919 (first received 13 January 2015). RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of SMS text messaging to improve the hospital-to-community transition in patients with acute coronary syndrome (Txt2Prevent): results from a pilot randomized controlled trial. JMIR mHealth and uHealth2021;9(5):e24530. [DOI: 10.2196/24530]RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of text messaging to improve the hospital-to-community transition in acute coronary syndrome patients (Txt2Prevent): intervention development and pilot randomized controlled trial protocol. JMIR Research Protocols2017;6(5):e91. [DOI: 10.2196/resprot.6968]">Ross 2021</a>; <a href="./references#CD011851-bbs2-0018" title="HuoX , SpatzES , DingQ , HorakP , ZhengX , MastersC , et al. Design and rationale of the Cardiovascular Health and Text Messaging (CHAT) study and the CHAT-Diabetes Mellitus (CHAT-DM) study: two randomised controlled trials of text messaging to improve secondary prevention for coronary heart disease and diabetes. BMJ Open2017;7(12):e018302. [DOI: 10.1136/bmjopen-2017-018302]ZhengX , SpatzES , BaiX , HuoX , DingQ , HorakP , et al. Effect of text messaging on risk factor management in patients with coronary heart disease: the CHAT randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(4):e005616. [DOI: 10.1161/CIRCOUTCOMES.119.005616]">Zheng 2019</a>). </p> </section> <section id="CD011851-sec-0056"> <h4 class="title">Incomplete outcome data</h4> <p>We assessed most studies (13 studies) as at low risk of attrition bias because dropout rates were low, dropout numbers were balanced between groups, and analysis followed the intention‐to‐treat principle. We judged six studies as at high risk of attrition bias (<a href="./references#CD011851-bbs2-0001" title="BaeJW , WooSI , LeeJ , ParkSD , KwonSW , ChoiSH , et al. mHealth interventions for lifestyle and risk factor modification in coronary heart disease: randomized controlled trial. JMIR mHealth and uHealth2021;9(9):e29928. [DOI: 10.2196/29928]KCT0005087. Effect of text messaging program on lifestyle and clinical outcomes in patients with cardiovascular disease. cris.nih.go.kr/cris/search/detailSearch.do/19282 (first received 11 September 2019). ">Bae 2021</a>; <a href="./references#CD011851-bbs2-0002" title="BermonA , UribeAF , Pérez-RiveroPF , Prieto-MerinoD , SaaibiJF , SilvaFA , et al. Efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: TXT2HEART Colombia randomized controlled trial. JMIR mHealth and uHealth2021;9(7):e25548. [DOI: 10.2196/25548]BermonA , Uribe-RodríguezAF , Pérez-RiveroPF , Prieto-MerinoD , RiveraDIC , GuioE , et al. Evaluation of the efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: the txt2heart Colombia randomised controlled trial protocol. BMJ Open2019;9:e028017. [DOI: 10.1136/ bmjopen-2018-028017]NCT03098186. TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention [TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention]. clinicaltrials.gov/ct2/show/NCT03098186 (first received 3 March 2017). ">Bermon 2021</a>; <a href="./references#CD011851-bbs2-0009" title="KamalAK , ShaikQN , PashaO , AzamI , IslamM , MemonAA , et al. Improving medication adherence in stroke patients through Short Text Messages (SMS4Stroke)-study protocol for a randomized, controlled trial. BMC Neurology2015;15:157. [DOI: 10.1186/s12883-015-0413-2]KamalAK , ShaikhQ , PashaO , AzamI , IslamM , MemonAA , et al. A randomized controlled behavioral intervention trial to improve medication adherence in adult stroke patients with prescription tailored short messaging service (SMS)-SMS4Stroke study. BMC Neurolology2015;15:212. [DOI: 10.1186/s12883-015-0471-5]">Kamal 2015</a>; <a href="./references#CD011851-bbs2-0012" title="NCT02793830. A mobile phone based medication reminder program [A mobile phone based medication reminder program for patients in China with coronary heart disease: a pilot study]. clinicaltrials.gov/ct2/show/NCT02793830 (first received 8 June 2016). NiZ , WuB , YangQ , YanLL , LiuC , ShawRJ . An mHealth intervention to improve medication adherence and health outcomes among patients with coronary heart disease: randomized controlled trial. Journal of Medical Internet Research2022;24(3):e27202. [DOI: 10.2196/27202]">Ni 2022</a>; <a href="./references#CD011851-bbs2-0015" title="NCT03414190. Impact of text messages to promote secondary prevention after acute coronary syndrome [Impact of a mobile phone text messages intervention on the secondary prevention of cardiovascular events after acute coronary syndrome]. clinicaltrials.gov/show/NCT03414190 (first received 29 January 2018). PassagliaLG , BrantLC , NascimentoBR , RibeiroAL . Impact of text messages in a middle-income country to promote secondary prevention after acute coronary syndrome (IMPACS): a randomized trial. Medicine2019;98(22):e15681. [DOI: 10.1097/MD.0000000000015681]PassagliaLG , BrantLC , SilvaJL , NascimentoBR , RibeiroAL . Text messages to promote secondary prevention after acute coronary syndrome (IMPACS trial). International Journal of Cardiovascular Sciences2021;35(2):202-13. [DOI: 10.36660/ijcs.20200378]">Passaglia 2021</a>; <a href="./references#CD011851-bbs2-0017" title="NCT02336919. The use of texting messaging to improve the hospital-to-community transition period in cardiovascular disease patients (Txt2Prevent) [The use of texting messaging to improve the hospital-to-community transition and prevent readmission in patients with cardiovascular disease (Txt2Prevent)]. clinicaltrials.gov/ct2/show/NCT02336919 (first received 13 January 2015). RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of SMS text messaging to improve the hospital-to-community transition in patients with acute coronary syndrome (Txt2Prevent): results from a pilot randomized controlled trial. JMIR mHealth and uHealth2021;9(5):e24530. [DOI: 10.2196/24530]RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of text messaging to improve the hospital-to-community transition in acute coronary syndrome patients (Txt2Prevent): intervention development and pilot randomized controlled trial protocol. JMIR Research Protocols2017;6(5):e91. [DOI: 10.2196/resprot.6968]">Ross 2021</a>). In <a href="./references#CD011851-bbs2-0001" title="BaeJW , WooSI , LeeJ , ParkSD , KwonSW , ChoiSH , et al. mHealth interventions for lifestyle and risk factor modification in coronary heart disease: randomized controlled trial. JMIR mHealth and uHealth2021;9(9):e29928. [DOI: 10.2196/29928]KCT0005087. Effect of text messaging program on lifestyle and clinical outcomes in patients with cardiovascular disease. cris.nih.go.kr/cris/search/detailSearch.do/19282 (first received 11 September 2019). ">Bae 2021</a>, intention‐to‐treat analysis was not performed. Furthermore, 70/439 (15.9%) and 44/440 (10%) participants were lost to follow‐up in the control and intervention groups, respectively. In <a href="./references#CD011851-bbs2-0009" title="KamalAK , ShaikQN , PashaO , AzamI , IslamM , MemonAA , et al. Improving medication adherence in stroke patients through Short Text Messages (SMS4Stroke)-study protocol for a randomized, controlled trial. BMC Neurology2015;15:157. [DOI: 10.1186/s12883-015-0413-2]KamalAK , ShaikhQ , PashaO , AzamI , IslamM , MemonAA , et al. A randomized controlled behavioral intervention trial to improve medication adherence in adult stroke patients with prescription tailored short messaging service (SMS)-SMS4Stroke study. BMC Neurolology2015;15:212. [DOI: 10.1186/s12883-015-0471-5]">Kamal 2015</a>, a large proportion of participants (20%) were lost to follow‐up. In <a href="./references#CD011851-bbs2-0015" title="NCT03414190. Impact of text messages to promote secondary prevention after acute coronary syndrome [Impact of a mobile phone text messages intervention on the secondary prevention of cardiovascular events after acute coronary syndrome]. clinicaltrials.gov/show/NCT03414190 (first received 29 January 2018). PassagliaLG , BrantLC , NascimentoBR , RibeiroAL . Impact of text messages in a middle-income country to promote secondary prevention after acute coronary syndrome (IMPACS): a randomized trial. Medicine2019;98(22):e15681. [DOI: 10.1097/MD.0000000000015681]PassagliaLG , BrantLC , SilvaJL , NascimentoBR , RibeiroAL . Text messages to promote secondary prevention after acute coronary syndrome (IMPACS trial). International Journal of Cardiovascular Sciences2021;35(2):202-13. [DOI: 10.36660/ijcs.20200378]">Passaglia 2021</a>, 18.3% of participants were lost to follow‐up, and analysis was not conducted based on the intention‐to‐treat principle. In <a href="./references#CD011851-bbs2-0017" title="NCT02336919. The use of texting messaging to improve the hospital-to-community transition period in cardiovascular disease patients (Txt2Prevent) [The use of texting messaging to improve the hospital-to-community transition and prevent readmission in patients with cardiovascular disease (Txt2Prevent)]. clinicaltrials.gov/ct2/show/NCT02336919 (first received 13 January 2015). RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of SMS text messaging to improve the hospital-to-community transition in patients with acute coronary syndrome (Txt2Prevent): results from a pilot randomized controlled trial. JMIR mHealth and uHealth2021;9(5):e24530. [DOI: 10.2196/24530]RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of text messaging to improve the hospital-to-community transition in acute coronary syndrome patients (Txt2Prevent): intervention development and pilot randomized controlled trial protocol. JMIR Research Protocols2017;6(5):e91. [DOI: 10.2196/resprot.6968]">Ross 2021</a>, there was a significant imbalance between groups for withdrawals or dropouts (5% in the control and 19% in the intervention group). In <a href="./references#CD011851-bbs2-0012" title="NCT02793830. A mobile phone based medication reminder program [A mobile phone based medication reminder program for patients in China with coronary heart disease: a pilot study]. clinicaltrials.gov/ct2/show/NCT02793830 (first received 8 June 2016). NiZ , WuB , YangQ , YanLL , LiuC , ShawRJ . An mHealth intervention to improve medication adherence and health outcomes among patients with coronary heart disease: randomized controlled trial. Journal of Medical Internet Research2022;24(3):e27202. [DOI: 10.2196/27202]">Ni 2022</a>, 18.4% of the intervention group and 11.2% of the control group did not complete the baseline survey, and analysis was not conducted based on the intention‐to‐treat principle. <a href="./references#CD011851-bbs2-0002" title="BermonA , UribeAF , Pérez-RiveroPF , Prieto-MerinoD , SaaibiJF , SilvaFA , et al. Efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: TXT2HEART Colombia randomized controlled trial. JMIR mHealth and uHealth2021;9(7):e25548. [DOI: 10.2196/25548]BermonA , Uribe-RodríguezAF , Pérez-RiveroPF , Prieto-MerinoD , RiveraDIC , GuioE , et al. Evaluation of the efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: the txt2heart Colombia randomised controlled trial protocol. BMJ Open2019;9:e028017. [DOI: 10.1136/ bmjopen-2018-028017]NCT03098186. TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention [TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention]. clinicaltrials.gov/ct2/show/NCT03098186 (first received 3 March 2017). ">Bermon 2021</a> presented imbalances in numbers and reasons for missing data between the intervention group (15.3%) and the control group (11.5%). </p> </section> <section id="CD011851-sec-0057"> <h4 class="title">Selective reporting</h4> <p>For eight studies, we were able to access the trial protocol or registry, and all prespecified outcomes were reported in the results (<a href="./references#CD011851-bbs2-0001" title="BaeJW , WooSI , LeeJ , ParkSD , KwonSW , ChoiSH , et al. mHealth interventions for lifestyle and risk factor modification in coronary heart disease: randomized controlled trial. JMIR mHealth and uHealth2021;9(9):e29928. [DOI: 10.2196/29928]KCT0005087. Effect of text messaging program on lifestyle and clinical outcomes in patients with cardiovascular disease. cris.nih.go.kr/cris/search/detailSearch.do/19282 (first received 11 September 2019). ">Bae 2021</a>; <a href="./references#CD011851-bbs2-0002" title="BermonA , UribeAF , Pérez-RiveroPF , Prieto-MerinoD , SaaibiJF , SilvaFA , et al. Efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: TXT2HEART Colombia randomized controlled trial. JMIR mHealth and uHealth2021;9(7):e25548. [DOI: 10.2196/25548]BermonA , Uribe-RodríguezAF , Pérez-RiveroPF , Prieto-MerinoD , RiveraDIC , GuioE , et al. Evaluation of the efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: the txt2heart Colombia randomised controlled trial protocol. BMJ Open2019;9:e028017. [DOI: 10.1136/ bmjopen-2018-028017]NCT03098186. TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention [TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention]. clinicaltrials.gov/ct2/show/NCT03098186 (first received 3 March 2017). ">Bermon 2021</a>; <a href="./references#CD011851-bbs2-0005" title="ACTRN12613000793718. TEXT messages to improve MEDication adherence &amp; Secondary prevention – TEXTMEDS [TEXT messages to improve MEDication adherence &amp; Secondary prevention in patients with acute coronary syndrome - TEXTMEDS]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364448&amp;isReview=true (first received 18 June 2013). ChowCK , KlimisH , ThiagalingamA , RedfernJ , HillisGS , BriegerD , et al. Text messages to improve medication adherence and secondary prevention after acute coronary syndrome: the TEXTMEDS randomized clinical trial. Circulation2022;145(19):1443-55. [DOI: 10.1161/CIRCULATIONAHA.121.056161]ChowCK , ThiagalingamA , SantoK , KokC , ThakkarJ , StepienS , et al. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol. BMJ Open2018;8:e019463. [DOI: 10.1136/bmjopen-2017-019463]">Chow 2022</a>; <a href="./references#CD011851-bbs2-0006" title="ACTRN12613000901707. Text4Heart: a text message and internet-based comprehensive cardiac rehabilitation intervention [A randomised controlled trial to determine the efficacy of a text message and Internet-based comprehensive cardiac rehabilitation programme to improve adherence to lifestyle change compared with usual care in New Zealand adults with a diagnosis of cardiovascular disease]. anzctr.org.au/ACTRN12613000901707.aspx (first received 9 August 2013). DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Improving coronary heart disease self-management using mobile technologies (Text4Heart): a randomised controlled trial protocol. Trials2014;15(71):1-9. [DOI: 10.1186/1745-6215-15-71]DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Text message and internet support for coronary heart disease self-management: results from the Text4Heart randomized controlled trial. Journal of Medical Internet Research2015;17(10):e237. [DOI: 10.2196/jmir.4944]">Dale 2015a</a>; <a href="./references#CD011851-bbs2-0009" title="KamalAK , ShaikQN , PashaO , AzamI , IslamM , MemonAA , et al. Improving medication adherence in stroke patients through Short Text Messages (SMS4Stroke)-study protocol for a randomized, controlled trial. BMC Neurology2015;15:157. [DOI: 10.1186/s12883-015-0413-2]KamalAK , ShaikhQ , PashaO , AzamI , IslamM , MemonAA , et al. A randomized controlled behavioral intervention trial to improve medication adherence in adult stroke patients with prescription tailored short messaging service (SMS)-SMS4Stroke study. BMC Neurolology2015;15:212. [DOI: 10.1186/s12883-015-0471-5]">Kamal 2015</a>; <a href="./references#CD011851-bbs2-0011" title="ACTRN12616000422426. Text4Heart Partnership: a text messaging program to enhance self-management of cardiovascular disease [Text messaging to enhance self-management of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12616000422426 (first received 23 March 2016). MaddisonR , JiangY , StewartR , ScottT , KerrA , WhittakerR , et al. An intervention to improve medication adherence in people with heart disease (Text4HeartII): randomized controlled trial. JMIR mHealth and uHealth2021;9(6):e24952. [DOI: 10.2196/24952]MaddisonR , StewartR , DoughtyR , ScottT , KerrA , BenatarJ , et al. Text4Heart II - improving medication adherence in people with heart disease: a study protocol for a randomized controlled trial. Trials2018;19(1):70. [DOI: 10.1186/s13063-018-2468-z]">Maddison 2021</a>; <a href="./references#CD011851-bbs2-0015" title="NCT03414190. Impact of text messages to promote secondary prevention after acute coronary syndrome [Impact of a mobile phone text messages intervention on the secondary prevention of cardiovascular events after acute coronary syndrome]. clinicaltrials.gov/show/NCT03414190 (first received 29 January 2018). PassagliaLG , BrantLC , NascimentoBR , RibeiroAL . Impact of text messages in a middle-income country to promote secondary prevention after acute coronary syndrome (IMPACS): a randomized trial. Medicine2019;98(22):e15681. [DOI: 10.1097/MD.0000000000015681]PassagliaLG , BrantLC , SilvaJL , NascimentoBR , RibeiroAL . Text messages to promote secondary prevention after acute coronary syndrome (IMPACS trial). International Journal of Cardiovascular Sciences2021;35(2):202-13. [DOI: 10.36660/ijcs.20200378]">Passaglia 2021</a>; <a href="./references#CD011851-bbs2-0017" title="NCT02336919. The use of texting messaging to improve the hospital-to-community transition period in cardiovascular disease patients (Txt2Prevent) [The use of texting messaging to improve the hospital-to-community transition and prevent readmission in patients with cardiovascular disease (Txt2Prevent)]. clinicaltrials.gov/ct2/show/NCT02336919 (first received 13 January 2015). RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of SMS text messaging to improve the hospital-to-community transition in patients with acute coronary syndrome (Txt2Prevent): results from a pilot randomized controlled trial. JMIR mHealth and uHealth2021;9(5):e24530. [DOI: 10.2196/24530]RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of text messaging to improve the hospital-to-community transition in acute coronary syndrome patients (Txt2Prevent): intervention development and pilot randomized controlled trial protocol. JMIR Research Protocols2017;6(5):e91. [DOI: 10.2196/resprot.6968]">Ross 2021</a>). We therefore judged these eight studies to be at low risk of reporting bias. We judged four studies to be at high risk of reporting bias (<a href="./references#CD011851-bbs2-0004" title="ACTRN12611000161921. Tobacco, EXercise and dieT MEssages (TEXT ME): the effect of semi-personalised lifestyle reminder text message intervention on cardiovascular disease risk [Tobacco, EXercise and dieT MEssages (TEXT ME): The effect of a semi-personalised lifestyle reminder text message intervention on cardiovascular risk factors in patients with cardiovascular disease and those who are at high risk of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12611000161921 (first received 3 February 2011). ChowCK , RedfernJ , HillisGS , ThakkarJ , SantoK , HackettML , et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA2015;314(12):1255-63. [DOI: 10.1001/jama.2015.10945]ChowCK , RedfernJ , ThiagalingamA , JanS , WhittakerR , HackettM , et al. Design and rationale of the tobacco, exercise and diet messages (TEXT ME) trial of a text message-based intervention for ongoing prevention of cardiovascular disease in people with coronary disease: a randomised controlled trial protocol. BMJ Open2012;2(1):e000606. [DOI: 10.1136/bmjopen-2011-000606]RedfernJ , SantoK , CooreyG , ThakkarJ , HackettM , ThiagalingamA , et al. Factors influencing engagement, perceived usefulness and behavioral mechanisms associated with a text message support program. PLOS ONE2016;11(10):e0163929. [DOI: 10.1371/journal.pone.0163929]ThakkarJ , RedfernJ , De KeizerL , ThiagalingamA , ChowC . Patient perceptions of text message-based intervention for secondary prevention of cardiovascular events. Heart, Lung and Circulation2013;22(Suppl 1):S264. [DOI: 10.1016/j.hlc.2013.05.630]ThakkarJ , RedfernJ , ThiagalingamA , ChowCK . Patterns, predictors and effects of texting intervention on physical activity in CHD – insights from the TEXT ME randomized clinical trial. European Journal of Preventive Cardiology2016;23(17):1894-902. [DOI: 10.1177/2047487316664190]">Chow 2015</a>; <a href="./references#CD011851-bbs2-0008" title="HuoX , KrumholzHM , BaiX , SpatzES , DingQ , HorakP , et al. Effects of mobile text messaging on glycemic control in patients with coronary heart disease and diabetes mellitus: a randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(9):e005805. [DOI: 10.1161/CIRCOUTCOMES.119.005805]NCT02883842. Cardiovascular Health and Text Messaging-Diabetes Mellitus (CHAT-DM) Study [Effectiveness of text messaging on risk factors control and medication adherence among patients with Coronary Heart Disease and Diabetes in China: cardiovascular health andtext messaging-Diabetes Mellitus (CHAT-DM) study]. clinicaltrials.gov/ct2/show/NCT02883842 (first received 30 August 2016). ">Huo 2019</a>; <a href="./references#CD011851-bbs2-0016" title="QuiliciJ , FugonL , BeguinS , MorangePE , BonnetJL , AlessiMC , et al. Effect of motivational mobile phone short message service on aspirin adherence after coronary stenting for acute coronary syndrome. International Journal of Cardiology2013;168(1):568-9. [DOI: 10.1016/j.ijcard.2013.01.252]">Quilici 2013</a>; <a href="./references#CD011851-bbs2-0018" title="HuoX , SpatzES , DingQ , HorakP , ZhengX , MastersC , et al. Design and rationale of the Cardiovascular Health and Text Messaging (CHAT) study and the CHAT-Diabetes Mellitus (CHAT-DM) study: two randomised controlled trials of text messaging to improve secondary prevention for coronary heart disease and diabetes. BMJ Open2017;7(12):e018302. [DOI: 10.1136/bmjopen-2017-018302]ZhengX , SpatzES , BaiX , HuoX , DingQ , HorakP , et al. Effect of text messaging on risk factor management in patients with coronary heart disease: the CHAT randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(4):e005616. [DOI: 10.1161/CIRCOUTCOMES.119.005616]">Zheng 2019</a>). For <a href="./references#CD011851-bbs2-0016" title="QuiliciJ , FugonL , BeguinS , MorangePE , BonnetJL , AlessiMC , et al. Effect of motivational mobile phone short message service on aspirin adherence after coronary stenting for acute coronary syndrome. International Journal of Cardiology2013;168(1):568-9. [DOI: 10.1016/j.ijcard.2013.01.252]">Quilici 2013</a>, the data were minimal (published as a letter to the editor), and details within the report differed. In <a href="./references#CD011851-bbs2-0008" title="HuoX , KrumholzHM , BaiX , SpatzES , DingQ , HorakP , et al. Effects of mobile text messaging on glycemic control in patients with coronary heart disease and diabetes mellitus: a randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(9):e005805. [DOI: 10.1161/CIRCOUTCOMES.119.005805]NCT02883842. Cardiovascular Health and Text Messaging-Diabetes Mellitus (CHAT-DM) Study [Effectiveness of text messaging on risk factors control and medication adherence among patients with Coronary Heart Disease and Diabetes in China: cardiovascular health andtext messaging-Diabetes Mellitus (CHAT-DM) study]. clinicaltrials.gov/ct2/show/NCT02883842 (first received 30 August 2016). ">Huo 2019</a> and <a href="./references#CD011851-bbs2-0018" title="HuoX , SpatzES , DingQ , HorakP , ZhengX , MastersC , et al. Design and rationale of the Cardiovascular Health and Text Messaging (CHAT) study and the CHAT-Diabetes Mellitus (CHAT-DM) study: two randomised controlled trials of text messaging to improve secondary prevention for coronary heart disease and diabetes. BMJ Open2017;7(12):e018302. [DOI: 10.1136/bmjopen-2017-018302]ZhengX , SpatzES , BaiX , HuoX , DingQ , HorakP , et al. Effect of text messaging on risk factor management in patients with coronary heart disease: the CHAT randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(4):e005616. [DOI: 10.1161/CIRCOUTCOMES.119.005616]">Zheng 2019</a>, death, non‐fatal myocardial infarction, stroke, and rehospitalisation were specified as outcomes of interest in the protocol, but these outcomes were not reported in the findings, representing a deviation from the original stated methodology. In <a href="./references#CD011851-bbs2-0004" title="ACTRN12611000161921. Tobacco, EXercise and dieT MEssages (TEXT ME): the effect of semi-personalised lifestyle reminder text message intervention on cardiovascular disease risk [Tobacco, EXercise and dieT MEssages (TEXT ME): The effect of a semi-personalised lifestyle reminder text message intervention on cardiovascular risk factors in patients with cardiovascular disease and those who are at high risk of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12611000161921 (first received 3 February 2011). ChowCK , RedfernJ , HillisGS , ThakkarJ , SantoK , HackettML , et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA2015;314(12):1255-63. [DOI: 10.1001/jama.2015.10945]ChowCK , RedfernJ , ThiagalingamA , JanS , WhittakerR , HackettM , et al. Design and rationale of the tobacco, exercise and diet messages (TEXT ME) trial of a text message-based intervention for ongoing prevention of cardiovascular disease in people with coronary disease: a randomised controlled trial protocol. BMJ Open2012;2(1):e000606. [DOI: 10.1136/bmjopen-2011-000606]RedfernJ , SantoK , CooreyG , ThakkarJ , HackettM , ThiagalingamA , et al. Factors influencing engagement, perceived usefulness and behavioral mechanisms associated with a text message support program. PLOS ONE2016;11(10):e0163929. [DOI: 10.1371/journal.pone.0163929]ThakkarJ , RedfernJ , De KeizerL , ThiagalingamA , ChowC . Patient perceptions of text message-based intervention for secondary prevention of cardiovascular events. Heart, Lung and Circulation2013;22(Suppl 1):S264. [DOI: 10.1016/j.hlc.2013.05.630]ThakkarJ , RedfernJ , ThiagalingamA , ChowCK . Patterns, predictors and effects of texting intervention on physical activity in CHD – insights from the TEXT ME randomized clinical trial. European Journal of Preventive Cardiology2016;23(17):1894-902. [DOI: 10.1177/2047487316664190]">Chow 2015</a>, prespecified outcomes, including psychosocial factors and fruit/vegetable intake, were not reported in the paper. We assessed the remaining six studies as at unclear risk of bias as we did not identify a protocol or trial registration to permit a judgement of reporting bias (<a href="./references#CD011851-bbs2-0003" title="ChenC , LiX , KangY , LiuH , LiangYD , ZhangQ . Post-discharge short service message improves short-term clinical outcome and self-care behavior in Chinese patients with chronic heart failure. European Heart Journal2018;39(Suppl 1):797-8. [DOI: 10.1093/eurheartj/ehy563.P3770]ChenC , LiX , SunL , CaoS , KangY , HongL , et al. Post-discharge short message service improves short-term clinical outcome and self-care behaviour in chronic heart failure. ESC Heart Failure2019;6(1):164-73. [DOI: 10.1002/ehf2.12380]ChiCTR-INR-17012316. Effect of post-discharge text messages on clinical outcomes in patients with heart failure [Effect of post-discharge text messages on clinical outcomes in patients with heart failure]. trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR-INR-17012316 (first received 9 August 2018). LiX , ChenC , YouGY , ZhangQ . Post-discharge text messaging intervention improved clinical outcomes in patients with heart failure. European Heart Journal2016;37(Suppl 1):727-8. [DOI: 10.1093/eurheartj/ehw433]">Chen 2019</a>; <a href="./references#CD011851-bbs2-0007" title="FangR , LiX . Electronic messaging support service programs improve adherence to lipid-lowering therapy among outpatients with coronary artery disease: an exploratory randomised control study. Journal of Clinical Nursing2016;25(5-6):664-71. [DOI: 10.1111/jocn.12988]">Fang 2016</a>; <a href="./references#CD011851-bbs2-0010" title="KhonsariS , SubramanianP , ChinnaK , LatifLA , LingLW , GholamiO . Effect of a reminder system using an automated short message service on medication adherence following acute coronary syndrome. European Journal of Cardiovascular Nursing2015;14(2):170-9. [DOI: 10.1177/1474515114521910]">Khonsari 2015</a>; <a href="./references#CD011851-bbs2-0012" title="NCT02793830. A mobile phone based medication reminder program [A mobile phone based medication reminder program for patients in China with coronary heart disease: a pilot study]. clinicaltrials.gov/ct2/show/NCT02793830 (first received 8 June 2016). NiZ , WuB , YangQ , YanLL , LiuC , ShawRJ . An mHealth intervention to improve medication adherence and health outcomes among patients with coronary heart disease: randomized controlled trial. Journal of Medical Internet Research2022;24(3):e27202. [DOI: 10.2196/27202]">Ni 2022</a>; <a href="./references#CD011851-bbs2-0013" title="NCT02783287. The impact of text messaging on medication adherence and exercise regimen among post-myocardial infarction patients. clinicaltrials.gov/ct2/show/NCT02783287 (first received 26 May 2016). PandeyA , ChoudhryN . An m-health application of daily text messages to address forgetfulness as contributor to non-adherence to medications post-myocardial infarction. Circulation2015;132:A18641. [DOI: 10.1161/circ.132.suppl_3.18641]PandeyA , KrummeAA , PatelT , ChoudhryNK . The impact of text messaging on medication adherence and exercise among postmyocardial infarction patients: randomized controlled pilot trial. JMIR mHealth and uHealth2017;5(8):e110. [DOI: 10.2196/mhealth.7144]PandeyAK , ChoudhryN . Text message reminders to address medication non-adherence in post-MI patients: a one year intervention study. Canadian Journal of Cardiology2014;30(10):S179. [DOI: 10.1016/j.cjca.2014.07.280]">Pandey 2017</a>; <a href="./references#CD011851-bbs2-0014" title="ParkLG , Howie-EsquivelJ , ChungM , DracupK . A text messaging intervention improves medication adherence for patients with coronary heart disease: a randomized controlled trial. Circulation2013;128(Suppl 22):A15249. [DOI: 10.1161/circ.128.suppl_22.A15249]ParkLG , Howie-EsquivelJ , ChungML , DracupK . A text messaging intervention to promote medication adherence for patients with coronary heart disease: a randomized controlled trial. Patient Education and Counseling2014;94(2):261-8. [DOI: 10.1016/j.pec.2013.10.027]ParkLG , Howie-EsquivelJ , WhooleyMA , DracupK . Psychosocial factors and medication adherence among patients with coronary heart disease: a text messaging intervention. European Journal of Cardiovascular Nursing2015;14(3):264-73. [DOI: 10.1177/1474515114537024]">Park 2014a</a>). </p> </section> <section id="CD011851-sec-0058"> <h4 class="title">Other potential sources of bias</h4> <p>We assessed 14 studies as at low risk of bias for this domain, as there are no differences between groups at baseline, and they appeared to be free of other sources of bias (<a href="./references#CD011851-bbs2-0001" title="BaeJW , WooSI , LeeJ , ParkSD , KwonSW , ChoiSH , et al. mHealth interventions for lifestyle and risk factor modification in coronary heart disease: randomized controlled trial. JMIR mHealth and uHealth2021;9(9):e29928. [DOI: 10.2196/29928]KCT0005087. Effect of text messaging program on lifestyle and clinical outcomes in patients with cardiovascular disease. cris.nih.go.kr/cris/search/detailSearch.do/19282 (first received 11 September 2019). ">Bae 2021</a>; <a href="./references#CD011851-bbs2-0002" title="BermonA , UribeAF , Pérez-RiveroPF , Prieto-MerinoD , SaaibiJF , SilvaFA , et al. Efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: TXT2HEART Colombia randomized controlled trial. JMIR mHealth and uHealth2021;9(7):e25548. [DOI: 10.2196/25548]BermonA , Uribe-RodríguezAF , Pérez-RiveroPF , Prieto-MerinoD , RiveraDIC , GuioE , et al. Evaluation of the efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: the txt2heart Colombia randomised controlled trial protocol. BMJ Open2019;9:e028017. [DOI: 10.1136/ bmjopen-2018-028017]NCT03098186. TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention [TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention]. clinicaltrials.gov/ct2/show/NCT03098186 (first received 3 March 2017). ">Bermon 2021</a>; <a href="./references#CD011851-bbs2-0003" title="ChenC , LiX , KangY , LiuH , LiangYD , ZhangQ . Post-discharge short service message improves short-term clinical outcome and self-care behavior in Chinese patients with chronic heart failure. European Heart Journal2018;39(Suppl 1):797-8. [DOI: 10.1093/eurheartj/ehy563.P3770]ChenC , LiX , SunL , CaoS , KangY , HongL , et al. Post-discharge short message service improves short-term clinical outcome and self-care behaviour in chronic heart failure. ESC Heart Failure2019;6(1):164-73. [DOI: 10.1002/ehf2.12380]ChiCTR-INR-17012316. Effect of post-discharge text messages on clinical outcomes in patients with heart failure [Effect of post-discharge text messages on clinical outcomes in patients with heart failure]. trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR-INR-17012316 (first received 9 August 2018). LiX , ChenC , YouGY , ZhangQ . Post-discharge text messaging intervention improved clinical outcomes in patients with heart failure. European Heart Journal2016;37(Suppl 1):727-8. [DOI: 10.1093/eurheartj/ehw433]">Chen 2019</a>; <a href="./references#CD011851-bbs2-0004" title="ACTRN12611000161921. Tobacco, EXercise and dieT MEssages (TEXT ME): the effect of semi-personalised lifestyle reminder text message intervention on cardiovascular disease risk [Tobacco, EXercise and dieT MEssages (TEXT ME): The effect of a semi-personalised lifestyle reminder text message intervention on cardiovascular risk factors in patients with cardiovascular disease and those who are at high risk of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12611000161921 (first received 3 February 2011). ChowCK , RedfernJ , HillisGS , ThakkarJ , SantoK , HackettML , et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA2015;314(12):1255-63. [DOI: 10.1001/jama.2015.10945]ChowCK , RedfernJ , ThiagalingamA , JanS , WhittakerR , HackettM , et al. Design and rationale of the tobacco, exercise and diet messages (TEXT ME) trial of a text message-based intervention for ongoing prevention of cardiovascular disease in people with coronary disease: a randomised controlled trial protocol. BMJ Open2012;2(1):e000606. [DOI: 10.1136/bmjopen-2011-000606]RedfernJ , SantoK , CooreyG , ThakkarJ , HackettM , ThiagalingamA , et al. Factors influencing engagement, perceived usefulness and behavioral mechanisms associated with a text message support program. PLOS ONE2016;11(10):e0163929. [DOI: 10.1371/journal.pone.0163929]ThakkarJ , RedfernJ , De KeizerL , ThiagalingamA , ChowC . Patient perceptions of text message-based intervention for secondary prevention of cardiovascular events. Heart, Lung and Circulation2013;22(Suppl 1):S264. [DOI: 10.1016/j.hlc.2013.05.630]ThakkarJ , RedfernJ , ThiagalingamA , ChowCK . Patterns, predictors and effects of texting intervention on physical activity in CHD – insights from the TEXT ME randomized clinical trial. European Journal of Preventive Cardiology2016;23(17):1894-902. [DOI: 10.1177/2047487316664190]">Chow 2015</a>; <a href="./references#CD011851-bbs2-0005" title="ACTRN12613000793718. TEXT messages to improve MEDication adherence &amp; Secondary prevention – TEXTMEDS [TEXT messages to improve MEDication adherence &amp; Secondary prevention in patients with acute coronary syndrome - TEXTMEDS]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364448&amp;isReview=true (first received 18 June 2013). ChowCK , KlimisH , ThiagalingamA , RedfernJ , HillisGS , BriegerD , et al. Text messages to improve medication adherence and secondary prevention after acute coronary syndrome: the TEXTMEDS randomized clinical trial. Circulation2022;145(19):1443-55. [DOI: 10.1161/CIRCULATIONAHA.121.056161]ChowCK , ThiagalingamA , SantoK , KokC , ThakkarJ , StepienS , et al. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol. BMJ Open2018;8:e019463. [DOI: 10.1136/bmjopen-2017-019463]">Chow 2022</a>; <a href="./references#CD011851-bbs2-0006" title="ACTRN12613000901707. Text4Heart: a text message and internet-based comprehensive cardiac rehabilitation intervention [A randomised controlled trial to determine the efficacy of a text message and Internet-based comprehensive cardiac rehabilitation programme to improve adherence to lifestyle change compared with usual care in New Zealand adults with a diagnosis of cardiovascular disease]. anzctr.org.au/ACTRN12613000901707.aspx (first received 9 August 2013). DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Improving coronary heart disease self-management using mobile technologies (Text4Heart): a randomised controlled trial protocol. Trials2014;15(71):1-9. [DOI: 10.1186/1745-6215-15-71]DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Text message and internet support for coronary heart disease self-management: results from the Text4Heart randomized controlled trial. Journal of Medical Internet Research2015;17(10):e237. [DOI: 10.2196/jmir.4944]">Dale 2015a</a>; <a href="./references#CD011851-bbs2-0007" title="FangR , LiX . Electronic messaging support service programs improve adherence to lipid-lowering therapy among outpatients with coronary artery disease: an exploratory randomised control study. Journal of Clinical Nursing2016;25(5-6):664-71. [DOI: 10.1111/jocn.12988]">Fang 2016</a>; <a href="./references#CD011851-bbs2-0008" title="HuoX , KrumholzHM , BaiX , SpatzES , DingQ , HorakP , et al. Effects of mobile text messaging on glycemic control in patients with coronary heart disease and diabetes mellitus: a randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(9):e005805. [DOI: 10.1161/CIRCOUTCOMES.119.005805]NCT02883842. Cardiovascular Health and Text Messaging-Diabetes Mellitus (CHAT-DM) Study [Effectiveness of text messaging on risk factors control and medication adherence among patients with Coronary Heart Disease and Diabetes in China: cardiovascular health andtext messaging-Diabetes Mellitus (CHAT-DM) study]. clinicaltrials.gov/ct2/show/NCT02883842 (first received 30 August 2016). ">Huo 2019</a>; <a href="./references#CD011851-bbs2-0009" title="KamalAK , ShaikQN , PashaO , AzamI , IslamM , MemonAA , et al. Improving medication adherence in stroke patients through Short Text Messages (SMS4Stroke)-study protocol for a randomized, controlled trial. BMC Neurology2015;15:157. [DOI: 10.1186/s12883-015-0413-2]KamalAK , ShaikhQ , PashaO , AzamI , IslamM , MemonAA , et al. A randomized controlled behavioral intervention trial to improve medication adherence in adult stroke patients with prescription tailored short messaging service (SMS)-SMS4Stroke study. BMC Neurolology2015;15:212. [DOI: 10.1186/s12883-015-0471-5]">Kamal 2015</a>; <a href="./references#CD011851-bbs2-0010" title="KhonsariS , SubramanianP , ChinnaK , LatifLA , LingLW , GholamiO . Effect of a reminder system using an automated short message service on medication adherence following acute coronary syndrome. European Journal of Cardiovascular Nursing2015;14(2):170-9. [DOI: 10.1177/1474515114521910]">Khonsari 2015</a>; <a href="./references#CD011851-bbs2-0011" title="ACTRN12616000422426. Text4Heart Partnership: a text messaging program to enhance self-management of cardiovascular disease [Text messaging to enhance self-management of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12616000422426 (first received 23 March 2016). MaddisonR , JiangY , StewartR , ScottT , KerrA , WhittakerR , et al. An intervention to improve medication adherence in people with heart disease (Text4HeartII): randomized controlled trial. JMIR mHealth and uHealth2021;9(6):e24952. [DOI: 10.2196/24952]MaddisonR , StewartR , DoughtyR , ScottT , KerrA , BenatarJ , et al. Text4Heart II - improving medication adherence in people with heart disease: a study protocol for a randomized controlled trial. Trials2018;19(1):70. [DOI: 10.1186/s13063-018-2468-z]">Maddison 2021</a>; <a href="./references#CD011851-bbs2-0012" title="NCT02793830. A mobile phone based medication reminder program [A mobile phone based medication reminder program for patients in China with coronary heart disease: a pilot study]. clinicaltrials.gov/ct2/show/NCT02793830 (first received 8 June 2016). NiZ , WuB , YangQ , YanLL , LiuC , ShawRJ . An mHealth intervention to improve medication adherence and health outcomes among patients with coronary heart disease: randomized controlled trial. Journal of Medical Internet Research2022;24(3):e27202. [DOI: 10.2196/27202]">Ni 2022</a>; <a href="./references#CD011851-bbs2-0014" title="ParkLG , Howie-EsquivelJ , ChungM , DracupK . A text messaging intervention improves medication adherence for patients with coronary heart disease: a randomized controlled trial. Circulation2013;128(Suppl 22):A15249. [DOI: 10.1161/circ.128.suppl_22.A15249]ParkLG , Howie-EsquivelJ , ChungML , DracupK . A text messaging intervention to promote medication adherence for patients with coronary heart disease: a randomized controlled trial. Patient Education and Counseling2014;94(2):261-8. [DOI: 10.1016/j.pec.2013.10.027]ParkLG , Howie-EsquivelJ , WhooleyMA , DracupK . Psychosocial factors and medication adherence among patients with coronary heart disease: a text messaging intervention. European Journal of Cardiovascular Nursing2015;14(3):264-73. [DOI: 10.1177/1474515114537024]">Park 2014a</a>; <a href="./references#CD011851-bbs2-0018" title="HuoX , SpatzES , DingQ , HorakP , ZhengX , MastersC , et al. Design and rationale of the Cardiovascular Health and Text Messaging (CHAT) study and the CHAT-Diabetes Mellitus (CHAT-DM) study: two randomised controlled trials of text messaging to improve secondary prevention for coronary heart disease and diabetes. BMJ Open2017;7(12):e018302. [DOI: 10.1136/bmjopen-2017-018302]ZhengX , SpatzES , BaiX , HuoX , DingQ , HorakP , et al. Effect of text messaging on risk factor management in patients with coronary heart disease: the CHAT randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(4):e005616. [DOI: 10.1161/CIRCOUTCOMES.119.005616]">Zheng 2019</a>). We judged four studies as at high risk of other bias (<a href="./references#CD011851-bbs2-0013" title="NCT02783287. The impact of text messaging on medication adherence and exercise regimen among post-myocardial infarction patients. clinicaltrials.gov/ct2/show/NCT02783287 (first received 26 May 2016). PandeyA , ChoudhryN . An m-health application of daily text messages to address forgetfulness as contributor to non-adherence to medications post-myocardial infarction. Circulation2015;132:A18641. [DOI: 10.1161/circ.132.suppl_3.18641]PandeyA , KrummeAA , PatelT , ChoudhryNK . The impact of text messaging on medication adherence and exercise among postmyocardial infarction patients: randomized controlled pilot trial. JMIR mHealth and uHealth2017;5(8):e110. [DOI: 10.2196/mhealth.7144]PandeyAK , ChoudhryN . Text message reminders to address medication non-adherence in post-MI patients: a one year intervention study. Canadian Journal of Cardiology2014;30(10):S179. [DOI: 10.1016/j.cjca.2014.07.280]">Pandey 2017</a>; <a href="./references#CD011851-bbs2-0015" title="NCT03414190. Impact of text messages to promote secondary prevention after acute coronary syndrome [Impact of a mobile phone text messages intervention on the secondary prevention of cardiovascular events after acute coronary syndrome]. clinicaltrials.gov/show/NCT03414190 (first received 29 January 2018). PassagliaLG , BrantLC , NascimentoBR , RibeiroAL . Impact of text messages in a middle-income country to promote secondary prevention after acute coronary syndrome (IMPACS): a randomized trial. Medicine2019;98(22):e15681. [DOI: 10.1097/MD.0000000000015681]PassagliaLG , BrantLC , SilvaJL , NascimentoBR , RibeiroAL . Text messages to promote secondary prevention after acute coronary syndrome (IMPACS trial). International Journal of Cardiovascular Sciences2021;35(2):202-13. [DOI: 10.36660/ijcs.20200378]">Passaglia 2021</a>; <a href="./references#CD011851-bbs2-0016" title="QuiliciJ , FugonL , BeguinS , MorangePE , BonnetJL , AlessiMC , et al. Effect of motivational mobile phone short message service on aspirin adherence after coronary stenting for acute coronary syndrome. International Journal of Cardiology2013;168(1):568-9. [DOI: 10.1016/j.ijcard.2013.01.252]">Quilici 2013</a>; <a href="./references#CD011851-bbs2-0017" title="NCT02336919. The use of texting messaging to improve the hospital-to-community transition period in cardiovascular disease patients (Txt2Prevent) [The use of texting messaging to improve the hospital-to-community transition and prevent readmission in patients with cardiovascular disease (Txt2Prevent)]. clinicaltrials.gov/ct2/show/NCT02336919 (first received 13 January 2015). RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of SMS text messaging to improve the hospital-to-community transition in patients with acute coronary syndrome (Txt2Prevent): results from a pilot randomized controlled trial. JMIR mHealth and uHealth2021;9(5):e24530. [DOI: 10.2196/24530]RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of text messaging to improve the hospital-to-community transition in acute coronary syndrome patients (Txt2Prevent): intervention development and pilot randomized controlled trial protocol. JMIR Research Protocols2017;6(5):e91. [DOI: 10.2196/resprot.6968]">Ross 2021</a>). In <a href="./references#CD011851-bbs2-0016" title="QuiliciJ , FugonL , BeguinS , MorangePE , BonnetJL , AlessiMC , et al. Effect of motivational mobile phone short message service on aspirin adherence after coronary stenting for acute coronary syndrome. International Journal of Cardiology2013;168(1):568-9. [DOI: 10.1016/j.ijcard.2013.01.252]">Quilici 2013</a>, the only source of information is a published letter to an editor in which the outcome data for self‐reported non‐adherence differs between the text and Figure 2. <a href="./references#CD011851-bbs2-0017" title="NCT02336919. The use of texting messaging to improve the hospital-to-community transition period in cardiovascular disease patients (Txt2Prevent) [The use of texting messaging to improve the hospital-to-community transition and prevent readmission in patients with cardiovascular disease (Txt2Prevent)]. clinicaltrials.gov/ct2/show/NCT02336919 (first received 13 January 2015). RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of SMS text messaging to improve the hospital-to-community transition in patients with acute coronary syndrome (Txt2Prevent): results from a pilot randomized controlled trial. JMIR mHealth and uHealth2021;9(5):e24530. [DOI: 10.2196/24530]RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of text messaging to improve the hospital-to-community transition in acute coronary syndrome patients (Txt2Prevent): intervention development and pilot randomized controlled trial protocol. JMIR Research Protocols2017;6(5):e91. [DOI: 10.2196/resprot.6968]">Ross 2021</a> was a pilot study and did not determine a sample size based on power calculations, and thus was likely underpowered to detect clinically important differences. In <a href="./references#CD011851-bbs2-0015" title="NCT03414190. Impact of text messages to promote secondary prevention after acute coronary syndrome [Impact of a mobile phone text messages intervention on the secondary prevention of cardiovascular events after acute coronary syndrome]. clinicaltrials.gov/show/NCT03414190 (first received 29 January 2018). PassagliaLG , BrantLC , NascimentoBR , RibeiroAL . Impact of text messages in a middle-income country to promote secondary prevention after acute coronary syndrome (IMPACS): a randomized trial. Medicine2019;98(22):e15681. [DOI: 10.1097/MD.0000000000015681]PassagliaLG , BrantLC , SilvaJL , NascimentoBR , RibeiroAL . Text messages to promote secondary prevention after acute coronary syndrome (IMPACS trial). International Journal of Cardiovascular Sciences2021;35(2):202-13. [DOI: 10.36660/ijcs.20200378]">Passaglia 2021</a>, 20 participants (26.6%) in the intervention group did not receive text messaging though their system confirmed that messages were sent. This may have contributed to loss of study power and raises the possibility of a type II error. In <a href="./references#CD011851-bbs2-0013" title="NCT02783287. The impact of text messaging on medication adherence and exercise regimen among post-myocardial infarction patients. clinicaltrials.gov/ct2/show/NCT02783287 (first received 26 May 2016). PandeyA , ChoudhryN . An m-health application of daily text messages to address forgetfulness as contributor to non-adherence to medications post-myocardial infarction. Circulation2015;132:A18641. [DOI: 10.1161/circ.132.suppl_3.18641]PandeyA , KrummeAA , PatelT , ChoudhryNK . The impact of text messaging on medication adherence and exercise among postmyocardial infarction patients: randomized controlled pilot trial. JMIR mHealth and uHealth2017;5(8):e110. [DOI: 10.2196/mhealth.7144]PandeyAK , ChoudhryN . Text message reminders to address medication non-adherence in post-MI patients: a one year intervention study. Canadian Journal of Cardiology2014;30(10):S179. [DOI: 10.1016/j.cjca.2014.07.280]">Pandey 2017</a>, there were baseline imbalances between groups in gender: 88% male in the control group and 35% male in the intervention group. Self‐reported outcomes were widely reported in the included studies, which were susceptible to recall bias. We believe such bias could be balanced across the intervention and control groups, and therefore did not include recall bias as an other potential source of bias in this domain. </p> </section> </section> <section id="CD011851-sec-0059"> <h3 class="title" id="CD011851-sec-0059">Effects of interventions</h3> <p>See: <a href="./full#CD011851-tbl-0001"><b>Summary of findings 1</b> Mobile phone text messaging compared to usual care for medication adherence in secondary prevention of cardiovascular disease</a> </p> <p>The results and ratings of the certainty of the evidence for our key outcomes are presented for our main comparison, mobile phone text messaging versus usual care, in <a href="./full#CD011851-tbl-0001">summary of findings Table 1</a>. </p> <section id="CD011851-sec-0060"> <h4 class="title">Primary outcomes</h4> <section id="CD011851-sec-0061"> <h5 class="title">Medication adherence</h5> <p>All 18 included studies (8136 randomised participants) reported on indirect measures of medication adherence. Of the 18 studies, improvement in medication adherence were observed in 10 studies (<a href="./references#CD011851-bbs2-0001" title="BaeJW , WooSI , LeeJ , ParkSD , KwonSW , ChoiSH , et al. mHealth interventions for lifestyle and risk factor modification in coronary heart disease: randomized controlled trial. JMIR mHealth and uHealth2021;9(9):e29928. [DOI: 10.2196/29928]KCT0005087. Effect of text messaging program on lifestyle and clinical outcomes in patients with cardiovascular disease. cris.nih.go.kr/cris/search/detailSearch.do/19282 (first received 11 September 2019). ">Bae 2021</a>; <a href="./references#CD011851-bbs2-0003" title="ChenC , LiX , KangY , LiuH , LiangYD , ZhangQ . Post-discharge short service message improves short-term clinical outcome and self-care behavior in Chinese patients with chronic heart failure. European Heart Journal2018;39(Suppl 1):797-8. [DOI: 10.1093/eurheartj/ehy563.P3770]ChenC , LiX , SunL , CaoS , KangY , HongL , et al. Post-discharge short message service improves short-term clinical outcome and self-care behaviour in chronic heart failure. ESC Heart Failure2019;6(1):164-73. [DOI: 10.1002/ehf2.12380]ChiCTR-INR-17012316. Effect of post-discharge text messages on clinical outcomes in patients with heart failure [Effect of post-discharge text messages on clinical outcomes in patients with heart failure]. trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR-INR-17012316 (first received 9 August 2018). LiX , ChenC , YouGY , ZhangQ . Post-discharge text messaging intervention improved clinical outcomes in patients with heart failure. European Heart Journal2016;37(Suppl 1):727-8. [DOI: 10.1093/eurheartj/ehw433]">Chen 2019</a>; <a href="./references#CD011851-bbs2-0006" title="ACTRN12613000901707. Text4Heart: a text message and internet-based comprehensive cardiac rehabilitation intervention [A randomised controlled trial to determine the efficacy of a text message and Internet-based comprehensive cardiac rehabilitation programme to improve adherence to lifestyle change compared with usual care in New Zealand adults with a diagnosis of cardiovascular disease]. anzctr.org.au/ACTRN12613000901707.aspx (first received 9 August 2013). DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Improving coronary heart disease self-management using mobile technologies (Text4Heart): a randomised controlled trial protocol. Trials2014;15(71):1-9. [DOI: 10.1186/1745-6215-15-71]DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Text message and internet support for coronary heart disease self-management: results from the Text4Heart randomized controlled trial. Journal of Medical Internet Research2015;17(10):e237. [DOI: 10.2196/jmir.4944]">Dale 2015a</a>; <a href="./references#CD011851-bbs2-0007" title="FangR , LiX . Electronic messaging support service programs improve adherence to lipid-lowering therapy among outpatients with coronary artery disease: an exploratory randomised control study. Journal of Clinical Nursing2016;25(5-6):664-71. [DOI: 10.1111/jocn.12988]">Fang 2016</a>; <a href="./references#CD011851-bbs2-0009" title="KamalAK , ShaikQN , PashaO , AzamI , IslamM , MemonAA , et al. Improving medication adherence in stroke patients through Short Text Messages (SMS4Stroke)-study protocol for a randomized, controlled trial. BMC Neurology2015;15:157. [DOI: 10.1186/s12883-015-0413-2]KamalAK , ShaikhQ , PashaO , AzamI , IslamM , MemonAA , et al. A randomized controlled behavioral intervention trial to improve medication adherence in adult stroke patients with prescription tailored short messaging service (SMS)-SMS4Stroke study. BMC Neurolology2015;15:212. [DOI: 10.1186/s12883-015-0471-5]">Kamal 2015</a>; <a href="./references#CD011851-bbs2-0010" title="KhonsariS , SubramanianP , ChinnaK , LatifLA , LingLW , GholamiO . Effect of a reminder system using an automated short message service on medication adherence following acute coronary syndrome. European Journal of Cardiovascular Nursing2015;14(2):170-9. [DOI: 10.1177/1474515114521910]">Khonsari 2015</a>; <a href="./references#CD011851-bbs2-0012" title="NCT02793830. A mobile phone based medication reminder program [A mobile phone based medication reminder program for patients in China with coronary heart disease: a pilot study]. clinicaltrials.gov/ct2/show/NCT02793830 (first received 8 June 2016). NiZ , WuB , YangQ , YanLL , LiuC , ShawRJ . An mHealth intervention to improve medication adherence and health outcomes among patients with coronary heart disease: randomized controlled trial. Journal of Medical Internet Research2022;24(3):e27202. [DOI: 10.2196/27202]">Ni 2022</a>; <a href="./references#CD011851-bbs2-0013" title="NCT02783287. The impact of text messaging on medication adherence and exercise regimen among post-myocardial infarction patients. clinicaltrials.gov/ct2/show/NCT02783287 (first received 26 May 2016). PandeyA , ChoudhryN . An m-health application of daily text messages to address forgetfulness as contributor to non-adherence to medications post-myocardial infarction. Circulation2015;132:A18641. [DOI: 10.1161/circ.132.suppl_3.18641]PandeyA , KrummeAA , PatelT , ChoudhryNK . The impact of text messaging on medication adherence and exercise among postmyocardial infarction patients: randomized controlled pilot trial. JMIR mHealth and uHealth2017;5(8):e110. [DOI: 10.2196/mhealth.7144]PandeyAK , ChoudhryN . Text message reminders to address medication non-adherence in post-MI patients: a one year intervention study. Canadian Journal of Cardiology2014;30(10):S179. [DOI: 10.1016/j.cjca.2014.07.280]">Pandey 2017</a>; <a href="./references#CD011851-bbs2-0014" title="ParkLG , Howie-EsquivelJ , ChungM , DracupK . A text messaging intervention improves medication adherence for patients with coronary heart disease: a randomized controlled trial. Circulation2013;128(Suppl 22):A15249. [DOI: 10.1161/circ.128.suppl_22.A15249]ParkLG , Howie-EsquivelJ , ChungML , DracupK . A text messaging intervention to promote medication adherence for patients with coronary heart disease: a randomized controlled trial. Patient Education and Counseling2014;94(2):261-8. [DOI: 10.1016/j.pec.2013.10.027]ParkLG , Howie-EsquivelJ , WhooleyMA , DracupK . Psychosocial factors and medication adherence among patients with coronary heart disease: a text messaging intervention. European Journal of Cardiovascular Nursing2015;14(3):264-73. [DOI: 10.1177/1474515114537024]">Park 2014a</a>; <a href="./references#CD011851-bbs2-0016" title="QuiliciJ , FugonL , BeguinS , MorangePE , BonnetJL , AlessiMC , et al. Effect of motivational mobile phone short message service on aspirin adherence after coronary stenting for acute coronary syndrome. International Journal of Cardiology2013;168(1):568-9. [DOI: 10.1016/j.ijcard.2013.01.252]">Quilici 2013</a>). We found significant heterogeneity amongst studies in terms of measurement approach and timing of assessment. First, different evaluation score systems and inconsistent definitions were applied for the measurement of medication adherence. Second, characteristics of text messages varied in terms of content, duration, theoretic framework, personalisation, and directionality. Third, although all included participants were people with CVD, participant characteristics varied across studies. </p> <p>An overview of the trial results for medication adherence is presented in <a href="#CD011851-tbl-0003">Table 2</a>. Studies measured the level of medication adherence in different ways, including self‐report questionnaire, personal enquiry, medical record, pill count, and medication event monitoring system. </p> <div class="table" id="CD011851-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Overview of the trial results for medication adherence</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Outcome measure</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Scale used/measurement tool</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Continuous/categorical data</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Time point (months)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Number in intervention group</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Intervention group effect</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Number in control group)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Control group effect</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Narrative results</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD011851-bbs2-0001" title="BaeJW , WooSI , LeeJ , ParkSD , KwonSW , ChoiSH , et al. mHealth interventions for lifestyle and risk factor modification in coronary heart disease: randomized controlled trial. JMIR mHealth and uHealth2021;9(9):e29928. [DOI: 10.2196/29928]KCT0005087. Effect of text messaging program on lifestyle and clinical outcomes in patients with cardiovascular disease. cris.nih.go.kr/cris/search/detailSearch.do/19282 (first received 11 September 2019). ">Bae 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication adherence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6‐item Modified Morisky Scale (high score indicates better adherence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Continuous</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>377</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median (IQR) = 5 (5 to 5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median (IQR) = 5 (5 to 5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean difference 0.07, 95% CI −0.03 to 0.16; P = 0.19</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of participants taking medications as instructed on &gt; 25 days in the last month </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Categorical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>377</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>98.2%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92.1%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adjusted RR 1.10, 95% CI 1.00 to 1.10; P &lt; 0.001</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD011851-bbs2-0002" title="BermonA , UribeAF , Pérez-RiveroPF , Prieto-MerinoD , SaaibiJF , SilvaFA , et al. Efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: TXT2HEART Colombia randomized controlled trial. JMIR mHealth and uHealth2021;9(7):e25548. [DOI: 10.2196/25548]BermonA , Uribe-RodríguezAF , Pérez-RiveroPF , Prieto-MerinoD , RiveraDIC , GuioE , et al. Evaluation of the efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: the txt2heart Colombia randomised controlled trial protocol. BMJ Open2019;9:e028017. [DOI: 10.1136/ bmjopen-2018-028017]NCT03098186. TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention [TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention]. clinicaltrials.gov/ct2/show/NCT03098186 (first received 3 March 2017). ">Bermon 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication adherence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication Adherence Report Scale‐5 (high score indicates better adherence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Continuous</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>462</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean difference (SD) = −0.02 (3.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>468</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean difference (SD) = 0.2 (3.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adjusted mean difference −0.01, 95% CI −0.40 to 0.40; P = 0.96</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Subjective medication intake compliance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Continuous</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>462</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean difference (SD) = 0.1 (2.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>468</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean difference (SD) = 0.1 (1.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adjusted mean difference 0.02, 95% CI −0.20 to 0.20; P = 0.83</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011851-bbs2-0003" title="ChenC , LiX , KangY , LiuH , LiangYD , ZhangQ . Post-discharge short service message improves short-term clinical outcome and self-care behavior in Chinese patients with chronic heart failure. European Heart Journal2018;39(Suppl 1):797-8. [DOI: 10.1093/eurheartj/ehy563.P3770]ChenC , LiX , SunL , CaoS , KangY , HongL , et al. Post-discharge short message service improves short-term clinical outcome and self-care behaviour in chronic heart failure. ESC Heart Failure2019;6(1):164-73. [DOI: 10.1002/ehf2.12380]ChiCTR-INR-17012316. Effect of post-discharge text messages on clinical outcomes in patients with heart failure [Effect of post-discharge text messages on clinical outcomes in patients with heart failure]. trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR-INR-17012316 (first received 9 August 2018). LiX , ChenC , YouGY , ZhangQ . Post-discharge text messaging intervention improved clinical outcomes in patients with heart failure. European Heart Journal2016;37(Suppl 1):727-8. [DOI: 10.1093/eurheartj/ehw433]">Chen 2019</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of participants taking medications as prescribed</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Categorical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>209</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>78.9%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>69.5%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.14, 95% CI 1.01 to 1.28; P = 0.029</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><a href="./references#CD011851-bbs2-0004" title="ACTRN12611000161921. Tobacco, EXercise and dieT MEssages (TEXT ME): the effect of semi-personalised lifestyle reminder text message intervention on cardiovascular disease risk [Tobacco, EXercise and dieT MEssages (TEXT ME): The effect of a semi-personalised lifestyle reminder text message intervention on cardiovascular risk factors in patients with cardiovascular disease and those who are at high risk of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12611000161921 (first received 3 February 2011). ChowCK , RedfernJ , HillisGS , ThakkarJ , SantoK , HackettML , et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA2015;314(12):1255-63. [DOI: 10.1001/jama.2015.10945]ChowCK , RedfernJ , ThiagalingamA , JanS , WhittakerR , HackettM , et al. Design and rationale of the tobacco, exercise and diet messages (TEXT ME) trial of a text message-based intervention for ongoing prevention of cardiovascular disease in people with coronary disease: a randomised controlled trial protocol. BMJ Open2012;2(1):e000606. [DOI: 10.1136/bmjopen-2011-000606]RedfernJ , SantoK , CooreyG , ThakkarJ , HackettM , ThiagalingamA , et al. Factors influencing engagement, perceived usefulness and behavioral mechanisms associated with a text message support program. PLOS ONE2016;11(10):e0163929. [DOI: 10.1371/journal.pone.0163929]ThakkarJ , RedfernJ , De KeizerL , ThiagalingamA , ChowC . Patient perceptions of text message-based intervention for secondary prevention of cardiovascular events. Heart, Lung and Circulation2013;22(Suppl 1):S264. [DOI: 10.1016/j.hlc.2013.05.630]ThakkarJ , RedfernJ , ThiagalingamA , ChowCK . Patterns, predictors and effects of texting intervention on physical activity in CHD – insights from the TEXT ME randomized clinical trial. European Journal of Preventive Cardiology2016;23(17):1894-902. [DOI: 10.1177/2047487316664190]">Chow 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medications‐ ACE inhibitor/ARB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>Categorical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>339</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>66.1%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>354</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>71.8%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>P value was not reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Aspirin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="5" valign="top"> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>339</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90.6%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>354</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>93.8%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>P value was not reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Beta‐blocker</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>338</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>64.5%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>354</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>63.0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>P value was not reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Statin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>339</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>91.7%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>354</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92.9%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>P value was not reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>At least 3 of the 4 medications (ACE inhibitor/ARB, aspirin, beta‐blocker, and statin)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>338</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>78.1%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>354</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>83.1%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.94, 95% CI 0.87 to 1.01; P = 0.10</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All 4 medications (ACE inhibitor/ARB, aspirin, beta‐blocker, and statin)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>338</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39.3%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42.1%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>354</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.93, 95% CI 0.78 to 1.12; P = 0.46</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><a href="./references#CD011851-bbs2-0005" title="ACTRN12613000793718. TEXT messages to improve MEDication adherence &amp; Secondary prevention – TEXTMEDS [TEXT messages to improve MEDication adherence &amp; Secondary prevention in patients with acute coronary syndrome - TEXTMEDS]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364448&amp;isReview=true (first received 18 June 2013). ChowCK , KlimisH , ThiagalingamA , RedfernJ , HillisGS , BriegerD , et al. Text messages to improve medication adherence and secondary prevention after acute coronary syndrome: the TEXTMEDS randomized clinical trial. Circulation2022;145(19):1443-55. [DOI: 10.1161/CIRCULATIONAHA.121.056161]ChowCK , ThiagalingamA , SantoK , KokC , ThakkarJ , StepienS , et al. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol. BMJ Open2018;8:e019463. [DOI: 10.1136/bmjopen-2017-019463]">Chow 2022</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of participants with proportion of days covered &gt; 80% for 5 medications at both 6 and 12 months </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>Categorical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>697</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50.4%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>682</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>54.3%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No difference in adherence to all recommended medications at 6 and 12 months between the intervention and control groups (RR 0.93, 95% CI 0.84 to 1.03, P = 0.15) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adherence to Aspirin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>671</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96.3%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>638</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96.1%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.00, 95% CI 0.98 to 1.02; P = 0.86</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Beta‐blocker</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>613</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>84.2%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>581</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>83.6%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.01, 95% CI 0.96 to 1.06; P = 0.80</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ACE inhibitor/ARB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>636</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>76.9%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>621</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80.2%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.96, 95% CI 0.90 to 1.02; P = 0.15</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Statin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>668</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>94.6%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>655</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>95.3%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.99, 95% CI 0.97 to 1.02; P = 0.59</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Antiplatelet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>636</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>83.6%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>632</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>84.3%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.99, 95% CI 0.95 to 1.04; P = 0.74</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011851-bbs2-0006" title="ACTRN12613000901707. Text4Heart: a text message and internet-based comprehensive cardiac rehabilitation intervention [A randomised controlled trial to determine the efficacy of a text message and Internet-based comprehensive cardiac rehabilitation programme to improve adherence to lifestyle change compared with usual care in New Zealand adults with a diagnosis of cardiovascular disease]. anzctr.org.au/ACTRN12613000901707.aspx (first received 9 August 2013). DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Improving coronary heart disease self-management using mobile technologies (Text4Heart): a randomised controlled trial protocol. Trials2014;15(71):1-9. [DOI: 10.1186/1745-6215-15-71]DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Text message and internet support for coronary heart disease self-management: results from the Text4Heart randomized controlled trial. Journal of Medical Internet Research2015;17(10):e237. [DOI: 10.2196/jmir.4944]">Dale 2015a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication adherence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8‐item Morisky Medication Adherence Questionnaire (high score indicates better adherence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Continuous</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean (SD) = 7.3 (0.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean (SD) = 6.8 (1.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The intervention group reported greater medication adherence score than the control group (mean difference 0.58, 95% CI 0.19 to 0.97; P = 0.004). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011851-bbs2-0007" title="FangR , LiX . Electronic messaging support service programs improve adherence to lipid-lowering therapy among outpatients with coronary artery disease: an exploratory randomised control study. Journal of Clinical Nursing2016;25(5-6):664-71. [DOI: 10.1111/jocn.12988]">Fang 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication adherence ‐ statin prescriptions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4‐item Morisky Medication Adherence Scale (high score indicates worse adherence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Continuous</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>93</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants in the SMS group had better adherence than those in the phone group (OR 0.34, 95% CI 0.18 to 0.63). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD011851-bbs2-0008" title="HuoX , KrumholzHM , BaiX , SpatzES , DingQ , HorakP , et al. Effects of mobile text messaging on glycemic control in patients with coronary heart disease and diabetes mellitus: a randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(9):e005805. [DOI: 10.1161/CIRCOUTCOMES.119.005805]NCT02883842. Cardiovascular Health and Text Messaging-Diabetes Mellitus (CHAT-DM) Study [Effectiveness of text messaging on risk factors control and medication adherence among patients with Coronary Heart Disease and Diabetes in China: cardiovascular health andtext messaging-Diabetes Mellitus (CHAT-DM) study]. clinicaltrials.gov/ct2/show/NCT02883842 (first received 30 August 2016). ">Huo 2019</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication ‐ ACE inhibitor/ARB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p>Categorical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p>251</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p>251</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42.6%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was no difference in the proportion of participants who took ACE inhibitor/ARB (P = 0.32). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication ‐ aspirin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>86.5%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>87.7%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was no difference in the proportion of participants who took aspirin (P = 0.69).</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication ‐ beta‐blocker</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>62.2%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58.2%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was no difference in the proportion of participants who took beta‐blocker (P = 0.36). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication ‐ statin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>84.1%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>87.3%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was no difference in the proportion of participants who took statin (P = 0.31).</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication ‐ all 4 cardioprotective medications</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30.7%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23.9%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was no difference in the proportion of participants who took all 4 cardioprotective medications (P = 0.089). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication ‐ insulin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10.8%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.9%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was no difference in the proportion of participants who took insulin (P = 0.28).</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication ‐ oral antidiabetic medication</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>43%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44.6%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was no difference in the proportion of participants who took oral antidiabetic medication (P = 0.72). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011851-bbs2-0009" title="KamalAK , ShaikQN , PashaO , AzamI , IslamM , MemonAA , et al. Improving medication adherence in stroke patients through Short Text Messages (SMS4Stroke)-study protocol for a randomized, controlled trial. BMC Neurology2015;15:157. [DOI: 10.1186/s12883-015-0413-2]KamalAK , ShaikhQ , PashaO , AzamI , IslamM , MemonAA , et al. A randomized controlled behavioral intervention trial to improve medication adherence in adult stroke patients with prescription tailored short messaging service (SMS)-SMS4Stroke study. BMC Neurolology2015;15:212. [DOI: 10.1186/s12883-015-0471-5]">Kamal 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication adherence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Morisky Medication Adherence Scale (high score indicates better adherence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Continuous</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean (SD) = 7.4 (0.93)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean (SD) = 6.7 (1.32)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adjusted mean difference 0.54, 95% CI 0.22 to 0.85</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011851-bbs2-0010" title="KhonsariS , SubramanianP , ChinnaK , LatifLA , LingLW , GholamiO . Effect of a reminder system using an automated short message service on medication adherence following acute coronary syndrome. European Journal of Cardiovascular Nursing2015;14(2):170-9. [DOI: 10.1177/1474515114521910]">Khonsari 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication adherence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8‐item Morisky Medication Adherence Scale (high score indicates better adherence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Categorical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High adherence = 64.5%; medium adherence = 19.4%; low adherence = 16.1%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High adherence = 12.9%; medium adherence = 29%; low adherence = 58.1%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The risk of being low‐adherent amongst the control group was 4.09 times greater than in the intervention group (RR 4.09, 95% CI 1.82 to 9.18). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="8" valign="top"> <p><a href="./references#CD011851-bbs2-0011" title="ACTRN12616000422426. Text4Heart Partnership: a text messaging program to enhance self-management of cardiovascular disease [Text messaging to enhance self-management of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12616000422426 (first received 23 March 2016). MaddisonR , JiangY , StewartR , ScottT , KerrA , WhittakerR , et al. An intervention to improve medication adherence in people with heart disease (Text4HeartII): randomized controlled trial. JMIR mHealth and uHealth2021;9(6):e24952. [DOI: 10.2196/24952]MaddisonR , StewartR , DoughtyR , ScottT , KerrA , BenatarJ , et al. Text4Heart II - improving medication adherence in people with heart disease: a study protocol for a randomized controlled trial. Trials2018;19(1):70. [DOI: 10.1186/s13063-018-2468-z]">Maddison 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication adherence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8‐item Morisky Medication Adherence Scale (High score indicates worse adherence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Continuous</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>153</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>153</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adjusted mean difference 0.30, 95% CI 0.01 to 0.59; P = 0.04</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication adherence ‐ aspirin + statin + blood pressure‐lowering drug (ACE inhibitor, ARB, beta‐blocker) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p>Medication possession ratio by linking community pharmacy dispensing records via the National Pharmaceuticals Collection database </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p>Categorical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p>12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>54.2%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>104</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>67.9%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adjusted OR 0.56, 95% CI 0.35 to 0.89; P = 0.01</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication adherence ‐ aspirin + statin + beta‐blocker + ACE inhibitor/ARB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>36.6%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45.7%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adjusted OR 0.68, 95% CI 0.43 to 1.08; P = 0.11</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication adherence ‐ statin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>119</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>77.7%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>84.3%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adjusted OR 0.65, 95% CI 0.36 to 1.16; P = 0.15</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication adherence ‐ aspirin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>119</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>77.7%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>123</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80.3%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adjusted OR 0.85, 95% CI 0.49 to 1.49; P = 0.58</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication adherence ‐ beta‐blocker</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58.1%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>66.6%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adjusted OR 0.69, 95% CI 0.43 to 1.11; P = 0.13</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication adherence ‐ ACE inhibitor/ARB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>63.4%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>123</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80.3%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adjusted OR 0.42, 95% CI 0.25 to 0.71; P = 0.001</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication adherence ‐ blood pressure‐lowering drugs (ACE inhibitor/ARB and/or beta‐blocker)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>113</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>73.8%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>139</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90.8%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adjusted OR 0.28, 95% CI 0.15 to 0.55; P &lt; 0.001</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011851-bbs2-0012" title="NCT02793830. A mobile phone based medication reminder program [A mobile phone based medication reminder program for patients in China with coronary heart disease: a pilot study]. clinicaltrials.gov/ct2/show/NCT02793830 (first received 8 June 2016). NiZ , WuB , YangQ , YanLL , LiuC , ShawRJ . An mHealth intervention to improve medication adherence and health outcomes among patients with coronary heart disease: randomized controlled trial. Journal of Medical Internet Research2022;24(3):e27202. [DOI: 10.2196/27202]">Ni 2022</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication non‐adherence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3‐item, 5‐point Voils Extent Scale (high score indicates worse adherence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Continuous</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean difference (SD) = −1.58 (2.49)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>93</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean difference (SD) = −0.08 (3.15)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean decrease in medication non‐adherence score in the intervention group was greater than the mean decrease in the control group (P &lt; 0.001). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD011851-bbs2-0013" title="NCT02783287. The impact of text messaging on medication adherence and exercise regimen among post-myocardial infarction patients. clinicaltrials.gov/ct2/show/NCT02783287 (first received 26 May 2016). PandeyA , ChoudhryN . An m-health application of daily text messages to address forgetfulness as contributor to non-adherence to medications post-myocardial infarction. Circulation2015;132:A18641. [DOI: 10.1161/circ.132.suppl_3.18641]PandeyA , KrummeAA , PatelT , ChoudhryNK . The impact of text messaging on medication adherence and exercise among postmyocardial infarction patients: randomized controlled pilot trial. JMIR mHealth and uHealth2017;5(8):e110. [DOI: 10.2196/mhealth.7144]PandeyAK , ChoudhryN . Text message reminders to address medication non-adherence in post-MI patients: a one year intervention study. Canadian Journal of Cardiology2014;30(10):S179. [DOI: 10.1016/j.cjca.2014.07.280]">Pandey 2017</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Average percentage of days covered during 12 months' follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Logbooks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Categorical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>94% (95% CI 92 to 96)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80% (95% CI 73 to 86)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean difference in percentage of days covered between groups was 14% (95% CI 7 to 21, P &lt; 0.001). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of participants with proportion of days covered &gt; 80% over the 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All intervention group participants were optimally adherent to their prescribed medications during follow‐up compared with 50% (8/16) of control group participants (P &lt; 0.001). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD011851-bbs2-0014" title="ParkLG , Howie-EsquivelJ , ChungM , DracupK . A text messaging intervention improves medication adherence for patients with coronary heart disease: a randomized controlled trial. Circulation2013;128(Suppl 22):A15249. [DOI: 10.1161/circ.128.suppl_22.A15249]ParkLG , Howie-EsquivelJ , ChungML , DracupK . A text messaging intervention to promote medication adherence for patients with coronary heart disease: a randomized controlled trial. Patient Education and Counseling2014;94(2):261-8. [DOI: 10.1016/j.pec.2013.10.027]ParkLG , Howie-EsquivelJ , WhooleyMA , DracupK . Psychosocial factors and medication adherence among patients with coronary heart disease: a text messaging intervention. European Journal of Cardiovascular Nursing2015;14(3):264-73. [DOI: 10.1177/1474515114537024]">Park 2014a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication adherence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Morisky Medication Adherence Scale (high score indicates better adherence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Continuous</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean (SD) = 6.43 (1.22)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean (SD) = 6.96 (1.44)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No difference was found between groups over time (P = 0.16).</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication adherence ‐ antiplatelets</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Medication event monitoring system (MEMS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Continuous</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1 month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean doses taken: 28.2 (3.6)</p> <p>Per cent doses taken: 93.7 (11.9)</p> <p>Per cent correct number doses: 88.0 (14.0)</p> <p>Per cent doses taken on schedule: 86.2 (15.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean doses taken: 23.7 (8.3)</p> <p>Per cent doses taken: 79.1 (27.7)</p> <p>Per cent correct number doses: 72.4 (27.4)</p> <p>Per cent doses taken on schedule: 69.0 (29.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants who received text messages for antiplatelets had a higher percentage of correct doses taken (P = 0.02), percentage number of doses taken (P = 0.01), and percentage of prescribed doses taken on schedule (P = 0.01). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication adherence ‐ statins</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean doses taken: 27.7 (4.2)</p> <p>Per cent doses taken: 92.4 (14)</p> <p>Per cent correct number doses: 85.4 (16.6)</p> <p>Per cent doses taken on schedule: 84.1 (19.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean doses taken: 25 (6.4)</p> <p>Per cent doses taken: 83.3 (21.3)</p> <p>Per cent correct number doses: 73.4 (23.8)</p> <p>Per cent doses taken on schedule: 74.4 (21.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No difference between groups for statin medication</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011851-bbs2-0015" title="NCT03414190. Impact of text messages to promote secondary prevention after acute coronary syndrome [Impact of a mobile phone text messages intervention on the secondary prevention of cardiovascular events after acute coronary syndrome]. clinicaltrials.gov/show/NCT03414190 (first received 29 January 2018). PassagliaLG , BrantLC , NascimentoBR , RibeiroAL . Impact of text messages in a middle-income country to promote secondary prevention after acute coronary syndrome (IMPACS): a randomized trial. Medicine2019;98(22):e15681. [DOI: 10.1097/MD.0000000000015681]PassagliaLG , BrantLC , SilvaJL , NascimentoBR , RibeiroAL . Text messages to promote secondary prevention after acute coronary syndrome (IMPACS trial). International Journal of Cardiovascular Sciences2021;35(2):202-13. [DOI: 10.36660/ijcs.20200378]">Passaglia 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication adherence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Treatment Adherence Measure (MAT) form (high score indicates better adherence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Categorical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>93.1%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 0.55, 95% CI 0.17 to 1.72; P = 0.30</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD011851-bbs2-0016" title="QuiliciJ , FugonL , BeguinS , MorangePE , BonnetJL , AlessiMC , et al. Effect of motivational mobile phone short message service on aspirin adherence after coronary stenting for acute coronary syndrome. International Journal of Cardiology2013;168(1):568-9. [DOI: 10.1016/j.ijcard.2013.01.252]">Quilici 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of participants with good medication adherence ‐aspirin (good adherence was defined as taking &gt; 95% of prescribed doses in the past 30 days) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Categorical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>250</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>97.2%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>249</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92.8%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intervention improved self‐reported aspirin adherence (OR 0.37, 95% CI 0.15 to 0.90; P = 0.02). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication adherence ‐ aspirin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Platelet function testing</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Categorical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>250</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>94.8%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>249</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88.8%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Controlled non‐adherent patients accounted for 11.2% of the standard care group versus 5.2% in the SMS intervention group (OR 0.43, 95% CI 0.22 to 0.86; P = 0.01). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD011851-bbs2-0017" title="NCT02336919. The use of texting messaging to improve the hospital-to-community transition period in cardiovascular disease patients (Txt2Prevent) [The use of texting messaging to improve the hospital-to-community transition and prevent readmission in patients with cardiovascular disease (Txt2Prevent)]. clinicaltrials.gov/ct2/show/NCT02336919 (first received 13 January 2015). RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of SMS text messaging to improve the hospital-to-community transition in patients with acute coronary syndrome (Txt2Prevent): results from a pilot randomized controlled trial. JMIR mHealth and uHealth2021;9(5):e24530. [DOI: 10.2196/24530]RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of text messaging to improve the hospital-to-community transition in acute coronary syndrome patients (Txt2Prevent): intervention development and pilot randomized controlled trial protocol. JMIR Research Protocols2017;6(5):e91. [DOI: 10.2196/resprot.6968]">Ross 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication adherence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>8‐item Morisky Medication Adherence Scale (high score indicates better adherence)</p> <p>Low adherence (&lt; 6), medium adherence (6 to 7), or high adherence (8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Continuous</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean (95% CI) = 6.75 (6.34 to 7.16)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean (95% CI) = 7.05 (6.72 to 7.38)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean difference −0.30, 95% CI −0.83 to 0.23; P = 0.27</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of high medication adherence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Categorical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>34%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>"When categorized into low, medium, and high adherence, 34% (11/32) of those in the Txt2Prevent group and 42% (15/36) of those in the usual care group were classified as high‐adherers (χ2 2=2.10, <i>P</i>=.35)." </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD011851-bbs2-0018" title="HuoX , SpatzES , DingQ , HorakP , ZhengX , MastersC , et al. Design and rationale of the Cardiovascular Health and Text Messaging (CHAT) study and the CHAT-Diabetes Mellitus (CHAT-DM) study: two randomised controlled trials of text messaging to improve secondary prevention for coronary heart disease and diabetes. BMJ Open2017;7(12):e018302. [DOI: 10.1136/bmjopen-2017-018302]ZhengX , SpatzES , BaiX , HuoX , DingQ , HorakP , et al. Effect of text messaging on risk factor management in patients with coronary heart disease: the CHAT randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(4):e005616. [DOI: 10.1161/CIRCOUTCOMES.119.005616]">Zheng 2019</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication ‐ ACE inhibitor/ARB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p>Categorical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p>411</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40.9%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p>411</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>46.2%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.96, 95% CI 0.9 to 1.1; P = 0.35</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication ‐ aspirin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90.8%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.00, 95% CI 0.97 to 1.02; P = 0.78</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication ‐ beta‐blocker</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58.2%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>64%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.00, 95% CI 0.95 to 1.1; P = 0.76</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication ‐ statin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>85.4%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>85.2%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.01, 95% CI 0.96 to 1.05; P = 0.78</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication ‐ calcium channel blocker</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17.5%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19.7%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.98, 95% CI 0.8 to 1.2; P = 0.83</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication ‐ diuretics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.2%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.9%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.20, 95% CI 0.7 to 2.1; P = 0.60</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication ‐ aspirin + statin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>81.3%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80.3%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.00, 95% CI 0.95 to 1.05; P = 0.99</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>ACE: angiotensin‐converting enzyme; ARB: angiotensin II receptor blockers; CI: confidence interval; IQR: interquartile range; OR: odds ratio; RR: risk ratio; SD: standard deviation; SMS: short message service </p> </div> </div> <section id="CD011851-sec-0062"> <h6 class="title">Validated survey measures</h6> <p>The most commonly used method to assess medication adherence was survey. A total of 11 studies used validated surveys to measure medication adherence. Eight studies measured medication adherence with the validated eight‐item Morisky Medication Adherence Scale (MMAS‐8) (<a href="./references#CD011851-bbs2-0001" title="BaeJW , WooSI , LeeJ , ParkSD , KwonSW , ChoiSH , et al. mHealth interventions for lifestyle and risk factor modification in coronary heart disease: randomized controlled trial. JMIR mHealth and uHealth2021;9(9):e29928. [DOI: 10.2196/29928]KCT0005087. Effect of text messaging program on lifestyle and clinical outcomes in patients with cardiovascular disease. cris.nih.go.kr/cris/search/detailSearch.do/19282 (first received 11 September 2019). ">Bae 2021</a>; <a href="./references#CD011851-bbs2-0006" title="ACTRN12613000901707. Text4Heart: a text message and internet-based comprehensive cardiac rehabilitation intervention [A randomised controlled trial to determine the efficacy of a text message and Internet-based comprehensive cardiac rehabilitation programme to improve adherence to lifestyle change compared with usual care in New Zealand adults with a diagnosis of cardiovascular disease]. anzctr.org.au/ACTRN12613000901707.aspx (first received 9 August 2013). DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Improving coronary heart disease self-management using mobile technologies (Text4Heart): a randomised controlled trial protocol. Trials2014;15(71):1-9. [DOI: 10.1186/1745-6215-15-71]DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Text message and internet support for coronary heart disease self-management: results from the Text4Heart randomized controlled trial. Journal of Medical Internet Research2015;17(10):e237. [DOI: 10.2196/jmir.4944]">Dale 2015a</a>; <a href="./references#CD011851-bbs2-0007" title="FangR , LiX . Electronic messaging support service programs improve adherence to lipid-lowering therapy among outpatients with coronary artery disease: an exploratory randomised control study. Journal of Clinical Nursing2016;25(5-6):664-71. [DOI: 10.1111/jocn.12988]">Fang 2016</a>; <a href="./references#CD011851-bbs2-0009" title="KamalAK , ShaikQN , PashaO , AzamI , IslamM , MemonAA , et al. Improving medication adherence in stroke patients through Short Text Messages (SMS4Stroke)-study protocol for a randomized, controlled trial. BMC Neurology2015;15:157. [DOI: 10.1186/s12883-015-0413-2]KamalAK , ShaikhQ , PashaO , AzamI , IslamM , MemonAA , et al. A randomized controlled behavioral intervention trial to improve medication adherence in adult stroke patients with prescription tailored short messaging service (SMS)-SMS4Stroke study. BMC Neurolology2015;15:212. [DOI: 10.1186/s12883-015-0471-5]">Kamal 2015</a>; <a href="./references#CD011851-bbs2-0010" title="KhonsariS , SubramanianP , ChinnaK , LatifLA , LingLW , GholamiO . Effect of a reminder system using an automated short message service on medication adherence following acute coronary syndrome. European Journal of Cardiovascular Nursing2015;14(2):170-9. [DOI: 10.1177/1474515114521910]">Khonsari 2015</a>; <a href="./references#CD011851-bbs2-0011" title="ACTRN12616000422426. Text4Heart Partnership: a text messaging program to enhance self-management of cardiovascular disease [Text messaging to enhance self-management of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12616000422426 (first received 23 March 2016). MaddisonR , JiangY , StewartR , ScottT , KerrA , WhittakerR , et al. An intervention to improve medication adherence in people with heart disease (Text4HeartII): randomized controlled trial. JMIR mHealth and uHealth2021;9(6):e24952. [DOI: 10.2196/24952]MaddisonR , StewartR , DoughtyR , ScottT , KerrA , BenatarJ , et al. Text4Heart II - improving medication adherence in people with heart disease: a study protocol for a randomized controlled trial. Trials2018;19(1):70. [DOI: 10.1186/s13063-018-2468-z]">Maddison 2021</a>; <a href="./references#CD011851-bbs2-0014" title="ParkLG , Howie-EsquivelJ , ChungM , DracupK . A text messaging intervention improves medication adherence for patients with coronary heart disease: a randomized controlled trial. Circulation2013;128(Suppl 22):A15249. [DOI: 10.1161/circ.128.suppl_22.A15249]ParkLG , Howie-EsquivelJ , ChungML , DracupK . A text messaging intervention to promote medication adherence for patients with coronary heart disease: a randomized controlled trial. Patient Education and Counseling2014;94(2):261-8. [DOI: 10.1016/j.pec.2013.10.027]ParkLG , Howie-EsquivelJ , WhooleyMA , DracupK . Psychosocial factors and medication adherence among patients with coronary heart disease: a text messaging intervention. European Journal of Cardiovascular Nursing2015;14(3):264-73. [DOI: 10.1177/1474515114537024]">Park 2014a</a>; <a href="./references#CD011851-bbs2-0017" title="NCT02336919. The use of texting messaging to improve the hospital-to-community transition period in cardiovascular disease patients (Txt2Prevent) [The use of texting messaging to improve the hospital-to-community transition and prevent readmission in patients with cardiovascular disease (Txt2Prevent)]. clinicaltrials.gov/ct2/show/NCT02336919 (first received 13 January 2015). RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of SMS text messaging to improve the hospital-to-community transition in patients with acute coronary syndrome (Txt2Prevent): results from a pilot randomized controlled trial. JMIR mHealth and uHealth2021;9(5):e24530. [DOI: 10.2196/24530]RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of text messaging to improve the hospital-to-community transition in acute coronary syndrome patients (Txt2Prevent): intervention development and pilot randomized controlled trial protocol. JMIR Research Protocols2017;6(5):e91. [DOI: 10.2196/resprot.6968]">Ross 2021</a>). MMAS‐8 is a patient‐reported metric and validated tool that is widely used in adherence research. Three studies used other validated surveys to measure medication adherence, including the three‐item, five‐point Voils Extent Scale (<a href="./references#CD011851-bbs2-0012" title="NCT02793830. A mobile phone based medication reminder program [A mobile phone based medication reminder program for patients in China with coronary heart disease: a pilot study]. clinicaltrials.gov/ct2/show/NCT02793830 (first received 8 June 2016). NiZ , WuB , YangQ , YanLL , LiuC , ShawRJ . An mHealth intervention to improve medication adherence and health outcomes among patients with coronary heart disease: randomized controlled trial. Journal of Medical Internet Research2022;24(3):e27202. [DOI: 10.2196/27202]">Ni 2022</a>), Measurement of Adherence to Treatments (MAT) form (<a href="./references#CD011851-bbs2-0015" title="NCT03414190. Impact of text messages to promote secondary prevention after acute coronary syndrome [Impact of a mobile phone text messages intervention on the secondary prevention of cardiovascular events after acute coronary syndrome]. clinicaltrials.gov/show/NCT03414190 (first received 29 January 2018). PassagliaLG , BrantLC , NascimentoBR , RibeiroAL . Impact of text messages in a middle-income country to promote secondary prevention after acute coronary syndrome (IMPACS): a randomized trial. Medicine2019;98(22):e15681. [DOI: 10.1097/MD.0000000000015681]PassagliaLG , BrantLC , SilvaJL , NascimentoBR , RibeiroAL . Text messages to promote secondary prevention after acute coronary syndrome (IMPACS trial). International Journal of Cardiovascular Sciences2021;35(2):202-13. [DOI: 10.36660/ijcs.20200378]">Passaglia 2021</a>), and Medication Adherence Report Scale‐5 (MARS‐5) (<a href="./references#CD011851-bbs2-0002" title="BermonA , UribeAF , Pérez-RiveroPF , Prieto-MerinoD , SaaibiJF , SilvaFA , et al. Efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: TXT2HEART Colombia randomized controlled trial. JMIR mHealth and uHealth2021;9(7):e25548. [DOI: 10.2196/25548]BermonA , Uribe-RodríguezAF , Pérez-RiveroPF , Prieto-MerinoD , RiveraDIC , GuioE , et al. Evaluation of the efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: the txt2heart Colombia randomised controlled trial protocol. BMJ Open2019;9:e028017. [DOI: 10.1136/ bmjopen-2018-028017]NCT03098186. TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention [TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention]. clinicaltrials.gov/ct2/show/NCT03098186 (first received 3 March 2017). ">Bermon 2021</a>). </p> <p><a href="./references#CD011851-bbs2-0006" title="ACTRN12613000901707. Text4Heart: a text message and internet-based comprehensive cardiac rehabilitation intervention [A randomised controlled trial to determine the efficacy of a text message and Internet-based comprehensive cardiac rehabilitation programme to improve adherence to lifestyle change compared with usual care in New Zealand adults with a diagnosis of cardiovascular disease]. anzctr.org.au/ACTRN12613000901707.aspx (first received 9 August 2013). DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Improving coronary heart disease self-management using mobile technologies (Text4Heart): a randomised controlled trial protocol. Trials2014;15(71):1-9. [DOI: 10.1186/1745-6215-15-71]DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Text message and internet support for coronary heart disease self-management: results from the Text4Heart randomized controlled trial. Journal of Medical Internet Research2015;17(10):e237. [DOI: 10.2196/jmir.4944]">Dale 2015a</a> followed up 116 participants for six months and found that participants in the intervention group had a greater medication adherence score (mean difference (MD) 0.58, 95% confidence interval (CI) 0.19, 0.97; P = 0.004) compared to usual care. In particular, this was an MMAS‐8 score of 7.3 (standard deviation (SD) 0.9) for the intervention group and 6.8 (SD 1.2) for the control group at six months' follow‐up. <a href="./references#CD011851-bbs2-0007" title="FangR , LiX . Electronic messaging support service programs improve adherence to lipid-lowering therapy among outpatients with coronary artery disease: an exploratory randomised control study. Journal of Clinical Nursing2016;25(5-6):664-71. [DOI: 10.1111/jocn.12988]">Fang 2016</a>, had a three‐arm design with SMS, SMS + micro letter, or telephone calls (follow‐up of six months and 271 participants analysed) and reported that participants given SMS alone had reduced odds of being non‐adherent compared to those who received telephone reminders (odds ratio (OR) 0.34, 95% CI 0.18 to 0.63), and that participants given SMS + micro letter had the lowest odds of being non‐adherent compared to telephone reminders (OR 0.07, 95% CI 0.03 to 0.15). <a href="./references#CD011851-bbs2-0009" title="KamalAK , ShaikQN , PashaO , AzamI , IslamM , MemonAA , et al. Improving medication adherence in stroke patients through Short Text Messages (SMS4Stroke)-study protocol for a randomized, controlled trial. BMC Neurology2015;15:157. [DOI: 10.1186/s12883-015-0413-2]KamalAK , ShaikhQ , PashaO , AzamI , IslamM , MemonAA , et al. A randomized controlled behavioral intervention trial to improve medication adherence in adult stroke patients with prescription tailored short messaging service (SMS)-SMS4Stroke study. BMC Neurolology2015;15:212. [DOI: 10.1186/s12883-015-0471-5]">Kamal 2015</a> (200 participants, two‐month follow‐up) reported higher levels of adherence in the intervention arm (adjusted MD 0.54, 95% CI 0.22 to 0.85). <a href="./references#CD011851-bbs2-0010" title="KhonsariS , SubramanianP , ChinnaK , LatifLA , LingLW , GholamiO . Effect of a reminder system using an automated short message service on medication adherence following acute coronary syndrome. European Journal of Cardiovascular Nursing2015;14(2):170-9. [DOI: 10.1177/1474515114521910]">Khonsari 2015</a> (62 participants) reported that "the risk of being low adherent [(score 3‐8 according to <a href="./references#CD011851-bbs2-0081" title="MoriskyDE , GreenLW , LevineDM . Concurrent and predictive validity of a self-reported measure of medication adherence. Medical Care1986;24:67-74. [DOI: 10.1097/00005650-198601000-00007]">Morisky 1986</a>)] among the control group is 4.09 times greater than the intervention group (Relative Risk (RR) 4.09, 95% CI 1.82 to 9.18, p&lt;0.001)" at eight weeks' follow‐up. The same study also reported that the proportion of participants with low adherence at two‐month follow‐up was 16.1% in the intervention group and 58.1% in the control group. <a href="./references#CD011851-bbs2-0014" title="ParkLG , Howie-EsquivelJ , ChungM , DracupK . A text messaging intervention improves medication adherence for patients with coronary heart disease: a randomized controlled trial. Circulation2013;128(Suppl 22):A15249. [DOI: 10.1161/circ.128.suppl_22.A15249]ParkLG , Howie-EsquivelJ , ChungML , DracupK . A text messaging intervention to promote medication adherence for patients with coronary heart disease: a randomized controlled trial. Patient Education and Counseling2014;94(2):261-8. [DOI: 10.1016/j.pec.2013.10.027]ParkLG , Howie-EsquivelJ , WhooleyMA , DracupK . Psychosocial factors and medication adherence among patients with coronary heart disease: a text messaging intervention. European Journal of Cardiovascular Nursing2015;14(3):264-73. [DOI: 10.1177/1474515114537024]">Park 2014a</a>, with the shortest follow‐up of 30 days and 28 participants analysed in each group, reported a baseline MMAS‐8 score of 6.20 (SD 1.66) for the intervention group and 5.85 (SD 2.10) for the control group. At follow‐up, the score had risen for both groups, but was higher for the control group at 6.73 (SD 1.49) than for the intervention group at 6.43 (SD 1.22) (no P value reported). <a href="./references#CD011851-bbs2-0012" title="NCT02793830. A mobile phone based medication reminder program [A mobile phone based medication reminder program for patients in China with coronary heart disease: a pilot study]. clinicaltrials.gov/ct2/show/NCT02793830 (first received 8 June 2016). NiZ , WuB , YangQ , YanLL , LiuC , ShawRJ . An mHealth intervention to improve medication adherence and health outcomes among patients with coronary heart disease: randomized controlled trial. Journal of Medical Internet Research2022;24(3):e27202. [DOI: 10.2196/27202]">Ni 2022</a> found that the mean decrease in medication non‐adherence score in the intervention group (−1.58, SD 2.49) was greater than in the control group (−0.08, SD 3.15) at 90 days (P &lt; 0.001). <a href="./references#CD011851-bbs2-0015" title="NCT03414190. Impact of text messages to promote secondary prevention after acute coronary syndrome [Impact of a mobile phone text messages intervention on the secondary prevention of cardiovascular events after acute coronary syndrome]. clinicaltrials.gov/show/NCT03414190 (first received 29 January 2018). PassagliaLG , BrantLC , NascimentoBR , RibeiroAL . Impact of text messages in a middle-income country to promote secondary prevention after acute coronary syndrome (IMPACS): a randomized trial. Medicine2019;98(22):e15681. [DOI: 10.1097/MD.0000000000015681]PassagliaLG , BrantLC , SilvaJL , NascimentoBR , RibeiroAL . Text messages to promote secondary prevention after acute coronary syndrome (IMPACS trial). International Journal of Cardiovascular Sciences2021;35(2):202-13. [DOI: 10.36660/ijcs.20200378]">Passaglia 2021</a> reported no difference in the proportion of participants who adhered to the medications between intervention (88%) and control group (93.1%) at six months' follow‐up (P = 0.297). <a href="./references#CD011851-bbs2-0017" title="NCT02336919. The use of texting messaging to improve the hospital-to-community transition period in cardiovascular disease patients (Txt2Prevent) [The use of texting messaging to improve the hospital-to-community transition and prevent readmission in patients with cardiovascular disease (Txt2Prevent)]. clinicaltrials.gov/ct2/show/NCT02336919 (first received 13 January 2015). RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of SMS text messaging to improve the hospital-to-community transition in patients with acute coronary syndrome (Txt2Prevent): results from a pilot randomized controlled trial. JMIR mHealth and uHealth2021;9(5):e24530. [DOI: 10.2196/24530]RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of text messaging to improve the hospital-to-community transition in acute coronary syndrome patients (Txt2Prevent): intervention development and pilot randomized controlled trial protocol. JMIR Research Protocols2017;6(5):e91. [DOI: 10.2196/resprot.6968]">Ross 2021</a> showed no differences in medication adherence scores between intervention and control groups at 60 days (MD −0.3, 95% CI −0.83 to 0.23; P = 0.27). <a href="./references#CD011851-bbs2-0011" title="ACTRN12616000422426. Text4Heart Partnership: a text messaging program to enhance self-management of cardiovascular disease [Text messaging to enhance self-management of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12616000422426 (first received 23 March 2016). MaddisonR , JiangY , StewartR , ScottT , KerrA , WhittakerR , et al. An intervention to improve medication adherence in people with heart disease (Text4HeartII): randomized controlled trial. JMIR mHealth and uHealth2021;9(6):e24952. [DOI: 10.2196/24952]MaddisonR , StewartR , DoughtyR , ScottT , KerrA , BenatarJ , et al. Text4Heart II - improving medication adherence in people with heart disease: a study protocol for a randomized controlled trial. Trials2018;19(1):70. [DOI: 10.1186/s13063-018-2468-z]">Maddison 2021</a> found a higher medication adherence score in the control group than in the intervention group (adjusted MD 0.3, 95% CI 0.01 to 0.59; P = 0.04). <a href="./references#CD011851-bbs2-0002" title="BermonA , UribeAF , Pérez-RiveroPF , Prieto-MerinoD , SaaibiJF , SilvaFA , et al. Efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: TXT2HEART Colombia randomized controlled trial. JMIR mHealth and uHealth2021;9(7):e25548. [DOI: 10.2196/25548]BermonA , Uribe-RodríguezAF , Pérez-RiveroPF , Prieto-MerinoD , RiveraDIC , GuioE , et al. Evaluation of the efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: the txt2heart Colombia randomised controlled trial protocol. BMJ Open2019;9:e028017. [DOI: 10.1136/ bmjopen-2018-028017]NCT03098186. TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention [TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention]. clinicaltrials.gov/ct2/show/NCT03098186 (first received 3 March 2017). ">Bermon 2021</a> did not find differences in medication adherence at 12 months between intervention and control groups (MD −0.01, 95% CI −0.4 to 0.4; P = 0.96). <a href="./references#CD011851-bbs2-0001" title="BaeJW , WooSI , LeeJ , ParkSD , KwonSW , ChoiSH , et al. mHealth interventions for lifestyle and risk factor modification in coronary heart disease: randomized controlled trial. JMIR mHealth and uHealth2021;9(9):e29928. [DOI: 10.2196/29928]KCT0005087. Effect of text messaging program on lifestyle and clinical outcomes in patients with cardiovascular disease. cris.nih.go.kr/cris/search/detailSearch.do/19282 (first received 11 September 2019). ">Bae 2021</a> reported no difference between intervention and control groups at six months (MD 0.07, 95% CI −0.03 to 0.16; P = 0.19). </p> </section> <section id="CD011851-sec-0063"> <h6 class="title">Objective measures</h6> <p>In addition to the MMAS‐8 score, <a href="./references#CD011851-bbs2-0014" title="ParkLG , Howie-EsquivelJ , ChungM , DracupK . A text messaging intervention improves medication adherence for patients with coronary heart disease: a randomized controlled trial. Circulation2013;128(Suppl 22):A15249. [DOI: 10.1161/circ.128.suppl_22.A15249]ParkLG , Howie-EsquivelJ , ChungML , DracupK . A text messaging intervention to promote medication adherence for patients with coronary heart disease: a randomized controlled trial. Patient Education and Counseling2014;94(2):261-8. [DOI: 10.1016/j.pec.2013.10.027]ParkLG , Howie-EsquivelJ , WhooleyMA , DracupK . Psychosocial factors and medication adherence among patients with coronary heart disease: a text messaging intervention. European Journal of Cardiovascular Nursing2015;14(3):264-73. [DOI: 10.1177/1474515114537024]">Park 2014a</a> used a medication event monitoring system (MEMS) (opening of the two electronic pill bottles provided a time‐stamp corresponding with medication self‐administration) to test for medication adherence, with the following results. Antiplatelet doses taken on schedule were 86.2% (SD 15.4) in the intervention group and 85.7% (SD 18.2) in the control group. For statins, 84.1% (SD 19.4) of doses were taken on schedule by the intervention group and 79.7% (SD 19.3) in the control group. The correct number of antiplatelet doses taken were 88.0% (SD 14.0) in the intervention group and 87.2% (SD 16.5) in the control group. For statins, the correct number of doses taken was 85.4% (SD 16.6) in the intervention group and 81.3% (SD 16.4) in the control group. </p> <p><a href="./references#CD011851-bbs2-0011" title="ACTRN12616000422426. Text4Heart Partnership: a text messaging program to enhance self-management of cardiovascular disease [Text messaging to enhance self-management of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12616000422426 (first received 23 March 2016). MaddisonR , JiangY , StewartR , ScottT , KerrA , WhittakerR , et al. An intervention to improve medication adherence in people with heart disease (Text4HeartII): randomized controlled trial. JMIR mHealth and uHealth2021;9(6):e24952. [DOI: 10.2196/24952]MaddisonR , StewartR , DoughtyR , ScottT , KerrA , BenatarJ , et al. Text4Heart II - improving medication adherence in people with heart disease: a study protocol for a randomized controlled trial. Trials2018;19(1):70. [DOI: 10.1186/s13063-018-2468-z]">Maddison 2021</a> provided an objective assessment of medication adherence at 24 and 52 weeks based on a medication possession ratio (MPR) of 80% or more for three medication classes (statin, aspirin, and blood pressure‐lowering medications). Adherence to the three medication classes was lower in the intervention group than in the control group at 24 weeks (OR 0.60, 95% CI 0.38 to 0.96; P = 0.03) and 52 weeks (OR 0.56, 95% CI 0.35 to 0.89; P = 0.01). </p> <p>In <a href="./references#CD011851-bbs2-0005" title="ACTRN12613000793718. TEXT messages to improve MEDication adherence &amp; Secondary prevention – TEXTMEDS [TEXT messages to improve MEDication adherence &amp; Secondary prevention in patients with acute coronary syndrome - TEXTMEDS]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364448&amp;isReview=true (first received 18 June 2013). ChowCK , KlimisH , ThiagalingamA , RedfernJ , HillisGS , BriegerD , et al. Text messages to improve medication adherence and secondary prevention after acute coronary syndrome: the TEXTMEDS randomized clinical trial. Circulation2022;145(19):1443-55. [DOI: 10.1161/CIRCULATIONAHA.121.056161]ChowCK , ThiagalingamA , SantoK , KokC , ThakkarJ , StepienS , et al. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol. BMJ Open2018;8:e019463. [DOI: 10.1136/bmjopen-2017-019463]">Chow 2022</a>, self‐reported cardioprotective medication use was validated through prescription data obtained via linkage with the Pharmaceutical Benefits Scheme (PBS), which is a comprehensive database for all prescribed medications in Australia (<a href="./references#CD011851-bbs2-0061" title="Department of Health and Aged Care. Pharmaceutical Benefits Scheme (PBS). www.pbs.gov.au/pbs/home (accessed 30 August 2023).">Department of Health and Aged Care 2023</a>). The authors found no evidence of a difference in medication adherence between the intervention and control groups. </p> <p>In addition to self‐reported aspirin adherence, <a href="./references#CD011851-bbs2-0016" title="QuiliciJ , FugonL , BeguinS , MorangePE , BonnetJL , AlessiMC , et al. Effect of motivational mobile phone short message service on aspirin adherence after coronary stenting for acute coronary syndrome. International Journal of Cardiology2013;168(1):568-9. [DOI: 10.1016/j.ijcard.2013.01.252]">Quilici 2013</a> also objectively measured aspirin adherence by platelet function testing. They found that text messaging might result in a reduction in non‐adherence to medication (OR 0.43, 95% CI 0.22 to 0.86; P = 0.01). </p> </section> <section id="CD011851-sec-0064"> <h6 class="title">Self‐reported measures</h6> <p><a href="./references#CD011851-bbs2-0013" title="NCT02783287. The impact of text messaging on medication adherence and exercise regimen among post-myocardial infarction patients. clinicaltrials.gov/ct2/show/NCT02783287 (first received 26 May 2016). PandeyA , ChoudhryN . An m-health application of daily text messages to address forgetfulness as contributor to non-adherence to medications post-myocardial infarction. Circulation2015;132:A18641. [DOI: 10.1161/circ.132.suppl_3.18641]PandeyA , KrummeAA , PatelT , ChoudhryNK . The impact of text messaging on medication adherence and exercise among postmyocardial infarction patients: randomized controlled pilot trial. JMIR mHealth and uHealth2017;5(8):e110. [DOI: 10.2196/mhealth.7144]PandeyAK , ChoudhryN . Text message reminders to address medication non-adherence in post-MI patients: a one year intervention study. Canadian Journal of Cardiology2014;30(10):S179. [DOI: 10.1016/j.cjca.2014.07.280]">Pandey 2017</a> assessed medication adherence in 33 participants with self‐reported logs at 12 months. This resulted in 90% adherence in the intervention group compared to 70% in the control group (P &lt; 0.001). Self‐reported data from <a href="./references#CD011851-bbs2-0016" title="QuiliciJ , FugonL , BeguinS , MorangePE , BonnetJL , AlessiMC , et al. Effect of motivational mobile phone short message service on aspirin adherence after coronary stenting for acute coronary syndrome. International Journal of Cardiology2013;168(1):568-9. [DOI: 10.1016/j.ijcard.2013.01.252]">Quilici 2013</a> differed between the text and Figure 2, but showed a higher adherence in the intervention group at 30 days' follow‐up (96.4% (text)/97.2% (Figure 2)) than in the control group (93.6% (text)/92.8 (Figure 2)). The OR for self‐reported aspirin non‐adherence as provided in the paper was 0.37 (95% CI 0.15 to 0.90; P = 0.02). The platelet testing confirmed this by showing a 94.8% adherence in the intervention group and 88.8% in the control group. The paper reported the OR for non‐adherence as 0.43 (95% CI 0.22 to 0.86; P = 0.01). <a href="./references#CD011851-bbs2-0001" title="BaeJW , WooSI , LeeJ , ParkSD , KwonSW , ChoiSH , et al. mHealth interventions for lifestyle and risk factor modification in coronary heart disease: randomized controlled trial. JMIR mHealth and uHealth2021;9(9):e29928. [DOI: 10.2196/29928]KCT0005087. Effect of text messaging program on lifestyle and clinical outcomes in patients with cardiovascular disease. cris.nih.go.kr/cris/search/detailSearch.do/19282 (first received 11 September 2019). ">Bae 2021</a> and <a href="./references#CD011851-bbs2-0005" title="ACTRN12613000793718. TEXT messages to improve MEDication adherence &amp; Secondary prevention – TEXTMEDS [TEXT messages to improve MEDication adherence &amp; Secondary prevention in patients with acute coronary syndrome - TEXTMEDS]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364448&amp;isReview=true (first received 18 June 2013). ChowCK , KlimisH , ThiagalingamA , RedfernJ , HillisGS , BriegerD , et al. Text messages to improve medication adherence and secondary prevention after acute coronary syndrome: the TEXTMEDS randomized clinical trial. Circulation2022;145(19):1443-55. [DOI: 10.1161/CIRCULATIONAHA.121.056161]ChowCK , ThiagalingamA , SantoK , KokC , ThakkarJ , StepienS , et al. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol. BMJ Open2018;8:e019463. [DOI: 10.1136/bmjopen-2017-019463]">Chow 2022</a> measured self‐reported medication adherence by assessing if the proportion of indicated medications taken was &gt; 80% (&gt; 24/30 days in the preceding one month). <a href="./references#CD011851-bbs2-0001" title="BaeJW , WooSI , LeeJ , ParkSD , KwonSW , ChoiSH , et al. mHealth interventions for lifestyle and risk factor modification in coronary heart disease: randomized controlled trial. JMIR mHealth and uHealth2021;9(9):e29928. [DOI: 10.2196/29928]KCT0005087. Effect of text messaging program on lifestyle and clinical outcomes in patients with cardiovascular disease. cris.nih.go.kr/cris/search/detailSearch.do/19282 (first received 11 September 2019). ">Bae 2021</a> resulted in 98.2% adherence in the intervention group compared to 92.1% in the control group (risk ratio (RR) 1.1, 95% CI 1.0 to 1.1; P &lt; 0.001) at six months. <a href="./references#CD011851-bbs2-0005" title="ACTRN12613000793718. TEXT messages to improve MEDication adherence &amp; Secondary prevention – TEXTMEDS [TEXT messages to improve MEDication adherence &amp; Secondary prevention in patients with acute coronary syndrome - TEXTMEDS]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364448&amp;isReview=true (first received 18 June 2013). ChowCK , KlimisH , ThiagalingamA , RedfernJ , HillisGS , BriegerD , et al. Text messages to improve medication adherence and secondary prevention after acute coronary syndrome: the TEXTMEDS randomized clinical trial. Circulation2022;145(19):1443-55. [DOI: 10.1161/CIRCULATIONAHA.121.056161]ChowCK , ThiagalingamA , SantoK , KokC , ThakkarJ , StepienS , et al. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol. BMJ Open2018;8:e019463. [DOI: 10.1136/bmjopen-2017-019463]">Chow 2022</a> measured adherence to each medication class (aspirin, beta‐blocker, ACEI/ARB, statin, second antiplatelet) and combined five medications at 12 months; however, no evidence of an effect was found. <a href="./references#CD011851-bbs2-0002" title="BermonA , UribeAF , Pérez-RiveroPF , Prieto-MerinoD , SaaibiJF , SilvaFA , et al. Efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: TXT2HEART Colombia randomized controlled trial. JMIR mHealth and uHealth2021;9(7):e25548. [DOI: 10.2196/25548]BermonA , Uribe-RodríguezAF , Pérez-RiveroPF , Prieto-MerinoD , RiveraDIC , GuioE , et al. Evaluation of the efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: the txt2heart Colombia randomised controlled trial protocol. BMJ Open2019;9:e028017. [DOI: 10.1136/ bmjopen-2018-028017]NCT03098186. TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention [TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention]. clinicaltrials.gov/ct2/show/NCT03098186 (first received 3 March 2017). ">Bermon 2021</a> measured self‐reported medication adherence through the assessment of participant’s subjective medication intake compliance on days 7 and 30. No differences were found on days 7 and 30. <a href="./references#CD011851-bbs2-0003" title="ChenC , LiX , KangY , LiuH , LiangYD , ZhangQ . Post-discharge short service message improves short-term clinical outcome and self-care behavior in Chinese patients with chronic heart failure. European Heart Journal2018;39(Suppl 1):797-8. [DOI: 10.1093/eurheartj/ehy563.P3770]ChenC , LiX , SunL , CaoS , KangY , HongL , et al. Post-discharge short message service improves short-term clinical outcome and self-care behaviour in chronic heart failure. ESC Heart Failure2019;6(1):164-73. [DOI: 10.1002/ehf2.12380]ChiCTR-INR-17012316. Effect of post-discharge text messages on clinical outcomes in patients with heart failure [Effect of post-discharge text messages on clinical outcomes in patients with heart failure]. trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR-INR-17012316 (first received 9 August 2018). LiX , ChenC , YouGY , ZhangQ . Post-discharge text messaging intervention improved clinical outcomes in patients with heart failure. European Heart Journal2016;37(Suppl 1):727-8. [DOI: 10.1093/eurheartj/ehw433]">Chen 2019</a> assessed medication adherence at six months by asking if participants took medication as prescribed without any medication withdrawal and reduction. They found that medication adherence in the intervention group (78.9%) was higher than in the control group (69.5%), with an RR of 1.14 (95% CI 1.01 to 1.28; P = 0.029). <a href="./references#CD011851-bbs2-0018" title="HuoX , SpatzES , DingQ , HorakP , ZhengX , MastersC , et al. Design and rationale of the Cardiovascular Health and Text Messaging (CHAT) study and the CHAT-Diabetes Mellitus (CHAT-DM) study: two randomised controlled trials of text messaging to improve secondary prevention for coronary heart disease and diabetes. BMJ Open2017;7(12):e018302. [DOI: 10.1136/bmjopen-2017-018302]ZhengX , SpatzES , BaiX , HuoX , DingQ , HorakP , et al. Effect of text messaging on risk factor management in patients with coronary heart disease: the CHAT randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(4):e005616. [DOI: 10.1161/CIRCOUTCOMES.119.005616]">Zheng 2019</a> reported medication usage at six months' follow‐up and did not find any difference in medication usage for each medication class (ACEI/ARB, aspirin, beta‐blocker, calcium channel blockers, diuretics, statin). Similarly, <a href="./references#CD011851-bbs2-0008" title="HuoX , KrumholzHM , BaiX , SpatzES , DingQ , HorakP , et al. Effects of mobile text messaging on glycemic control in patients with coronary heart disease and diabetes mellitus: a randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(9):e005805. [DOI: 10.1161/CIRCOUTCOMES.119.005805]NCT02883842. Cardiovascular Health and Text Messaging-Diabetes Mellitus (CHAT-DM) Study [Effectiveness of text messaging on risk factors control and medication adherence among patients with Coronary Heart Disease and Diabetes in China: cardiovascular health andtext messaging-Diabetes Mellitus (CHAT-DM) study]. clinicaltrials.gov/ct2/show/NCT02883842 (first received 30 August 2016). ">Huo 2019</a> reported the proportion of participants who were taking secondary preventive medications, insulin, and oral antidiabetic medication at six months; no evidence of differences was found. In addition, <a href="./references#CD011851-bbs2-0004" title="ACTRN12611000161921. Tobacco, EXercise and dieT MEssages (TEXT ME): the effect of semi-personalised lifestyle reminder text message intervention on cardiovascular disease risk [Tobacco, EXercise and dieT MEssages (TEXT ME): The effect of a semi-personalised lifestyle reminder text message intervention on cardiovascular risk factors in patients with cardiovascular disease and those who are at high risk of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12611000161921 (first received 3 February 2011). ChowCK , RedfernJ , HillisGS , ThakkarJ , SantoK , HackettML , et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA2015;314(12):1255-63. [DOI: 10.1001/jama.2015.10945]ChowCK , RedfernJ , ThiagalingamA , JanS , WhittakerR , HackettM , et al. Design and rationale of the tobacco, exercise and diet messages (TEXT ME) trial of a text message-based intervention for ongoing prevention of cardiovascular disease in people with coronary disease: a randomised controlled trial protocol. BMJ Open2012;2(1):e000606. [DOI: 10.1136/bmjopen-2011-000606]RedfernJ , SantoK , CooreyG , ThakkarJ , HackettM , ThiagalingamA , et al. Factors influencing engagement, perceived usefulness and behavioral mechanisms associated with a text message support program. PLOS ONE2016;11(10):e0163929. [DOI: 10.1371/journal.pone.0163929]ThakkarJ , RedfernJ , De KeizerL , ThiagalingamA , ChowC . Patient perceptions of text message-based intervention for secondary prevention of cardiovascular events. Heart, Lung and Circulation2013;22(Suppl 1):S264. [DOI: 10.1016/j.hlc.2013.05.630]ThakkarJ , RedfernJ , ThiagalingamA , ChowCK . Patterns, predictors and effects of texting intervention on physical activity in CHD – insights from the TEXT ME randomized clinical trial. European Journal of Preventive Cardiology2016;23(17):1894-902. [DOI: 10.1177/2047487316664190]">Chow 2015</a> reported the proportion of participants taking cardioprotective medications at six months' follow‐up. There were no differences in the proportion taking cardioprotective medications between groups. </p> </section> </section> <section id="CD011851-sec-0065"> <h5 class="title">Fatal cardiovascular events</h5> <p>Meta‐analysis using a random‐effects model found that text messaging may have little to no effect on fatal cardiovascular events compared to usual care (OR 0.83, 95% CI 0.47 to 1.45; I<sup>2</sup> = 0%; 4 studies, 1654 participants; low‐certainty evidence; <a href="./references#CD011851-fig-0004" title="">Analysis 1.1</a>). </p> <p>When using a fixed‐effect model in our sensitivity analysis, the estimate was exactly the same as the results from a random‐effects model (OR 0.83, 95% CI 0.47 to 1.45; I<sup>2</sup> = 0%; 4 studies, 1654 participants; low‐certainty evidence; <a href="./references#CD011851-fig-0005" title="">Analysis 1.2</a>). </p> </section> <section id="CD011851-sec-0066"> <h5 class="title">Non‐fatal cardiovascular events (coronary heart disease, revascularisation, stroke)</h5> <p>Meta‐analysis for non‐fatal cardiovascular events was not possible because of the lack of reported outcomes. We found very low‐certainty evidence that text messaging may have little to no effect on non‐fatal cardiovascular events. Only two studies reported non‐fatal cardiovascular events, and neither reported a difference between groups. </p> <p><a href="./references#CD011851-bbs2-0005" title="ACTRN12613000793718. TEXT messages to improve MEDication adherence &amp; Secondary prevention – TEXTMEDS [TEXT messages to improve MEDication adherence &amp; Secondary prevention in patients with acute coronary syndrome - TEXTMEDS]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364448&amp;isReview=true (first received 18 June 2013). ChowCK , KlimisH , ThiagalingamA , RedfernJ , HillisGS , BriegerD , et al. Text messages to improve medication adherence and secondary prevention after acute coronary syndrome: the TEXTMEDS randomized clinical trial. Circulation2022;145(19):1443-55. [DOI: 10.1161/CIRCULATIONAHA.121.056161]ChowCK , ThiagalingamA , SantoK , KokC , ThakkarJ , StepienS , et al. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol. BMJ Open2018;8:e019463. [DOI: 10.1136/bmjopen-2017-019463]">Chow 2022</a> reported a number of cardiovascular events, including myocardial infarction (intervention: 2.6% versus control: 2.8%), acute coronary syndrome (intervention: 1.1% versus control: 1.2%), new or worsening angina (intervention: 7.3% versus control: 8.1%), new or worsening heart failure (intervention: 1.7% versus control: 1.3%), coronary angiogram or percutaneous coronary intervention (PCI) (intervention: 8.8% versus control: 9.4%), coronary artery bypass graft (intervention: 3.4% versus control: 2.2%), stroke (intervention: 0.9% versus control: 0.6%), transient ischaemic attack (intervention: 0.6% versus control: 0.3%). <a href="./references#CD011851-bbs2-0003" title="ChenC , LiX , KangY , LiuH , LiangYD , ZhangQ . Post-discharge short service message improves short-term clinical outcome and self-care behavior in Chinese patients with chronic heart failure. European Heart Journal2018;39(Suppl 1):797-8. [DOI: 10.1093/eurheartj/ehy563.P3770]ChenC , LiX , SunL , CaoS , KangY , HongL , et al. Post-discharge short message service improves short-term clinical outcome and self-care behaviour in chronic heart failure. ESC Heart Failure2019;6(1):164-73. [DOI: 10.1002/ehf2.12380]ChiCTR-INR-17012316. Effect of post-discharge text messages on clinical outcomes in patients with heart failure [Effect of post-discharge text messages on clinical outcomes in patients with heart failure]. trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR-INR-17012316 (first received 9 August 2018). LiX , ChenC , YouGY , ZhangQ . Post-discharge text messaging intervention improved clinical outcomes in patients with heart failure. European Heart Journal2016;37(Suppl 1):727-8. [DOI: 10.1093/eurheartj/ehw433]">Chen 2019</a> reported no difference between the intervention group (27.4%) and the control group (31.9%) in the incidence of heart failure‐related events (OR 0.86, 95% CI 0.66 to 1.12; P &gt; 0.05 as reported by authors, results not shown in the forest plot). </p> </section> <section id="CD011851-sec-0067"> <h5 class="title">Combined cardiovascular disease (CVD) event (fatal or non‐fatal events)</h5> <p>Meta‐analysis for combined CVD event was not possible because of the lack of reported data. Based on one study, we found very low‐certainty evidence that text messaging may have little to no effect on combined CVD event. <a href="./references#CD011851-bbs2-0005" title="ACTRN12613000793718. TEXT messages to improve MEDication adherence &amp; Secondary prevention – TEXTMEDS [TEXT messages to improve MEDication adherence &amp; Secondary prevention in patients with acute coronary syndrome - TEXTMEDS]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364448&amp;isReview=true (first received 18 June 2013). ChowCK , KlimisH , ThiagalingamA , RedfernJ , HillisGS , BriegerD , et al. Text messages to improve medication adherence and secondary prevention after acute coronary syndrome: the TEXTMEDS randomized clinical trial. Circulation2022;145(19):1443-55. [DOI: 10.1161/CIRCULATIONAHA.121.056161]ChowCK , ThiagalingamA , SantoK , KokC , ThakkarJ , StepienS , et al. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol. BMJ Open2018;8:e019463. [DOI: 10.1136/bmjopen-2017-019463]">Chow 2022</a> reported no difference between the intervention group (18.2%) and the control group (17.9%) for combined CVD event (RR 1.02, 95% CI 0.81 to 1.28; P = 0.87, results not shown in the forest plot). </p> </section> </section> <section id="CD011851-sec-0068"> <h4 class="title">Secondary outcomes</h4> <section id="CD011851-sec-0069"> <h5 class="title">Low‐density lipoprotein (LDL) cholesterol for the effect of statins</h5> <p>Of the eight studies evaluating LDL, all of them analysed LDL as a continuous outcome. Meta‐analysis using a random‐effects model found that text messaging may have little to no effect on LDL cholesterol compared to usual care (MD −1.79 mg/dL, 95% CI −4.71 to 1.12; I<sup>2</sup> = 61%; 8 studies, 4983 participants; very low‐certainty evidence; <a href="./references#CD011851-fig-0006" title="">Analysis 1.3</a>), but the evidence is very uncertain. We converted mmol/L cholesterol to mg/dL using a multiplier of 38.67, as recommended by <a href="./references#CD011851-bbs2-0095" title="RuggeB , BalshemH , SehgalH , RelevoR , GormanP , HelfandM . Screening and Treatment of Subclinical Hypothyroidism or Hyperthyroidism. Report No.: 11(12)-EHC033-EF.AHRQ Comparative Effectiveness Reviews. Rockville, MD: Agency for Healthcare Research and Quality, 2011. [PMID: 22299183]">Rugge 2011</a>. </p> <p>When using a fixed‐effect model in our sensitivity analysis, we found that the evidence is very uncertain for the effect of text messaging on LDL cholesterol compared to usual care (MD −1.76 mg/dL, 95% CI −3.49 to −0.03; I<sup>2</sup> = 61%; 8 studies, 4983 participants; very low‐certainty evidence; <a href="./references#CD011851-fig-0007" title="">Analysis 1.4</a>). </p> <p>When excluding studies at high risk of bias, the evidence is very uncertain for the effect of text messaging on LDL cholesterol compared to usual care (MD −1.60 mg/dL, 95% CI −8.02 to 4.82; I<sup>2</sup> = 75%; 3 studies, 1872 participants; very low‐certainty evidence; <a href="./references#CD011851-fig-0008" title="">Analysis 1.5</a>). </p> </section> <section id="CD011851-sec-0070"> <h5 class="title">Blood pressure for antihypertensive drugs</h5> <section id="CD011851-sec-0071"> <h6 class="title">Systolic blood pressure (SBP)</h6> <p>Of the nine studies recording SBP, all of them reported SBP as a continuous outcome and reported endpoint value. However, one study only reported mean change from baseline within intervention and control groups, and SD for mean change (<a href="./references#CD011851-bbs2-0012" title="NCT02793830. A mobile phone based medication reminder program [A mobile phone based medication reminder program for patients in China with coronary heart disease: a pilot study]. clinicaltrials.gov/ct2/show/NCT02793830 (first received 8 June 2016). NiZ , WuB , YangQ , YanLL , LiuC , ShawRJ . An mHealth intervention to improve medication adherence and health outcomes among patients with coronary heart disease: randomized controlled trial. Journal of Medical Internet Research2022;24(3):e27202. [DOI: 10.2196/27202]">Ni 2022</a>). Mean/SD at the endpoint were not reported and could not be transformed due to lack of information. Consequently, data from this study could not be pooled, and it was excluded from the meta‐analysis. </p> <p>Meta‐analysis using a random‐effects model found that text messaging may have little to no effect on SBP compared to usual care (MD −0.93 mmHg, 95% CI −3.55 to 1.69; I<sup>2</sup> = 87%; 8 studies, 5173 participants; very low‐certainty evidence; <a href="./references#CD011851-fig-0009" title="">Analysis 1.6</a>), but the evidence is very uncertain. </p> <p>When using a fixed‐effect model in our sensitivity analysis, the results showed that text messaging may reduce SBP compared to usual care (MD −1.39 mmHg, 95% CI −2.27 to −0.51; I<sup>2</sup> = 87%; 8 studies, 5173 participants; very low‐certainty evidence; <a href="./references#CD011851-fig-0010" title="">Analysis 1.7</a>), but the evidence is very uncertain. </p> <p>When excluding studies at high risk of bias, the results showed that text messaging may have little to no effect on SBP compared to usual care (MD −0.13, 95% CI −2.28 to 2.02; I<sup>2</sup> = 46%; 3 studies, 2062 participants; very low‐certainty evidence; <a href="./references#CD011851-fig-0011" title="">Analysis 1.8</a>), but the evidence is very uncertain. </p> <p>We detected one outlier where the CI did not overlap with the CI of the summary effect size. When this outlier was removed, the sensitivity analysis showed that the evidence is very uncertain for the effects of text messaging on SBP (MD 0.04, 95% CI −1.26 to 1.34; I<sup>2</sup> = 36%; 7 studies, 4463 participants; very low‐certainty evidence; <a href="./references#CD011851-fig-0012" title="">Analysis 1.9</a>). </p> </section> <section id="CD011851-sec-0072"> <h6 class="title">Diastolic blood pressure (DBP)</h6> <p>Of the six studies evaluating DBP, all of them analysed DBP as a continuous outcome and reported endpoint value. However, one study only reported mean change from baseline within intervention and control groups, and SD for mean change (<a href="./references#CD011851-bbs2-0012" title="NCT02793830. A mobile phone based medication reminder program [A mobile phone based medication reminder program for patients in China with coronary heart disease: a pilot study]. clinicaltrials.gov/ct2/show/NCT02793830 (first received 8 June 2016). NiZ , WuB , YangQ , YanLL , LiuC , ShawRJ . An mHealth intervention to improve medication adherence and health outcomes among patients with coronary heart disease: randomized controlled trial. Journal of Medical Internet Research2022;24(3):e27202. [DOI: 10.2196/27202]">Ni 2022</a>). Mean/SD at the endpoint were not reported and could not be transformed due to lack of information. Consequently, data from this study could not be pooled, and it was excluded from the meta‐analysis. </p> <p>Meta‐analysis using a random‐effects model found that text messaging may have little to no effect on DBP compared to usual care (MD −1.00 mmHg, 95% CI −2.49 to 0.50; I<sup>2</sup> = 67%; 5 studies, 3137 participants; very low‐certainty evidence; <a href="./references#CD011851-fig-0013" title="">Analysis 1.10</a>), but the evidence is very uncertain. </p> <p>When using a fixed‐effect model in our sensitivity analysis, the results showed that text messaging might reduce DBP compared to usual care (MD −0.91 mmHg, 95% CI −1.63 to −0.19; I<sup>2</sup> = 67%; 5 studies, 3137 participants; very low‐certainty evidence; <a href="./references#CD011851-fig-0014" title="">Analysis 1.11</a>), but the evidence is very uncertain. </p> <p>When excluding studies at high risk of bias, the results showed that text messaging had little to no effect on DBP compared to usual care (MD 0.09, 95% CI −0.96 to 1.14; I<sup>2</sup> = 0%; 2 studies, 1335 participants; very low‐certainty evidence; <a href="./references#CD011851-fig-0015" title="">Analysis 1.12</a>), but the evidence is very uncertain. </p> </section> </section> <section id="CD011851-sec-0073"> <h5 class="title">Heart rate for the effect of beta‐blockers</h5> <p>Five studies evaluated heart rate as a continuous outcome. One study, <a href="./references#CD011851-bbs2-0012" title="NCT02793830. A mobile phone based medication reminder program [A mobile phone based medication reminder program for patients in China with coronary heart disease: a pilot study]. clinicaltrials.gov/ct2/show/NCT02793830 (first received 8 June 2016). NiZ , WuB , YangQ , YanLL , LiuC , ShawRJ . An mHealth intervention to improve medication adherence and health outcomes among patients with coronary heart disease: randomized controlled trial. Journal of Medical Internet Research2022;24(3):e27202. [DOI: 10.2196/27202]">Ni 2022</a>, only reported mean change from baseline within intervention and control groups, and SD for mean change. Mean/SD at the endpoint were not reported and could not be transformed due to lack of information. Consequently, data from this study could not be pooled, and it was excluded from the meta‐analysis. </p> <p>Meta‐analysis using a random‐effects model found that text messaging may have little to no effect on heart rate compared to usual care (MD −0.46 beats per minute (bpm), 95% CI −1.74 to 0.82; I<sup>2</sup> = 57%; 4 studies, 2946 participants; very low‐certainty evidence; <a href="./references#CD011851-fig-0016" title="">Analysis 1.13</a>), but the evidence is very uncertain. </p> <p>When using a fixed‐effect model in our sensitivity analysis, the results showed that text messaging may have little to no effect on heart rate compared to usual care (MD −0.57 bpm, 95% CI −1.34 to 0.21; I<sup>2</sup> = 57%; 4 studies, 2946 participants; very low‐certainty evidence; <a href="./references#CD011851-fig-0017" title="">Analysis 1.14</a>), but the evidence is very uncertain. </p> <p>When excluding studies at high risk of bias, only one study was left, which showed that text messaging may have little to no effect on heart rate compared to usual care (MD −0.40 bpm, 95% CI −1.64 to 0.84; 1 study, 1159 participants; very low‐certainty evidence; <a href="./references#CD011851-fig-0018" title="">Analysis 1.15</a>), but the evidence is very uncertain. </p> </section> <section id="CD011851-sec-0074"> <h5 class="title">Urinary 11‐dehydrothromboxane B2 for the antiplatelet effects of aspirin</h5> <p>No study reported data on this outcome.</p> </section> <section id="CD011851-sec-0075"> <h5 class="title">Adverse effects</h5> <p>Only one study evaluated road traffic crashes related to the intervention (<a href="./references#CD011851-bbs2-0002" title="BermonA , UribeAF , Pérez-RiveroPF , Prieto-MerinoD , SaaibiJF , SilvaFA , et al. Efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: TXT2HEART Colombia randomized controlled trial. JMIR mHealth and uHealth2021;9(7):e25548. [DOI: 10.2196/25548]BermonA , Uribe-RodríguezAF , Pérez-RiveroPF , Prieto-MerinoD , RiveraDIC , GuioE , et al. Evaluation of the efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: the txt2heart Colombia randomised controlled trial protocol. BMJ Open2019;9:e028017. [DOI: 10.1136/ bmjopen-2018-028017]NCT03098186. TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention [TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention]. clinicaltrials.gov/ct2/show/NCT03098186 (first received 3 March 2017). ">Bermon 2021</a>). However, <a href="./references#CD011851-bbs2-0002" title="BermonA , UribeAF , Pérez-RiveroPF , Prieto-MerinoD , SaaibiJF , SilvaFA , et al. Efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: TXT2HEART Colombia randomized controlled trial. JMIR mHealth and uHealth2021;9(7):e25548. [DOI: 10.2196/25548]BermonA , Uribe-RodríguezAF , Pérez-RiveroPF , Prieto-MerinoD , RiveraDIC , GuioE , et al. Evaluation of the efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: the txt2heart Colombia randomised controlled trial protocol. BMJ Open2019;9:e028017. [DOI: 10.1136/ bmjopen-2018-028017]NCT03098186. TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention [TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention]. clinicaltrials.gov/ct2/show/NCT03098186 (first received 3 March 2017). ">Bermon 2021</a> stated that no adverse effects were reported by participants, and no traffic accidents occurred in their study. </p> <p>No study reported repetitive thumb injury related to the intervention.</p> </section> <section id="CD011851-sec-0076"> <h5 class="title">Patient‐reported experience</h5> <p>Perception of the text messaging intervention was reported in 13 out of 18 studies as utility, acceptability, satisfaction, and recommendation of the programme to other patients. All 13 studies reported high levels of satisfaction, acceptability, and utility with the intervention, expressed strong desire for programme continuation, and demonstrated high interest in the concept. <a href="./references#CD011851-bbs2-0009" title="KamalAK , ShaikQN , PashaO , AzamI , IslamM , MemonAA , et al. Improving medication adherence in stroke patients through Short Text Messages (SMS4Stroke)-study protocol for a randomized, controlled trial. BMC Neurology2015;15:157. [DOI: 10.1186/s12883-015-0413-2]KamalAK , ShaikhQ , PashaO , AzamI , IslamM , MemonAA , et al. A randomized controlled behavioral intervention trial to improve medication adherence in adult stroke patients with prescription tailored short messaging service (SMS)-SMS4Stroke study. BMC Neurolology2015;15:212. [DOI: 10.1186/s12883-015-0471-5]">Kamal 2015</a> reported that 96% of participants were satisfied with the intervention, and 95.6% of participants felt the intervention was acceptable. <a href="./references#CD011851-bbs2-0014" title="ParkLG , Howie-EsquivelJ , ChungM , DracupK . A text messaging intervention improves medication adherence for patients with coronary heart disease: a randomized controlled trial. Circulation2013;128(Suppl 22):A15249. [DOI: 10.1161/circ.128.suppl_22.A15249]ParkLG , Howie-EsquivelJ , ChungML , DracupK . A text messaging intervention to promote medication adherence for patients with coronary heart disease: a randomized controlled trial. Patient Education and Counseling2014;94(2):261-8. [DOI: 10.1016/j.pec.2013.10.027]ParkLG , Howie-EsquivelJ , WhooleyMA , DracupK . Psychosocial factors and medication adherence among patients with coronary heart disease: a text messaging intervention. European Journal of Cardiovascular Nursing2015;14(3):264-73. [DOI: 10.1177/1474515114537024]">Park 2014a</a> reported that in the intervention group receiving text messaging reminders and education, 82% participants strongly or moderately agreed that they were satisfied with receiving text messaging for health, and 71% strongly or moderately agreed that it helped them take their medications. <a href="./references#CD011851-bbs2-0006" title="ACTRN12613000901707. Text4Heart: a text message and internet-based comprehensive cardiac rehabilitation intervention [A randomised controlled trial to determine the efficacy of a text message and Internet-based comprehensive cardiac rehabilitation programme to improve adherence to lifestyle change compared with usual care in New Zealand adults with a diagnosis of cardiovascular disease]. anzctr.org.au/ACTRN12613000901707.aspx (first received 9 August 2013). DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Improving coronary heart disease self-management using mobile technologies (Text4Heart): a randomised controlled trial protocol. Trials2014;15(71):1-9. [DOI: 10.1186/1745-6215-15-71]DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Text message and internet support for coronary heart disease self-management: results from the Text4Heart randomized controlled trial. Journal of Medical Internet Research2015;17(10):e237. [DOI: 10.2196/jmir.4944]">Dale 2015a</a> reported that 77% of participants felt the Text4Heart programme (both text messaging and Web access) helped them change their behaviour, and 90% of participants would recommend the programme to other people who had a heart event. Most participants felt that the programme helped them learn about (47/61, 77%) and recover (51/61, 84%) from their heart event. <a href="./references#CD011851-bbs2-0016" title="QuiliciJ , FugonL , BeguinS , MorangePE , BonnetJL , AlessiMC , et al. Effect of motivational mobile phone short message service on aspirin adherence after coronary stenting for acute coronary syndrome. International Journal of Cardiology2013;168(1):568-9. [DOI: 10.1016/j.ijcard.2013.01.252]">Quilici 2013</a> reported that 92% of participants found the text messaging support to be valuable. <a href="./references#CD011851-bbs2-0004" title="ACTRN12611000161921. Tobacco, EXercise and dieT MEssages (TEXT ME): the effect of semi-personalised lifestyle reminder text message intervention on cardiovascular disease risk [Tobacco, EXercise and dieT MEssages (TEXT ME): The effect of a semi-personalised lifestyle reminder text message intervention on cardiovascular risk factors in patients with cardiovascular disease and those who are at high risk of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12611000161921 (first received 3 February 2011). ChowCK , RedfernJ , HillisGS , ThakkarJ , SantoK , HackettML , et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA2015;314(12):1255-63. [DOI: 10.1001/jama.2015.10945]ChowCK , RedfernJ , ThiagalingamA , JanS , WhittakerR , HackettM , et al. Design and rationale of the tobacco, exercise and diet messages (TEXT ME) trial of a text message-based intervention for ongoing prevention of cardiovascular disease in people with coronary disease: a randomised controlled trial protocol. BMJ Open2012;2(1):e000606. [DOI: 10.1136/bmjopen-2011-000606]RedfernJ , SantoK , CooreyG , ThakkarJ , HackettM , ThiagalingamA , et al. Factors influencing engagement, perceived usefulness and behavioral mechanisms associated with a text message support program. PLOS ONE2016;11(10):e0163929. [DOI: 10.1371/journal.pone.0163929]ThakkarJ , RedfernJ , De KeizerL , ThiagalingamA , ChowC . Patient perceptions of text message-based intervention for secondary prevention of cardiovascular events. Heart, Lung and Circulation2013;22(Suppl 1):S264. [DOI: 10.1016/j.hlc.2013.05.630]ThakkarJ , RedfernJ , ThiagalingamA , ChowCK . Patterns, predictors and effects of texting intervention on physical activity in CHD – insights from the TEXT ME randomized clinical trial. European Journal of Preventive Cardiology2016;23(17):1894-902. [DOI: 10.1177/2047487316664190]">Chow 2015</a> found that most participants agreed that the text message support programme was useful (91%), easy to understand (97%), and motivated their behaviour change (77%). </p> <p>The TEXTME study by <a href="./references#CD011851-bbs2-0004" title="ACTRN12611000161921. Tobacco, EXercise and dieT MEssages (TEXT ME): the effect of semi-personalised lifestyle reminder text message intervention on cardiovascular disease risk [Tobacco, EXercise and dieT MEssages (TEXT ME): The effect of a semi-personalised lifestyle reminder text message intervention on cardiovascular risk factors in patients with cardiovascular disease and those who are at high risk of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12611000161921 (first received 3 February 2011). ChowCK , RedfernJ , HillisGS , ThakkarJ , SantoK , HackettML , et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA2015;314(12):1255-63. [DOI: 10.1001/jama.2015.10945]ChowCK , RedfernJ , ThiagalingamA , JanS , WhittakerR , HackettM , et al. Design and rationale of the tobacco, exercise and diet messages (TEXT ME) trial of a text message-based intervention for ongoing prevention of cardiovascular disease in people with coronary disease: a randomised controlled trial protocol. BMJ Open2012;2(1):e000606. [DOI: 10.1136/bmjopen-2011-000606]RedfernJ , SantoK , CooreyG , ThakkarJ , HackettM , ThiagalingamA , et al. Factors influencing engagement, perceived usefulness and behavioral mechanisms associated with a text message support program. PLOS ONE2016;11(10):e0163929. [DOI: 10.1371/journal.pone.0163929]ThakkarJ , RedfernJ , De KeizerL , ThiagalingamA , ChowC . Patient perceptions of text message-based intervention for secondary prevention of cardiovascular events. Heart, Lung and Circulation2013;22(Suppl 1):S264. [DOI: 10.1016/j.hlc.2013.05.630]ThakkarJ , RedfernJ , ThiagalingamA , ChowCK . Patterns, predictors and effects of texting intervention on physical activity in CHD – insights from the TEXT ME randomized clinical trial. European Journal of Preventive Cardiology2016;23(17):1894-902. [DOI: 10.1177/2047487316664190]">Chow 2015</a> also has a parallel, detailed qualitative analysis that summarises engagement and behavioural mechanisms of the texting programme effectiveness (<a href="./references#CD011851-bbs2-0090" title="RedfernJ , SantoK , CooreyG , ThakkarJ , HackettM , ThiagalingamA , et al. Factors influencing engagement, perceived usefulness and behavioral mechanisms associated with a text message support program. PLOS ONE2016;11(10):e0163929. [DOI: 10.1371/journal.pone.0163929]">Redfern 2016</a>). The TEXTMEDS study by <a href="./references#CD011851-bbs2-0005" title="ACTRN12613000793718. TEXT messages to improve MEDication adherence &amp; Secondary prevention – TEXTMEDS [TEXT messages to improve MEDication adherence &amp; Secondary prevention in patients with acute coronary syndrome - TEXTMEDS]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364448&amp;isReview=true (first received 18 June 2013). ChowCK , KlimisH , ThiagalingamA , RedfernJ , HillisGS , BriegerD , et al. Text messages to improve medication adherence and secondary prevention after acute coronary syndrome: the TEXTMEDS randomized clinical trial. Circulation2022;145(19):1443-55. [DOI: 10.1161/CIRCULATIONAHA.121.056161]ChowCK , ThiagalingamA , SantoK , KokC , ThakkarJ , StepienS , et al. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol. BMJ Open2018;8:e019463. [DOI: 10.1136/bmjopen-2017-019463]">Chow 2022</a> reported that most people agreed or strongly agreed that the text message programme was useful (86%), easy to understand (94%), reminded them to take their regular medications (63%), and motivated them to change their lifestyle behaviour (63%). <a href="./references#CD011851-bbs2-0008" title="HuoX , KrumholzHM , BaiX , SpatzES , DingQ , HorakP , et al. Effects of mobile text messaging on glycemic control in patients with coronary heart disease and diabetes mellitus: a randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(9):e005805. [DOI: 10.1161/CIRCOUTCOMES.119.005805]NCT02883842. Cardiovascular Health and Text Messaging-Diabetes Mellitus (CHAT-DM) Study [Effectiveness of text messaging on risk factors control and medication adherence among patients with Coronary Heart Disease and Diabetes in China: cardiovascular health andtext messaging-Diabetes Mellitus (CHAT-DM) study]. clinicaltrials.gov/ct2/show/NCT02883842 (first received 30 August 2016). ">Huo 2019</a> found that almost all participants believed the text messages were useful (94.1%) and easy to understand (97.1%); 74.1% of participants reported saving messages for further learning, and 94% of participants would like to continue to receive the text messages to improve their knowledge and support disease management in the future. <a href="./references#CD011851-bbs2-0018" title="HuoX , SpatzES , DingQ , HorakP , ZhengX , MastersC , et al. Design and rationale of the Cardiovascular Health and Text Messaging (CHAT) study and the CHAT-Diabetes Mellitus (CHAT-DM) study: two randomised controlled trials of text messaging to improve secondary prevention for coronary heart disease and diabetes. BMJ Open2017;7(12):e018302. [DOI: 10.1136/bmjopen-2017-018302]ZhengX , SpatzES , BaiX , HuoX , DingQ , HorakP , et al. Effect of text messaging on risk factor management in patients with coronary heart disease: the CHAT randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(4):e005616. [DOI: 10.1161/CIRCOUTCOMES.119.005616]">Zheng 2019</a> found that participants perceived the text messages as useful (96.1%) and easy to understand (98.8%); 69.4% of participants saved messages for further learning, and 94.8% of participants would like to continue to receive the text messages in the future. <a href="./references#CD011851-bbs2-0011" title="ACTRN12616000422426. Text4Heart Partnership: a text messaging program to enhance self-management of cardiovascular disease [Text messaging to enhance self-management of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12616000422426 (first received 23 March 2016). MaddisonR , JiangY , StewartR , ScottT , KerrA , WhittakerR , et al. An intervention to improve medication adherence in people with heart disease (Text4HeartII): randomized controlled trial. JMIR mHealth and uHealth2021;9(6):e24952. [DOI: 10.2196/24952]MaddisonR , StewartR , DoughtyR , ScottT , KerrA , BenatarJ , et al. Text4Heart II - improving medication adherence in people with heart disease: a study protocol for a randomized controlled trial. Trials2018;19(1):70. [DOI: 10.1186/s13063-018-2468-z]">Maddison 2021</a> reported that 97.8% of participants would recommend the programme to others. The text messaging programme was perceived to be helpful in managing heart disease (82.6%); learning about heart condition (62.3%); recovery from heart condition (82.6%); and changing behaviour (56.5%). <a href="./references#CD011851-bbs2-0001" title="BaeJW , WooSI , LeeJ , ParkSD , KwonSW , ChoiSH , et al. mHealth interventions for lifestyle and risk factor modification in coronary heart disease: randomized controlled trial. JMIR mHealth and uHealth2021;9(9):e29928. [DOI: 10.2196/29928]KCT0005087. Effect of text messaging program on lifestyle and clinical outcomes in patients with cardiovascular disease. cris.nih.go.kr/cris/search/detailSearch.do/19282 (first received 11 September 2019). ">Bae 2021</a> reported that text messages were perceived to be helpful (82.0%), easy to understand (94.6%), a good motivation for changing behaviour (78.2%), and reminding to take medication (52.7%). </p> <p>In <a href="./references#CD011851-bbs2-0010" title="KhonsariS , SubramanianP , ChinnaK , LatifLA , LingLW , GholamiO . Effect of a reminder system using an automated short message service on medication adherence following acute coronary syndrome. European Journal of Cardiovascular Nursing2015;14(2):170-9. [DOI: 10.1177/1474515114521910]">Khonsari 2015</a>, most participants found that the SMS was useful (93.5%) and helped them take their medications (64.5%). All participants (100%) would recommend the intervention to other patients, and 80.6% of the participants requested that the text messaging reminders be continued. <a href="./references#CD011851-bbs2-0017" title="NCT02336919. The use of texting messaging to improve the hospital-to-community transition period in cardiovascular disease patients (Txt2Prevent) [The use of texting messaging to improve the hospital-to-community transition and prevent readmission in patients with cardiovascular disease (Txt2Prevent)]. clinicaltrials.gov/ct2/show/NCT02336919 (first received 13 January 2015). RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of SMS text messaging to improve the hospital-to-community transition in patients with acute coronary syndrome (Txt2Prevent): results from a pilot randomized controlled trial. JMIR mHealth and uHealth2021;9(5):e24530. [DOI: 10.2196/24530]RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of text messaging to improve the hospital-to-community transition in acute coronary syndrome patients (Txt2Prevent): intervention development and pilot randomized controlled trial protocol. JMIR Research Protocols2017;6(5):e91. [DOI: 10.2196/resprot.6968]">Ross 2021</a> reported that 94% of participants agreed or strongly agreed that they were satisfied; 74% agreed or strongly agreed that it helped them manage their condition; and 94.4% would recommend the programme to others. <a href="./references#CD011851-bbs2-0015" title="NCT03414190. Impact of text messages to promote secondary prevention after acute coronary syndrome [Impact of a mobile phone text messages intervention on the secondary prevention of cardiovascular events after acute coronary syndrome]. clinicaltrials.gov/show/NCT03414190 (first received 29 January 2018). PassagliaLG , BrantLC , NascimentoBR , RibeiroAL . Impact of text messages in a middle-income country to promote secondary prevention after acute coronary syndrome (IMPACS): a randomized trial. Medicine2019;98(22):e15681. [DOI: 10.1097/MD.0000000000015681]PassagliaLG , BrantLC , SilvaJL , NascimentoBR , RibeiroAL . Text messages to promote secondary prevention after acute coronary syndrome (IMPACS trial). International Journal of Cardiovascular Sciences2021;35(2):202-13. [DOI: 10.36660/ijcs.20200378]">Passaglia 2021</a> found that 79.2% of participants read all SMS; 88.7% totally agree that SMS helped them change daily habits; and 86.8% totally agree that the messages were helpful for their treatment. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD011851-sec-0077" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD011851-sec-0077"></div> <section id="CD011851-sec-0078"> <h3 class="title" id="CD011851-sec-0078">Summary of main results</h3> <p>We identified 18 studies eligible for inclusion in the review, seven from the original review and 11 newly added in the current update. The number of newly added studies shows the rapid growth in this research area and increased evidence of using text messaging in CVD secondary prevention. A total of 8136 participants were included in the analysis. The 18 included studies were conducted in 11 countries, including six high‐income countries and five middle‐income countries. None of the included studies was from a low‐income country. All 18 studies included participants with CVDs. Participants had various CVDs, including acute coronary syndrome, coronary heart disease, stroke, myocardial infarction, heart failure, and angina. Mean duration of the text messaging was five months. There was variation in the characteristics of text messages amongst studies (delivery method, frequency, theoretic grounding, content used, personalisation, directionality). The message content primarily included mixed functionalities, covering medication reminders, and healthy lifestyle information. We assessed the overall risk of bias for all studies as high, as all studies had at least one domain at unclear or high risk of bias (<a href="#CD011851-fig-0003">Figure 3</a>). </p> <p>This review provides very low‐certainty evidence of the effects of text messaging on medication adherence (<a href="./full#CD011851-tbl-0001">summary of findings Table 1</a>). All 18 studies included in this review reported on medication adherence. Ten out of 18 studies showed a beneficial effect of mobile phone text messaging for medication adherence (<a href="./references#CD011851-bbs2-0001" title="BaeJW , WooSI , LeeJ , ParkSD , KwonSW , ChoiSH , et al. mHealth interventions for lifestyle and risk factor modification in coronary heart disease: randomized controlled trial. JMIR mHealth and uHealth2021;9(9):e29928. [DOI: 10.2196/29928]KCT0005087. Effect of text messaging program on lifestyle and clinical outcomes in patients with cardiovascular disease. cris.nih.go.kr/cris/search/detailSearch.do/19282 (first received 11 September 2019). ">Bae 2021</a>; <a href="./references#CD011851-bbs2-0003" title="ChenC , LiX , KangY , LiuH , LiangYD , ZhangQ . Post-discharge short service message improves short-term clinical outcome and self-care behavior in Chinese patients with chronic heart failure. European Heart Journal2018;39(Suppl 1):797-8. [DOI: 10.1093/eurheartj/ehy563.P3770]ChenC , LiX , SunL , CaoS , KangY , HongL , et al. Post-discharge short message service improves short-term clinical outcome and self-care behaviour in chronic heart failure. ESC Heart Failure2019;6(1):164-73. [DOI: 10.1002/ehf2.12380]ChiCTR-INR-17012316. Effect of post-discharge text messages on clinical outcomes in patients with heart failure [Effect of post-discharge text messages on clinical outcomes in patients with heart failure]. trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR-INR-17012316 (first received 9 August 2018). LiX , ChenC , YouGY , ZhangQ . Post-discharge text messaging intervention improved clinical outcomes in patients with heart failure. European Heart Journal2016;37(Suppl 1):727-8. [DOI: 10.1093/eurheartj/ehw433]">Chen 2019</a>; <a href="./references#CD011851-bbs2-0006" title="ACTRN12613000901707. Text4Heart: a text message and internet-based comprehensive cardiac rehabilitation intervention [A randomised controlled trial to determine the efficacy of a text message and Internet-based comprehensive cardiac rehabilitation programme to improve adherence to lifestyle change compared with usual care in New Zealand adults with a diagnosis of cardiovascular disease]. anzctr.org.au/ACTRN12613000901707.aspx (first received 9 August 2013). DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Improving coronary heart disease self-management using mobile technologies (Text4Heart): a randomised controlled trial protocol. Trials2014;15(71):1-9. [DOI: 10.1186/1745-6215-15-71]DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Text message and internet support for coronary heart disease self-management: results from the Text4Heart randomized controlled trial. Journal of Medical Internet Research2015;17(10):e237. [DOI: 10.2196/jmir.4944]">Dale 2015a</a>; <a href="./references#CD011851-bbs2-0007" title="FangR , LiX . Electronic messaging support service programs improve adherence to lipid-lowering therapy among outpatients with coronary artery disease: an exploratory randomised control study. Journal of Clinical Nursing2016;25(5-6):664-71. [DOI: 10.1111/jocn.12988]">Fang 2016</a>; <a href="./references#CD011851-bbs2-0009" title="KamalAK , ShaikQN , PashaO , AzamI , IslamM , MemonAA , et al. Improving medication adherence in stroke patients through Short Text Messages (SMS4Stroke)-study protocol for a randomized, controlled trial. BMC Neurology2015;15:157. [DOI: 10.1186/s12883-015-0413-2]KamalAK , ShaikhQ , PashaO , AzamI , IslamM , MemonAA , et al. A randomized controlled behavioral intervention trial to improve medication adherence in adult stroke patients with prescription tailored short messaging service (SMS)-SMS4Stroke study. BMC Neurolology2015;15:212. [DOI: 10.1186/s12883-015-0471-5]">Kamal 2015</a>; <a href="./references#CD011851-bbs2-0010" title="KhonsariS , SubramanianP , ChinnaK , LatifLA , LingLW , GholamiO . Effect of a reminder system using an automated short message service on medication adherence following acute coronary syndrome. European Journal of Cardiovascular Nursing2015;14(2):170-9. [DOI: 10.1177/1474515114521910]">Khonsari 2015</a>; <a href="./references#CD011851-bbs2-0012" title="NCT02793830. A mobile phone based medication reminder program [A mobile phone based medication reminder program for patients in China with coronary heart disease: a pilot study]. clinicaltrials.gov/ct2/show/NCT02793830 (first received 8 June 2016). NiZ , WuB , YangQ , YanLL , LiuC , ShawRJ . An mHealth intervention to improve medication adherence and health outcomes among patients with coronary heart disease: randomized controlled trial. Journal of Medical Internet Research2022;24(3):e27202. [DOI: 10.2196/27202]">Ni 2022</a>; <a href="./references#CD011851-bbs2-0013" title="NCT02783287. The impact of text messaging on medication adherence and exercise regimen among post-myocardial infarction patients. clinicaltrials.gov/ct2/show/NCT02783287 (first received 26 May 2016). PandeyA , ChoudhryN . An m-health application of daily text messages to address forgetfulness as contributor to non-adherence to medications post-myocardial infarction. Circulation2015;132:A18641. [DOI: 10.1161/circ.132.suppl_3.18641]PandeyA , KrummeAA , PatelT , ChoudhryNK . The impact of text messaging on medication adherence and exercise among postmyocardial infarction patients: randomized controlled pilot trial. JMIR mHealth and uHealth2017;5(8):e110. [DOI: 10.2196/mhealth.7144]PandeyAK , ChoudhryN . Text message reminders to address medication non-adherence in post-MI patients: a one year intervention study. Canadian Journal of Cardiology2014;30(10):S179. [DOI: 10.1016/j.cjca.2014.07.280]">Pandey 2017</a>; <a href="./references#CD011851-bbs2-0014" title="ParkLG , Howie-EsquivelJ , ChungM , DracupK . A text messaging intervention improves medication adherence for patients with coronary heart disease: a randomized controlled trial. Circulation2013;128(Suppl 22):A15249. [DOI: 10.1161/circ.128.suppl_22.A15249]ParkLG , Howie-EsquivelJ , ChungML , DracupK . A text messaging intervention to promote medication adherence for patients with coronary heart disease: a randomized controlled trial. Patient Education and Counseling2014;94(2):261-8. [DOI: 10.1016/j.pec.2013.10.027]ParkLG , Howie-EsquivelJ , WhooleyMA , DracupK . Psychosocial factors and medication adherence among patients with coronary heart disease: a text messaging intervention. European Journal of Cardiovascular Nursing2015;14(3):264-73. [DOI: 10.1177/1474515114537024]">Park 2014a</a>; <a href="./references#CD011851-bbs2-0016" title="QuiliciJ , FugonL , BeguinS , MorangePE , BonnetJL , AlessiMC , et al. Effect of motivational mobile phone short message service on aspirin adherence after coronary stenting for acute coronary syndrome. International Journal of Cardiology2013;168(1):568-9. [DOI: 10.1016/j.ijcard.2013.01.252]">Quilici 2013</a>). The other eight studies showed that text messaging resulted in either a reduction or no difference in medication adherence when compared with usual care. Due to the heterogeneity with respect to diverse measurement methods and various definitions, medication adherence was not pooled in a meta‐analysis, thus the evidence is uncertain. </p> <p>The certainty of evidence relating to the effect of text messaging on fatal cardiovascular events, LDL cholesterol, blood pressure, and heart rate was low or very low. Pooled analysis found that text messaging may provide little to no benefit for fatal cardiovascular events, LDL cholesterol, SBP, DBP, and heart rate compared to usual care. Sensitivity analyses removing studies with high risk of bias and outliers revealed similar findings that text messaging has little to no effect on LDL cholesterol, SBP, DBP, and heart rate. </p> <p>There was insufficient evidence of text messaging interventions for non‐fatal cardiovascular events, combined CVD events, urinary 11‐dehydrothromboxane B2, and adverse events due to sparse data available for synthesis. No study measured urinary 11‐ dehydrothromboxane B2. Only two studies measured non‐fatal cardiovascular events, and only one study measured combined CVD events and adverse events. Studies reported high levels of acceptability, utility, and satisfaction with the text messaging programme. </p> <p>Overall, these data suggest that the current evidence for text messaging in the CVD population is of low and very low certainty, and therefore insufficient to guide clinical practice and policy. The results showed little to no evidence of an effect of text messaging on medication adherence, fatal cardiovascular events, non‐fatal cardiovascular events, combined CVD events, blood pressure, LDL cholesterol, and heart rate. However, people with CVD tend to have a high level of satisfaction, acceptability, and utility with text messaging. Along with the growth of mobile phone usage globally, future work should also focus on a deep understanding of the enablers and barriers associated with the effectiveness of interventions. </p> </section> <section id="CD011851-sec-0079"> <h3 class="title" id="CD011851-sec-0079">Overall completeness and applicability of evidence</h3> <p>The search strategy identified all relevant studies up until August 2023. The 18 included studies varied in terms of their context, intervention characteristics, and the measurement method and definitions of study outcomes, which makes summarising the data difficult and reduces the certainty of the estimates produced. The studies included in our meta‐analysis had relatively small sample sizes, short study durations, and were of low quality. Small sample size hindered our ability to generalise our findings to a wide population. Short‐term durations prevented evaluation of long‐term intervention effectiveness. The low quality of the included studies reduced our confidence in the certainty of evidence. </p> <p>The evidence in this review is applicable to a predominantly male population aged between 50 and 65 years. Participants had various CVDs, including acute coronary syndrome, coronary heart disease, stroke, myocardial infarction, heart failure, and angina, therefore indicating an appropriate representation of population. </p> <p>Eight studies took place in high‐income countries (USA, Australia, Korea, Canada, and New Zealand), and eight took place in upper‐middle‐income countries (China, Malaysia, Brazil, and Colombia). Only one study was conducted in a lower‐middle‐income country (Pakistan) (<a href="./references#CD011851-bbs2-0109" title="World Bank. The world by income and region. datatopics.worldbank.org/world-development-indicators/the-world-by-income-and-region.html (accessed 30 August 2023).">World Bank 2023</a>). It was uncertain where one study was conducted, but it was likely from a high‐income country (France). It is therefore unclear whether the results would apply to low‐income countries. </p> <p>All studies used text messaging as a central component of the intervention. However, the characteristics of text messaging (e.g. message frequencies, timing, content, degree of personalisation, ability for patients to respond, and degree of automation) varied across the 18 studies. The various characteristics and delivery method of text messages may have influenced how the intervention might work in a CVD population. In addition, details about the specific theoretical framework, directionality, and personalisation of text messages were lacking in some studies. Seven out of 18 studies did not specify if text messages were designed based on a theoretical approach or framework (e.g. behavioural change techniques or psychological theories). We attempted but were unable to classify the content of messages according to behaviour change techniques due to limited description of behaviour change techniques and text message contents in the studies. Future studies should include comprehensive descriptions of the interventions delivered. </p> <p>Most of the included studies examined medications and diseases singly, which has implications for the generalisability of results, given that most people may have comorbidities or be on multiple medications. It is worth noting that some studies listed medication adherence as a secondary outcome rather than a primary outcome, which suggests that these studies may not be designed around the focus of our review. </p> <p>Although all 18 included studies reported the primary outcome of medication adherence, the variability in outcome measures and measurement tools used limited our ability to conduct meta‐analysis. In addition, only a few studies reported data on adverse effects, non‐fatal cardiovascular events, and combined cardiovascular events, and no studies reported on urinary 11‐dehydrothromboxane B2. Insufficient reporting makes it difficult to draw any conclusions for these outcomes. </p> <p>The most common comparator for the text messaging intervention was reported as "usual care". However, details on usual care were lacking in most of the included studies. In addition, definitions of usual care varied across studies, which were likely to influence the size of the effect estimates. </p> <p>We identified nine ongoing studies, ranging from 78 participants, <a href="./references#CD011851-bbs2-0043" title="ISRCTN10549665. Improving medication taking in patients with coronary heart disease using a mobile health technology, a feasibility study. www.isrctn.com/ISRCTN10549665 (first received 26 November 2019). [DOI: 10.1186/ISRCTN10549665]">ISRCTN10549665</a>, to 2500 participants, <a href="./references#CD011851-bbs2-0037" title="ACTRN12621000754842. Efficacy and safety of adjunctive virtual models of care in the secondary prevention of cardiovascular events in adults discharged from hospital after myocardial infarction or decompensated heart failure. anzctr.org.au/ACTRN12621000754842.aspx (first received 16 June 2021). ">ACTRN12621000754842</a>. Three of these nine studies are being conducted in high‐income countries. As these nine studies have not yet reported any results, our findings were limited to those studies that have reported results and could be pooled in meta‐analysis. </p> <p>There appears to be little or no difference between mobile text messaging and usual care in improving medication adherence for secondary prevention of CVD. There are many potential factors that could contribute to the narrow gap in medication adherence between intervention and control groups. These factors may include low quality of study design, simple intervention design, short duration of intervention delivery, lack of theoretical framework in the development of text messages, small sample size of participants, etc. For example, <a href="./references#CD011851-bbs2-0017" title="NCT02336919. The use of texting messaging to improve the hospital-to-community transition period in cardiovascular disease patients (Txt2Prevent) [The use of texting messaging to improve the hospital-to-community transition and prevent readmission in patients with cardiovascular disease (Txt2Prevent)]. clinicaltrials.gov/ct2/show/NCT02336919 (first received 13 January 2015). RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of SMS text messaging to improve the hospital-to-community transition in patients with acute coronary syndrome (Txt2Prevent): results from a pilot randomized controlled trial. JMIR mHealth and uHealth2021;9(5):e24530. [DOI: 10.2196/24530]RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of text messaging to improve the hospital-to-community transition in acute coronary syndrome patients (Txt2Prevent): intervention development and pilot randomized controlled trial protocol. JMIR Research Protocols2017;6(5):e91. [DOI: 10.2196/resprot.6968]">Ross 2021</a> only used a simple design of text messaging programme (one‐way messages, prespecified order of SMS text messages that was not personalised), and only sent seven text messages that covered medication‐related topics. Furthermore, random messages received by participants in the control group may remind them to take their medications and lead to biased results. However, most control groups included in this review did not send text messages to participants, and so the impact of this bias on the results was very minimal. </p> </section> <section id="CD011851-sec-0080"> <h3 class="title" id="CD011851-sec-0080">Quality of the evidence</h3> <p>Overall, the summary of findings table shows evidence varying between low and very low certainty. </p> <p>The included studies were of poor methodological quality, with each study having at least one risk of bias domain judged as unclear or high risk. All studies were at high risk of bias for blinding of participants and personnel (performance bias). Eleven out of 18 studies were at either high or unclear risk of bias for blinding of outcome assessors (detection bias). Only eight studies were at low risk for both allocation concealment and random sequence generation. Hence, we downgraded the certainty of evidence for all outcomes by one level, as the results of the meta‐analysis may have been influenced by the low quality of the included studies. Sensitivity analysis removing low‐quality studies revealed little to no effect for text messaging on LDL cholesterol, SBP, DBP, and heart rate. However, very few studies of high quality were included in the review. Future studies would benefit from having robust study designs. </p> <p>We identified considerable heterogeneity, including methodological heterogeneity due to differences in the criteria for defining outcome measures and measurement method, and clinical heterogeneity related to the characteristics of text messaging. Although all of the included studies used mobile phones to deliver the intervention, we identified substantial differences in the actual content of the SMS. Seven studies lacked information on whether message content was supported by psychological or behaviour change models. The considerable heterogeneity not only has implications for the applicability of the evidence, but also indicates that the quality of reporting for trials evaluating mobile phone interventions is very poor. Additionally, CIs across studies showed minimal overlap. Consequently, we downgraded the certainty of the evidence one level for inconsistency for all outcomes except fatal cardiovascular events, which had low statistical heterogeneity. </p> <p>We also downgraded the certainty of the evidence for all outcomes by one level for imprecision because the included studies showed different directions of effect, and CIs crossed the no‐effect line and encompassed positive and negative effects. Indirectness was less of an issue in this review update. All included participants had CVDs, indicating an appropriate representation of population. Publication bias could not be assessed reliably for outcomes due to the small number of studies (&lt; 10) that could be included in the meta‐analysis. </p> </section> <section id="CD011851-sec-0081"> <h3 class="title" id="CD011851-sec-0081">Potential biases in the review process</h3> <p>We acknowledge that, although systematic searches across a number of resources were conducted, any search has limitations for pragmatic reasons. Publication bias with the tendency to report positive findings cannot be excluded. Furthermore, some of the included studies had missing endpoint data, which restricted the inclusion of these studies in the meta‐analysis. Consequently, unpublished and missing data might lead to bias in the pooled effect (<a href="./references#CD011851-bbs2-0074" title="HopewellS , LoudonK , ClarkeMJ , OxmanAD , DickersinK . Publication bias in clinical trials due to statistical significance or direction of trial results. Cochrane Database of Systematic Reviews2009, Issue 1. Art. No: MR000006. [DOI: 10.1002/14651858.MR000006.pub3]">Hopewell 2009</a>). We tried to overcome this potential limitation by searching clinical trial registries for data on prospectively registered trials. However, eligible studies published after the last search date could have been missed. In addition, although we did not exclude non‐English articles, non‐English articles published in non‐English journals might have been missed in this review and could have potentially introduced language bias. </p> <p>We were unable to perform planned subgroup analyses to investigate reasons for heterogeneity due to a lack of details or limited number of studies reporting on the outcome of interest. Study effects may be influenced by the observed heterogeneity. It should be noted that some included studies may not have reported all the data they collected, as study protocols were not available for all studies. As a result, the analysis may be incomplete. Another potential source of bias is that due to variations in approaches used to measure and report outcomes, we were unable to include all reported data in the meta‐analysis. Consequently, internal validity of the meta‐analysis might be affected. For example, studies reporting on medication adherence reported the data as either proportion of days of medication covered or mean change in medication adherence score, making it difficult to group all studies for a comprehensive synthesis and comparison, and limiting our confidence in conclusions on the efficacy of interventions. Furthermore, medication event monitoring system (MEMS) data have their limitations, as patients may unscrew the MEMS cap without actually ingesting the medication. Finally, the use of available data in data analysis may not reflect the entire evidence base and thus threaten the validity of the results. We found two studies that did not report non‐fatal cardiovascular events as per their protocol. We attempted to contact the study authors to obtain the data, but received no response. </p> </section> <section id="CD011851-sec-0082"> <h3 class="title" id="CD011851-sec-0082">Agreements and disagreements with other studies or reviews</h3> <p>This review update includes 11 new studies compared with the original review. Our findings of mixed evidence for the effects of text messaging and no reported harms are consistent with the previous review (<a href="./references#CD011851-bbs2-0114" title="AdlerAJ , MartinN , MarianiJ , TajerCD , OwolabiOO , FreeC , et al. Mobile phone text messaging to improve medication adherence in secondary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews2017, Issue 4. Art. No: CD011851. [DOI: 10.1002/14651858.CD011851.pub2]">Adler 2017</a>). It is worth noting that in the previous review, six of seven included studies showed a beneficial effect on improving medication adherence. However, of the 11 new studies included in the review update, only three studies demonstrated a positive effect on medication adherence. The potential reasons contributing to this interesting finding need further exploration, which may be influenced by participant characteristics and intervention delivery format. Compared with the original review, which included small‐scale studies, the new studies identified in the review update were applied in more countries and larger populations, indicating a higher level of generalisability of study findings. </p> <p>Limited systematic reviews have examined the effect of text messaging on medication adherence in people with CVD. <a href="./references#CD011851-bbs2-0112" title="ZhaoYY , DangFP , ZhaiTT , LiHJ , WangRJ , RenJJ . The effect of text message reminders on medication adherence among patients with coronary heart disease: a systematic review and meta-analysis. Medicine2019;98(52):e18353. [DOI: 10.1097/MD.0000000000018353]">Zhao 2019</a> conducted a systematic review and meta‐analysis evaluating the effect of text message reminders on medication adherence in people with coronary heart disease. Their study included only 2 trials with 144 participants for meta‐analysis and found that medication adherence in the intervention group was 2.85 times greater than in the control group. Compared with <a href="./references#CD011851-bbs2-0112" title="ZhaoYY , DangFP , ZhaiTT , LiHJ , WangRJ , RenJJ . The effect of text message reminders on medication adherence among patients with coronary heart disease: a systematic review and meta-analysis. Medicine2019;98(52):e18353. [DOI: 10.1097/MD.0000000000018353]">Zhao 2019</a>, our review update expanded participants to CVD and included more studies for a comprehensive analysis. The mixed results observed in the 18 included studies may reflect the challenges involved in improving adherence, which are possibly attributed to multiple intentional (e.g. cost, side effects, availability) and unintentional (e.g. forgetfulness, lack of health literacy) factors (<a href="./references#CD011851-bbs2-0103" title="ThorneloeRJ , GriffithsCE , EmsleyR , AshcroftDM , CordingleyL , BarkerJ , et al. Intentional and unintentional medication non-adherence in psoriasis: the role of patients’ medication beliefs and habit strength. Journal of Investigative Dermatology2018;138(4):785-94. [DOI: 10.1016/j.jid.2017.11.015]">Thorneloe 2018</a>). It might not be easy to address intentional medication adherence solely by text messaging, which may partly explain the inconsistent results of text messaging across studies. How best to design text messaging interventions to address intentional factors to non‐adherence to medication is important. Our review found that, of the 10 studies reporting benefits on medication adherence, eight studies incorporated medication reminders as straight message contents, which might be considered as a key element of text messaging in overcoming medication non‐adherence (<a href="./references#CD011851-bbs2-0001" title="BaeJW , WooSI , LeeJ , ParkSD , KwonSW , ChoiSH , et al. mHealth interventions for lifestyle and risk factor modification in coronary heart disease: randomized controlled trial. JMIR mHealth and uHealth2021;9(9):e29928. [DOI: 10.2196/29928]KCT0005087. Effect of text messaging program on lifestyle and clinical outcomes in patients with cardiovascular disease. cris.nih.go.kr/cris/search/detailSearch.do/19282 (first received 11 September 2019). ">Bae 2021</a>; <a href="./references#CD011851-bbs2-0003" title="ChenC , LiX , KangY , LiuH , LiangYD , ZhangQ . Post-discharge short service message improves short-term clinical outcome and self-care behavior in Chinese patients with chronic heart failure. European Heart Journal2018;39(Suppl 1):797-8. [DOI: 10.1093/eurheartj/ehy563.P3770]ChenC , LiX , SunL , CaoS , KangY , HongL , et al. Post-discharge short message service improves short-term clinical outcome and self-care behaviour in chronic heart failure. ESC Heart Failure2019;6(1):164-73. [DOI: 10.1002/ehf2.12380]ChiCTR-INR-17012316. Effect of post-discharge text messages on clinical outcomes in patients with heart failure [Effect of post-discharge text messages on clinical outcomes in patients with heart failure]. trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR-INR-17012316 (first received 9 August 2018). LiX , ChenC , YouGY , ZhangQ . Post-discharge text messaging intervention improved clinical outcomes in patients with heart failure. European Heart Journal2016;37(Suppl 1):727-8. [DOI: 10.1093/eurheartj/ehw433]">Chen 2019</a>; <a href="./references#CD011851-bbs2-0007" title="FangR , LiX . Electronic messaging support service programs improve adherence to lipid-lowering therapy among outpatients with coronary artery disease: an exploratory randomised control study. Journal of Clinical Nursing2016;25(5-6):664-71. [DOI: 10.1111/jocn.12988]">Fang 2016</a>; <a href="./references#CD011851-bbs2-0009" title="KamalAK , ShaikQN , PashaO , AzamI , IslamM , MemonAA , et al. Improving medication adherence in stroke patients through Short Text Messages (SMS4Stroke)-study protocol for a randomized, controlled trial. BMC Neurology2015;15:157. [DOI: 10.1186/s12883-015-0413-2]KamalAK , ShaikhQ , PashaO , AzamI , IslamM , MemonAA , et al. A randomized controlled behavioral intervention trial to improve medication adherence in adult stroke patients with prescription tailored short messaging service (SMS)-SMS4Stroke study. BMC Neurolology2015;15:212. [DOI: 10.1186/s12883-015-0471-5]">Kamal 2015</a>; <a href="./references#CD011851-bbs2-0010" title="KhonsariS , SubramanianP , ChinnaK , LatifLA , LingLW , GholamiO . Effect of a reminder system using an automated short message service on medication adherence following acute coronary syndrome. European Journal of Cardiovascular Nursing2015;14(2):170-9. [DOI: 10.1177/1474515114521910]">Khonsari 2015</a>; <a href="./references#CD011851-bbs2-0012" title="NCT02793830. A mobile phone based medication reminder program [A mobile phone based medication reminder program for patients in China with coronary heart disease: a pilot study]. clinicaltrials.gov/ct2/show/NCT02793830 (first received 8 June 2016). NiZ , WuB , YangQ , YanLL , LiuC , ShawRJ . An mHealth intervention to improve medication adherence and health outcomes among patients with coronary heart disease: randomized controlled trial. Journal of Medical Internet Research2022;24(3):e27202. [DOI: 10.2196/27202]">Ni 2022</a>; <a href="./references#CD011851-bbs2-0013" title="NCT02783287. The impact of text messaging on medication adherence and exercise regimen among post-myocardial infarction patients. clinicaltrials.gov/ct2/show/NCT02783287 (first received 26 May 2016). PandeyA , ChoudhryN . An m-health application of daily text messages to address forgetfulness as contributor to non-adherence to medications post-myocardial infarction. Circulation2015;132:A18641. [DOI: 10.1161/circ.132.suppl_3.18641]PandeyA , KrummeAA , PatelT , ChoudhryNK . The impact of text messaging on medication adherence and exercise among postmyocardial infarction patients: randomized controlled pilot trial. JMIR mHealth and uHealth2017;5(8):e110. [DOI: 10.2196/mhealth.7144]PandeyAK , ChoudhryN . Text message reminders to address medication non-adherence in post-MI patients: a one year intervention study. Canadian Journal of Cardiology2014;30(10):S179. [DOI: 10.1016/j.cjca.2014.07.280]">Pandey 2017</a>; <a href="./references#CD011851-bbs2-0014" title="ParkLG , Howie-EsquivelJ , ChungM , DracupK . A text messaging intervention improves medication adherence for patients with coronary heart disease: a randomized controlled trial. Circulation2013;128(Suppl 22):A15249. [DOI: 10.1161/circ.128.suppl_22.A15249]ParkLG , Howie-EsquivelJ , ChungML , DracupK . A text messaging intervention to promote medication adherence for patients with coronary heart disease: a randomized controlled trial. Patient Education and Counseling2014;94(2):261-8. [DOI: 10.1016/j.pec.2013.10.027]ParkLG , Howie-EsquivelJ , WhooleyMA , DracupK . Psychosocial factors and medication adherence among patients with coronary heart disease: a text messaging intervention. European Journal of Cardiovascular Nursing2015;14(3):264-73. [DOI: 10.1177/1474515114537024]">Park 2014a</a>). However, there was insufficient power to quantitatively explore heterogeneity due to different content. Another systematic review including nine studies on the use of text messaging interventions for secondary prevention of CVD found that text messaging was effective in improving medication adherence (<a href="./references#CD011851-bbs2-0105" title="UnalE , GiakoumidakisK , KhanE , PatelarouE . Mobile phone text messaging for improving secondary prevention in cardiovascular diseases: a systematic review. Heart &amp; Lung2018;47(4):351-9. [DOI: 10.1016/j.hrtlng.2018.05.009]">Unal 2018</a>). However, half of their included studies (four out of nine) included hypertension as the primary condition, which was inconsistent with the inclusion criteria of our review. Our review is comparable to a previous systematic review of mobile phone interventions (e.g. text messaging, mobile apps, or telemonitoring) in the secondary prevention of CVD, which found that text messaging might positively impact the secondary prevention of CVD, but failed to draw any robust conclusions due to high heterogeneity and inability to conduct meta‐analysis (<a href="./references#CD011851-bbs2-0087" title="ParkLG , BeattyA , StaffordZ , WhooleyMA . Mobile phone interventions for the secondary prevention of cardiovascular disease. Progress in Cardiovascular Diseases2016;58(6):639-50. [DOI: 10.1016/j.pcad.2016.03.002]">Park 2016</a>). </p> <p>Whilst there is not a great deal of evidence on mobile text messaging for adherence in secondary prevention, it can be useful to look into research into what has been successful in tackling other chronic conditions. <a href="./references#CD011851-bbs2-0064" title="Ershad SarabiR , SadoughiF , Jamshidi OrakR , BahaadinbeigyK . The effectiveness of mobile phone text messaging in improving medication adherence for patients with chronic diseases: a systematic review. Iranian Red Crescent Medical Journal2016;18(5):e25183. [DOI: 10.5812/ircmj.25183]">Ershad 2016</a> conducted a systematic review to examine the effectiveness of mobile phone text messaging in improving medication adherence for people with chronic diseases. They included 34 studies, including 22 RCTs, one quasi‐experimental, two prospective, two observational, and four cohort studies. Although meta‐analysis was not conducted due to the high heterogeneity in the types of included studies, they found that in 85% of included studies, text messaging improved medication adherence in people with chronic diseases. One review on mobile text messaging for medication adherence in all chronic diseases found that mobile text messaging nearly doubled the odds of medication adherence (<a href="./references#CD011851-bbs2-0102" title="ThakkarJ , KurupR , LabaTL , SantoK , ThiagalingamA , RodgersA , et al. Mobile phone text messaging for medication adherence in chronic disease: a meta-analysis. JAMA Internal Medicine2016;176(3):340-9. [DOI: 10.1001/jamainternmed.2015.7667]">Thakkar 2016</a>). However, the issue of heterogeneity still existed, as substantial statistical heterogeneity (I<sup>2</sup> = 62%) across the included studies was identified. Furthermore, the included RCTs had a short intervention duration (12 weeks), and whether the adherence improvement could translate into the benefits in clinical outcomes was not assessed. In contrast to the positive findings of medication adherence found in these two reviews, our review update did not demonstrate consistent results. It is uncertain whether text messaging is more effective in improving medication adherence for other chronic conditions when compared with people with CVD. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD011851-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/urn:x-wiley:14651858:media:CD011851:CD011851-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD011851-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_n/nCD011851-FIG-01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_t/tCD011851-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/full#CD011851-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_n/nCD011851-FIG-01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011851-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/urn:x-wiley:14651858:media:CD011851:CD011851-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD011851-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_n/nCD011851-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_t/tCD011851-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/full#CD011851-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_n/nCD011851-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011851-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/urn:x-wiley:14651858:media:CD011851:CD011851-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD011851-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_n/nCD011851-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_t/tCD011851-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/full#CD011851-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_n/nCD011851-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011851-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/urn:x-wiley:14651858:media:CD011851:CD011851-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Text messaging versus usual care, Outcome 1: Fatal cardiovascular events" data-id="CD011851-fig-0004" src="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_n/nCD011851-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_t/tCD011851-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Text messaging versus usual care, Outcome 1: Fatal cardiovascular events</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/references#CD011851-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_n/nCD011851-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011851-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/urn:x-wiley:14651858:media:CD011851:CD011851-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Text messaging versus usual care, Outcome 2: Fatal cardiovascular events: sensitivity analysis using fixed‐effect model" data-id="CD011851-fig-0005" src="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_n/nCD011851-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_t/tCD011851-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Text messaging versus usual care, Outcome 2: Fatal cardiovascular events: sensitivity analysis using fixed‐effect model </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/references#CD011851-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_n/nCD011851-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011851-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/urn:x-wiley:14651858:media:CD011851:CD011851-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Text messaging versus usual care, Outcome 3: Low‐density lipoprotein cholesterol" data-id="CD011851-fig-0006" src="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_n/nCD011851-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_t/tCD011851-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Text messaging versus usual care, Outcome 3: Low‐density lipoprotein cholesterol </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/references#CD011851-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_n/nCD011851-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011851-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/urn:x-wiley:14651858:media:CD011851:CD011851-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Text messaging versus usual care, Outcome 4: Low‐density lipoprotein cholesterol: sensitivity analysis using fixed‐effect model" data-id="CD011851-fig-0007" src="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_n/nCD011851-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_t/tCD011851-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: Text messaging versus usual care, Outcome 4: Low‐density lipoprotein cholesterol: sensitivity analysis using fixed‐effect model </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/references#CD011851-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_n/nCD011851-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011851-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/urn:x-wiley:14651858:media:CD011851:CD011851-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Text messaging versus usual care, Outcome 5: Low‐density lipoprotein cholesterol: sensitivity analysis excluding studies with high risk of bias" data-id="CD011851-fig-0008" src="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_n/nCD011851-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_t/tCD011851-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: Text messaging versus usual care, Outcome 5: Low‐density lipoprotein cholesterol: sensitivity analysis excluding studies with high risk of bias </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/references#CD011851-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_n/nCD011851-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011851-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/urn:x-wiley:14651858:media:CD011851:CD011851-CMP-001.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Text messaging versus usual care, Outcome 6: Systolic blood pressure" data-id="CD011851-fig-0009" src="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_n/nCD011851-CMP-001.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_t/tCD011851-CMP-001.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1: Text messaging versus usual care, Outcome 6: Systolic blood pressure</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/references#CD011851-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_n/nCD011851-CMP-001.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011851-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/urn:x-wiley:14651858:media:CD011851:CD011851-CMP-001.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Text messaging versus usual care, Outcome 7: Systolic blood pressure: sensitivity analysis using fixed‐effect model" data-id="CD011851-fig-0010" src="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_n/nCD011851-CMP-001.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_t/tCD011851-CMP-001.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1: Text messaging versus usual care, Outcome 7: Systolic blood pressure: sensitivity analysis using fixed‐effect model </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/references#CD011851-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_n/nCD011851-CMP-001.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011851-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/urn:x-wiley:14651858:media:CD011851:CD011851-CMP-001.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Text messaging versus usual care, Outcome 8: Systolic blood pressure: sensitivity of analysis excluding studies with high risk of bias" data-id="CD011851-fig-0011" src="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_n/nCD011851-CMP-001.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_t/tCD011851-CMP-001.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1: Text messaging versus usual care, Outcome 8: Systolic blood pressure: sensitivity of analysis excluding studies with high risk of bias </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/references#CD011851-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_n/nCD011851-CMP-001.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011851-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/urn:x-wiley:14651858:media:CD011851:CD011851-CMP-001.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Text messaging versus usual care, Outcome 9: Systolic blood pressure: sensitivity analysis excluding outlier" data-id="CD011851-fig-0012" src="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_n/nCD011851-CMP-001.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_t/tCD011851-CMP-001.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1: Text messaging versus usual care, Outcome 9: Systolic blood pressure: sensitivity analysis excluding outlier </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/references#CD011851-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_n/nCD011851-CMP-001.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011851-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/urn:x-wiley:14651858:media:CD011851:CD011851-CMP-001.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Text messaging versus usual care, Outcome 10: Diastolic blood pressure" data-id="CD011851-fig-0013" src="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_n/nCD011851-CMP-001.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_t/tCD011851-CMP-001.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1: Text messaging versus usual care, Outcome 10: Diastolic blood pressure</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/references#CD011851-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_n/nCD011851-CMP-001.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011851-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/urn:x-wiley:14651858:media:CD011851:CD011851-CMP-001.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Text messaging versus usual care, Outcome 11: Diastolic blood pressure: sensitivity analysis using fixed‐effect model" data-id="CD011851-fig-0014" src="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_n/nCD011851-CMP-001.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_t/tCD011851-CMP-001.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1: Text messaging versus usual care, Outcome 11: Diastolic blood pressure: sensitivity analysis using fixed‐effect model </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/references#CD011851-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_n/nCD011851-CMP-001.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011851-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/urn:x-wiley:14651858:media:CD011851:CD011851-CMP-001.12" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Text messaging versus usual care, Outcome 12: Diastolic blood pressure: sensitivity analysis excluding studies with high risk of bias" data-id="CD011851-fig-0015" src="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_n/nCD011851-CMP-001.12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_t/tCD011851-CMP-001.12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1: Text messaging versus usual care, Outcome 12: Diastolic blood pressure: sensitivity analysis excluding studies with high risk of bias </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/references#CD011851-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_n/nCD011851-CMP-001.12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011851-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/urn:x-wiley:14651858:media:CD011851:CD011851-CMP-001.13" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Text messaging versus usual care, Outcome 13: Heart rate" data-id="CD011851-fig-0016" src="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_n/nCD011851-CMP-001.13.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_t/tCD011851-CMP-001.13.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1: Text messaging versus usual care, Outcome 13: Heart rate</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/references#CD011851-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_n/nCD011851-CMP-001.13.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011851-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/urn:x-wiley:14651858:media:CD011851:CD011851-CMP-001.14" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Text messaging versus usual care, Outcome 14: Heart rate: sensitivity analysis using fixed‐effect model" data-id="CD011851-fig-0017" src="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_n/nCD011851-CMP-001.14.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_t/tCD011851-CMP-001.14.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1: Text messaging versus usual care, Outcome 14: Heart rate: sensitivity analysis using fixed‐effect model </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/references#CD011851-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_n/nCD011851-CMP-001.14.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011851-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/urn:x-wiley:14651858:media:CD011851:CD011851-CMP-001.15" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Text messaging versus usual care, Outcome 15: Heart rate: sensitivity analysis excluding studies with high risk of bias" data-id="CD011851-fig-0018" src="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_n/nCD011851-CMP-001.15.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_t/tCD011851-CMP-001.15.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1: Text messaging versus usual care, Outcome 15: Heart rate: sensitivity analysis excluding studies with high risk of bias </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/references#CD011851-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/media/CDSR/CD011851/image_n/nCD011851-CMP-001.15.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD011851-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Mobile phone text messaging compared to usual care for medication adherence in secondary prevention of cardiovascular disease</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p>Mobile phone text messaging compared to usual care for medication adherence in secondary prevention of cardiovascular disease </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with established arterial occlusive events<br/><b>Setting:</b> hospital/cardiac rehabilitation facility<br/><b>Intervention:</b> mobile phone text messaging<br/><b>Comparison:</b> usual care </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>No. of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with usual care</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with text messaging interventions</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Medication adherence</b> (self‐reported adherence, questionnaire, tablet counts, medication event monitoring systems, pharmacy prescription data) </p> <p>Follow‐up: range 1 to 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>10 out of 18 studies showed a beneficial effect of text messaging on medication adherence compared to usual care. The other 8 studies showed that text messaging resulted in either a reduction or no difference in medication adherence when compared with usual care. </p> <p>Of the 10 studies showing beneficial effects, 4 studies found that text messaging improved the proportion of participants who took medications as prescribed (RR 1.10, RR 1.14, OR 0.43, and OR 0.37, respectively). 3 studies found an improved medication adherence score with text messaging (MD varied from 0.54 to 1.50). 2 studies found that text messaging reduced the risk of being low adherent (RR 4.09) or non‐adherent (OR 0.34). 1 study found that text messaging improved the percentage of correct doses taken by 12.0% (P = 0.02) and percentage of prescribed doses taken on schedule by 9.7% (P = 0.01). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8136<br/>(18 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low<sup>a,b,c</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Fatal cardiovascular events</b> (percentage of people having fatal cardiovascular events) </p> <p>Follow‐up: range 1 to 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.83 (0.47 to 1.45)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1654</p> <p>(4 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝</p> <p><b>Low<sup>a,c</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>36 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>30 per 1000</b> </p> <p>(17 to 52)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Non‐fatal cardiovascular events</b> (percentage of people having non‐fatal cardiovascular events) </p> <p>Follow‐up: range 1 to 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>2 studies reported non‐fatal cardiovascular events, neither of which reported a difference between groups. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low<sup>a,b,c</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Combined CVD events</b> (percentage of people having combined CVD events) </p> <p>Follow‐up: range 1 to 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>1 study reported combined CVD events and found no difference between groups.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low<sup>a,b,c</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Low‐density lipoprotein cholesterol (mg/dL)</b> </p> <p>(endpoint low‐density lipoprotein cholesterol reading)</p> <p>Follow‐up: range 1 to 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean low‐density lipoprotein cholesterol score ranged across the control groups from <b>73.47 to 99.3</b>. </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean low‐density lipoprotein cholesterol score in the intervention groups was, on average, <b>1.79 lower</b> (95% CI −4.71 to 1.12). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4983</p> <p>(8 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low<sup>a,b,c</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Blood pressure (mmHg)</b> (endpoint blood pressure reading) </p> <p>Follow‐up: range 1 to 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Systolic blood pressure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>5173</p> <p>(8 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low<sup>a,b,c</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean systolic blood pressure score ranged across the control groups from <b>121.0 to 136.0</b>. </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean systolic blood pressure score in the intervention groups was, on average, <b>0.93 lower</b> (95% CI −3.55 to 1.69). </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Diastolic blood pressure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>3137</p> <p>(5 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low<sup>a,b,c</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean diastolic blood pressure score ranged across the control groups from <b>72.2 to 84.0</b>. </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean diastolic blood pressure score in the intervention groups was, on average, <b>1.00 lower</b> (95% CI −2.49 to 0.50). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Heart rate (beats per minute)</b> (endpoint heart rate reading) </p> <p>Follow‐up: range 1 to 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean heart rate score ranged across the control groups from <b>67.0 to 69.0</b>. </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean heart rate score in the intervention groups was, on average, <b>0.46 lower</b> (95% CI −1.74 to 0.82). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2946</p> <p>(4 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low<sup>a,b,c</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Abbreviations: CI:</b> confidence interval; <b>CVD:</b> cardiovascular disease; <b>MD:</b> mean difference; <b>OR:</b> odds ratio; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for risk of bias: most trials were at unclear or high risk of bias for multiple domains.<br/><sup>b</sup>Downgraded one level for inconsistency: trial results included large variations in the degree to which the outcome was affected, or substantial heterogeneity (e.g. varying characteristics of the intervention and the comparators, diverse measurement methods, and various definitions of medication adherence).<br/><sup>c</sup>Downgraded one level for imprecision: very few events, or wide CIs encompassing intervention benefit and harm. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Mobile phone text messaging compared to usual care for medication adherence in secondary prevention of cardiovascular disease</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/full#CD011851-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011851-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">SMS development</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>SMS = reminder</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Description of process to design SMS</b> (e.g. did the authors describe the process used to construct the content of the text messages?) </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Evaluation of causes for non‐adherence</b> (e.g. did they evaluate causes for non‐adherence in the target population?) </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Used psychological theories to develop SMS</b> (e.g. were psychological theories used to develop the messages to target the identified behavioural determinants of non‐adherence?) </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Used behaviour change techniques to develop SMS</b> (e.g. were behaviour change techniques employed to develop the messages?) </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>SMS designed according to participant characteristics</b> (e.g. were different text messages developed according to participants' characteristics?) </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Pilot phase to evaluate clarity, grammar of SMS</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011851-bbs2-0001" title="BaeJW , WooSI , LeeJ , ParkSD , KwonSW , ChoiSH , et al. mHealth interventions for lifestyle and risk factor modification in coronary heart disease: randomized controlled trial. JMIR mHealth and uHealth2021;9(9):e29928. [DOI: 10.2196/29928]KCT0005087. Effect of text messaging program on lifestyle and clinical outcomes in patients with cardiovascular disease. cris.nih.go.kr/cris/search/detailSearch.do/19282 (first received 11 September 2019). ">Bae 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes, messages contain medication adherence contents</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes. “The contents of the SMS text messages were based on the Tobacco, Exercise, and Diet Messages (TEXTME) trial and the Australian Heart Foundation Healthy Living Guidelines. The cardiologists, nurses, clinical nutritionists, and preventive medicine experts reviewed the text messages in the TEXTME trial and modified them considering the Asian diet and culture.” (<a href="./references#CD011851-bbs2-0001" title="BaeJW , WooSI , LeeJ , ParkSD , KwonSW , ChoiSH , et al. mHealth interventions for lifestyle and risk factor modification in coronary heart disease: randomized controlled trial. JMIR mHealth and uHealth2021;9(9):e29928. [DOI: 10.2196/29928]KCT0005087. Effect of text messaging program on lifestyle and clinical outcomes in patients with cardiovascular disease. cris.nih.go.kr/cris/search/detailSearch.do/19282 (first received 11 September 2019). ">Bae 2021</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes. “The message sending program delivered semipersonalised text messages considering the smoking status and diet pattern of the participants ‐ vegetarian or not ‐ with their names.” (<a href="./references#CD011851-bbs2-0001" title="BaeJW , WooSI , LeeJ , ParkSD , KwonSW , ChoiSH , et al. mHealth interventions for lifestyle and risk factor modification in coronary heart disease: randomized controlled trial. JMIR mHealth and uHealth2021;9(9):e29928. [DOI: 10.2196/29928]KCT0005087. Effect of text messaging program on lifestyle and clinical outcomes in patients with cardiovascular disease. cris.nih.go.kr/cris/search/detailSearch.do/19282 (first received 11 September 2019). ">Bae 2021</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011851-bbs2-0002" title="BermonA , UribeAF , Pérez-RiveroPF , Prieto-MerinoD , SaaibiJF , SilvaFA , et al. Efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: TXT2HEART Colombia randomized controlled trial. JMIR mHealth and uHealth2021;9(7):e25548. [DOI: 10.2196/25548]BermonA , Uribe-RodríguezAF , Pérez-RiveroPF , Prieto-MerinoD , RiveraDIC , GuioE , et al. Evaluation of the efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: the txt2heart Colombia randomised controlled trial protocol. BMJ Open2019;9:e028017. [DOI: 10.1136/ bmjopen-2018-028017]NCT03098186. TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention [TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention]. clinicaltrials.gov/ct2/show/NCT03098186 (first received 3 March 2017). ">Bermon 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No, the text messages were not reminders for medication intake or appointments, but an intervention to increase awareness and commitment to medication taking. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes. “A protocol was carried out to determine the content, quantity, and frequency of SMS text messages through focus groups, validation of experts, user feedback, and pretest.” (<a href="./references#CD011851-bbs2-0002" title="BermonA , UribeAF , Pérez-RiveroPF , Prieto-MerinoD , SaaibiJF , SilvaFA , et al. Efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: TXT2HEART Colombia randomized controlled trial. JMIR mHealth and uHealth2021;9(7):e25548. [DOI: 10.2196/25548]BermonA , Uribe-RodríguezAF , Pérez-RiveroPF , Prieto-MerinoD , RiveraDIC , GuioE , et al. Evaluation of the efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: the txt2heart Colombia randomised controlled trial protocol. BMJ Open2019;9:e028017. [DOI: 10.1136/ bmjopen-2018-028017]NCT03098186. TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention [TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention]. clinicaltrials.gov/ct2/show/NCT03098186 (first received 3 March 2017). ">Bermon 2021</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes, based on the transtheoretical model of health behaviour change</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011851-bbs2-0003" title="ChenC , LiX , KangY , LiuH , LiangYD , ZhangQ . Post-discharge short service message improves short-term clinical outcome and self-care behavior in Chinese patients with chronic heart failure. European Heart Journal2018;39(Suppl 1):797-8. [DOI: 10.1093/eurheartj/ehy563.P3770]ChenC , LiX , SunL , CaoS , KangY , HongL , et al. Post-discharge short message service improves short-term clinical outcome and self-care behaviour in chronic heart failure. ESC Heart Failure2019;6(1):164-73. [DOI: 10.1002/ehf2.12380]ChiCTR-INR-17012316. Effect of post-discharge text messages on clinical outcomes in patients with heart failure [Effect of post-discharge text messages on clinical outcomes in patients with heart failure]. trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR-INR-17012316 (first received 9 August 2018). LiX , ChenC , YouGY , ZhangQ . Post-discharge text messaging intervention improved clinical outcomes in patients with heart failure. European Heart Journal2016;37(Suppl 1):727-8. [DOI: 10.1093/eurheartj/ehw433]">Chen 2019</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes, medication reminder</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes, all contents of text messages were pre‐written and reviewed by heart failure specialists and senior nursing specialists. The contents were developed based on heart failure diagnosis and management guidelines, evidence from review articles, and educational materials from Heart Failure Society of America. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011851-bbs2-0004" title="ACTRN12611000161921. Tobacco, EXercise and dieT MEssages (TEXT ME): the effect of semi-personalised lifestyle reminder text message intervention on cardiovascular disease risk [Tobacco, EXercise and dieT MEssages (TEXT ME): The effect of a semi-personalised lifestyle reminder text message intervention on cardiovascular risk factors in patients with cardiovascular disease and those who are at high risk of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12611000161921 (first received 3 February 2011). ChowCK , RedfernJ , HillisGS , ThakkarJ , SantoK , HackettML , et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA2015;314(12):1255-63. [DOI: 10.1001/jama.2015.10945]ChowCK , RedfernJ , ThiagalingamA , JanS , WhittakerR , HackettM , et al. Design and rationale of the tobacco, exercise and diet messages (TEXT ME) trial of a text message-based intervention for ongoing prevention of cardiovascular disease in people with coronary disease: a randomised controlled trial protocol. BMJ Open2012;2(1):e000606. [DOI: 10.1136/bmjopen-2011-000606]RedfernJ , SantoK , CooreyG , ThakkarJ , HackettM , ThiagalingamA , et al. Factors influencing engagement, perceived usefulness and behavioral mechanisms associated with a text message support program. PLOS ONE2016;11(10):e0163929. [DOI: 10.1371/journal.pone.0163929]ThakkarJ , RedfernJ , De KeizerL , ThiagalingamA , ChowC . Patient perceptions of text message-based intervention for secondary prevention of cardiovascular events. Heart, Lung and Circulation2013;22(Suppl 1):S264. [DOI: 10.1016/j.hlc.2013.05.630]ThakkarJ , RedfernJ , ThiagalingamA , ChowCK . Patterns, predictors and effects of texting intervention on physical activity in CHD – insights from the TEXT ME randomized clinical trial. European Journal of Preventive Cardiology2016;23(17):1894-902. [DOI: 10.1177/2047487316664190]">Chow 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes, a bank of messages was developed with input from investigators, clinicians, academics, and patients through a multistage iterative process. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes. “The message management program selected messages for each participant at random from the bank of messages from all relevant content areas as per the prespecified algorithms and using baseline data entered into the message management system. e.g. nonsmokers would not be sent smoking messages, and vegetarians would not be sent information about meat. Some messages were merged with patient’s preferred names.” (<a href="./references#CD011851-bbs2-0004" title="ACTRN12611000161921. Tobacco, EXercise and dieT MEssages (TEXT ME): the effect of semi-personalised lifestyle reminder text message intervention on cardiovascular disease risk [Tobacco, EXercise and dieT MEssages (TEXT ME): The effect of a semi-personalised lifestyle reminder text message intervention on cardiovascular risk factors in patients with cardiovascular disease and those who are at high risk of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12611000161921 (first received 3 February 2011). ChowCK , RedfernJ , HillisGS , ThakkarJ , SantoK , HackettML , et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA2015;314(12):1255-63. [DOI: 10.1001/jama.2015.10945]ChowCK , RedfernJ , ThiagalingamA , JanS , WhittakerR , HackettM , et al. Design and rationale of the tobacco, exercise and diet messages (TEXT ME) trial of a text message-based intervention for ongoing prevention of cardiovascular disease in people with coronary disease: a randomised controlled trial protocol. BMJ Open2012;2(1):e000606. [DOI: 10.1136/bmjopen-2011-000606]RedfernJ , SantoK , CooreyG , ThakkarJ , HackettM , ThiagalingamA , et al. Factors influencing engagement, perceived usefulness and behavioral mechanisms associated with a text message support program. PLOS ONE2016;11(10):e0163929. [DOI: 10.1371/journal.pone.0163929]ThakkarJ , RedfernJ , De KeizerL , ThiagalingamA , ChowC . Patient perceptions of text message-based intervention for secondary prevention of cardiovascular events. Heart, Lung and Circulation2013;22(Suppl 1):S264. [DOI: 10.1016/j.hlc.2013.05.630]ThakkarJ , RedfernJ , ThiagalingamA , ChowCK . Patterns, predictors and effects of texting intervention on physical activity in CHD – insights from the TEXT ME randomized clinical trial. European Journal of Preventive Cardiology2016;23(17):1894-902. [DOI: 10.1177/2047487316664190]">Chow 2015</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011851-bbs2-0005" title="ACTRN12613000793718. TEXT messages to improve MEDication adherence &amp; Secondary prevention – TEXTMEDS [TEXT messages to improve MEDication adherence &amp; Secondary prevention in patients with acute coronary syndrome - TEXTMEDS]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364448&amp;isReview=true (first received 18 June 2013). ChowCK , KlimisH , ThiagalingamA , RedfernJ , HillisGS , BriegerD , et al. Text messages to improve medication adherence and secondary prevention after acute coronary syndrome: the TEXTMEDS randomized clinical trial. Circulation2022;145(19):1443-55. [DOI: 10.1161/CIRCULATIONAHA.121.056161]ChowCK , ThiagalingamA , SantoK , KokC , ThakkarJ , StepienS , et al. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol. BMJ Open2018;8:e019463. [DOI: 10.1136/bmjopen-2017-019463]">Chow 2022</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes. The medication messages provided information about how medications worked, common side effects, and tips on how to take medication regularly. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes, the content of the messages was customised to participant characteristics such as medication class prescription, dietary habits (vegetarian or non‐vegetarian), and/or smoking status. Furthermore, messages were ‘personalised’, that is the preferred name of the participant was incorporated into some messages. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011851-bbs2-0006" title="ACTRN12613000901707. Text4Heart: a text message and internet-based comprehensive cardiac rehabilitation intervention [A randomised controlled trial to determine the efficacy of a text message and Internet-based comprehensive cardiac rehabilitation programme to improve adherence to lifestyle change compared with usual care in New Zealand adults with a diagnosis of cardiovascular disease]. anzctr.org.au/ACTRN12613000901707.aspx (first received 9 August 2013). DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Improving coronary heart disease self-management using mobile technologies (Text4Heart): a randomised controlled trial protocol. Trials2014;15(71):1-9. [DOI: 10.1186/1745-6215-15-71]DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Text message and internet support for coronary heart disease self-management: results from the Text4Heart randomized controlled trial. Journal of Medical Internet Research2015;17(10):e237. [DOI: 10.2196/jmir.4944]">Dale 2015a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>“We created and refined the Text4Heart intervention through formative and pretesting studies following the mHealth Development and Evaluation<br/>Framework.” (<a href="./references#CD011851-bbs2-0057" title="DaleLP , WhittakerR , EylesH , Ni MhurchuC , BallK , SmithN , et al. Cardiovascular disease self-management: pilot testing of an mHealth healthy eating program. Journal of Personalized Medicine2014;4(1):88-101. [DOI: 10.3390/jpm4010088]">Dale 2014a</a>) Also, another study that helped inform the physical activity component (<a href="./references#CD011851-bbs2-0059" title="DaleLP , WhittakerR , DixonR , StewartR , JiangY , CarterK , et al. Acceptability of a mobile health exercise-based cardiac rehabilitation intervention: a randomized trial. Journal of Cardiopulmonary Rehabilitation and Prevention2015;35(5):312-9. [DOI: 10.1097/HCR.0000000000000125]">Dale 2015b</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Messages were based on social cognitive theory and the common sense model (<a href="./references#CD011851-bbs2-0058" title="DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Improving coronary heart disease self management using mobile technologies (Text4Heart): a randomised controlled trial protocol. Trials2014;15(71):1-9. [DOI: 10.1186/1745-6215-15-71]">Dale 2014b</a>). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes. All messages were coded according to their theoretical construct and corresponding behaviour change techniques. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No, but participants could pick messages on the health behaviour they were most interested in changing (physical activity, healthy eating, smoking cessation, or stress management). Messages were also personalised with participant’s preferred name. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes, the healthy eating messages were pilot tested. Feedback from participants was used to refine the messages (<a href="./references#CD011851-bbs2-0057" title="DaleLP , WhittakerR , EylesH , Ni MhurchuC , BallK , SmithN , et al. Cardiovascular disease self-management: pilot testing of an mHealth healthy eating program. Journal of Personalized Medicine2014;4(1):88-101. [DOI: 10.3390/jpm4010088]">Dale 2014a</a>). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011851-bbs2-0007" title="FangR , LiX . Electronic messaging support service programs improve adherence to lipid-lowering therapy among outpatients with coronary artery disease: an exploratory randomised control study. Journal of Clinical Nursing2016;25(5-6):664-71. [DOI: 10.1111/jocn.12988]">Fang 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011851-bbs2-0008" title="HuoX , KrumholzHM , BaiX , SpatzES , DingQ , HorakP , et al. Effects of mobile text messaging on glycemic control in patients with coronary heart disease and diabetes mellitus: a randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(9):e005805. [DOI: 10.1161/CIRCOUTCOMES.119.005805]NCT02883842. Cardiovascular Health and Text Messaging-Diabetes Mellitus (CHAT-DM) Study [Effectiveness of text messaging on risk factors control and medication adherence among patients with Coronary Heart Disease and Diabetes in China: cardiovascular health andtext messaging-Diabetes Mellitus (CHAT-DM) study]. clinicaltrials.gov/ct2/show/NCT02883842 (first received 30 August 2016). ">Huo 2019</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes. “A multidisciplinary team of cardiologists, endocrinologists, psychologists, nurses, linguists, and patients developed the text message bank through a systematic and iterative approach. Messages were drafted based on existing evidence‐based guidelines and standards of care, and they incorporated behavioural change techniques to provide advice, motivation, and support.” (<a href="./references#CD011851-bbs2-0008" title="HuoX , KrumholzHM , BaiX , SpatzES , DingQ , HorakP , et al. Effects of mobile text messaging on glycemic control in patients with coronary heart disease and diabetes mellitus: a randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(9):e005805. [DOI: 10.1161/CIRCOUTCOMES.119.005805]NCT02883842. Cardiovascular Health and Text Messaging-Diabetes Mellitus (CHAT-DM) Study [Effectiveness of text messaging on risk factors control and medication adherence among patients with Coronary Heart Disease and Diabetes in China: cardiovascular health andtext messaging-Diabetes Mellitus (CHAT-DM) study]. clinicaltrials.gov/ct2/show/NCT02883842 (first received 30 August 2016). ">Huo 2019</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No. Some messages were personalised with the participant’s preferred name.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes. “A pilot study was conducted to elicit patient feedback on the messages, and the text bank was updated to improve clarity and practical usefulness. Messages were also modified to increase their applicability to the<br/>Chinese culture and compatibility with Chinese values. For example, some messages used aphorisms and catchy rhyme schemes to make them more appealing to patients.” (<a href="./references#CD011851-bbs2-0008" title="HuoX , KrumholzHM , BaiX , SpatzES , DingQ , HorakP , et al. Effects of mobile text messaging on glycemic control in patients with coronary heart disease and diabetes mellitus: a randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(9):e005805. [DOI: 10.1161/CIRCOUTCOMES.119.005805]NCT02883842. Cardiovascular Health and Text Messaging-Diabetes Mellitus (CHAT-DM) Study [Effectiveness of text messaging on risk factors control and medication adherence among patients with Coronary Heart Disease and Diabetes in China: cardiovascular health andtext messaging-Diabetes Mellitus (CHAT-DM) study]. clinicaltrials.gov/ct2/show/NCT02883842 (first received 30 August 2016). ">Huo 2019</a>) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011851-bbs2-0009" title="KamalAK , ShaikQN , PashaO , AzamI , IslamM , MemonAA , et al. Improving medication adherence in stroke patients through Short Text Messages (SMS4Stroke)-study protocol for a randomized, controlled trial. BMC Neurology2015;15:157. [DOI: 10.1186/s12883-015-0413-2]KamalAK , ShaikhQ , PashaO , AzamI , IslamM , MemonAA , et al. A randomized controlled behavioral intervention trial to improve medication adherence in adult stroke patients with prescription tailored short messaging service (SMS)-SMS4Stroke study. BMC Neurolology2015;15:212. [DOI: 10.1186/s12883-015-0471-5]">Kamal 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011851-bbs2-0010" title="KhonsariS , SubramanianP , ChinnaK , LatifLA , LingLW , GholamiO . Effect of a reminder system using an automated short message service on medication adherence following acute coronary syndrome. European Journal of Cardiovascular Nursing2015;14(2):170-9. [DOI: 10.1177/1474515114521910]">Khonsari 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The content of the text messages was based on the WHO multidimensional adherence model (<a href="./references#CD011851-bbs2-0106" title="World Health Organization. Chapter V - Towards the solution. In: Adherence to Long-Term Therapies: Evidence for Action. World Health Organization, 2003:27-38. [ ISBN: 9241545992]">WHO 2003</a>). In constructing the content of the text messages, the study authors focused on the most common reasons for medication non‐adherence based on the WHO model that were unintentional on the patient’s part (forgetfulness and carelessness with medication usage), and included a therapy‐related dimension (misunderstanding of treatment instructions: meds name, dosage and timing) (<a href="./references#CD011851-bbs2-0069" title="GadkariAS , McHorneyCA . Unintentional non-adherence to chronic prescription medications: how unintentional is it really. BMC Health Services Research2012;12:98. [DOI: 10.1186/1472-6963-12-98]">Gadkari 2012</a>). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>According to the study methods, participants were recruited during an admission for<br/>ACS prior to discharge from the cardiology ward. This means that all participants were primarily diagnosed with ACS without any experience of taking cardiac medications.<br/>Evaluating causes for non‐adherence<br/>in the target population was therefore not applicable. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The WHO multidimensional adherence model that guided this study included many different aspects to describe medication non‐adherence behaviour, including psychological factors (<a href="./references#CD011851-bbs2-0106" title="World Health Organization. Chapter V - Towards the solution. In: Adherence to Long-Term Therapies: Evidence for Action. World Health Organization, 2003:27-38. [ ISBN: 9241545992]">WHO 2003</a>). It is<br/>emphasised that no single determinant is responsible for non‐adherence to treatment because the adherence phenomenon is multidimensional and results from the interplay of 5 sets of factors (dimensions), including: </p> <p>A. social and economic factors;<br/>B. therapy‐related factors;<br/>C. condition‐related factors;<br/>D. healthcare team and system‐related factors; and<br/>E. patient‐related factors. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Development of the automated SMS reminder system in this study was useful for deploying spaced repetition strategies via text messaging. Basically, spaced repetition strategy posits that instruction which is repeated at intervals has a great impact on improving a behaviour (<a href="./references#CD011851-bbs2-0063" title="EbbinghausH . Über das Gedächtnis: Untersuchungen zur experimentellen Psychologie. Leipzig: Dunker, 1885. [OCLC: (OCoLC)5876733]">Ebbinghaus 1885</a>). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The intervention was piloted with 10 cardiac patients during the first stage of the study. During this phase, a variety of test scenarios and clarity of SMS content were analysed. Text messages were further modified to achieve the desired functions. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011851-bbs2-0011" title="ACTRN12616000422426. Text4Heart Partnership: a text messaging program to enhance self-management of cardiovascular disease [Text messaging to enhance self-management of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12616000422426 (first received 23 March 2016). MaddisonR , JiangY , StewartR , ScottT , KerrA , WhittakerR , et al. An intervention to improve medication adherence in people with heart disease (Text4HeartII): randomized controlled trial. JMIR mHealth and uHealth2021;9(6):e24952. [DOI: 10.2196/24952]MaddisonR , StewartR , DoughtyR , ScottT , KerrA , BenatarJ , et al. Text4Heart II - improving medication adherence in people with heart disease: a study protocol for a randomized controlled trial. Trials2018;19(1):70. [DOI: 10.1186/s13063-018-2468-z]">Maddison 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes. All message content was grounded in psychological theory (Common Sense Model). “The content was focused on modifying people’s perceptions of the symptoms, timeline, cause, consequences, personal control over, and the ability of treatment to prevent cardiovascular disease as well as altering the key mediators of behaviour change, including self‐efficacy, social support, and motivation.” (<a href="./references#CD011851-bbs2-0011" title="ACTRN12616000422426. Text4Heart Partnership: a text messaging program to enhance self-management of cardiovascular disease [Text messaging to enhance self-management of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12616000422426 (first received 23 March 2016). MaddisonR , JiangY , StewartR , ScottT , KerrA , WhittakerR , et al. An intervention to improve medication adherence in people with heart disease (Text4HeartII): randomized controlled trial. JMIR mHealth and uHealth2021;9(6):e24952. [DOI: 10.2196/24952]MaddisonR , StewartR , DoughtyR , ScottT , KerrA , BenatarJ , et al. Text4Heart II - improving medication adherence in people with heart disease: a study protocol for a randomized controlled trial. Trials2018;19(1):70. [DOI: 10.1186/s13063-018-2468-z]">Maddison 2021</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes. All message content was grounded in behaviour change (social cognitive) theory. “The content was focused on modifying people’s perceptions of the symptoms, timeline, cause, consequences, personal control over, and the ability of treatment to prevent cardiovascular disease as well as altering the key mediators of behaviour change, including self‐efficacy, social support, and motivation.” (<a href="./references#CD011851-bbs2-0011" title="ACTRN12616000422426. Text4Heart Partnership: a text messaging program to enhance self-management of cardiovascular disease [Text messaging to enhance self-management of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12616000422426 (first received 23 March 2016). MaddisonR , JiangY , StewartR , ScottT , KerrA , WhittakerR , et al. An intervention to improve medication adherence in people with heart disease (Text4HeartII): randomized controlled trial. JMIR mHealth and uHealth2021;9(6):e24952. [DOI: 10.2196/24952]MaddisonR , StewartR , DoughtyR , ScottT , KerrA , BenatarJ , et al. Text4Heart II - improving medication adherence in people with heart disease: a study protocol for a randomized controlled trial. Trials2018;19(1):70. [DOI: 10.1186/s13063-018-2468-z]">Maddison 2021</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes. The content of messages was based on the original Text4Heart pilot programme, with some modifications. Message content from weeks 12 to 24 was modified to promote maintenance of the behaviours and relapse prevention. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011851-bbs2-0012" title="NCT02793830. A mobile phone based medication reminder program [A mobile phone based medication reminder program for patients in China with coronary heart disease: a pilot study]. clinicaltrials.gov/ct2/show/NCT02793830 (first received 8 June 2016). NiZ , WuB , YangQ , YanLL , LiuC , ShawRJ . An mHealth intervention to improve medication adherence and health outcomes among patients with coronary heart disease: randomized controlled trial. Journal of Medical Internet Research2022;24(3):e27202. [DOI: 10.2196/27202]">Ni 2022</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes, message reminders</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes, personalised reminders</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes. The interventions were refined based on the pilot study.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011851-bbs2-0013" title="NCT02783287. The impact of text messaging on medication adherence and exercise regimen among post-myocardial infarction patients. clinicaltrials.gov/ct2/show/NCT02783287 (first received 26 May 2016). PandeyA , ChoudhryN . An m-health application of daily text messages to address forgetfulness as contributor to non-adherence to medications post-myocardial infarction. Circulation2015;132:A18641. [DOI: 10.1161/circ.132.suppl_3.18641]PandeyA , KrummeAA , PatelT , ChoudhryNK . The impact of text messaging on medication adherence and exercise among postmyocardial infarction patients: randomized controlled pilot trial. JMIR mHealth and uHealth2017;5(8):e110. [DOI: 10.2196/mhealth.7144]PandeyAK , ChoudhryN . Text message reminders to address medication non-adherence in post-MI patients: a one year intervention study. Canadian Journal of Cardiology2014;30(10):S179. [DOI: 10.1016/j.cjca.2014.07.280]">Pandey 2017</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes, medication reminders</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011851-bbs2-0014" title="ParkLG , Howie-EsquivelJ , ChungM , DracupK . A text messaging intervention improves medication adherence for patients with coronary heart disease: a randomized controlled trial. Circulation2013;128(Suppl 22):A15249. [DOI: 10.1161/circ.128.suppl_22.A15249]ParkLG , Howie-EsquivelJ , ChungML , DracupK . A text messaging intervention to promote medication adherence for patients with coronary heart disease: a randomized controlled trial. Patient Education and Counseling2014;94(2):261-8. [DOI: 10.1016/j.pec.2013.10.027]ParkLG , Howie-EsquivelJ , WhooleyMA , DracupK . Psychosocial factors and medication adherence among patients with coronary heart disease: a text messaging intervention. European Journal of Cardiovascular Nursing2015;14(3):264-73. [DOI: 10.1177/1474515114537024]">Park 2014a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011851-bbs2-0015" title="NCT03414190. Impact of text messages to promote secondary prevention after acute coronary syndrome [Impact of a mobile phone text messages intervention on the secondary prevention of cardiovascular events after acute coronary syndrome]. clinicaltrials.gov/show/NCT03414190 (first received 29 January 2018). PassagliaLG , BrantLC , NascimentoBR , RibeiroAL . Impact of text messages in a middle-income country to promote secondary prevention after acute coronary syndrome (IMPACS): a randomized trial. Medicine2019;98(22):e15681. [DOI: 10.1097/MD.0000000000015681]PassagliaLG , BrantLC , SilvaJL , NascimentoBR , RibeiroAL . Text messages to promote secondary prevention after acute coronary syndrome (IMPACS trial). International Journal of Cardiovascular Sciences2021;35(2):202-13. [DOI: 10.36660/ijcs.20200378]">Passaglia 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes, text messages were developed by the research group, and reviewed by individuals not involved in the study to check for language issues and evaluation of understanding. The content of the messages was based on the Brazilian Society of Cardiology Guidelines. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No, semi‐personalised</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A pilot study was conducted to test the software developed and the initial acceptability of text messages sent. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011851-bbs2-0016" title="QuiliciJ , FugonL , BeguinS , MorangePE , BonnetJL , AlessiMC , et al. Effect of motivational mobile phone short message service on aspirin adherence after coronary stenting for acute coronary syndrome. International Journal of Cardiology2013;168(1):568-9. [DOI: 10.1016/j.ijcard.2013.01.252]">Quilici 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011851-bbs2-0017" title="NCT02336919. The use of texting messaging to improve the hospital-to-community transition period in cardiovascular disease patients (Txt2Prevent) [The use of texting messaging to improve the hospital-to-community transition and prevent readmission in patients with cardiovascular disease (Txt2Prevent)]. clinicaltrials.gov/ct2/show/NCT02336919 (first received 13 January 2015). RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of SMS text messaging to improve the hospital-to-community transition in patients with acute coronary syndrome (Txt2Prevent): results from a pilot randomized controlled trial. JMIR mHealth and uHealth2021;9(5):e24530. [DOI: 10.2196/24530]RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of text messaging to improve the hospital-to-community transition in acute coronary syndrome patients (Txt2Prevent): intervention development and pilot randomized controlled trial protocol. JMIR Research Protocols2017;6(5):e91. [DOI: 10.2196/resprot.6968]">Ross 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes, medication reminders</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes. The content of the text messages was developed by a clinical advisory committee (including cardiologists, a general practitioner, a community pharmacist, a cardiac nurse specialist, patient‐users, a programmer, a benefits evaluation specialist, and researchers). Messages were further revised based on the guiding principles, discharge materials, and interviews with patients. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>“Instead of conforming to a single one of the many branded theories of behaviour change, the intervention reflects a set of cross‐cutting theoretical domains; the themes in the messages relate to concerns about knowledge, skills, roles and identity, beliefs about capabilities (eg, self‐efficacy), beliefs about consequences, motivation, attention and decision processes (e.g. cues to action such as reminders), environmental context and resources, social influences, emotion, and action plans.” (<a href="./references#CD011851-bbs2-0017" title="NCT02336919. The use of texting messaging to improve the hospital-to-community transition period in cardiovascular disease patients (Txt2Prevent) [The use of texting messaging to improve the hospital-to-community transition and prevent readmission in patients with cardiovascular disease (Txt2Prevent)]. clinicaltrials.gov/ct2/show/NCT02336919 (first received 13 January 2015). RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of SMS text messaging to improve the hospital-to-community transition in patients with acute coronary syndrome (Txt2Prevent): results from a pilot randomized controlled trial. JMIR mHealth and uHealth2021;9(5):e24530. [DOI: 10.2196/24530]RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of text messaging to improve the hospital-to-community transition in acute coronary syndrome patients (Txt2Prevent): intervention development and pilot randomized controlled trial protocol. JMIR Research Protocols2017;6(5):e91. [DOI: 10.2196/resprot.6968]">Ross 2021</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>“Instead of conforming to a single one of the many branded theories of behaviour change, the intervention reflects a set of cross‐cutting theoretical domains; the themes in the messages relate to concerns about knowledge, skills, roles and identity, beliefs about capabilities (eg, self‐efficacy), beliefs about consequences, motivation, attention and decision processes (e.g. cues to action such as reminders), environmental context and resources, social influences, emotion, and action plans.” (<a href="./references#CD011851-bbs2-0017" title="NCT02336919. The use of texting messaging to improve the hospital-to-community transition period in cardiovascular disease patients (Txt2Prevent) [The use of texting messaging to improve the hospital-to-community transition and prevent readmission in patients with cardiovascular disease (Txt2Prevent)]. clinicaltrials.gov/ct2/show/NCT02336919 (first received 13 January 2015). RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of SMS text messaging to improve the hospital-to-community transition in patients with acute coronary syndrome (Txt2Prevent): results from a pilot randomized controlled trial. JMIR mHealth and uHealth2021;9(5):e24530. [DOI: 10.2196/24530]RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of text messaging to improve the hospital-to-community transition in acute coronary syndrome patients (Txt2Prevent): intervention development and pilot randomized controlled trial protocol. JMIR Research Protocols2017;6(5):e91. [DOI: 10.2196/resprot.6968]">Ross 2021</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No, but participants received different SMS text messages on 2 occasions based on their smoking status. No other aspects were personalised. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes, this was a pilot study.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011851-bbs2-0018" title="HuoX , SpatzES , DingQ , HorakP , ZhengX , MastersC , et al. Design and rationale of the Cardiovascular Health and Text Messaging (CHAT) study and the CHAT-Diabetes Mellitus (CHAT-DM) study: two randomised controlled trials of text messaging to improve secondary prevention for coronary heart disease and diabetes. BMJ Open2017;7(12):e018302. [DOI: 10.1136/bmjopen-2017-018302]ZhengX , SpatzES , BaiX , HuoX , DingQ , HorakP , et al. Effect of text messaging on risk factor management in patients with coronary heart disease: the CHAT randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(4):e005616. [DOI: 10.1161/CIRCOUTCOMES.119.005616]">Zheng 2019</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes, it reminded people to take their medications and follow‐up.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes. “A multidisciplinary team of cardiologists, endocrinologists, psychologists, nurses, linguists, and patients developed the text message bank through a systematic and iterative approach.” (<a href="./references#CD011851-bbs2-0008" title="HuoX , KrumholzHM , BaiX , SpatzES , DingQ , HorakP , et al. Effects of mobile text messaging on glycemic control in patients with coronary heart disease and diabetes mellitus: a randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(9):e005805. [DOI: 10.1161/CIRCOUTCOMES.119.005805]NCT02883842. Cardiovascular Health and Text Messaging-Diabetes Mellitus (CHAT-DM) Study [Effectiveness of text messaging on risk factors control and medication adherence among patients with Coronary Heart Disease and Diabetes in China: cardiovascular health andtext messaging-Diabetes Mellitus (CHAT-DM) study]. clinicaltrials.gov/ct2/show/NCT02883842 (first received 30 August 2016). ">Huo 2019</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No, but semi‐personalised with participants' preferred name</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes. To make the messages more simple, culturally adaptable, and easy to understand, a user test and pilot study were conducted to collect patient feedback on the text bank messages. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p>ACS: acute coronary syndrome; SMS: short message service; WHO: World Health Organization</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">SMS development</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/full#CD011851-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011851-tbl-0003"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Overview of the trial results for medication adherence</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Outcome measure</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Scale used/measurement tool</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Continuous/categorical data</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Time point (months)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Number in intervention group</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Intervention group effect</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Number in control group)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Control group effect</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Narrative results</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD011851-bbs2-0001" title="BaeJW , WooSI , LeeJ , ParkSD , KwonSW , ChoiSH , et al. mHealth interventions for lifestyle and risk factor modification in coronary heart disease: randomized controlled trial. JMIR mHealth and uHealth2021;9(9):e29928. [DOI: 10.2196/29928]KCT0005087. Effect of text messaging program on lifestyle and clinical outcomes in patients with cardiovascular disease. cris.nih.go.kr/cris/search/detailSearch.do/19282 (first received 11 September 2019). ">Bae 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication adherence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6‐item Modified Morisky Scale (high score indicates better adherence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Continuous</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>377</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median (IQR) = 5 (5 to 5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median (IQR) = 5 (5 to 5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean difference 0.07, 95% CI −0.03 to 0.16; P = 0.19</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of participants taking medications as instructed on &gt; 25 days in the last month </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Categorical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>377</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>98.2%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92.1%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adjusted RR 1.10, 95% CI 1.00 to 1.10; P &lt; 0.001</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD011851-bbs2-0002" title="BermonA , UribeAF , Pérez-RiveroPF , Prieto-MerinoD , SaaibiJF , SilvaFA , et al. Efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: TXT2HEART Colombia randomized controlled trial. JMIR mHealth and uHealth2021;9(7):e25548. [DOI: 10.2196/25548]BermonA , Uribe-RodríguezAF , Pérez-RiveroPF , Prieto-MerinoD , RiveraDIC , GuioE , et al. Evaluation of the efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: the txt2heart Colombia randomised controlled trial protocol. BMJ Open2019;9:e028017. [DOI: 10.1136/ bmjopen-2018-028017]NCT03098186. TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention [TXT2HEART COLOMBIA: evaluation of the efficacy and safety of text messages to improve adherence to cardiovascular medications in secondary prevention]. clinicaltrials.gov/ct2/show/NCT03098186 (first received 3 March 2017). ">Bermon 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication adherence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication Adherence Report Scale‐5 (high score indicates better adherence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Continuous</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>462</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean difference (SD) = −0.02 (3.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>468</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean difference (SD) = 0.2 (3.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adjusted mean difference −0.01, 95% CI −0.40 to 0.40; P = 0.96</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Subjective medication intake compliance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Continuous</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>462</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean difference (SD) = 0.1 (2.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>468</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean difference (SD) = 0.1 (1.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adjusted mean difference 0.02, 95% CI −0.20 to 0.20; P = 0.83</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011851-bbs2-0003" title="ChenC , LiX , KangY , LiuH , LiangYD , ZhangQ . Post-discharge short service message improves short-term clinical outcome and self-care behavior in Chinese patients with chronic heart failure. European Heart Journal2018;39(Suppl 1):797-8. [DOI: 10.1093/eurheartj/ehy563.P3770]ChenC , LiX , SunL , CaoS , KangY , HongL , et al. Post-discharge short message service improves short-term clinical outcome and self-care behaviour in chronic heart failure. ESC Heart Failure2019;6(1):164-73. [DOI: 10.1002/ehf2.12380]ChiCTR-INR-17012316. Effect of post-discharge text messages on clinical outcomes in patients with heart failure [Effect of post-discharge text messages on clinical outcomes in patients with heart failure]. trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR-INR-17012316 (first received 9 August 2018). LiX , ChenC , YouGY , ZhangQ . Post-discharge text messaging intervention improved clinical outcomes in patients with heart failure. European Heart Journal2016;37(Suppl 1):727-8. [DOI: 10.1093/eurheartj/ehw433]">Chen 2019</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of participants taking medications as prescribed</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Categorical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>209</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>78.9%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>69.5%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.14, 95% CI 1.01 to 1.28; P = 0.029</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><a href="./references#CD011851-bbs2-0004" title="ACTRN12611000161921. Tobacco, EXercise and dieT MEssages (TEXT ME): the effect of semi-personalised lifestyle reminder text message intervention on cardiovascular disease risk [Tobacco, EXercise and dieT MEssages (TEXT ME): The effect of a semi-personalised lifestyle reminder text message intervention on cardiovascular risk factors in patients with cardiovascular disease and those who are at high risk of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12611000161921 (first received 3 February 2011). ChowCK , RedfernJ , HillisGS , ThakkarJ , SantoK , HackettML , et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA2015;314(12):1255-63. [DOI: 10.1001/jama.2015.10945]ChowCK , RedfernJ , ThiagalingamA , JanS , WhittakerR , HackettM , et al. Design and rationale of the tobacco, exercise and diet messages (TEXT ME) trial of a text message-based intervention for ongoing prevention of cardiovascular disease in people with coronary disease: a randomised controlled trial protocol. BMJ Open2012;2(1):e000606. [DOI: 10.1136/bmjopen-2011-000606]RedfernJ , SantoK , CooreyG , ThakkarJ , HackettM , ThiagalingamA , et al. Factors influencing engagement, perceived usefulness and behavioral mechanisms associated with a text message support program. PLOS ONE2016;11(10):e0163929. [DOI: 10.1371/journal.pone.0163929]ThakkarJ , RedfernJ , De KeizerL , ThiagalingamA , ChowC . Patient perceptions of text message-based intervention for secondary prevention of cardiovascular events. Heart, Lung and Circulation2013;22(Suppl 1):S264. [DOI: 10.1016/j.hlc.2013.05.630]ThakkarJ , RedfernJ , ThiagalingamA , ChowCK . Patterns, predictors and effects of texting intervention on physical activity in CHD – insights from the TEXT ME randomized clinical trial. European Journal of Preventive Cardiology2016;23(17):1894-902. [DOI: 10.1177/2047487316664190]">Chow 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medications‐ ACE inhibitor/ARB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>Categorical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>339</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>66.1%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>354</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>71.8%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>P value was not reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Aspirin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="5" valign="top"> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>339</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90.6%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>354</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>93.8%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>P value was not reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Beta‐blocker</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>338</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>64.5%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>354</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>63.0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>P value was not reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Statin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>339</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>91.7%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>354</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92.9%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>P value was not reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>At least 3 of the 4 medications (ACE inhibitor/ARB, aspirin, beta‐blocker, and statin)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>338</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>78.1%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>354</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>83.1%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.94, 95% CI 0.87 to 1.01; P = 0.10</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All 4 medications (ACE inhibitor/ARB, aspirin, beta‐blocker, and statin)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>338</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39.3%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42.1%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>354</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.93, 95% CI 0.78 to 1.12; P = 0.46</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><a href="./references#CD011851-bbs2-0005" title="ACTRN12613000793718. TEXT messages to improve MEDication adherence &amp; Secondary prevention – TEXTMEDS [TEXT messages to improve MEDication adherence &amp; Secondary prevention in patients with acute coronary syndrome - TEXTMEDS]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364448&amp;isReview=true (first received 18 June 2013). ChowCK , KlimisH , ThiagalingamA , RedfernJ , HillisGS , BriegerD , et al. Text messages to improve medication adherence and secondary prevention after acute coronary syndrome: the TEXTMEDS randomized clinical trial. Circulation2022;145(19):1443-55. [DOI: 10.1161/CIRCULATIONAHA.121.056161]ChowCK , ThiagalingamA , SantoK , KokC , ThakkarJ , StepienS , et al. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol. BMJ Open2018;8:e019463. [DOI: 10.1136/bmjopen-2017-019463]">Chow 2022</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of participants with proportion of days covered &gt; 80% for 5 medications at both 6 and 12 months </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>Categorical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>697</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50.4%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>682</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>54.3%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No difference in adherence to all recommended medications at 6 and 12 months between the intervention and control groups (RR 0.93, 95% CI 0.84 to 1.03, P = 0.15) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adherence to Aspirin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>671</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96.3%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>638</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96.1%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.00, 95% CI 0.98 to 1.02; P = 0.86</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Beta‐blocker</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>613</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>84.2%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>581</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>83.6%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.01, 95% CI 0.96 to 1.06; P = 0.80</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ACE inhibitor/ARB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>636</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>76.9%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>621</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80.2%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.96, 95% CI 0.90 to 1.02; P = 0.15</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Statin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>668</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>94.6%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>655</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>95.3%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.99, 95% CI 0.97 to 1.02; P = 0.59</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Antiplatelet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>636</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>83.6%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>632</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>84.3%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.99, 95% CI 0.95 to 1.04; P = 0.74</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011851-bbs2-0006" title="ACTRN12613000901707. Text4Heart: a text message and internet-based comprehensive cardiac rehabilitation intervention [A randomised controlled trial to determine the efficacy of a text message and Internet-based comprehensive cardiac rehabilitation programme to improve adherence to lifestyle change compared with usual care in New Zealand adults with a diagnosis of cardiovascular disease]. anzctr.org.au/ACTRN12613000901707.aspx (first received 9 August 2013). DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Improving coronary heart disease self-management using mobile technologies (Text4Heart): a randomised controlled trial protocol. Trials2014;15(71):1-9. [DOI: 10.1186/1745-6215-15-71]DaleLP , WhittakerR , JiangY , StewartR , RollestonA , MaddisonR . Text message and internet support for coronary heart disease self-management: results from the Text4Heart randomized controlled trial. Journal of Medical Internet Research2015;17(10):e237. [DOI: 10.2196/jmir.4944]">Dale 2015a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication adherence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8‐item Morisky Medication Adherence Questionnaire (high score indicates better adherence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Continuous</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean (SD) = 7.3 (0.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean (SD) = 6.8 (1.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The intervention group reported greater medication adherence score than the control group (mean difference 0.58, 95% CI 0.19 to 0.97; P = 0.004). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011851-bbs2-0007" title="FangR , LiX . Electronic messaging support service programs improve adherence to lipid-lowering therapy among outpatients with coronary artery disease: an exploratory randomised control study. Journal of Clinical Nursing2016;25(5-6):664-71. [DOI: 10.1111/jocn.12988]">Fang 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication adherence ‐ statin prescriptions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4‐item Morisky Medication Adherence Scale (high score indicates worse adherence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Continuous</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>93</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants in the SMS group had better adherence than those in the phone group (OR 0.34, 95% CI 0.18 to 0.63). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD011851-bbs2-0008" title="HuoX , KrumholzHM , BaiX , SpatzES , DingQ , HorakP , et al. Effects of mobile text messaging on glycemic control in patients with coronary heart disease and diabetes mellitus: a randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(9):e005805. [DOI: 10.1161/CIRCOUTCOMES.119.005805]NCT02883842. Cardiovascular Health and Text Messaging-Diabetes Mellitus (CHAT-DM) Study [Effectiveness of text messaging on risk factors control and medication adherence among patients with Coronary Heart Disease and Diabetes in China: cardiovascular health andtext messaging-Diabetes Mellitus (CHAT-DM) study]. clinicaltrials.gov/ct2/show/NCT02883842 (first received 30 August 2016). ">Huo 2019</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication ‐ ACE inhibitor/ARB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p>Categorical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p>251</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p>251</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42.6%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was no difference in the proportion of participants who took ACE inhibitor/ARB (P = 0.32). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication ‐ aspirin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>86.5%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>87.7%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was no difference in the proportion of participants who took aspirin (P = 0.69).</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication ‐ beta‐blocker</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>62.2%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58.2%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was no difference in the proportion of participants who took beta‐blocker (P = 0.36). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication ‐ statin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>84.1%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>87.3%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was no difference in the proportion of participants who took statin (P = 0.31).</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication ‐ all 4 cardioprotective medications</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30.7%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23.9%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was no difference in the proportion of participants who took all 4 cardioprotective medications (P = 0.089). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication ‐ insulin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10.8%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.9%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was no difference in the proportion of participants who took insulin (P = 0.28).</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication ‐ oral antidiabetic medication</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>43%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44.6%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was no difference in the proportion of participants who took oral antidiabetic medication (P = 0.72). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011851-bbs2-0009" title="KamalAK , ShaikQN , PashaO , AzamI , IslamM , MemonAA , et al. Improving medication adherence in stroke patients through Short Text Messages (SMS4Stroke)-study protocol for a randomized, controlled trial. BMC Neurology2015;15:157. [DOI: 10.1186/s12883-015-0413-2]KamalAK , ShaikhQ , PashaO , AzamI , IslamM , MemonAA , et al. A randomized controlled behavioral intervention trial to improve medication adherence in adult stroke patients with prescription tailored short messaging service (SMS)-SMS4Stroke study. BMC Neurolology2015;15:212. [DOI: 10.1186/s12883-015-0471-5]">Kamal 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication adherence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Morisky Medication Adherence Scale (high score indicates better adherence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Continuous</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean (SD) = 7.4 (0.93)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean (SD) = 6.7 (1.32)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adjusted mean difference 0.54, 95% CI 0.22 to 0.85</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011851-bbs2-0010" title="KhonsariS , SubramanianP , ChinnaK , LatifLA , LingLW , GholamiO . Effect of a reminder system using an automated short message service on medication adherence following acute coronary syndrome. European Journal of Cardiovascular Nursing2015;14(2):170-9. [DOI: 10.1177/1474515114521910]">Khonsari 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication adherence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8‐item Morisky Medication Adherence Scale (high score indicates better adherence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Categorical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High adherence = 64.5%; medium adherence = 19.4%; low adherence = 16.1%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High adherence = 12.9%; medium adherence = 29%; low adherence = 58.1%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The risk of being low‐adherent amongst the control group was 4.09 times greater than in the intervention group (RR 4.09, 95% CI 1.82 to 9.18). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="8" valign="top"> <p><a href="./references#CD011851-bbs2-0011" title="ACTRN12616000422426. Text4Heart Partnership: a text messaging program to enhance self-management of cardiovascular disease [Text messaging to enhance self-management of cardiovascular disease]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12616000422426 (first received 23 March 2016). MaddisonR , JiangY , StewartR , ScottT , KerrA , WhittakerR , et al. An intervention to improve medication adherence in people with heart disease (Text4HeartII): randomized controlled trial. JMIR mHealth and uHealth2021;9(6):e24952. [DOI: 10.2196/24952]MaddisonR , StewartR , DoughtyR , ScottT , KerrA , BenatarJ , et al. Text4Heart II - improving medication adherence in people with heart disease: a study protocol for a randomized controlled trial. Trials2018;19(1):70. [DOI: 10.1186/s13063-018-2468-z]">Maddison 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication adherence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8‐item Morisky Medication Adherence Scale (High score indicates worse adherence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Continuous</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>153</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>153</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adjusted mean difference 0.30, 95% CI 0.01 to 0.59; P = 0.04</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication adherence ‐ aspirin + statin + blood pressure‐lowering drug (ACE inhibitor, ARB, beta‐blocker) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p>Medication possession ratio by linking community pharmacy dispensing records via the National Pharmaceuticals Collection database </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p>Categorical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p>12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>54.2%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>104</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>67.9%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adjusted OR 0.56, 95% CI 0.35 to 0.89; P = 0.01</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication adherence ‐ aspirin + statin + beta‐blocker + ACE inhibitor/ARB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>36.6%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45.7%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adjusted OR 0.68, 95% CI 0.43 to 1.08; P = 0.11</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication adherence ‐ statin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>119</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>77.7%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>84.3%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adjusted OR 0.65, 95% CI 0.36 to 1.16; P = 0.15</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication adherence ‐ aspirin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>119</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>77.7%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>123</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80.3%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adjusted OR 0.85, 95% CI 0.49 to 1.49; P = 0.58</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication adherence ‐ beta‐blocker</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58.1%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>66.6%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adjusted OR 0.69, 95% CI 0.43 to 1.11; P = 0.13</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication adherence ‐ ACE inhibitor/ARB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>63.4%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>123</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80.3%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adjusted OR 0.42, 95% CI 0.25 to 0.71; P = 0.001</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication adherence ‐ blood pressure‐lowering drugs (ACE inhibitor/ARB and/or beta‐blocker)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>113</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>73.8%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>139</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90.8%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adjusted OR 0.28, 95% CI 0.15 to 0.55; P &lt; 0.001</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011851-bbs2-0012" title="NCT02793830. A mobile phone based medication reminder program [A mobile phone based medication reminder program for patients in China with coronary heart disease: a pilot study]. clinicaltrials.gov/ct2/show/NCT02793830 (first received 8 June 2016). NiZ , WuB , YangQ , YanLL , LiuC , ShawRJ . An mHealth intervention to improve medication adherence and health outcomes among patients with coronary heart disease: randomized controlled trial. Journal of Medical Internet Research2022;24(3):e27202. [DOI: 10.2196/27202]">Ni 2022</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication non‐adherence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3‐item, 5‐point Voils Extent Scale (high score indicates worse adherence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Continuous</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean difference (SD) = −1.58 (2.49)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>93</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean difference (SD) = −0.08 (3.15)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean decrease in medication non‐adherence score in the intervention group was greater than the mean decrease in the control group (P &lt; 0.001). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD011851-bbs2-0013" title="NCT02783287. The impact of text messaging on medication adherence and exercise regimen among post-myocardial infarction patients. clinicaltrials.gov/ct2/show/NCT02783287 (first received 26 May 2016). PandeyA , ChoudhryN . An m-health application of daily text messages to address forgetfulness as contributor to non-adherence to medications post-myocardial infarction. Circulation2015;132:A18641. [DOI: 10.1161/circ.132.suppl_3.18641]PandeyA , KrummeAA , PatelT , ChoudhryNK . The impact of text messaging on medication adherence and exercise among postmyocardial infarction patients: randomized controlled pilot trial. JMIR mHealth and uHealth2017;5(8):e110. [DOI: 10.2196/mhealth.7144]PandeyAK , ChoudhryN . Text message reminders to address medication non-adherence in post-MI patients: a one year intervention study. Canadian Journal of Cardiology2014;30(10):S179. [DOI: 10.1016/j.cjca.2014.07.280]">Pandey 2017</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Average percentage of days covered during 12 months' follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Logbooks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Categorical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>94% (95% CI 92 to 96)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80% (95% CI 73 to 86)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean difference in percentage of days covered between groups was 14% (95% CI 7 to 21, P &lt; 0.001). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of participants with proportion of days covered &gt; 80% over the 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All intervention group participants were optimally adherent to their prescribed medications during follow‐up compared with 50% (8/16) of control group participants (P &lt; 0.001). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD011851-bbs2-0014" title="ParkLG , Howie-EsquivelJ , ChungM , DracupK . A text messaging intervention improves medication adherence for patients with coronary heart disease: a randomized controlled trial. Circulation2013;128(Suppl 22):A15249. [DOI: 10.1161/circ.128.suppl_22.A15249]ParkLG , Howie-EsquivelJ , ChungML , DracupK . A text messaging intervention to promote medication adherence for patients with coronary heart disease: a randomized controlled trial. Patient Education and Counseling2014;94(2):261-8. [DOI: 10.1016/j.pec.2013.10.027]ParkLG , Howie-EsquivelJ , WhooleyMA , DracupK . Psychosocial factors and medication adherence among patients with coronary heart disease: a text messaging intervention. European Journal of Cardiovascular Nursing2015;14(3):264-73. [DOI: 10.1177/1474515114537024]">Park 2014a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication adherence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Morisky Medication Adherence Scale (high score indicates better adherence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Continuous</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean (SD) = 6.43 (1.22)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean (SD) = 6.96 (1.44)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No difference was found between groups over time (P = 0.16).</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication adherence ‐ antiplatelets</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Medication event monitoring system (MEMS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Continuous</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1 month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean doses taken: 28.2 (3.6)</p> <p>Per cent doses taken: 93.7 (11.9)</p> <p>Per cent correct number doses: 88.0 (14.0)</p> <p>Per cent doses taken on schedule: 86.2 (15.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean doses taken: 23.7 (8.3)</p> <p>Per cent doses taken: 79.1 (27.7)</p> <p>Per cent correct number doses: 72.4 (27.4)</p> <p>Per cent doses taken on schedule: 69.0 (29.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants who received text messages for antiplatelets had a higher percentage of correct doses taken (P = 0.02), percentage number of doses taken (P = 0.01), and percentage of prescribed doses taken on schedule (P = 0.01). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication adherence ‐ statins</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean doses taken: 27.7 (4.2)</p> <p>Per cent doses taken: 92.4 (14)</p> <p>Per cent correct number doses: 85.4 (16.6)</p> <p>Per cent doses taken on schedule: 84.1 (19.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean doses taken: 25 (6.4)</p> <p>Per cent doses taken: 83.3 (21.3)</p> <p>Per cent correct number doses: 73.4 (23.8)</p> <p>Per cent doses taken on schedule: 74.4 (21.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No difference between groups for statin medication</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011851-bbs2-0015" title="NCT03414190. Impact of text messages to promote secondary prevention after acute coronary syndrome [Impact of a mobile phone text messages intervention on the secondary prevention of cardiovascular events after acute coronary syndrome]. clinicaltrials.gov/show/NCT03414190 (first received 29 January 2018). PassagliaLG , BrantLC , NascimentoBR , RibeiroAL . Impact of text messages in a middle-income country to promote secondary prevention after acute coronary syndrome (IMPACS): a randomized trial. Medicine2019;98(22):e15681. [DOI: 10.1097/MD.0000000000015681]PassagliaLG , BrantLC , SilvaJL , NascimentoBR , RibeiroAL . Text messages to promote secondary prevention after acute coronary syndrome (IMPACS trial). International Journal of Cardiovascular Sciences2021;35(2):202-13. [DOI: 10.36660/ijcs.20200378]">Passaglia 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication adherence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Treatment Adherence Measure (MAT) form (high score indicates better adherence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Categorical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>93.1%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 0.55, 95% CI 0.17 to 1.72; P = 0.30</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD011851-bbs2-0016" title="QuiliciJ , FugonL , BeguinS , MorangePE , BonnetJL , AlessiMC , et al. Effect of motivational mobile phone short message service on aspirin adherence after coronary stenting for acute coronary syndrome. International Journal of Cardiology2013;168(1):568-9. [DOI: 10.1016/j.ijcard.2013.01.252]">Quilici 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of participants with good medication adherence ‐aspirin (good adherence was defined as taking &gt; 95% of prescribed doses in the past 30 days) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Categorical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>250</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>97.2%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>249</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92.8%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intervention improved self‐reported aspirin adherence (OR 0.37, 95% CI 0.15 to 0.90; P = 0.02). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication adherence ‐ aspirin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Platelet function testing</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Categorical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>250</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>94.8%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>249</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88.8%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Controlled non‐adherent patients accounted for 11.2% of the standard care group versus 5.2% in the SMS intervention group (OR 0.43, 95% CI 0.22 to 0.86; P = 0.01). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD011851-bbs2-0017" title="NCT02336919. The use of texting messaging to improve the hospital-to-community transition period in cardiovascular disease patients (Txt2Prevent) [The use of texting messaging to improve the hospital-to-community transition and prevent readmission in patients with cardiovascular disease (Txt2Prevent)]. clinicaltrials.gov/ct2/show/NCT02336919 (first received 13 January 2015). RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of SMS text messaging to improve the hospital-to-community transition in patients with acute coronary syndrome (Txt2Prevent): results from a pilot randomized controlled trial. JMIR mHealth and uHealth2021;9(5):e24530. [DOI: 10.2196/24530]RossES , SakakibaraBM , MackayMH , WhitehurstDG , SingerJ , TomaM , et al. The use of text messaging to improve the hospital-to-community transition in acute coronary syndrome patients (Txt2Prevent): intervention development and pilot randomized controlled trial protocol. JMIR Research Protocols2017;6(5):e91. [DOI: 10.2196/resprot.6968]">Ross 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication adherence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>8‐item Morisky Medication Adherence Scale (high score indicates better adherence)</p> <p>Low adherence (&lt; 6), medium adherence (6 to 7), or high adherence (8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Continuous</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean (95% CI) = 6.75 (6.34 to 7.16)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean (95% CI) = 7.05 (6.72 to 7.38)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean difference −0.30, 95% CI −0.83 to 0.23; P = 0.27</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of high medication adherence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Categorical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>34%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>"When categorized into low, medium, and high adherence, 34% (11/32) of those in the Txt2Prevent group and 42% (15/36) of those in the usual care group were classified as high‐adherers (χ2 2=2.10, <i>P</i>=.35)." </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><a href="./references#CD011851-bbs2-0018" title="HuoX , SpatzES , DingQ , HorakP , ZhengX , MastersC , et al. Design and rationale of the Cardiovascular Health and Text Messaging (CHAT) study and the CHAT-Diabetes Mellitus (CHAT-DM) study: two randomised controlled trials of text messaging to improve secondary prevention for coronary heart disease and diabetes. BMJ Open2017;7(12):e018302. [DOI: 10.1136/bmjopen-2017-018302]ZhengX , SpatzES , BaiX , HuoX , DingQ , HorakP , et al. Effect of text messaging on risk factor management in patients with coronary heart disease: the CHAT randomized clinical trial. Circulation Cardiovascular Quality and Outcomes2019;12(4):e005616. [DOI: 10.1161/CIRCOUTCOMES.119.005616]">Zheng 2019</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication ‐ ACE inhibitor/ARB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p>Categorical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p>411</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40.9%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p>411</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>46.2%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.96, 95% CI 0.9 to 1.1; P = 0.35</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication ‐ aspirin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90.8%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.00, 95% CI 0.97 to 1.02; P = 0.78</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication ‐ beta‐blocker</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58.2%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>64%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.00, 95% CI 0.95 to 1.1; P = 0.76</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication ‐ statin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>85.4%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>85.2%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.01, 95% CI 0.96 to 1.05; P = 0.78</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication ‐ calcium channel blocker</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17.5%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19.7%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.98, 95% CI 0.8 to 1.2; P = 0.83</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication ‐ diuretics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.2%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.9%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.20, 95% CI 0.7 to 2.1; P = 0.60</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medication ‐ aspirin + statin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>81.3%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80.3%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.00, 95% CI 0.95 to 1.05; P = 0.99</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="10"> <div class="table-footnote"> <p>ACE: angiotensin‐converting enzyme; ARB: angiotensin II receptor blockers; CI: confidence interval; IQR: interquartile range; OR: odds ratio; RR: risk ratio; SD: standard deviation; SMS: short message service </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Overview of the trial results for medication adherence</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/full#CD011851-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011851-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Text messaging versus usual care</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Fatal cardiovascular events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1654</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.47, 1.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Fatal cardiovascular events: sensitivity analysis using fixed‐effect model <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1654</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.47, 1.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Low‐density lipoprotein cholesterol <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4983</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.79 [‐4.71, 1.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Low‐density lipoprotein cholesterol: sensitivity analysis using fixed‐effect model <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4983</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.76 [‐3.49, ‐0.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 Low‐density lipoprotein cholesterol: sensitivity analysis excluding studies with high risk of bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1872</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.60 [‐8.02, 4.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.6 Systolic blood pressure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5173</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.93 [‐3.55, 1.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.7 Systolic blood pressure: sensitivity analysis using fixed‐effect model <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5173</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.39 [‐2.27, ‐0.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.8 Systolic blood pressure: sensitivity of analysis excluding studies with high risk of bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2062</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.13 [‐2.28, 2.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.9 Systolic blood pressure: sensitivity analysis excluding outlier <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4463</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.04 [‐1.26, 1.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.10 Diastolic blood pressure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3137</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.00 [‐2.49, 0.50]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.11 Diastolic blood pressure: sensitivity analysis using fixed‐effect model <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3137</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.91 [‐1.63, ‐0.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.12 Diastolic blood pressure: sensitivity analysis excluding studies with high risk of bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1335</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [‐0.96, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.13 Heart rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2946</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.46 [‐1.74, 0.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.14 Heart rate: sensitivity analysis using fixed‐effect model <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2946</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.57 [‐1.34, 0.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.15 Heart rate: sensitivity analysis excluding studies with high risk of bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Text messaging versus usual care</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011851.pub3/references#CD011851-tbl-0004">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD011851.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD011851-note-0007">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD011851-note-0016">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD011851-note-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD011851-note-0014">Français</a> </li> <li class="section-language"> <a class="" href="id#CD011851-note-0012">Bahasa Indonesia</a> </li> <li class="section-language"> <a class="" href="ko#CD011851-note-0010">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD011851-note-0011">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD011851-note-0015">Polski</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD011851-note-0008">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD011851-note-0009">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011851\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011851\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011851\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011851\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011851\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011851\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011851\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011851\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011851\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011851\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011851\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011851\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011851\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011851\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011851\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011851\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011851\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011851\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=UiM8QuvV&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011851.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011851.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD011851.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD011851.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011851.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740718941874"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011851.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740718941878"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011851.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ddca12bff1be5',t:'MTc0MDcxODk0Mi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 